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Abstract 
At mitosis, chromosomes must be accurately partitioned between the two newly 
forming daughter cells. To ensure that no vital genetic information is lost, this must 
happen with the utmost accuracy and to this end the process is controlled and 
monitored by a mechanism known as the spindle assembly checkpoint. This 
mechanism is highly conserved throughout eukaryotes. The proteins of this 
checkpoint are located at the kinetochore, a proteinaceous structure that overlies the 
centromeric DNA. The checkpoint functions by sensing attachment and/or tension of 
the microtubules at the kinetochore and halting the progression of the cell cycle. This 
is achieved by inhibiting the anaphase promoting complex, an E3 ubiquitin ligase 
that triggers the onset of anaphase by targeting key proteins for degrading. 
One such checkpoint protein localised to the kinetochore in vertebrate cells is 
BubR 1. I have cloned the chicken BubRi cDNA and raised antibodies to the protein. 
The protein is highly conserved when compared to other vertebrate BubRis with 
55% identity and 70% similarity to human. The antibody recognises a protein of 
approximately 150 kDa and stains the kinetochores of chicken cells during 
prometaphase with the signal disappearing as they become attached to microtubules, 
a localisation typical of spindle checkpoint proteins. In order to further characterise 
the function of this protein in vertebrates, I have attempted to generate a chicken 
DT40 cell line conditionally null for BubRi. I have successfully targeted one allele 
of the BubRi locus in DT40 cells. BubRi (+/-) cells grow normally and have an 
intact checkpoint. Since I expect BubRi to be essential, the gene must be expressed 
under the control of the tetracycline operator in the heterozygote cells. Attempts to 
target the second allele have failed thus far, although the expected targeting 
frequency is 1/20 clones. It appears that expression of exogenous BubRi is 
detrimental to these cells and they shut off expression when possible. It seems that 
expression levels of this essential checkpoint component are critical to avoid 
problems within the cell. 
In addition to this study in chicken cells I have cloned two other vertebrate 
checkpoint components from Xenopus laevis. The proteins ZwlO and Rod were 
initially identified in Drosophila and since no homologues have been identified in 
yeast these are considered as metazoan-specific components of the spindle assembly 
checkpoint. In order to study the checkpoint and the kinetochore, I have cloned 
partial Xenopus cDNA for ZwlO and Rod and raised antibodies to these proteins. 
ZwlO is localised to the kinetochores of metaphase Xenopus cells and along with 
Rod is present in a complex of approximately ilS in Xenopus egg extracts. The 
cloning and generation of antibodies to these proteins in Xenopus will hopefully be 





For the continuation of life, be it multiplication of a single celled organism, 
development of a fertilised embryo or regeneration of a tissue, cells must accurately 
replicate their DNA and then equally segregate it between the two newly forming 
daughter cells. This process is known as the cell cycle and is controlled by the 
activation or inactivation of members of a conserved family of proteins known as 
cyclin-dependant kinases. Various checkpoints are present throughout the cell cycle 
to ensure that mistakes are minimised. The classical definition of a cell cycle 
checkpoint is a point which the cycle cannot proceed beyond until certain criteria 
have been met. In the case of the spindle assembly checkpoint, anaphase cannot 
ensue until all chromosomes are attached in a biorientated fashion and are under 
tension. 
The spindle assembly checkpoint is the mechanism which ensures that the newly 
replicated DNA is segregated accurately between the two new daughter cells. This 
checkpoint is highly conserved and regulated by a number of different proteins that 
form multiple complexes. This checkpoint works by sensing tension and/or 
attachment of microtubules to the kinetochore and sends an inhibitory 'wait 
anaphase' signal to the APC/C (Anaphase Promoting Complex or Cyclosome). The 
APC/C is a multi-subunit complex which targets proteins for ubiquitination and 
hence degradation. Once the spindle assembly checkpoint is satisfied, the APC/C is 
activated. One key event leading to the progression of the cell cycle is the cleavage 
of a molecule called securin, which in turn leads to the activation of separase which 
cleaves Scc 1, a component of the cohesin complex. The cohesin complex is required 
for sister chromatid pairing and holds the chromosomes together, once Sccl is 
cleaved this releases the cohesion at the centromeres allowing the cell to progress 
into anaphase. 
Errors in this checkpoint lead to aberrant segregation, which can lead to aneuploidy. 
At meiosis this can cause birth defects such as Down's Syndrome and at mitosis has 
been implicated in the progression of cancer (tumour progression). 
1.2 Cell cycle progression 
The cell cycle is divided into four phases. 61, S phase where DNA replication 
occurs, G2 and M (mitosis or cell division), GI and G2 are gap phases between 
replication and division. Figure 1.1 shows a schematic representation of the cell 
cycle indicating the changes in the DNA, which occur, and the various checkpoints. 
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Schematic representation of the cell cycle, showing the various stages and the checkpoints. As 
discussed in the text the G I checkpoint or restriction point, DNA damage checkpoint and spindle 
assembly checkpoint are indicated. Diagram adapted from Cell Biology by Pollard and Eamshaw. 
CDK (cyclin dependant kinases) require the binding of a cyclin for activity. In 
addition to the regulation of these kinases by cyclin binding the CDK must also be 
phosphorylated and there are known specific cyclin-CDK inhibitors. More than ten 
cdks, which control various stages of the cell cycle, have been identified in 




a role in both G  to S and G2 to M transition and cdk4 and cdk6 play a role in the 
restriction point. The restriction point is a checkpoint in the GI phase of the cycle, 
which ensures that a cell does not go into replication unless the size and state of the 
cell are appropriate (for review see (Zetterberg et al., 1995; Planas-Silva & 
Weinberg, 1997)). 
There are 16 human cyclins, which although being diverse proteins share a core 
structure. The complex of cyclin and cdk regulates the cell cycle along with many 
other activators and inhibitors which alter the phosphorylation and localisation state 
of these proteins. 
1.3 Chromosome structure 
In order that the DNA can fit into the nucleus of a eukaryotic cell it must condense 
and compact enormously. Estimates for an average human cell are that the 6.6 x 10 
base pairs of DNA, which stretch up to 2 metres must be packaged into the human 
cell nucleus of 5 - 20 Lm in diameter. The precise details of this compaction still 
remain to be fully elucidated. However, it is known that the DNA associates with 
proteins to form a structure known as chromatin. The main proteins involved in the 
compaction of the DNA are the histones. DNA wraps around a complex of histone 
molecules to form a structure known as a nucleosorne, resulting in a 7-fold 
compaction of the naked DNA (Kornberg, 1974). In turn the nucleosomes are 
compacted further to form the 30 nm fibre, which results in a 40 fold shortening. The 
next stage of compaction, and perhaps the highest order of packaging of the 
interphase nucleus, has been identified as a fibre of between 100-300 nm in diameter, 
which has been termed the chromonema fibre. This structure appears to be organised 
into loop domains where specific regions of the DNA may anchor to the 
chromosome scaffold thus forming loops (Marsden & Laemmli, 1979). 
Upon entry into mitosis the chromosomes must condense further in order that they 
can become attached to the apparatus of the mitotic spindle and be segregated. 
During anaphase the chromosomes must move a distance of 5 - 20 gm, and therefore 
must be highly compacted in order that this movement can occur. This condensation 
process begins at prophase before nuclear envelope breakdown. The process of 
condensation is still poorly understood. However, it is clear that a complex known as 
condensin is required for this process. The two most abundant non-histone protein 
r1 
components of the metaphase chromosomes are topoisomerase II and the condensin 
complex. Topoisomerase II is an ATP-dependant DNA strand-passing enzyme. 
Presumably, it is required in abundance on the mitotic chromosomes to help untangle 
the DNA as it is organised into a highly condensed state. The condensin complex 
was initially isolated from Xenopus egg extracts (Hirano & Mitchison, 1994) and is 
composed of five subunits, which are conserved from yeast to humans. This 
complex organises condensation by altering the topology of DNA loops, since it is 
able to introduce positive writhe (Kimura et al., 1999), and positive supercoiling into 
DNA molecules (Kimura & Hirano, 1997; Kimura etal., 2001). The five subunit 
complex is composed of two SMC (Structural Maintenance of Chromosomes, SMC2 
and SMC4) proteins, which form a V-shaped dimer. Each SMC molecule is 
composed of two antiparallel, coiled-coil arms with a flexible hinge. The most recent 
model for the dimerisation is that this is mediated by a hinge-hinge interaction 
between self-folded monomers (Hirano & Hirano, 2002). The SMC components are 
associated with the regulatory subcomplex consisting of three non-SMC proteins 
namely, XCAP-D/Cndl, XCAP-H/Cnd2 and XCAP-G/Cnd3. It is known that the 
interaction between the regulatory subcomplex and the SMC components increases 
the DNA binding and ATPase activity of the complex (Kimura & Hirano, 2000). The 
most recent model proposed by (Bazett-Jones et al., 2002), suggests that the complex 
introduces positive supercoils into the DNA resulting in a compacted structure. It is 
known that condensation is absolutely required for chromosome segregation, since 
yeast mutants in components of this complex fail to segregate their chromosomes 
resulting in a 'cut' phenotype (Saka et al., 1994; Strunnikov et al., 1995: Sutani et 
al., 1999; Freeman et al., 2000). In addition, work in Caenorhabditis elegans has 
shown that the condensin complex is required for chromosome condensation and 
segregation (Hagstrom et al., 2002). Also, a study in DT40 cells shows that the 
condensin subunit SMC2 is required for some lateral condensation of the 
chromosome. However, the main defect is the failure in anaphase (D. Hudson, 
personal communication). This along with other data from Drosophila (Steffensen et 
al., 2001) has led to the hypothesis that condensation is required for overall 
chromosome structure and segregation. 
1.4 Chromosome cohesion and segregation 
Cohesion between sister chromatids is established during replication and this 
cohesion must be reversed in order that the chromosomes can separate at anaphase. 
The complex required to keep sister chromatids together is known as the cohesin 
complex. Like the condensin complex it is composed of SMC and non—SMC 
proteins (Losada etal., 1998; Darwiche etal., 1999). The SMC proteins, SMC1 and 
SMC3, form a V- shaped heterodimer. Each protein is folded back on itself at the 
hinge region and the hinge region is the point of interaction forming a V-shaped 
molecule (Haering etal., 2002). SMC1 and SMC3 interact with Sec 1, which bridges 
the two head domains resulting in the formation of a loop. It has been proposed that 
the replicated DNA may be trapped within this proteinaceous ring (Haering et al., 
2002). This therefore led to a proposed model where the DNA strands are held 
together by topological rather than chemical means. SccI is the protein whose 
cleavage by separase triggers anaphase allowing the chromatids to move apart to the 
spindle poles (Uhlmann et al., 1999; Rao et al., 2001). The dissociation of cohesin 
from the chromosomes occurs in two distinct stages in eukaryotes. The first stage 
occurs during prophase in tandem with the association of the condensin complex 
onto the mitotic chromosomes (Sumara et al., 2000; Waizenegger et al., 2000). At 
this stage, cohesin is lost from the chromosome arms but remains associated at the 
centromere regions. It is known that this dissociation is, at least in part, regulated by 
polo-like kinase (PLK) (Alexandru et al., 2001; Sumara et al., 2002). Cohesin 
remains at the centromere regions until the onset of anaphase. The dissociation is 
prevented by the spindle assembly checkpoint, as discussed previously, until all the 
kinetochores are properly aligned on the metaphase plate with microtubule 
attachments to each pole and under tension. At this time the APC/C is activated 
leading to the degradation of securin (Pdslp) (Cohen-Fix ci al., 1996), which 
releases activated separase (Esplp) (Ciosk et al., 1998), resulting in the cleavage of 
Sccl (Uhlmann etal., 1999) and dissociation of the sister chromatids. 
1.5 Chromosomal Passenger Proteins 
The chromosome passengers are a group of proteins recognised by their distinctive 
localisation during mitosis, whereby they move from the chromosome arms during 
prometaphase to the centromeres and then to the spindle rnidzone during anaphase. 
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This group of proteins consists of three members, namely, INCENP, AuroraB and 
Survivin. 
INCENP was the first of these proteins to be characterised and before any knockout 
study or RNAi an indication of its role came from studies of a deletion mutant, 1-
405. Expression of the deletion mutant results in the mislocalisation of the 
endogenous INCENP and causes defects in chromosome congression, segregation 
and cytokinesis (Mackay et al., 1998). Knocking out INCENP in mouse resulted in 
very early embryonic lethality, with embryos only surviving to the 32 - 64 cell stage 
with defects in cytokinesis and abnormal bundling of microtubules (Cutts et al., 
1999). 
Initial indications in yeast (Kim et al., 1999), which were subsequently confirmed in 
vivo from Xenopus egg extracts, identified a complex formed between INCENP and 
AuroraB kinase (Adams et al., 2000). The Aurora kinases were initially identified in 
yeast (Chan & Botstein, 1993) and subsequently in Drosophila as genes which 
regulate the structure and function of the mitotic spindle (Glover et al., 1995). 
Different organisms have different members of this family of proteins, for example 
three in human, two in Drosophila and C. elegans and only one, Ipli, in yeast. The 
Aurora family of protein kinases are implicated in human cancers with aurora-A 
being amplified in several human cancers and aurora-B and C being overexpressed in 
many human cancer cell lines. 
Survivin is also now known to be a component of the passenger complex in Xenopus 
(Bolton et al., 2002), C. elegans (Kaitna et al., 2000; Speliotes et al., 2000) and 
human (Wheatley et al., 2001). This is a small protein containing a BIR (baculovirus 
lAP repeat) domain. Other known TAP proteins bind and inhibit caspases and 
therefore play a role in apoptosis. Survivin's role, if any, in apoptosis is 
controversial. Its main role appears to be in mitosis. As with the other passengers 
Survivin regulates chromosome movement and spindle events. The function of 
Survivin has been investigated by gene disruption in mouse, this resulted in 
embryonic lethality at day 4.5 with the cells having disrupted microtubule formation 
and becoming polyploid (Uren et al., 2000). INCENP (Slil5), Aurora-B (1p] 1) and 
Survivin (Bin), have been shown to be physically associated in budding yeast 
(Cheeseman etal., 2002). 
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1.6 Centromere/kinetochore 
The centromere is the specialised region of the chromosome where the microtubules 
attach. It is a nucleoprotein structure requiring both DNA and protein to function. 
What constitutes a centromere and how the position is faithfully maintained through 
cell division is still under active investigation, although a growing number of facts 
are now known. The kinetochore is a proteinaceous structure, which is embedded in 
the surface of the centromeric heterochromatin, and more precisely is the region 
where mjcrotubules attach and the movements of the chromosome are directed. 
1.6.1 Centromere Structure 
The centromeric DNA varies in size between different organisms, ranging from just 
125 bp in the yeast Saccharomyces cerevisiae to megabases in humans. The DNA 
sequence of the centromere has been fully characterised in the model organism S. 
cerevisiae, budding yeast, which has 16 chromosomes. A consensus sequence, with 
three DNA elements, has been defined in this organism and these elements are 
referred to as CDEI, CDEII and CDEIII. It seems that these sequences specify 
protein binding sites and that they are sufficient to act as a centromere. This has been 
demonstrated by experiments where the centromere elements have been introduced 
into plasmid DNA which as a result, becomes mitotically stable and segregates as if 
chromosomal. 
In S. cerevisiae a 125 bp region of DNA is sufficient to direct segregation of the 
chromosomes. In stark contrast to this, the structure of the centromere of the yeast, 
Schitzosacchara;nyces pombe, fission yeast, spans a region of 35,000 - 110,00 bp. 
This organism has three chromosomes, which are larger than those of S. cerevisiae. 
In addition, the centromere DNA is strikingly different. In S. pombe the centromeres 
have a central core of 4 - 7 kb of unique sequence, which is flanked by complex 
arrays of repeated sequence. It is also known that the centromeric DNA of this 
organism is heterochromatic since genes in the centromere are repressed (Allshire et 
at., 1995). Investigation of the centromeric DNA sequences has also been carried 
out in higher organisms. In Drosophila nielanogaster the centromeres investigated 
are larger, around 420 kb, and are rich in simple satellite DNA sequences and 
transposable elements (Murphy & Karpen, 1995). No sequences were found to be in 
common with yeast centromeres and interestingly none of the sequence was unique 
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to the centromere region: all sequence found could also be found on the chromosome 
arms of Drosophila. The structure of mammalian centromere DNA has also been 
investigated and is mainly composed of satellite DNA sequences. Satellite DNA is 
composed of repeated copies of short DNA sequences clustered together in head to 
tail arrays. The main constituent of primate centromere DNA is alpha satellite which 
consists of 171 bp monomers organised into high order repeats. Some monomers 
have 17 bp CENP-B boxes contained within them, which function to bind the 
centromeric protein CENP-B. 
1.6.2 Constitutive centromere components 
A number of constitutive centromere proteins have been identified and these appear 
to be conserved throughout eukaryotes. One such protein is CENP-A, which is a 
Histone H3 variant (Shelby et al., 1997). The histones are proteins involved in 
wrapping up the naked DNA into its functional chromatin form. It has been 
discovered that, at centromeres, histone H3 is replaced by CENP-A which 
presumably plays some role in defining the centromeric DNA and allows it to 
function in a specific manner (Vafa & Sullivan, 1997). CENP-A is essential for life 
(Howman et al., 2000), and is required for the targeting of another centromeric 
protein CENP-C. Orthologues of CENP-A have also been found in yeast, S. 
cerevisae and S. pombe and are called CSE4p and spCENP-A/Cenl respectively 
(Meluh etal., 1998; Takahashi etal., 2000). 
Another constitutive centromere protein is CENP-B. This protein is highly conserved 
and binds to specific sequences of DNA known as CENP-B boxes which are present 
in centromeric DNA (Masumoto et al., 1989). The role of CENP-B within the 
centromere is not clearly understood and one striking observation is that mice null 
for CENP-B are viable and have no obvious defects in centromere function (Hudson 
et al., 1998; Kapoor ci' al., 1998; Perez-Castro et al., 1998). Recently, it has been 
shown that both CENP-B boxes and aiphoid DNA sequence are required for de novo 
mammalian artificial chromosome formation (Ohzeki etal., 2002). In addition it has 
been noted that the vertebrate Y chromosome contains little or no CENP-B boxes 
(Kipling & Warburton, 1997), nor does the centromeric DNA of African green 
monkey cells (Goldberg et al., 1996). CENP-B shares homology with a transposable 
element of the pogo superfamily and for many years the link between transposable 
elements and centromeres was unclear. Recent evidence has shown that components 
of the RNAi machinery are somehow involved in centromere function, primarily in 
silencing of the chromatin (Volpe et al., 2002). RNAi or RNA interference is a 
mechanism by which genes are post-transcriptionally silenced in a sequence specific 
manner by double stranded RNA (for review see (Hammond et al., 2001)). It has 
been suggested, from evidence in Drosophila and C.elegans (Ketting et al., 1999; 
Aravin et al., 2001) that RNAi may have evolved in order to immobilise transposable 
elements. This may therefore be a clue towards answering questions as to CENP-B's 
role at the centromere. 
CENP-C, another constitutive centromere component, is a DNA binding protein 
concentrated at the inner plate of the kinetochore. It is known that this protein is 
essential for the viability of vertebrate cells (Fukagawa & Brown, 1997; Kalitsis et 
al., 1998), and is involved in the assembly and functioning of the kinetochore 
(Tomkiel et al., 1994; Fukagawa & Brown, 1997). Like CENP-A, orthologues of 
CENP-C have been identified in yeast, namely mif2 in S. cerevisae (Meeks-Wagner 
et al., 1986; Meluh & Koshland, 1995) and Cnp3 in S. pombe (R. Alishire, Personal 
Communication). 
CENP-G is a protein localised to the inner kinetochore plate which associates with 
alpha- satellite DNA (He et al., 1998). It is known to be associated with 
neocentromeres and the inactive centromere (Gimelli et al., 2000). CENP-G has not 
been cloned and little further is known about it. 
In recent years two other constitutive centromere proteins have been identified, 
namely CENP-H and CENP-I. CENP-H was initially identified in mouse as a 33 
kDa centromere associated protein with a coiled-coil domain (Sugata et al., 1999). 
Subsequently, it has been identified in human (Sugata et al., 2000). It is localised to 
the inner kinetochore plate alongside CENP-A and CENP-C during both interphase 
and mitosis and has been shown to be present at neocentromeres but not at inactive 
centromeres. In addition, CENP-H can bind to itself and to the mitotic centromere 
associated kinesin, MCAK (Sugata et al., 2000). A conditional DT40 knockout of 
CENP-H has been generated and this revealed that the protein is necessary for the 
progression of the cell cycle since null cells arrest at metaphase (Fukagawa et al., 
2001). In addition CENP-H is required for the targeting of CENP-C, but not CENP-
A, to the kinetochore. 
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CENP-I has also been identified as a constitutive centromere component in 
vertebrate cells and, in a manner similar to CENP-H, the function has been analysed 
by the generation of a conditionally null DT40 cell line (Nishihashi et al., 2002). 
CENP-I has homology to the S. pombe centromere protein Mis6 and co-localises 
with CENP-A, CENP-C and CENP-H throughout the cell cycle. As is the case with 
CENP-H, CENP-I is required for the localisation of CENP-C to the kinetochore, but 
not for the localisation of CENP-A. In addition cells lacking CENP-I arrested in 
prometaphase without misaligned chromosomes. It has been shown in S. pombe that 
Mis6 is required for the recruitment of CENP-A to the kinetochore (Takahashi et al., 
2000). 
Recently, Misl2 was identified as a novel kinetochore protein family which is 
conserved from yeast to human and essential for equal chromosome segregation 
(Goshima et al., 2003). The human homologue is localised to a region 
indistinguishable from CENP-A. Depletion of Mis 12 in human cells by RNAi 
resulted in a number of defects including misaligned metaphase chromosomes, 
lagging anaphase chromosomes, and an abnormally long metaphase spindle length 
(Goshima et al., 2003). Table 1.1 summarises the current understanding of the 
constitutive centromere proteins. 
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Table].]. Summary of centromere associated proteins 
Centromere protein Comments and key references 
CENP-A • 	Historic variant (Shelby etal., 1997), which marks and allows the 
formation of a centromere (Vafa & Sullivan, 1997) 
• 	Essential for life and required for targeting of CENP-C (Howman ci 
al.. 2000) 
• 	Found at neocentromeres, active centromeres but not inactive 
centromere (du Sart etal., 1997) 
• 	Inner kinetochore plate protein (Warburton etal., 1997) 
CENP-B • Binds CENP-B boxes (Masurnoto ci al., 1989) 
• 	Significance of this not understood since Y- chromosome (Kipling 
& Warburton, 1997) and African green monkey cells (Goldberg et 
al., 1996) lack them at the centromere 
• 	CENP-B mice are viable (Hudson etal., 1998; Kapoor etal., 1998; 
Perez-Castro etal.. 1998) 
• 	Not found at neocentromeres, but localised to both the active and 
inactive centromere (Earnshaw etal., 1989) 
CENP-C • 	Inner kinetochore protein required for assembly and function 
(Tonikiel et al., 1994) 
• 	Essential for viability (Fukagawa & Brown, 1997; Kalitsis etal., 
1998) 
• 	Found at neocentromeres, active centromeres but not inactive 
centromere_(Earnshaw_etal.._1989) 
CENP-E • 	Kinesin like motor protein (Yen et al., 1992; Wood etal., 1997) 
• Not a constitutive centromere protein, but localised to the 
kinetochore during prometaphase (Yen et al., 199 1) 
• 	Plays a role in the spindle assembly checkpoint in vertebrates 
(Ahrieu_eral.,_2000) 
CENP-F • 	400 kDa outer kinetochore protein (Rattner eral., 1993) 
• Not a constitutive centromere protein, but localised to the 
kinetochore from prophase to anaphase (Liao etal., 1995) 
• 	Modified 	 (Hussein 	Taylor, _by_fariiesylation_ 	_&_ _2002) 
CENP-G • A constitutive inner kinetochore plate protein (He eral., 1998) 
• 	Associates with neocentromeres and inactive centromeres (Gimelli 
ci al., 2000) 
CENP-H • 	Inner kinetochore plate protein which interacts with MCAK (Sugata 
ci al., 2000) 
• 	Required for cell cycle progression and targeting of CENP-C, but 
not CENP-A to the kinctochore (Fukagawa ci al., 2001) 
• 	Present at the active centromere only (Sugata ci al., 2000) 
CENP-1 • S. cerevisae Mis6 hornologue 
• 	Inner kinetochore plate protein required for cell cycle progression 
and targeting of CENP-C, but not CENP-A to the kinetochore 
(Nishihashi ci al., 2002) 
• 	Required for CENP-A targeting In S. pombe (Takahashi ci al., 
2000) 
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It is becoming increasingly obvious that the position and heritability of the 
centromere is regulated in an epigenetic manner i.e. not totally controlled by the 
DNA sequence. The study of neocentromeres and dicentric chromosomes has been 
particularly useful in defining what is required to make a functional centromere. A 
neocentromere can form de novo on a chromosome at a site which is not normally 
centromeric in terms of the DNA sequence. The best studied neocentromere is 
mardel (10), which can recruit the appropriate proteins and function as a centromere 
(Voullaire et al., 1993). The sequence of this neocentromere has been investigated 
and found to be identical to normal chromosome 10 (du Sart et al., 1997; Lo et al., 
2001), indicating that the sequence does not define centromere function. It is 
interesting to note that the constitutive centromere proteins CENP-A and CENP-C 
are localised to neocentromeres, but CENP-B is not, presumably due to the lack of 
CENP-B boxes. 
In nature, dicentric chromosomes also occur by chromosome rearrangement. 
However, for the chromosome to be mitotically stable, one of these centromeres 
must be inactivated and cannot function. It is known that CENP-A and CENP-C 
(Earnshaw et al., 1989; Sullivan & Schwartz, 1995) are found only at the active 
centromere, whereas CENP-B is found at both (Earnshaw et al., 1989), again putting 
into question the role of CENP-B at the centromere. The study of neocentromeres 
and artificial centromeres has increased the knowledge about centromeres but still it 
remains to be answered what truly defines a centromere. It is clearly some 
combination of the centromeric sequence and proteins associated and recruited in the 
normal situation. However, in the aberrant situation of a neocentromere, the proteins 
are enough to define the centromere and this in turn can be inherited. 
The kinetochore is a proteinaceous structure which lies above the centromeric DNA. 
The structure of the kinetochore has been studied in vertebrate cells where it is 
described as a trilaminar plate (Brinkley & Stubblefield, 1966; Jokelainen, 1967; 
McEwen et at., 1998) with three domains where different proteins are localised 
(Figure 1.3). The regions are the inner plate, where DNA associated proteins such as 
CENP-A and CENP-B can be found; the outer plate, where checkpoint molecules 
such as BubRI are located; and the fibrous corona, where motor proteins such as 
CENP-E reside. In addition to these locations, a new domain has been described with 








tension sensing ? 
the fibrous corona (H. Maiato, personal communication). The function of the 
kinetochore is two fold, firstly as the specific site of attachment of the microtubules 
to the chromosome and, secondly as the location of checkpoint proteins which assess 
the attachment and tension of the microtubules. The relationship between the 
centromere and the kinetochore is illustrated in Figure 1.2. The localisation of a 
number of kinetochore associated proteins is indicated. 
Figure 1.2. Relationship between centroniere and kin etochore. 
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Schematic representation of the kinetochore indicating the various zones and the localisation of some 
kinetochore-associated proteins. (Diagram from W. C. Earnshaw). 
Figure 1.3 shows the trilaminar plate structure of the kinetochore as identified by 
electron microscopy. 
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Diagram showing the structure of the kinetochore in relation to the electron microscopy images. 
Diagram adapted from Cell Biology by Pollard and Eamshaw. 
1.7 Spindle assembly 
The mitotic spindle is required to pull the chromosomes to opposite poles of the cell 
during anaphase. It is nucleated from the centrosome or microtubule organising 
centre (MTOC), referred to as the spindle pole body in yeast. The spindle also plays 
a role in determining the position and orientation of the cleavage furrow and 
regulating exit from mitosis (Khodjakov & Rieder. 2001: Pie] & Bornens. 2001). The 
centrosome is a complex structure composed of a number of different proteins. Each 
centrosome is assembled around two barrel shaped centrioles. The centrioles 
themselves are composed of 9 triplets of short microtubules that are embedded in the 
pericentriolar matrix (PCM) (Dutcher. 2001). The PCM contains the y-tubulin ring 
complex (y-TURC), which is essential for nucleation of the microtubules (Bobinnec 
et al.. 1998). The centrosome must be replicated before cell division occurs. As in 
the case of DNA replication, centrosome duplication occurs in a semi-conservative 
manner. A number of processes constitute the centrosome cycle, namely, 
duplication, maturation, separation and disorientation. These processes are regulated 
by phosphorylation and proteolysis of key cell cycle regulators such as cdk2/cyclinE 
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(Lacey et al., 1999; Hinchcliffe & Sluder, 2002). In addition to the centrosomes' 
role in nucleating and organising the mitotic spindle, it is known to play a key role in 
the regulation of cell cycle progression. This was defined by experiments where the 
centrosome of vertebrate cells was destroyed by laser ablation (Khodjakov et al., 
2000). Surprisingly cells with one or no functional centrosomes were able to form a 
bipolar spindle and progress through mitosis presumably by a centrosome 
independent pathway. Subsequently, it was shown that these cells had a higher 
failure rate in cytokinesis and did not enter a subsequent S phase (Khodjakov & 
Rieder. 2001). Similar experiments in African green monkey cells where the 
centrosornes were inicrosurgically removed also resulted in cells entering and 
completing mitosis, however, they were unable to enter the next S phase, these 
experiments lead to the conclusion that there are components of the centrosome not 
needed for the progression from G2 to M, but essential for the G 1 to S transition 
(Hinchcliffe et al., 2001). It is hardly surprising, therefore, that centrosome 
amplification can lead to chromosome instability and in turn to tumour development 
(Reviewed by (DAssoro etal., 2002)). 
1.8 Spindle assembly checkpoint 
The spindle assembly checkpoint is active when a kinetochore is either unattached or 
not under tension and sends a signal to inhibit the APC/C, preventing it from 
degrading key cell cycle regulators such as cyclin B and securin. This highly 
sensitive checkpoint requires a number of proteins, which form multiple complexes, 
in order to sense and transmit the 'wait anaphase' signal. Figure 1.4 shows an 
overview of the checkpoint indicating that anaphase onset is blocked by the 
inactivation of the APC. A vast body of literature now exists exploring the 
checkpoint in many different organisms. Since the spindle assembly checkpoint is 
the main subject of this thesis the components and mechanisms will be discussed in 
some detail. 
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Figure 1.4 Overview of spindle assembly checkpoint activation 
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Figure 1.4 Spindle assembly checkpoint inhibits the metaphase to anaphase transition. The metaphase to anaphase 
transition is blocked by activation of the spindle assembly checkpoint when one or more kinetochores are unattached or not 
under tension. The checkpoint proteins BubRi and Mad2 sequester cdc20 and prevent activation of the APC/C. Once all 
kinetochores are attached or under tension the checkpoint is somehow inactivated and cdc20 is released. This results in 
activation of the APC/C. Securin, which normally binds and inactivates separase is targeted for destruction by the APC/C. 
Active separase cleaves Seel, a subunit of the cohesin complex, cohesion is lost and the chromatids move apart. 	17 
Components of the spindle assembly checkpoint were initially identified as budding 
yeast mutants which failed to arrest in the presence of spindle damage. These were 
classed as either Mad (Mitotic Arrest Deficient) (Li & Murray, 1991), or Bub 
(Budding uninhibited by benzimidazole) mutants (Hoyt etal., 1991). Initially Mad 1, 
2 and 3 and Bubi, 2 and 3 were identified. Subsequently, Mpslp has been identified 
as an additional component of the checkpoint in yeast (Weiss & Winey, 1996) and 
vertebrates (Abrieu et al., 2001) and Bub2 has been redefined as having a role in 
mitotic exit (Fesquet et al., 1999; Fraschini etal., 1999; Li, 1999). 
The sensitivity of the spindle checkpoint and specifically the role of the kinetochore 
in generating the signal to block anaphase onset was described in a series of 
groundbreaking experiments, which showed that a single unattached kinetochore was 
sufficient to activate the checkpoint and prevent the cells from proceeding into 
anaphase (Rieder et al., 1994). Using laser irradiation to destroy the kinetochore on 
the last mono-orientated chromosome, Rieder and colleagues showed that this 
relieved the checkpoint and cells entered anaphase (Rieder et al., 1995). This work 
showed that the signal to delay the cell cycle is generated by the kinetochore and 
once the kinetochore was destroyed the cell reacted as if the checkpoint had been 
satisfied. 
The fact that the spindle checkpoint senses both attachment of microtubules and 
tension across the kinetochore was investigated in the spermitids of praying mantis. 
In this experiment, tension was applied to an improperly attached kinetochore using 
a micromanipulation needle. In a manner similar to the laser ablation studies, this 
tension, artificially applied, resulted in the cell proceeding into anaphase as though 
the checkpoint had been satisfied (Li & Nickjas, 1995). Further evidence of a tension 
sensing mechanism was established by the observation that the phosphoepitope 
specific monoclonal antibody 3F3/2 preferentially stains kinetochores that are not 
under tension (Gorbsky & Ricketts, 1993). When this antibody was microinjected 
into cells it caused a delay in the metaphase to anaphase transition (Campbell & 
Gorbsky, 1995). This has been further investigated by experiments in grasshopper 
spermatocytes where the kinetochore attachment was disrupted using a microneedle. 
This resulted in 3F3/2 staining at the kinetochores, which remained until the 
kinetochores were brought artificially under tension (Nicklas et al., 1995). This 
knowledge that the checkpoint signal was generated by the kinetochore and that this 
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signal was related to the tension generated by microtubule attachment to the 
kinetochore laid the groundwork for more detailed studies of the proteins and 
complexes involved, as discussed below. 
1.8.1 Bubi 
Cloning and identification of budding yeast Bubi revealed that it is a kinase able to 
autophosphorylate and phosphorylate Bub3 in vitro (Roberts et al., 1994), and 
interact physically with Bub3. Subsequently, vertebrate homologues of this 
checkpoint protein were identified (Pangilinan et al., 1997) and in particular the 
mouse protein was studied in depth (Taylor & McKeon, 1997). It was found that the 
N-terminal domain was required for kinetochore localisation, and that this domain 
expressed in HeLa cells had a dominant negative effect, causing a failure of cells to 
arrest in mitosis in the presence of spindle damage. The localisation of Bubl is 
slightly different to that observed for the checkpoint components Madi and Mad2 
since Bubi seems to be retained for longer at the kinetochores after stable 
attachments have been established (Sharp-Baker & Chen, 2001). This was seen 
particularly for the S. pombe homologue of Bubi where it remained at the 
kinetochores until telophase, perhaps suggesting another role for Bubl after the 
metaphase to anaphase transition (Bernard et al., 1998). The dependency of the 
checkpoint upon BubI was confirmed by a study in Xenopus where Bubi was 
immunodepleted (Sharp-Baker & Chen, 2001). This led to inactivation of the 
checkpoint and failure of Mad 1, Mad2, Bub3 and CENP-E to bind the kinetochore, 
indicating that Bubi plays a role upstream in the checkpoint, presumably being 
responsible for targeting of components to the kinetochore. Intriguingly, this study 
also revealed that the kinase domain of Bubi was not required for the checkpoint, a 
point which will be re-iterated upon discussion of the metazoan specific Bubi related 
protein, BubRi. 
1.8.2 Bub2 
Bub2 was initially identified and cloned from the screen which identified the Bub 
components of the spindle assembly checkpoint (Hoyt etal., 1991). In more recent 
years it has become apparent that Bub2 plays a different role to other components of 
the checkpoint and is part of an independent pathway regulating exit from mitosis, 
known as the mitotic exit network (MEN) (Fesquet et al., 1999; Fraschini et al., 
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1999). Bub2 prevents premature exit from mitosis when anaphase is inhibited 
(Alexandru et al., 1999). It does this by interacting with Bfal to form a GTPase 
activating protein, which inhibits the 0 protein Tern  and prevents cells from exiting 
mitosis when the checkpoint is active (Bloecher et al., 2000). 
1.8.3 Bub3 
Bub3 was cloned and described in the initial characterisation of the spindle 
checkpoint (Hoyt etal., 1991). Subsequently, Bub3 has been identified in a number 
of organisms including mouse (Mart inez-Exposito et al., 1999; Kalitsis et al., 2000), 
Aspergillus nidulas (Efirnov & Morris, 1998), Drosophila (Basu et al., 1998) and 
human (Taylor et al., 1998). Identification of Drosophila Bub3 confirmed its role in 
the spindle assembly checkpoint in metazoans (Basu et al., 1998). This study 
revealed that the localisation of Bub3 was disrupted by mutations in the Bubi' 
(BubRl) gene. However, Bub3 localisation was unaffected in flies mutant for the 
checkpoint proteins ZwlO and Rod, indicating that these proteins are in distinct 
pathways. Identification of human Bub3 reinforced the notion that Bubi and Bub3 
interact, since expression of Bubi altered the localisation of Bub3 (Taylor et al., 
1998). The domain of Bubi required for this interaction was identified and found to 
be the same as that required for kinetochore localisation, indicating a role for Bub3 
in the localisation of Bubl to the kinetochores (Taylor etal., 1998). This study also 
led to the identification of the mammalian homologue of Mad3 (BubRi) as a 
component of the checkpoint which interacted with Bub3. The requirement for 
complex formation between Bub3 and BubRi was demonstrated by the fact that 
ectopically expressed BubR I was only able to localise to the kinetochores of BHK 
(baby hamster kidney) cells when Bub3 was overexpressed in the same cell. This, 
therefore, leads to the hypothesis that Bub3 is required for the kinetochore 
localisation of both Bubi and BubRl in order for the checkpoint to function in 
vertebrate cells. The essential role of Bub3 in the spindle assembly checkpoint was 
further defined by the targeted disruption of this gene in mouse (Kalitsis et al., 
2000). The disruption caused embryonic lethality with the animals failing to survive 
beyond day 6.5 - 7.5 pc. The embryos were found to develop normally until day 3.5 
and then between days 4.5 - 6.5 accumulated a number of mitotic defects. These 
Drosophila Bubi is more closely related to BubRl from other species. 
20 
included chromatin bridging, lagging chromosomes, micronuclei and irregular 
nuclear morphology. The authors also showed that these cells were unable to 
activate the spindle assembly checkpoint, since embryos treated with microtubule 
depolymerising agents failed to arrest in metaphase (Kalitsis et al., 2000). 
It has been noted that Bub3 shares extensive sequence homology with a protein 
called RAE1 (GLE2) which binds to the nuclear pore complex component NUP98 
(Wang et al., 2001). RAE1 binds to NUP98 by way of a motif called GLEBS 
(GLE2p binding sequence). Both Bubi and BubRl have a motif with a high degree 
of similarity to the GLEBS motif, and this is the region with which they interact with 
Bub3. At present, the significance, if any, of this sequence similarity between 
components of the spindle assembly checkpoint and the nuclear pore complex 
remains unknown. However, it is interesting to note that in addition, Mad! and Mad2 
have been found at nuclear core complexes (Campbell et al., 2001). These 
observations could indicate either multiple cellular roles for checkpoint components 
or that the nuclear pore complex plays some role in the spindle assembly checkpoint. 
An interesting hypothesis suggested by these workers, is that localisation at the 
nuclear pore may play some role in loading checkpoint components onto the 
kinetochore in order that they can fulfil their role once the nuclear envelope has 
broken down. This idea is based upon observations that interphase centromeres 
associate with the nuclear envelope (Moroi etal., 1981; Haaf & Schmid, 1989; Ochs 
& Press, 1992). 
1.8.4 Madi 
Madi was initially identified in budding yeast and was shown to be 
hyperphosphorylated when cells were arrested in mitosis. This hyperphosphorylation 
of Madi was defective in Mad2, Bubi and Bub3 mutant backgrounds, but not in the 
Mad3 background (Hardwick & Murray, 1995). Subsequently, Mad  and Mad2 
have been found in tight association in budding yeast throughout the cell cycle. This 
association is considered critical for checkpoint function and the 
hyperphosphorylation of Mad! (Chen et al., 1999). Mad  was also identified in 
Xenopus in a complex with Mad2. Mad! was found to be necessary for the 
establishment and maintenance of the checkpoint in Xenopus egg extracts and the 
idea was postulated that MadI was required to recruit Mad2 to unattached 
kinetochores (Chen et at., 1998). Madi has also been found to facilitate the 
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localisation and hyperphosphorylation of BubRi in Xenopus egg extracts (Chen, 
2002). 
1.8.5 Mad2 
Mad2, as with the other checkpoint components, is conserved and has been identified 
and cloned from a number of organisms including budding yeast (Chen et al., 1999), 
human (Li & Benezra. 1996) and fission yeast (Ikui et al., 2002). Mad2 forms 
complexes with Mad! (Chen et al., 1999), which results in hyperphosphorylation of 
Mad!, and also with the activating subunit of the APC/C, Cdc20 (Fang et al., 1998; 
Kallio et al., 1998; Wassmann & Benezra, 1998; Sironi et al., 2001). Mad2's 
complex formation with Cdc20 sequesters the latter; therefore preventing both its 
association with the APC/C and inactivation until the spindle checkpoint is satisfied 
(Chen et al., 1998; Kallio et at., 1998). It has been established that Mad  is required 
for the kinetochore localisation of Mad2 (Chen et al., 1998; Sironi et al., 2001; Luo 
et al., 2002), and that Mad2 is required both at the kinetochore to sense activation of 
the spindle checkpoint (Waters et al., 1998) and to send an inhibitory signal to the 
APC by way of binding and inhibiting Cdc20 (Fang et al., 1998; Kallio et at., 1998; 
Wassmann & Benezra, 1998). 
A novel human kinetochore associated protein, I-led, was identified as an interactor 
of Mad  in a yeast two hybrid screen (Chen et al., 1997). Heci is a coiled-coil 
protein, which is the putative homologue of the budding yeast kinetochore 
component Ndc80 (Martin-Lluesma et al., 2002). RNAi depletion analysis in human 
cells revealed that Hec 1 is required for the recruitment of Mps I and the Mad 1/Mad2 
complex to the kinetochore. In addition, depletion of Hec 1 resulted in persistent 
activation of the spindle assembly checkpoint, although significant amounts of Mad  
and Mad2 were not present at the kinetochore (Martin-Lluesma et al., 2002). These 
results suggest that Mad2 does not need to be retained at the kinetochore for the 
spindle assembly checkpoint to be activated. 
The first mechanistic insights into the workings of the spindle assembly checkpoint 
have been established recently by solving the structure of Mad2 interacting with both 
Mad 1 and Cdc20. It has been revealed that Mad2 undergoes a major conformational 
change upon binding of either Mad  or Cdc20 (Luo etal., 2002; Sironi et al., 2002). 
In addition a Mad2 binding motif has been identified in common with both the Mad! 
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and Cdc20 sequence (Luo et al., 2002). It is becoming increasing clear that the 
Mad 1-Mad2 interaction is a priming step, which alters the conformation of Mad2 so 
that it is ready for the crucial role of binding Cdc20 and hence inhibiting the APC 
until all kinetochores are attached. However, questions still remain regarding where 
these interactions take place and how Madl is able to release Mad2 for binding 
Cdc20. The complex between Mad  and Mad2 has been found to be very strong and 
Mad  binds Mad2 in a competitive manner, actually inhibiting the Cdc20 interaction 
(Sironi etal., 2001; Sironi et al., 2002). 
It is not entirely clear as to where the Cdc20-Mad2 interaction takes place, although 
Cdc20 has been reported to localise to the kinetochore (Fang et al., 1998; Kallio et 
al., 1998). Once all the kinetochores are attached to microtubules, Mad2 must 
release Cdc20 in order that the APC can be activated. How this release of Cdc20 
occurs is still unknown although it has been proposed that microtubule attachment 
alters the structure of the kinetochore (Rieder & Salmon, 1998; Howell et al., 2000). 
This structural alteration may be the signal for Mad2 to release Cdc20 and for Mad2 
itself to leave the kinetochore. Mad2 is known to leave the kinetochore and 
translocate to the spindle pole by way of spindle fibres, with anaphase onset 
occurring 10 minutes later in PtK cells (Howell etal., 2000), presumably this is the 
length of time needed for the dissociation of the Mad2/Cdc2O complex, activation of 
the APC/C and the destruction of key proteins. 
Since Mad2 plays a role downstream in the checkpoint, inhibiting the function of the 
APC/C, it is interesting to address what happens when the gene is disrupted or 
removed. A Mad2 knockout mouse has been generated which is embryonic lethal at 
day 6.5-7.5 pc (Dobles eral.. 2000). The embryos grow normally until 5.5 pc, but are 
unable to arrest in the presence of spindle damage. By 6.5 pc there is chromosome 
missegregation and apoptosis. In addition, it has been discovered that Mad2 is 
haploinsufficient, since deletion of one Mad2 allele in the human colon carcinoma 
cell line, Hct-1 16 results in a defective checkpoint, premature sister chromatid 
separation and an increase in chromosome missegregation (Michel et al., 2001). In 
addition, embryonic fibroblasts from the Mad2 +1- mice showed premature sister 
chromatid separation and an increase in the number of aneuploid cells. 
Strikingly, the heterozygous mice had a high frequency of papillary lung 
adenocarcinomas by the age of 18-19 months. This is a very rare tumour, and the 
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development time is fairly long, presumably indicating that other co-operative 
mutations of oncogenes or tumour suppressors must have occurred in order to drive 
this transformation (Michel et al., 2001). In another study, it was shown that human 
breast tumour line T471), which is sensitive to taxol and nocodazole, had reduced 
Mad2 expression, and the cells failed to arrest after nocodazole treatment (Li & 
Benezra, 1996). 
An interaction between the oestrogen receptor P and Mad2 was identified by yeast 
two hybrid screen and confirmed by GST pulldown (Poelzl et al., 2000). Oestrogen 
receptors are lig and- activated transcription factors that regulate gene expression and 
cell growth, with ER-3 being involved in the regulation of cellular proliferation. The 
specific role of an interaction or complex formation between these two proteins is 
currently unknown. 
Mad2 has also found to interact with the cytoplasmic domain of the insulin receptor 
(O'Neill et al., 1997) and the ubiquitin-like protein, FAT 10 (Liu et al., 1999). Neither 
of these interactions has been explained in terms of Mad2's role in the spindle 
checkpoint. These observations do, however, emphasise the idea, as discussed for 
Bub3 and BubR 1, that components of the spindle checkpoint may have multiple 
roles within the cell. 
1.8.6 Mad3/ BubRi 
Initial identification of human BubRi classed it as a human Bubl related protein 
(Cahill et al., 1998; Jablonski et al., 1998; Taylor et al., 1998). Indeed Bubi and 
BubR 1 share a considerable degree of homology at both the N-terminus and within 
the kinase domain. However, subsequently by sequence analysis and functional 
studies, others have argued that BubRi should be classed as the functional 
homologue of budding yeast Mad3 (Hardwick et al., 2000) and fission yeast Mad3 
(Millband & Hardwick, 2002). The most striking difference between these proteins 
being that yeast Mad3 does not contain a kinase domain. However, since the 
requirement of BubRi's kinase domain within the checkpoint is somewhat 
controversial, this issue may be unimportant (Tang et al., 2001) (Fang, 2002). 
Initially identified as a gene mutated in human colorectal cancer cell lines (Cahill et 
al., 1998), it is now becoming apparent that Bub Ri is an important component of the 
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vertebrate checkpoint that interacts with a number of other proteins, senses 
kinetochore attachment and/or tension and inhibits the APC/C. Here I will discuss 
the known involvement of BubRi in the checkpoint, including the complexes it 
forms, and speculations concerning how BubRl actually senses unattached 
kinetochores and relays that signal to the APC/C. 
Cloning of the budding yeast checkpoint component Mad3 revealed that it has two 
domains at the N-terminus with a high degree of similarity to Bubi (Hardwick et al., 
2000). Mad3 interacts with Bub3, Mad2 and Cdc20 and it is known that the regions 
of homology to Bubi are crucial for these interactions (Hardwick et A. 2000). 
Figure 1.5 illustrates these domains, region I and region II in addition to the Bub3 
binding domain. 
Figure I.S. Sequence comparisons between BubRl, Bub] and Mad3 
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A, Homology regions I and IL as described by Hardwick et al.. 2000. Key to Clustal symbols. * - 
amino acid fully conserved. : strong group fully conserved, STA, NEQK. NHQK, NDEQ. QHRK, 
MILV, MIL, HY, FYW. . Weaker group fully conserved CSA, ATV, SAG. STNK, SlAP. SGNI), 
SNDEQK, NDEQHK, NEQHRK, FVLIM, HEY. Colouring of Clustal alignment Blue: AFILMVW, 
Purple: ED, Green: NQST, Yellow: P. Orange: G, Red:KR, Turquoise: YH, Salmon: C. B, Schematic 
representation of Bub 1 related proteins, indicating the conserved homology domain in red, the Bub3 
binding domain in pale blue and the kinase domain in dark blue. Diagram adapted from Taylor et al., 
1998. 
Identification of the fission yeast Mad3 has allowed the dependency for kinetochore 
localisation of Mad3 to be determined (Millband & Hardwick, 2002). The authors 
showed that Mad3 localisation is dependant upon Bubi, Bub3 and Mphl (fission 
yeast Mpsl), but not Madl or Mad2. In addition Mad3 was shown to co-
immunoprecipitate with Bub3, Mad2 and Cdc20. Fission yeast Mad3 is required for 
Mad2 to inhibit the APC/C (Millband & Hardwick, 2002). 
The first ever mutational analysis of a spindle assembly checkpoint component in a 
multi-cellular organism came from work on BubR I in Drosophila (Basu et al., 
1999). The gene mutated in this analysis was initially named Drosophila Bubi. 
However, subsequent analysis of this sequence reveals that it is more similar to 
vertebrate BubRl proteins identified, and therefore should be renamed BubRi (M. 
Goldberg, personal communication). This study revealed that flies with a P-element 
mutation (a near null), die during late larval stages. This death is due to severe 
mitotic abnormalities including accelerated exit from mitosis with chromosomes that 
are both mis-segregated and fragmented. In addition, an increase in levels of 
apoptosis was observed in these 'BubRi' mutant flies (Basu et al., 1999). 
Several studies have focussed on addressing the fact that metazoans have two Bub 1 
related proteins involved in the spindle checkpoint and on attempting to identify 
what different roles, if any, they play. It is known that both proteins are localised to 
the kinetochore with slightly different timing, with Bubi localising first at early 
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prophase onto the kinetochores in human cells (Jablonski etal., 1998). Studies on the 
Bubla and Bubib proteins in mouse show that they have different timing of 
expression, with Bubib (BubRi homologue) expression being delayed by 6 hours 
relative to Bub la (Bubi homologue) (Davenport etal., 1999). In addition it is known 
that BubRi contains a putative destruction box, which targets proteins for 
degradation via the APC, and BubI does not, presumably implying that the 
degradation of the proteins may be regulated differently. Both proteins form a 
number of complexes. However, to date only BubRI has been shown to bind Cdc20, 
in order to directly inhibit the APC/C (Wu et al.. 2000; Sudakin et al., 2001; Tang et 
al., 2001). It therefore seems that Bubi and BubRi have distinct roles within the 
checkpoint. Bubl may act upstream, forming a complex with Bub3 and Madl that 
may allow the binding of BubR I and Mad2 to the kinetochore in order to sense 
microtubule attachment and/or tension. 
The question as to whether BubR I and Mad2 sense specific signals still remains 
somewhat controversial. It is known that a single unattached kinetochore is able to 
halt cell cycle progression (Rieder et at., 1994), and that the lack of tension and 
attachment signals to the checkpoint (Li & Nicklas, 1995). Experiments using taxol 
(which suppresses microtubule dynamics) revealed that the Mad2 signal depends 
upon microtubule attachment and not tension (Waters et al., 1998). In this case, 
taxol was used to generate a state where the tension is lost at the kinetochore, as 
judged by the lack of 3F3/2 signal. 3F3/2 is a phosphorylated epitope present at 
kinetochores, which are not under tension (Gorbsky & Ricketts, 1993). Cells in this 
situation had no Mad2 signal, indicating that Mad2 is unable to sense the lack of 
tension and does not bind to the kinetochore and activate the checkpoint (Waters et 
al., 1998). These cells however, are still halted in the checkpoint indicating that 
something is able to sense lack of tension. Increasingly, it is being hypothesised that 
this is the function of BubRl (Skoufias etal., 2001; Taylor etal., 2001; Zhou et al., 
2002). This was also shown using a compound called vinbiastine which when used at 
nanomolar concentrations causes a loss of tension at the kinetochore while they are 
still attached to microtubules. In these treated cells, BubRl was recruited to the 
kinetochores but Mad2 was not (Skoufias et at., 2001). At higher vinblastine 
concentrations when microtubules disassemble and attachment becomes affected, 
Mad2 was then recruited. 
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Whether the Mad2 and BubRi sensing mechanisms are independent or part of the 
same pathway has been addressed by a recent paper studying PtK1 cells. In this 
study, it is shown that, if the growth temperature for these cells is decreased from 
37°C to 23°C, the time taken for anaphase can increase from 20 minutes to 100 
minutes (Shannon et al., 2002). It was shown that this delay is checkpoint dependant 
by the injection of the checkpoint inhibitor GST-MadlFlO, which subsequently 
alleviated the anaphase delay. GST-MadlFlO (amino acids 321-556) contains both 
the Mad  oligomerisation domain and the Mad2 binding domain and has been shown 
to induce premature anaphase specifically in a dominant negative manner by 
inhibiting the ability of Mad2 to inactivate Cdc20/APC (Canman et at., 2002; 
Canman etal., 2002). The authors of this paper, (Shannon etal., 2002), then went on 
to show that the kinetochores at metaphase were under 24% less tension at 23°C than 
37°C and that there were increased levels of 3F3/2, Bubl and BubRi associated with 
the kinetochores. Injection of anti-BuhRl antibodies also alleviated the delay, 
indicating that the BubRi protein is also required for this temperature sensitive 
delay. In addition the authors were able to show that although Mad2 and BubRi may 
sense distinct signals, they are part of the same pathway. By using both GST-
Mad IF1O to inhibit Mad2 and anti-BubRI they showed that the delay was decreased 
by the same amount of time if these inhibitors were used independently or together. 
Recently, a connection between the chromosomal passenger protein, Survivin, and 
the spindle assembly checkpoint has been identified in human cells following RNAi 
depletion of Survivin (Carvalho et al., Personal Communication). This study has 
shown that Survivin is required for the proper function of the checkpoint, but only in 
response to lack of tension. Cells, which have been depleted for Survivin, can exit 
mitosis after treatment with taxol, however, after treatment with nocodazole they are 
blocked in mitosis. Although BubRi can bind to the kinetochores in Survivin 
depleted cells it is not maintained for extended periods. These results further 
emphasise the notion that there are two arms to the checkpoint pathway one, which 
involves BubRi, and the other Mad2. 
An interaction between the kinetochore motor protein CENP-E and BubR 1 was 
initially identified by yeast two hybrid screen and was subsequently confirmed by 
immunoprecipitation from HeLa cells (Chan et al., 1998). This work gave initial 
insight into how a checkpoint protein may actually be able to sense the presence or 
attachment of the microtubule at the kinetochore. BubR I is also known to interact 
with the checkpoint component Bub3, as discussed previously (Taylor et al., 1998; 
Tang etal., 2001; Chen, 2002) with the likely role of Bub3 being to correctly localise 
BubRi to the kinetochore. BubRl is also known to interact with the activating 
subunit of the APC/C, Cdc20 (Wang etal., 2000; Sudakin etal.. 2001; Fang, 2002), 
and, in a manner similar to Mad2, it sequesters this protein, preventing the activation 
of the APC/C. It seems therefore, that BubRi is a checkpoint component that may 
have a central role in both directly sensing the microtubule-kinetochore status and 
then transducing this signal to the APC by way of interaction with Cdc20. 
As discussed previously, the necessity of BubRi's kinase domain for the function of 
the checkpoint has been thrown into doubt by the work of two groups. In human 
cells it was shown that a complex between BubRi and Bub3 exists and that this 
interacts with Cdc20 (Tang etal., 2001). In that study, it was shown that the kinase 
domain is not required for BubRl to inhibit the APC. An additional study in human 
cells also showed that both BubRi and Mad2 interacted with Cdc20 (Fang, 2002). 
The complex formed between BubRl and Cdc20 was of higher affinity than that 
between Mad2 and Cdc20 alone. However, it was shown that these proteins act 
synergistically and each promotes the other's binding to Cdc20. The inhibition of the 
APC by BubRl was again shown to be independent of its kinase activity (Fang, 
2002). In further agreement with these studies it has been shown that the kinase 
activity of BubRl is not essential for checkpoint activity in Xenopus (Chen, 2002). In 
the latter study, immunodepletion of BubRi from egg extracts reduced the 
kinetochore localisation of Bub I, Bub3, Mad!, Mad2 and CENP-E and impaired the 
interaction between Mad2 and Cdc20. These checkpoint defects could be rescued by 
addition of either wild type BubRi, kinase dead or a kinase domain truncation, 
indicating that the kinase domain is not essential. 
1.8.7 CENP-E 
CENP-E was initially identified as a human centromere protein when HeLa 
chromosome scaffold preparations were used to generate monoclonal antibodies 
(Yen et al., 1991). One such monoclonal antibody recognised a protein that had a 
localisation somewhat distinct from CENP-A, CENP-B and CENP-C in that it was 
not seen at the centromere during interphase, but associated with the centromeres at 
prometaphase and then redistributed to the spindle midzone as anaphase began (Yen 
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et al., 1991). This initial study recognised that CENP-E was involved in the 
transition of cells from metaphase to anaphase, since injection of antibodies to the 
protein blocked cells and caused a delay in anaphase. CENP-E is a kinesin-like, 
microtubule-dependant motor protein (Yen et al., 1992; Wood et al., 1997). 
Subsequently, CENP-E has been implicated as a component of the vertebrate spindle 
assembly checkpoint that is phosphorylated by MAPK (Zecevic et al., 1998) and 
interacts with BubRI (Chan et al., 1998), as mentioned previously. There are two 
Drosophila CENP-E proteins. CENP-meta and CENP-ana (Yucel et al., 2000). 
CENP-meta has a different cell cycle distribution compared to vertebrate CENP-E, in 
that it remains localised to the centromere at all stages of the cell cycle. A P-element 
disruption of CENP-meta leads to incomplete chromosome alignment at metaphase, 
indicating that this motor protein is required for chromosome congression. Its role in 
the spindle assembly checkpoint has been defined in both Xenopus and mammalian 
cells. In Xenopus, CENP-E has been found to be required for both establishing and 
maintaining the checkpoint, since extracts immunodepleted of this protein fail to 
arrest in the presence of spindle damage (Abrieu et al., 2000). Since an increase in 
the levels of Mad2 can overcome this block, it has been argued that CENP-E is 
upstream of Mad2 in the checkpoint pathway. The authors hypothesise that CENP-E 
acts as a kinetochore attachment sensor, which is capable of activating or silencing 
the checkpoint as required (Abrieu et al., 2000). Further insight into how CENP-E 
affects chromosome movements were revealed by depleting CENP-E levels in 
human cells using antisense oligonucleotides. It was found that CENP-E was 
required for the stable, biorientated attachment of chromosomes to the spindle and 
for the development of tension across the kinetochore (Yao et al., 2000). Recently, a 
mouse knockout of CENP-E has been generated (Putkey et al., 2002). Since no 
homozygous null embryos were detected at embryonic day 7.5 - 8.5 it was 
concluded that they did not survive beyond implantation. In order to determine the 
phenotype resulting from disruption of CENP-E Cre/loxP technology was employed. 
Selective disruption was carried out both in cultured primary fibroblast and in the 
mouse liver. Primary fibroblasts were treated with Cre recombinase by adenovirus 
infection. 90% of these cells lacked detectable levels of CENP-E and had a high 
frequency of mitotic abnormalities. Liver regeneration was studied in the absence of 
CENP-E, firstly by injection of Cre adenovirus, which is absorbed by the liver, then 
by injection of the toxin carbon tetrachloride, which induces liver damage. It was 
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found that the livers were able to recover normally in animals infected with the Cre 
adenovirus, but that mitotic abnormalities were observed including misaligned and 
lagging chromosomes (Putkey et al., 2002). 
1.8.8 Mpsl 
Mps 1 was initially identified as a gene essential for spindle pole body duplication in 
budding yeast (Winey et at., 1991). Subsequently, it was identified as a component 
of the spindle assembly checkpoint with kinase activity (Weiss & Winey, 1996). 
Recent identification of vertebrate homologues of Mpsl has raised questions 
concerning the potential dual role of this kinase in vertebrates (Abrieu et al., 2001; 
Fisk & Winey, 2001; Stucke et al., 2002). Overexpression of Mpslp in budding 
yeast constitutively activated the spindle assembly checkpoint, causing 
hyperphosphorylation of Madi (Hardwick et al., 1996). Phosphorylation of Madi 
by Mpslp is required for Mad  and Mad2 to associate with each other (Chen et at., 
1999), and also for the BublIBub3 complex to form (Brady & Hardwick, 2000). The 
fission yeast homologue of Mpslp, called Mph I, is capable of complementing both 
the checkpoint and SPB duplication defect in budding yeast lacking Mpslp. 
Surprisingly, however, fission yeast Mphl mutants show only checkpoint defects 
(He et at., 1998). 
Mpsl kinases share extensive sequence homology in the C-terminal kinase domain 
but have little or no homology at the N-terminus. In order to address the question as 
to whether the dual or multiple roles of yeast Mps 1 are conserved, the vertebrate 
homologues are now being studied. Identification of Xenopus Mps 1 revealed that it 
is a kinetochore-associated kinase that is required both to establish and maintain the 
spindle assembly checkpoint (Abrieu et at., 2001). In addition, this study established 
that Mpsl is upstream of Mad2 in the signalling pathway, since overexpression of 
Mad2 can overcome the checkpoint defect in extracts, which have been depleted of 
Mps 1. Mps 1 is also required for the recruitment and retention of the kinetochore 
motor protein CENP-E at the kinetochores in Xenopus (Abrieu et al., 2001). CENP-E 
localisation is in turn required for Mad  and Mad2 to be localised to the kinetochore. 
Human Mpsl was initially identified and named TTKJPYT (Mills etal., 1992; Hogg 
et at., 1994). Mouse Mpsl, initially named ESK, has been shown to regulate 
centrosome duplication (Fisk & Winey, 2001). In contrast to this, investigation of 
the human Mpsl using both antibody injection and siRNA technology showed that 
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this protein is indeed required for the spindle assembly checkpoint to function but 
not for centrosome duplication (Stucke et al.. 2002). 
1.8.9 MAPK 
MAPK (mitogen activated protein kinase) has been implicated as a component of the 
spindle assembly checkpoint in a number of systems. Immunofluorescence has 
shown that active MAPK is present at the kinetochores of vertebrate cells during 
prometaphase and that the signal intensity diminishes as the kinetochores become 
lined up on the metaphase plate and under tension (Shapiro et al., 1998; Zecevic et 
al., 1998). This localisation is observed for components of the checkpoint and is the 
pattern seen with the phosphoepitope recognised by the monoclonal antibody 3F3/2 
(Gorbsky & Ricketts, 1993), as discussed previously. In addition it has been shown 
that MAPK can phosphorylate the kinetochore motor protein CENP-E, which is 
known to have a role in the checkpoint, at sites known to be involved in microtubule 
interaction (Zecevic et al., 1998). Further indications that MAPK may play a role in 
the checkpoint have come from work in Xenopus egg extracts. Initially it was shown 
that extracts treated with nocodazole, not only showed an increase in cdc2/cyclinB 
levels indicative of a cell cycle block, but also an increase in MAP kinase activity 
(Minshull et al., 1994). Subsequently, it has been shown that extracts 
immunodepleted of MAPK fail to arrest the cell cycle in the presence of microtubule 
poisons (Takenaka et al., 1998). In order to address the question as to whether 
MAPK has a role in somatic cells, XTC cells were injected with the MAPK 
phosphatase, XCL 100, with the result that the cells failed to arrest after treatment 
with nocodazole (Wang et al., 1997). This seemed to indicate therefore that MAPK 
plays a crucial role in the function of the spindle assembly checkpoint in somatic 
cells. However, in the light of more recent work on the p38 kinase it may be that the 
inhibitor is not specific to MAPK and that additional or other proteins play a role in 
the checkpoint. p38 (also known as MPK2, CSBP or HOG 1) is a component of the 
MAPK superfamily. In a study addressing the role of MAPK family members in the 
checkpoint of somatic cell cycles, it was found that specifically p38 was activated in 
NIH 3T3 cells that had been arrested in mitosis by the addition of nocodazole 
(Takenaka et al., 1998). Cultured cells treated with a specific inhibitor of p38, 
S13203580, and subjected to nocodazole treatment had compromised checkpoint 
activity. In addition, when activated p38 was injected into two-cell Xenopus 
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embryos these failed to develop normally and arrested early in development with 
high histone Hi kinase activity (Takenaka et al., 1998), indicative of a mitotic arrest. 
It therefore seems that the activity of p38 is required for the spindle assembly 
checkpoint to function in somatic cells. 
1.8.10 Complexes and checkpoint activation 
Illuminating work identifying multiprotein complexes in S. cerevisae (Brady & 
Hardwick, 2000), and human cells (Sudakin et al., 2001; Tang et al., 200 1) allows a 
model to be drawn up that brings all this information together. In addition, a study in 
S. pombe regarding the timing, order and dependency of the checkpoint components 
helps in the formulation of this model (Miliband & Hardwick, 2002). In S. cerevisae 
it has been shown that a complex between Mad l -Bub l-Bub3 forms which is required 
for the checkpoint function and that this requires both Mad2 and Mps 1 for formation 
(Brady & Hardwick, 2000). In human cells two complexes have been identified. The 
first, with APC/C inhibitory activity, has been named the mitotic checkpoint 
complex (MCC) and consists of BubRi, Bub3, Cdc20 and Mad2 (Sudakin et al., 
2001). It was found that this is a pre-formed complex present and active in 
interphase cells but that only APC/C purified from mitotic cells was sensitive to 
inhibition. This complex is capable of inhibiting mitotic APC/C 3,000-fold more 
efficiently than recombinant Mad2. 
In another study, a 500 kDa complex was purified from mitotic HeLa cells which 
was composed of BubRl, Bub3 and Cdc20, but not Mad2 (Tang et al., 2001). As 
with the MCC complex, this has the ability to inhibit the APC/C, but in a Mad2 
independent manner. It is known from budding yeast that a complex of Mad 1 -Bub i 
and Bub3 forms and is present at the kinetochores and that the formation of this 
complex is dependant upon Mad2 and Mpsl (Brady & Hardwick, 2000). It has been 
suggested by Miliband and Hardwick (2002), that this complex may act as a 'landing 
pad' for Mad3, and, when this is associated with the kinetochore, it interacts or 
assists Mad2 in binding to Cdc20 and hence inhibits the APC. This model, however, 
does not take into account that BubRi is known to interact with CENP-E and rather 
than being a downstream effector may in addition sense microtubule attachment or 
tension through this motor protein. It has, however, been shown that BubRi 
becomes localised to the kinetochores later than Bubl in both human (Jablonski et 
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al., 1998) and mouse cells (Davenport et al., 1999). Insights into the mechanism of 
checkpoint activation have been obtained from studies of the structure of Mad2 
interacting with both Mad  and Cdc20 and it appears that the interaction with Mad  
is required as a priming step. The model is consistent with Mad2 being recruited 
later, interacting with Mad  already present at the kinetochore and then with Cdc20. 
Although there is a considerable amount of information about the spindle assembly 
checkpoint from both in vitro and in vivo studies from a number of different 
organisms, many questions still remain unanswered. In particular, how the 
checkpoint is turned off so rapidly once all kinetochores become properly attached, 
and how the signal from just one unattached kinetochore is enough to inhibit the 
APC/C throughout the whole cell. The checkpoint maybe inactivated by a 
redistribution of proteins away from the kinetochore, as is seen with Mad2, which 
moves along microtubules away from the kinetochore to the spindle poles (Howell et 
al., 2000). Although a picture is beginning to emerge as to how the various 
complexes interact at the kinetochore, the specific roles of individual components 
still remains to be fully elucidated. In addition, it remains to be fully determined if 
there are additional components of the checkpoint in metazoans as opposed to yeast. 
With such a large number of components it may also be interesting to determine if 
there is any redundancy in the system. Figure 1.6 is a proposed model based on the 
current understanding of how the checkpoint complexes may be recruited to the 
kinetochore to halt the progression from metaphase to anaphase until such time as all 
kinetochores have proper bipolar attachments. 
1.8.11 APC/C 
The anaphase promoting complex or cyclosome is a 20S complex consisting of 
between 10 and 12 subunits in vertebrates. It has E3 ubiquitin ligase activity and acts 
to target proteins for destruction by the 26S proteasome. The APC/C plays a key 
role in cell cycle progression as it targets key components for destruction at specified 
times in the cycle. Key molecules such as A and B type cyclins (Glotzer et al., 199 1) 
and securin (Cohen-Fix et al., 1996) are targeted by the APC/C, leading to the 
inactivation of cdkl kinase and mitotic exit. The process of ubiquitination involves a 
number of protein activities, the first of which is an El ubiquitin activating enzyme, 
which activates ubiquitin so that it can be transferred to an E2 ubiquitin conjugating 
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enzyme. The E2 can either then add ubiquitins directly to targets or transfer them to 
an E3 such as the APC/C. Transfer to the E3 adds a further level of specificity to the 
process. The proteins that APC/C targets, are recognised by specificity factors such 
as Cdc20 and Cdhl, which recognise specific sequences within proteins and hence 
target them for destruction. Cdc20 recognises a motif called the destruction box with 
the consensus RxxLxxxxN (Glotzer etal., 1991), whereas Cdhl recognises either the 
destruction box or KEN box, which has the consensus KENxxxN/D (Pfleger & 
Kirschner, 2000). APC/C Cdc20 is replaced as the specificity factor for APC/C by 
cdhl later in mitosis, when cdkl activity drops. The discovery that cdhl also 
recognises a specific sequence came from observations (Pfleger & Kirschner, 2000) 
that Cdc20 is itself targeted for degradation by the APC when the specificity changes 
from Cdc20 to Cdhl, leading to the identification of a KEN box. 
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Figure 1.6 Proposed model of Spindle Assembly Checkpoint 
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Figure 1.6 proposed model of spindle assembly checkpoint. Model for spindle assembly checkpoint activation based on a 
number of model organisms. The checkpoint proteins are recruited to the kinetochore in a number of complexes as discussed 
in the text. These must be rearranged to form the mitotic checkpoint complex (Sudakin el al., 2001) which results in inhibition 
of the APC. Once the checkpoint is satisfied cdc20 activates the APC, securin is degraded and separase is active to cleave 
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1.9 ZwlO and Rod 
The gene Zeste White 10 (zitlO) was identified in Drosophila melanogaster in a 
screen for mitotic mutants (Gatti & Goldberg, 199 1) and similarly rough deal (rod) 
was identified as a gene required for the faithful transmission of chromosomes to 
daughter cells at mitosis (Karess & Glover, 1989). The intriguing, dynamic mitotic 
distribution of the proteins encoded by these genes led to their subsequent 
identification as components of the spindle assembly checkpoint in both Drosophila 
and human cells. Both proteins are localised to the kinetochores early in mitosis, and 
have essentially the same distribution throughout mitosis. During prometaphase they 
become concentrated at the kinetochores, and as the cells progresses towards 
metaphase the proteins become redistributed to the kinetochore microtubules, both 
are then re-localised specifically at the kinetochores during early anaphase and 
maintain that localisation until telophase (Williams & Goldberg, 1994; Scaerou et 
al., 1999). Although these proteins appear to co-localise throughout the cell cycle 
there is some discrepancy in the literature regarding the timing of localisation of 
human Rod and ZwlO. Chan et al., show that in early prophase some kinetochores 
are positive for Rod but not ZwlO (Chan et al., 2000), whereas Scaerou et al., show 
the opposite in that these kinetochores at an early stage of prophase only have Zw 10 
present (Scaerou et al., 2001). 
Initial indications that these proteins act together came from a study which revealed 
that Zw 10 was mislocalised in rough deal (rod) and abnormal anaphase resolution 
(aar) mutants (Williams & Goldberg, 1994). Subsequently, these two proteins have 
been identified in other multicellular organisms. However, no orthologues of either 
have been identified in yeast. This has therefore lead to the postulation that these 
proteins add an increased level of complexity to the spindle assembly checkpoint, 
presumably due to the increased complexity of the kinetochore structure and the 
functions which it must orchestrate in metazoans. ZwlO has been identified in a 
number of organisms (Starr etal., 1997) which, shared a common ancestor around 1 
billion years ago (Doolittle et al., 1996) and have quite diverse kinetochore 
structures. These organisms include Drosophila, C. elegans with holokinetochores, 
Arabidopsis with the ball and cup kinetochore structure (for review see (Yu et al., 
2000)), mouse and human. These results appear to indicate that ZwlO at least is 
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evolutionarily conserved. To date, Rod has also been identified in human and C. 
elegans (Scaerou et al., 1999). 
Classically, the definition of a component of the spindle assembly checkpoint is a 
mutant that fails to arrest in metaphase in the presence of spindle damage. It has 
been shown that both Rod and ZwlO fall into this category and both are therefore 
now thought to contribute in some manner to the spindle assembly checkpoint in 
Drosophila (Basto etal., 2000) and human cells (Chan et al., 2000). Controversy still 
remains as to how these proteins interact, if at all, with the Mad and Bub components 
of the checkpoint and what particular function they carry out. It has been shown that 
Mad and Bub components are still able to localise to the kinetochores in Drosophila 
ZwlO and Rod mutants (Basto et al., 2000) and in human cells following injection of 
Rod and ZwlO antibodies (Chan et al., 2000). It is now known that these proteins 
are part of a multisubunit complex in both human (Chan et al., 2000) and Drosophila 
cells (Scaerou et al., 2001). This complex is approximately 19S or 700-900 kDa in 
Drosophila. 
Additional information about the function of this complex has been gleaned from the 
fact that these proteins are required for the targeting of cytoplasmic dynein to the 
kinetochore (Starr et al., 1998). Cytoplasmic dynein is a microtubule motor protein 
with a number of roles during mitosis, including movement of the spindle, movement 
of the chromosomes and trafficking of proteins along the spindle microtubules (for 
review see (Banks & Heald, 2001)). Drosophila zwlO mutants prevent the 
association of the dynein heavy chain with the kinetochore and this is thought to be 
due to an interaction between ZwlO and dynamitin (the p50 subunit of the dynactin 
complex) (Starr et al., 1998). In addition to this, it has been shown that the rate of 
poleward chromosome movement is reduced in Drosophila zwlO and rod mutants 
(Savoian et al., 2000), suggesting that this complex contributes to poleward 
chromosome motion, presumably through interaction with the dynein/dynactin 
complex. 
Zwint (ZwlO-interacting protein) interacts in a yeast two hybrid screen with human 
ZwlO (Starr etal., 2000). Zwint is a 43 kDa protein with a coiled-coil domain which 
has been postulated to target ZwlO to the kinetochore during prometaphase, since it 
is localised before ZwlO. It has also been shown to localise to neocentromeres and 
the active centromere of dicentric chromosomes (Starr et al., 2000). To date, no 
orthologues of Zwint have been identified in any organism outside the mammals. 
The main questions remaining unanswered about these proteins are how ZwlO and 
Rod actually function within the spindle checkpoint and the relevance of their 
interaction with the motor cytoplasmic dynein. It has been shown that dynein 
migrates from the kinetochores to the poles during prometaphase and metaphase and 
carries with it cargo, including the checkpoint protein Mad 2 (Howell et al., 2001) 
and Rod (Wojcik et al., 2001). It would appear therefore that this could be a 
mechanism to shut off the spindle assembly checkpoint to let anaphase proceed, and 
that Zw 10 and Rod contribute to this somehow through interactions with cytoplasmic 
dynein. Figure 1.7 shows a model which has been proposed for how Zw 10 and Rod 
interact at the kinetochore (Starr et al., 1998). 
Figure 1.7. ZwIO and Rod at the kinetochore. 
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Model of how ZwlO and Rod may interact with cytoplasmic dynein and dynactin at the kinetochore. 
Diagram taken from Starr etal., 1998. 
Table 1.2 summarises the components of the spindle assembly checkpoint which 
have been discussed. 
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Table 1.2. Summary of spindle assembly checkpoint proteins, their roles and 
interactions. 
Protein Comments and key references 
Mad 1 in budding yeast; 
• 	Binds and recruits Mad2 to the checkpoint (Brady & Hardwick, 2000) 
• hyperphosphorylated upon checkpoint activation (Hardwick & Murray. 
1995) 
• 	Binds BubI and Bub3 upon checkpoint activation (Brady & Hardwick, 
2000) 
In /unian, 
• 	Binds Bubi and Bub3 in vitro (Seeley etal., 1999) 
Mad2 in budding yeast; 
• 	Binds to Mad 1, Mad3 and Cdc20 (Hardwick etal., 2000) 
In vertebrates; 
• 	Identified complex with Mad I, BuhR I and Cdc20 (Sudakin ci' al., 2001) 
• Mouse knockout is embryonic lethal (Dobles ci' al.. 2000), with 
heterozygous animals being developing lung tumours indicating 
haploinsufliciency (Michel etal., 2001) 
• 	Inhibits the APC by binding and sequestering Cdc20 (Chen etal., 1998; 
Kallio etal., 1998) 
• 	Structures of Mad2-Cdc2O(Luo etal., 2000) and Mad l-Mad2 (Luo etal., 
2002) interactions solved by NMR 
Mad3IBubRl Mad3; 
• 	Interacts with Mad2 and Cdc20 (Hardwick etal., 2000) 
• Constitutively bound to Bub3 (Millhand & Hardwick, 2002) 
• 	Kinetochore recruitment requires BubI. Bub3, and Mps) (Millband & 
Hardwick, 2002) 
BubRi; 
• 	Shares homology regions with both BubI and Mad3, looks more similar to 
Mad3 but contains a kinase domain (Hardwick et al., 2000) 
• 	Binds motor protein CENP-E (Chan etal., 1999; Yao etal.. 2000) 
• Identified in complexes with Bub3, Mad2 and cdc20 (Sudakin etal., 2001) 
and Bub3 and Cdc20 only (Tang etal., 2001) 
• 	Kinase domain not required for checkpoint function (Tang et al., 2001; 
Chen, 2002) 
Bub I Budding yeast; 
• 	Binds Bub3 (Roberts etal., 1994) 
Binds Mad 	when checkpoint is active (Brady & Hardwick, 2000) 
Xenopus; 
• 	Kinase domain not required for the checkpoint (Sharp-Baker & Chen, 2001) 
• Required for kinetochore localisation of Mad], Mad2, Bub3 and CENP-E 
(Sharp-Baker & Chen, 2001) 
Bub3 Budding yeast; 
• 	Binds Mad] when checkpoint is active (Brady & Hardwick, 2000) 
Binds Mad 	and Buhi during a normal cell cycle (Brady & Hardwick, 2000) 
Vertebrates; 
• 	Identified in complexes with BubRl, Mad2 and Cdc20 (Sudakin etal., 
2001) BubRl and Cdc20 only (Tang eral., 2001) 
• 	Mouse knockout is embryonic lethal (Kalitsis etal., 2000) 
Mps I Budding yeast; 
• 	Phosphorylates Mad 	in vitro (Hardwick etal., 1996) 
Kinase with essential role in spindle pole body duplication (Weiss & Winey, 1996) 
Xenopus; 
• 	Required for recruitment of CENP-E, Mad 	and Mad2 to the kinetochores 
(Abrieu etal., 200 1) 
CENP-E • 	Kinesin like microtubule motor with no obvious yeast homologue (Yen et 
al., 1992; Wood ci' al., 1997) 
• 	Interacts with BuhRl (Chan etal., 1999; Yao etal., 2000) 
ZwIO • 	Identified as Drosophila mutant which failed to arrest in the presence of 
spindle damage (Gatti & Goldberg, 1991; Basto etal., 2000) 
• 	No yeast homologue identified 
• Required for the kinetochore localisation of cytoplasmic dynein (Starr et al., 
1998) 
• 	Interacts with Zwint (Starr et al., 2000) and found in complex with Rod 
(Scaerou etal., 200 1) 
Rod • 	Identified as Drosophila mutant which failed to arrest in the presence of 
spindle damage (Karess & Glover, 1989; Basto etal., 2000) 
• 	No yeast homologue identified 
• Interacts with dynein (Wojcik etal., 2001) and found in complex with ZwlO 
(Scaerou etal., 2001) 
(The table was adapted from the review by Milibanu et at., 2OUZ) 
1.10 Spindle assembly checkpoint and cancer 
For a number of years, it has been known that tumours are associated with 
chromosomal instabilities and aneuploidy (Lengauer et al., 1997). The molecular 
basis of this instability is largely unclear. However, there is a growing body of 
evidence that abnormalities in the function of the spindle assembly checkpoint may 
in some way contribute to the resulting aneuploidy and, more specifically, mutations 
in components of the checkpoint have been identified in some human tumours. The 
first identification of the human orthologues of the yeast spindle checkpoint 
components Bubi and Mad3 was described in a study by (Cahill et at., 1998) which, 
showed mutations in these genes in human colorectal cancers. Colorectal cancers can 
be defined as having either microsatellite instability (MIN) defects or chromosomal 
instability (CIN) defects. The molecular basis of the CIN defect was of interest since 
the cell lines derived from tumours were unable to arrest in metaphase in the 
presence of the microtubule disrupting drug nocodazole, indicating defects in the 
spindle assembly checkpoint. Two somatic mutations of human Bubi were 
identified in tumours but not present in neighbouring healthy tissue. Both these 
mutations were found to have a dominant negative effect when transfected into cells. 
In addition, two mutations of the human BubRl were identified in this study, the 
significance of which still remains to be determined. In contrast to the results 
reported by Cahill et al., a subsequent report has shown that CIN cell lines do 
actually undergo mitotic arrest in response to spindle damage, although the 
checkpoint may be somewhat compromised (Tighe etal., 2001). 
Numerous studies have been carried out to try and determine the prevalence of 
mutations in spindle checkpoint proteins in tumours and the subsequent 
consequences of these mutations. The results of these studies make it very hard to 
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conclude what impact, if any, mutations in components of the spindle assembly 
checkpoint have on the progression of human cancers. 
An additional study addressing the question of mutations in checkpoint genes arising 
in human colorectal cancers, found a new mis-sense mutation in Bub], however no 
mutations in the coding region of BubRi (Shichiri et al., 2002). Moreover, it was 
found that in a number of tumours there was a significant decrease in the expression 
levels of both Bubi and BubRi and that these correlated with lymph node metastasis 
and shorter relapse-free survival after the patients had undergone surgery. A study 
into adult T cell leukaemia/lymphoma (ATLL), which is associated with severe 
chromosome abnormalities, revealed mutations or deletions of Bubi or BubRl in 4 
out of 10 cases studied (Ohshima et al., 2000), suggesting that mutations in these 
genes might contribute to the chromosomal abnormalities in this cancer. In addition, 
a study into nasopharyngeal carcinoma, which is very common in south east Asia, 
showed that some cells lines derived from these tumours had a defective mitotic 
checkpoint co-incident with abberantly reduced expression of Mad2 (Wang et al., 
2000). 
In contrast to those mentioned above, a number of studies have failed to find any 
significant mutations in components of the spindle checkpoint. For example, a study 
into glioblastomas revealed only silent mutations or polymorphisms of Bub I, BubRi 
and Bub3 (Reis et al., 2001). Studies into lung cancers yielded similar results with 
no mutations, rearrangements or deletions in Bubi or BubRi (Sato et al., 2000), no 
mutations in Bubi, BubRi or Bub3 (Haruki et al., 2001) and no mutations in Mad2 
or its downstream interactor p55CDC (Takahashi etal., 1999). Thyroid cancers have 
also been investigated (Ouyang et al., 2002) and although a high number of these 
have aberrant checkpoints as judged by treatment with nocodazole, this does not 
correlate with mutations in Bubl or BubRl. A very thorough study of hepatocellular 
carcinomas, (Saeki et al., 2002) showed that although the spindle checkpoint was 
impaired, no mutations were found in Bub 1, BubRl, Bub3, Mad2 or Cdc20. 
One possible reason for the fact that mutations were not discovered in some of these 
cancers with aberrant spindle assembly checkpoints may simply be that the wrong 
genes were being investigated. It is apparent that the spindle assembly checkpoint is 
very complicated, involving a number of different proteins and complexes which are 
conserved from yeast to human and that the checkpoint is even more complex and 
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highly regulated in metazoans by the assistance of ZwlO and Rod, CENP-E and 
MAPK. Most studies of human cancers have focussed on Bubi and BubRi as 
potential targets for mutation and have neglected the other components of the 
checkpoint. Mad 1, Mad2, Bub3, ZwlO and Rod. Although it appears that Bubi and 
BubR 1 mutations do not play a significant role in many types of cancer, one or more 
of the other components may be doing so. As discussed previously Mad2 +1- mice 
develop papillary lung adenocarcinomas by the age of 18-19 months, indicating a 
role for this checkpoint protein in tumour progression (Michel et al., 2001). It is 
obvious that chromosome instabilities and aneuploidy are a common feature of a 
number of cancer types and that this evidently leads to progression of the disease and 
subsequent genetic abnormalities within the cells. For now, it remains controversial 
as to what effect mutations in components of the spindle assembly checkpoint have 
on the progression of human cancers. 
A further intriguing finding linking the spindle assembly checkpoint with colorectal 
cancer is the interaction between the Adenomatous Polyposis Coli (APC) protein and 
the Bub proteins. It is known that mutations in the APC gene are responsible for 
some forms of colon cancer (for review see (Kinzler & Vogeistein, 1996)). A 
number of roles are known for APC including regulation of the degradation of 3-
catenin in the Writ signalling pathway (for review see (McCartney & Peifer, 2000; 
Peifer & Polakis, 2000)), stabilisation of microtubules (Nathke et al., 1996; Mimori-
Kiyosue etal., 2000) and regulation of the cytoskeleton (McCartney et al., 1999). A 
recent study by Kaplan and colleagues has shown that cells with a truncated version 
of the APC gene are defective in chromosome segregation. APC is a plus end 
microtubule binding protein, which is embedded in the kinetochore. In addition it 
was shown that immunoprecipitates of APC from mitotic HeLa cells contained Bub 1 
and Bub3 and that recombinant complexes of Bubl-Bub3, BubRl-Bub3 and 
immunoprecipitated Bub 1 could efficiently and specifically phosphorylated APC 
(Kaplan etal., 2001). No specific role for APC in the spindle assembly checkpoint 
has yet been defined since cells mutant for the protein are able to arrest in the 
presence of nocodazole. However, it seems that APC's role as a kinetochore-
microtubule binding protein may contribute to the chromosomal instability observed 
in colorectal cancer through its interactions and regulation by the Bub components of 
the spindle assembly checkpoint. 
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A further intriguing observation is the link between Brca2 and BubR I. Brca2 is 
known to have a function in DNA repair and to bind to the Rad5 1 protein, a RecA 
orthologue that is involved in homologous recombination and double strand break 
repair (Shinohara et al., 1992; Baumann et al., 1997). One defective copy of the 
Brca2 gene pre-disposes to breast cancer (Wooster et al., 1995; Tavtigian et al., 
1996), and usually two defective copies occur in the tumour (Collins et al., 1995). 
Therefore this gene is defined as a tumour suppressor. 
Tumours from mice that are homozygous mutant for Brca2 have a dysfunctional 
spindle assembly checkpoint, and this is often accompanied by mutations in Bubi, 
BubRi and p53 (Lee et al., 1999). In addition to the observation that the spindle 
assembly checkpoint is dysfunctional in these tumours, a direct link between Brca2 
and the checkpoint has been identified in the form of an interaction between Brca2 
and BubRl. This interaction was identified in a yeast two-hybrid screen (Futamura et 
al., 2000). Furthermore, BubRl can phosphorylate Brca2 in vitro. Moreover, 
stimulation of the checkpoint by treating the cells with vincristine, which disrupts 
microtubules, increased the expression of both BubRl and Brca2 (Futamura et al., 
2000). The authors of this paper conclude that Brca2 may have a role in the spindle 
assembly checkpoint. However, it has been shown in both human and the Xenopus 
system that the kinase domain of BubRl is dispensable for its function in the 
checkpoint (Tang etal., 2001; Chen, 2002), so it could be worth considering the 
potential role of BubRl, and in particular its kinase activity, in other pathways such 
as DNA repair (Brca2) and signalling (APC). 
The involvement of p53 in the spindle assembly checkpoint remains somewhat 
controversial. Observations that cells from p53-null mouse embryos failed to arrest 
in metaphase in the presence of spindle damage induced by either nocodazole or 
colcemid led Cross et al., to conclude that, in mouse at least, the spindle assembly 
checkpoint was dependant upon p53 (Cross et al., 1995). This phenomenon has 
subsequently been investigated in human cells as it is known that some p53 missense 
mutations have a dominant gain of function activity, which leads to genetic 
instability. Fibroblasts from patients with Li-Fraumeni syndrome, which have one 
mutant copy of p53, were exposed to spindle damaging agents and polyploid cells 
were generated, indicating that the spindle assembly checkpoint failed to arrest the 
cells in mitosis (Gualberto et al., 1998). The same phenotype was observed with the 
expression of a mutant allele of p53, 53RSC  (relaxed spindle checkpoint). However, 
when p53 levels were decreased in human cells by a number of means including 
retroviral infection and anti-sense techniques and then the cells challenged with 
spindle disrupting agents, the spindle assembly checkpoint was maintained and the 
cells arrested. In order to extend these results, Gualberto et al., repeated the mouse 
experiments of Cross et al., and again found that, in the case of mouse the spindle 
checkpoint was dependant upon p53 function. Finally, human tumours lacking p53 
were tested but found to have a functional checkpoint. It therefore seems that a 
dominant mutant form of p53 affects the spindle checkpoint and can play a role in 
human tumourogenesis. Around 40% of p53 mutations identified in tumours fall into 
this category. 
1.11 Perspectives 
This thesis is divided into three results chapters which aim to address some of the 
issues raised concerning the spindle assembly checkpoint and the vertebrate 
kinetochore. More specifically, Chapter 3 focuses on the identification and 
characterisation of chicken BubRi. The cDNA was cloned from a library and 
sequenced, revealing that it had a high degree of similarity to other vertebrate BubR 1 
proteins. Subsequently, a polyclonal antibody was generated so that the localisation 
and function of this protein could be investigated in chicken cell lines. 
Chapter 4 focuses on the generation of a DT40 cell line with a targeted disruption of 
BubRl. DT40 is a hyper-recombinogenic chicken cell line which is a useful tool with 
which to investigate essential genes, since conditional cell lines can be generated. 
The first stage of this project was cloning the chicken genomic locus in order that 
targeting vectors could be generated. Once the first allele was targeted, attempts were 
made to express the rescue construct within these cells. 
The work in Chapter 5 aims to further the understanding of the vertebrate 
kinetochore and the spindle checkpoint by using Xenopus egg extracts. This system 
is a powerful tool with which to study cell cycle complexes. In particular the 
checkpoint components ZwlO and Rod were cloned from a Xenopus cDNA library 
and antibodies were raised to them. Preliminary work with these antibodies has 
ER 
identified a complex, in Xenopus egg extracts, of approximately 1 IS which contains 
ZwlO and Rod. Hopefully, the reagents generated in this study will be of use in the 
future in order to further investigate the vertebrate kinetochore. 
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Chapter 2 
Materials and Methods 
2.1 Materials 
2.1.1 Chemicals and Solutions 
All solutions were prepared using Milli-Q synthesis water (Millipore) and, where 
appropriate were autoclaved before use. All solutions used for RNA work were 
treated with 0.1% diethyl pyrocarbonate (DEPC), supplied by Sigma. Chemicals 
used were purchased from Sigma, BDH or Fisher. 
Acids, alcohols and solvents were supplied by Sigma, BDH or Fisher. 
Radioisotopes were supplied by Amersham and oligodeoxynucleotides primers 
were supplied by Sigma-Genosys. 
Table 2.1. Genotype of Eschericia coli strains used in this thesis 
Strain Genotype Use 
Top 10 F mcrA 	(mrr-hsdRMS-mcrBC) 480IacZAM 15 LMacX74 General cloning 
deoR recAl araD 139 A(ara-leu)7697 galU galK rpsL(StrR) 
endAl nupG  
XL-1 Blue recAl endAl gyrA96 thi-1 hsdR17 supE44 relAl lac [F Site-directed 
proAB lacl ZA Ml 5 Tn 10 (Tett)] mutagenesis 
XL-1 Blue A(mcrA)183 A(mcrCB-hsdSMR-mrr)173 endAl supE44 thi- X-ZAP chicken 
MRF I gyrA96 relAl lac [F'proAB lacl 4 ZAMI5 TnlO (Tc tr)l cDNA library screen 
XL-1 Blue A(mcrA)183 A(mcrcB-hsdSMR-mrr)173 endAl supE44 thi- XFixII chicken 
MRA-P2 I gyrA96 relAl lac (P2 lysogen) genomic library 
screen 
SOLR e14(McrA) A(mci-CB-hsdSMR-mrr)171 sbcC recB recJ in vivo excision 
uvrC umuC::Tn5 (Kan') lac gyrA96 relAl thi-1 endAl XR from X-ZAP cDNA 
[F'proAB laclqZAMl5 TnlO (Tct')r library 
C600 SupE44 hsdR thi-i thr-1 leuB6 lacYl tonA2I hflA ]50 Xenopus library 
[chr.:TnIO (tel')] screen XgtlO 




Table 2.2. Antibodies used in this thesis 
Antibody 	- Working dilution Reference 
AuroraB 1:500 Earnshaw laboratory 
BubRi 1:500 This thesis 
CENP-C 1:500 Ciaran Morrison 
INCENP 1:500 Earnshaw laboratory 
Monoclonal anti - HA (l2CA5) western 1:1000 Cell line from Earnshaw 
laboratory 
IF 1:500 
Monoclonal anti-tubulin (13512) western 1:10000 Sigma 
IF 1:2000 
ZWIO 1:500 This thesis 
Rod 1:500 This thesis 
Texas Red and FITC 
conjugated secondary 
antibodies for 
immunofluorescence (IF)  
1:200 Jackson Labs 
HRP-conjugated secondary 
antibodies for ECL  
1:10000 Amersham 
Table 2.3. Common reagents and buffers 
Reagent or buffer Details Notes 
10 x DNA loading dye 20% Ficoll, 0.1 M EDTA, pH 8.0, 1% Add to DNA sample 
SDS, 0.25% Bromophenol blue, 0.25% before running agarose 
xylene cyanol. gel. 
20 x XB salts 2 M KCI, 20 mM MgCl 2 , 2 mM CaCl2. Filter sterilised and 
stored at 4°C. 
3 x sample buffer 150 mM Tris:HCI pH 6.8,45% sucrose, 6 Add 3-mercaptoethanol 
mM K-EDTA p1-I 7.4,9% SDS, 0.03% to 10% final 
bromophenol blue. concentration just prior 
to use. 
Aprotinin Sigma A-6279 1,000 x 
Church buffer 0.5 M NaPi/ 7% SDS/ 1 mM EDTA For Southern 
hybridisation. 
CLAP Chymostatin (Sigma C-7268) All 1 mg/ml in DMSO 
Leupeptin (Calbiochem 108975) 1,000 x stock. 
Antipain (Sigma A-6191) 
Pepstatin A (Sigma P-4265)  
Coomassie Brilliant Blue R 0.5% Coomassie in methanol 5 x stock 
CSF Energy Mix 150 mM creatine phosphate, 20 	m Alp, stored aliquoted at 
20 mM MgCl 2 -20°C. 
CSF Extract buffer (CSF- 100 mM KCI, 0.1 mM CaCl7, 1 mM Made from 20 x XB 
XB) MgC1 2 , 10 mM potassium HEPES, pH 7.7, salts filter sterilised and 
50 mM sucrose, 5 mM EGTA, pH 7.7 stored at 4°C. 
Cytoskeleton buffer 137 mM NaCl, 5 mM KCI, 1.1 mM For IF of rnicrotubules. 
Na,HPO4 , 0.4 mM KH 2 PO4 , 2 mM MgCl 2 , 
2 mM EGTA, 5 mM PIPES, 5.5 mM 
pH'd to 6.1 and filter sterilised  
Dejellying solution lx XB salts, 2% w/v cysteine. Made up within 1 hour 
of use and titrated to pH 
7.8 with NaOH. 
Diluent 	-- 35% methanol, 14% acetic acid To dilute Coomassie to 
lx 
Extract Buffer (XB) 100 mM KC1, 0.1 mM CaCI 21 1 MM Made from 20 x XB 
MgCl,, 10 mM potassium HEPES, pH 7.7, salts filter sterilised and 
50 mM sucrose, stored at 4°C. 
Gerace buffer 5 x stock; 250 mM triethanolamine:HCI For blotting with 
pH7.4. 500 	m NaCl, 10 	m K-EDTA Protein A-' 25 1. 
pH 7.4. 2.5% Triton-X-lOO,0.5% SDS  
10 	m Tris :HCI pH 8.5, 0.2 mM EDTA, For IF of metaphase 
25 mM NaCl spreads. 
KCM 120 	m KCI, 20 	m NaCl. 10 	m Tris For IF. 
pH 8.0,05 mM EDTA pH 8.0, 0.1%  
Triton-X-100  
LB (Luria-Bertani Medium) 1% tryptone, 0.5% yeast extract. 1% NaCl, Prepared by the Media 
p1-1 adjusted to 7.0 with 5N NaOH. staff. 
MMR 100 mM NaCl, 2 mM KCI, 1 mM MgCl 2 , 10 x stock prepared and 
2mM CaCl2 , 0.1 mM EDTA, 5 mM titrated to pH 7.&with 
HEPES. pH 7.8. NaOH. 
NaPi Na2 HPO4.H20 I M stock, pH adjusted 
to 7.2 with HPO4 
PBS 137 mM NaCl, 2.7 mM KCI, 10 	m General use 
Na,HPO4 , 2 mM KH 2 PO4 . 
PMSF Sigma P-7626 100 mM in ethanol, 
10,000 x stock. 
Running buffer 25 mM Tris, 250 mM glycine, 0.1% SIDS For running SDS-PAGE 
gels. 
SDS-PAGE gel buffer 1.5 M Tris pH 8.8 Lower gel 
SDS-PAGE stacking gel 0.5 M Tris pH 6.8 Stacking buffer 
buffer  
Slow destain 10% methanol, 7% acetic acid To destain Coomassie. 
SM buffer For 1 L, 5.8 g NaCl, 2 g MgSO 4 .7H 20, 50 For the dilution of 
ml 1 M Tris-CI , pH 7.5, 5 ml 2% gelatin bacteriophage 2. stocks. 
solution. Sterilise by autoclaving  
SSC 10 x stock, 1.5 M NaClJ 0.15 M sodium General use 
citrate, adjust pH to 7.0 with citric acid  
Super broth 5 g tryptonc, 20 g yeast extract, 5 g NaCl For recombinant protein 
per litre. pH adjusted to 7.5 with 5 M expression, prepared by 
NaOH. the media staff. 
TAE For I L of 50 x stock, 242 g Tris base, 57.1 For agarose gels. 
ml glacial acetic acid and 100 nil 0.5 M 
EDTA, pH 8.0.  
Tail buffer 50 	m Tris pH 8.8, 100 	m EDTA, 100 For the preparation of 
mM NaCI, 1% SDS genomic DNA. 
TEEN 1 mM triethanolamine:HCI pH8.5, 0.2 mM For IF. 
EDTA, 25 mM NaCl  
TfbI 30 mM KAc, 100 mM RbCI,, 10 mm For the preparation of 
CaC1 2 , 50 mMMnCl 2 , 15% glycerol. pH to chemical competent 
5.8 with dilute HAc, filter sterilise and E. co/i. 
store at 4°C.  
TfblI 10 mM MOPS, 75 mM CaCI.,, 10 mM For the preparation of 
RbCl 2 , 15% glycerol. pH to 6.5 with KOH, chemical competent 
filter sterilise and store at 4 °C. E. co/i. 
Transfer buffer 48 mM Tris. 39 mM glycine, 20% For transferring SDS- 
__________________________ methanol and 0.0375% SDS I PAGE gels. 
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2.2 Methods 
2.2.1 Plasmid DNA preparation 
Small scale plasmid DNA preparations were performed using the Ultraclean 
Plasmid miniprep kit from MoBio laboratories Inc. according to manufacturer's 
instructions. Cultures of E.coli (2 ml) were grown overnight in the presence of 
antibiotics at 37°C with shaking. Larger midi (50 ml) or maxi (100 ml) 
preparations were performed using Qiagen Midi/MaxiPrep kit according to 
manufacturer's instructions. 
2.2.2 Agarose gel electrophoresis 
Unless otherwise stated, 1% agarose gels were prepared using Invitrogen 
electophoresis grade agarose in TAE buffer and contained 0.3 .Lg/ml ethidium 
bromide. These were elecrophoresed using Hybaid tanks in 1 x TAE according 
to manufacturer's instructions. Gels were analysed using a UV light box and 
photographed with a digital camera. 
2.2.3 Purification of DNA from agarose gels 
After gel electrophoresis bands were excised from the gel using a razor blade and 
placed in a 1.5 ml eppendorf tube. DNA was extracted using Qiagen Qiaquick 
Gel Extraction Kit according to manufacturer's instructions, and eluted from the 
column in de-ionised water (dH,0). 
2.2.4 Restriction digestion of DNA 
In general, restriction digests were performed using enzymes from New England 
Biolabs. The enzymes were used with the lOx buffer provided and BSA (0.1 
mg/ml) or any other required supplement. The digest was performed at the 
required temperature for 2-16 hours depending on the amount and type of DNA 
being digested. If appropriate, the enzyme was inactivated by heating to 65°C for 
15 minutes. 
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22.5 Generation of blunt ended DNA fragments 
T4 DNA polymerase, which has both 5'-3' polymerase activity and 3'-5' 
exonuclease activity, was used to blunt both 5' and 3' overhangs left after 
restriction digestion. T4 DNA polymerase was obtained from New England 
Biolabs, the reaction was carried out in the presence of lOx buffer and 
supplemented with BSA (0.1 mg/ml) and dNTPs (100 tM). 5U of enzyme/tg 
DNA was used and the reaction incubated at 37°C for 5 minutes and then heat 
inactivated at 75°C for 15 minutes. 
2.2.6 Dephosphorylation of 5' DNA ends 
Vectors for sub-cloning fragments were treated with Calf Intestinal Alkaline 
Phosphatase (CIP) after restriction digestion and prior to ligation in order to 
reduce the self-ligation of empty vector. CIP was obtained from New England 
Biolabs and was used with any restriction enzyme buffer. CIP was used at a 
concentration of 1U per pmol of DNA, the reaction was carried out at 37°C for 
1 hr. 
2.2.7 Ligation of DNA fragments 
Ligations were performed using T4 DNA ligase from New England Biolabs 
supplemented with the provided buffer. A vector:insert ratio of 1:3 was used 
where possible, and the reaction incubated at 18°C overnight or 25°C for 5 hours 
before transformation into competent E. coli. 
2.2.8 Preparation of chemical competent E. coil and transformation 
E. co/i were grown in LB at 37°C to ? nm A600  0.5, then transferred to ice for 5 
minutes. Cells were pelleted by centrifugation at 3300 g in the Heraeus 
benchtop megafuge for 15 minutes and then re-suspended in TfbI (40 ml per 100 
ml culture, see Table 2.3). Thereafter, cells were pelleted, re-suspended in TfbII 
(4 ml per initial 100 ml culture, see Table 2.3) and incubated on ice for 15 
minutes. 
In order to make highly efficient competent cells it is important to keep the cells 
as cold as possible during aliquoting. This was therefore carried out in the cold 
51 
room with all pipettes, tip and eppendorfs pre-chilled. The cells were snap frozen 
in liquid nitrogen and stored at -80°C. 
For transformations, 100 tl of cells were thawed on ice prior to the ligation 
reaction mixture being added, and the mixture was then incubated on ice for 20 
minutes. This was then heat shocked at 42°C for 90 seconds and chilled on ice 
for 2 minutes. 0.5 ml of LB was added and the cells incubated for 40 minutes at 
37°C. The cells were then pelleted by spinning at 600 g for 5 minutes. The 
majority of the supernatant was removed and the pellet re-suspended in 100 l,11. 
This was spread on agar plates containing the appropriate antibiotic selection. 
2.2.9 DNA Sequencing 
Samples were prepared for the ICMB (Institute of Cell and Molecular Biology, 
University of Edinburgh) sequencing facility to run on the ABI 3100 sequencing 
machine. 
200-250 ng of mini or midi prep DNA or phage DNA was used per reaction. 
This was mixed with 3.2 pmol primer and 4 1.11 of ABI big dye mix (Applied 
Biosystems) and the reaction volume was adjusted to 10 ltl with dH 7 O. PCR 
cycling was carried out as described below on the Personal Cycler (Biometra). 
Table 2.4. ABI sequencing reaction. 
Step Conditions Cycle 
95°C - 1 minute 
2 95°C - 1 minute 25 
50°C - 15 seconds 
60°C - 4 minutes 
The DNA pellet was then precipitated at room temperature for 15 minutes by 
adding I tl 3M sodium acetate and 25 111 100% ethanol per reaction. The DNA 
was then spun at 20,000 g for 15 minutes, washed with 70% ethanol and then re-
spun. The pellet was either air dried or dried under vacuum. 
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Sequences were analysed using computer programs including Editview (ABI 
Prism, Perkin Elmer), Gene Jockey (BioSoft) and Sequencher (Gene Codes 
Corporation). Plasmid maps were constructed using DNA Strider. 
2.2.10 Polymerase Chain Reaction (PCR) 
Polymerase chain reaction (PCR) was carried out on either a Personal Cycler 
(Biometra) or Robocycler Gradient 40 (Stratagene), depending upon the 
experiment being undertaken. Different polymerases were used depending on 
template and the experiment. Below is a summary of these polymerases, the 
primer and dNTP concentration used and an example of a programme. 
Differences to these methods are indicated in the text. 
2.2.10.1 	Taq polymerase (Roche) 
0.25 .tM primers 
100 rM dNTP's 
0.5 t1 enzyme per 50 jil reaction 
Table 2.5. PCR using Taq polyinerase 
Step Conditions Cycle 
1 95°C - 2 minutes 
2 95°C - 1 minute 
55°C - 1 minute 
72°C - 1 minute per kb 
25-30 
3 72°C - 10 minutes 
	
2.2.10.2 	Vent polymerase (NEB) 
As above for Taq polymerase. 
2.2.10.3 	Pfu Turbo (Stratagene) 
0.25 jiM primers 
250 p.M dNTP's 
2 p.1 enzyme per 50 p.1 reaction 
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Table 2.6. PCR using Pfu Turbo 
Step Conditions Cycle 
1 95°C - 2 minutes 
2 95°C—iminute 
55°C - 1 minute 
76°C - 2 minute per kb 
25-30 
3 76°C - 10 minutes 
2.2.10.4 	TaKaRA LA Taq (Takara Shuzo Co., Ltd.) 
0.25 jtM primers 
Buffer, MgC1 2 and dNTP's supplied with kit and reaction carried out according 
to manufacturer's instructions. Typical cycle as above for Taq polymerase. 
2.2.10.5 	Using phage library clones as a template for PCR 
This method was used for the rapid amplification of library insert DNA in order 
that it could be cloned and sequenced. The Xenopus cDNA library used was 
cloned into the XgtlO vector. High titre stocks were prepared from phage 
purified through a tertiary screen as described in section 2.20. The DNA was 
extracted from these stocks by phenol/chloroform extraction. Initially 500 il of 
phage stock was heated to 95°C for 2 minutes, 500 R1  of phenol/chloroform/ 
isoamyl alcohol (25:24:1) was then added and the sample centrifuged for 5 
minutes at 20, 000 g. The top aqueous phase was removed to a fresh tube and 
1/10 volume of 3M sodium acetate was added together with an equal volume of 
isopropanol. After inversion, this was centrifuged again at 20,000 g for 5 
minutes. The DNA pellet was then washed twice in 70% ethanol and air dried. It 
was then resuspended in 100 jil dH 20. This DNA was used as a template for the 
PCR using the XgtlO forward and reverse primers. The PCR products were 
cloned into pGEM-T and sequenced. 
2.2.11 	Reverse Transcriptase - PCR (RT-PCR) 
cDNA synthesis was carried out using the Superscript First-Strand Synthesis for 
RT-PCR kit from Invitrogen (Cat. #11904-018). RNA was prepared as described 
in section 2.18. cDNA was generated using oligo dT and synthesised according 
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to the manufacturer's instructions. PCR was carried out as described in section 
2.2.10. 
	
2.2.12 	5' Rapid amplification of cDNA ends (5' RACE) 
Rapid amplification of cDNA ends was carried out using a kit obtained from 
GibcoBRL (cat. #18374-041, 5' RACE system for rapid amplification of cDNA 
ends v.2) according to the manufacturer's instructions. This method allows the 
isolation and cloning of mRNA sequences where the 5' end is unknown. Initially 
RNA is reverse transcribed using a gene-specific primer. A homopolymeric tail 
is then added to this cDNA using terminal deoxynucleotide transferase. The 
unknown sequence can then be amplified using an additional gene-specific 
primer and an anchor primer, which contains sequence complementary to the 
homopolymeric tail together with an adapter region. 
2.2.13 	Site Directed Mutagenesis 
Site directed mutagenesis was carried out using the QuikChange Site-Directed 
Mutagenesis kit (Cat. #200519) obtained from Stratagene, according to 
manufacturer's instructions. This method involves designing a primer with the 
mutation in it. Both a forward and reverse primer are required and the template is 
amplified using PfuTurbo, resulting in the incorporation of the mutation into the 
PCR product. The PCR reaction is then digested with the enzyme Dprzl, which 
will digest only the methylated non-mutated parental DNA, leaving the newly 
synthesised mutated DNA to be transformed into bacteria. 
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Table 2.7. Constructs used in this project, description of cloning, use and 
reference to main text. 
Construct Description of cloning Description and reference 
pBluescriptKS-ggBubRl In vivo excision from X ZAP Chicken BubRI cDNA used 
library throughout this thesis. 
pGex-4T-1 ggBubRl 653-778 PCR with primers HD 	and N-terminal GST fusion for the 
HD2, cloned EcoR 1/blunt into generation of chicken BubRI 
EcoR 1/Xho l(blunt) sites of specific rabbit polyclonal 
pGEX-4T- 1. antibodies. Section 3.2.3 
pEGFP-Cl-ggBuhRl PCR of the 5' end of ggBubRl N-terminal GFP fusion of full 
with primers HD3 and HD4, length chicken BubRi. 
cloned into pEGFP-Cl. Ace 1/ 
Kpn I fragment cut from pbsKS- 
ggBubRl, cloned into pEGFP- 
______________________________ CI with 5' end.  
pUHGIO.3-ggBubRl PCR to fuse the STOP codon to Rescue construct (3'UTR 
the polyA signal and remove 356 mutated for RT-PCR screening 
bp of 3' UTR. PCR with HD5 purposes). Tet operator sequence 
and HD6, Nco I/Kpn I removed upstream of CMV promoter, 
from pbsKS-ggBubRl and allows the conditional expression 
replaced by smaller fragment of the cDNA once co-transfected 
with mutated 3' UTR. with tTA plasmid. Section 4.2.5 
pZeo-ggBubR 1-HA-His PCR to remove STOP codon C-terminal HA-His tag on full 
using HD 10 and HDI I. Cloned length chicken BubRi. Section 
into pZe0SV2HA-His with 5' 3.2.4 
fragment cut S,na L/Spe I from 
pbsKSggBubRl.  
KOV I (Bsr, HisD, Puro) see chapter 4 section 4.2.2 for Vector for targeted disruption of 
description of cloning. the BubRi locus in DT40 cells. 
Section 4.2.2 
KOV2 (Bsr, HisD, Hyg, Puro) see chapter 4 section 4.2.2 for Vector for targeted disruption of 
description of cloning. the BubRi locus in DT40 cells. 
Section 4.2.2 
pGEM-T.xlZwl0 (3' end) 200 bp PCR product generated 200 bp PCR product from 3' end 
using primers HD 12 and XGTIO of Xenopus ZwlO used to screen 
-R and cloned into pGEM-T. a Xenopus oocyte eDNA library. 
Section 5.2.5 
pGex-xIXw 10 (most C-terminal 200 bp PCR product generated N-terminal GST fusion of most 
50 amino acids) with primers HD 13 and HD 14, C-terminal 50 aa of Xenopus 
cloned into pGEX-4T- I Zw 10 in order to generate rabbit 
EcoRl/XhoI. polyclonal antibodies. Section 
5.2.5 
pGem-T -xlRod (3-4) 1.5 kb PCR product generated 1.5 kb PCR product of Xenopus 
using primers HD 15 and HDI6 Rod used to screen Xenopus 
and cloned into pGEM-T. oocyte cDNA library. Section 
5.2.6 
pGex-xlRod (most C-terminal SOObp PCR product generated N-terminal GST fusion of C- 
126 amino acids) using primers HD 17 and HD I 8, terminal 126 amino acids of 
cloned into pGEX-4T- I Xenopus Rod in order to generate 
EcoRl/Xhol. rabbit polyclonal antibodies. 
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Table 2.8. Primers used for cloning as described in Table 2.4 
Primer name Sequence 5' - 3' Use 
HD 1 GGGGAAYFCAGTG1TCTAAAGGAAGAC For cloning peptide 
for BubRI GST 
fusion HD2 GGGGGATCCCTCCAAATGAAAATGTGG 
HD3 CCCAAGCTTAGATGTCACGGGACGGTGAC 5' end of BubRi for 
pEGFP-Cl 
HD4 CmCTGTAGACYI'CAGC 
HD5 GATFGTCCATGGAGATCTGAG To fuse the stop 
codon to the polyA 




HD7 CCGGGTACCATGTCACGGGACGGTGACGAT 5' arm from KOVI 
HD8 CGCGGATCCCTGAYVFCTGAYT'CGAATFCT 
HD9 CGCGGATCCGATCCAAGGGTFCATFACAGC 5' arm for KOV2 
HDIO GTTATITIACTAGTFTGTVT'AT To remove stop 
codon for BubR I - 
HA-His fusion HD 11 ATAGflTAGCGGCCGCCTGTGAAAACAGAACTFCTC 
HD12 TATGCAGGCCAGC17GCAGGA To clone 3' end of 
XenopusZwlO from 
XGT1O library XGTIO-R CTFATGAGTATflTC1TCCAGGGTA 
HD13 CCGGAAYI'CATGCAGGCCAGCTFGCAG C-terminal 50 amino 
acids of Xenopus 
ZwlO as GST fusion HD 14 CCGCTCGAGflTGATC1TFGCCAGGGC 
HD 15 CCCAAAGTAAAGCCGGAAGATC Fragment of Xenopus 
Rod. 
HDI6 TGAGTGGGCTGCAGCTATT'GCT 
HDI7 CCGCTCGAGATrTAAAAAGGCCmAC C-terminal 126 
amino acids of 
Xenopus Rod as GST 
fusion. 
HDI8 CCGGAM1CTfGTFAATLTCCCACATG 
HDI9 ATGGAGGCAGCGGAGACAGAGG For RT-PCR of 
human Zwint 
HD20 TCATGGCAAAACATCTCCA 
HD2 I CAGGCCTTCTGTCAAAACTG 5' External probe for 
targeting 
HD22 CTTCAAGCTCTGCGTGATFA 
2.2.14 	Preparation of genomic DNA from tissue culture cells 
Genomic DNA was prepared from DT40 cells in order to screen colonies for 
targeting events by Southern hybridisation. DT40 cell colonies were picked from 
96 wells into 3 ml of medium (see Table 2.10) and grown for 2-3 days until the 
cells were confluent, half for freezing and half for DNA preparation. The cells 
(1.5 ml) were pelleted by centrifugation at 240 g for 5 minutes. The cells were 
then lysed in 0.5 ml tail buffer (50 mM Tris pH 8.8, 100 mM EDTA, 100 mM 
NaCl, 1% SDS) containing 0.5 mg/mI proteinase K and incubated overnight at 
37°C. The samples were shaken vigorously for 1-2 minutes then 200 tl of 6 M 
(saturated) NaCl was added and the shaking repeated. The samples were 
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centrifuged at 20, 000 g for 10 minutes. The supernatant was transferred to a 
fresh tube and 1 volume of isopropanol was added to precipitate the DNA. The 
samples were centrifuged again at 20, 000 g for 10 minutes, and the DNA pellet 
washed in 70% ethanol and spun again at 20, 000 g for 10 minutes. The DNA 
pellet was air dried and re-suspended in 70 111  dH2O. 
	
2.2.15 	Southern Blot 
DNA was digested as described in section 2.2.4. In the case of genomic DNA 
this was always carried out in a volume of 50 il with the addition of RNase (10 
tg/ml) and BSA, and the reaction was incubated overnight at 37°C. Digested 
DNA was electrophoresed on a 0.8% agarose gel as described in section 2.2.2 
and photographed alongside a fluorescent ruler in order to calculate the size of 
bands after blotting. The gel was then depurinated in 0.25 M HCl for 20 minutes 
and denatured in 0.5 M NaOH/ 1.5 M NaCl for 20 minutes. The gel was 
transferred onto nylon membrane (Amersham Hybond-N), in 10 x SSC (see 
Table 2.3), by upwards capillary transfer (Russel, 2001). After transfer, the 
membrane was UV crosslinked with 0.12 J using the UV Stratalinker 2400 
(Stratagene), prior to hybridisation (section 2.2.17) with a radiolabelled probe 
(section 2.2.16). 
2.2.16 	Random priming with 32P 
Random priming and incorporation of radiolabelled ct-32P-dCTP was carried out 
using the Megaprirne DNA labelling kit (Arnersham, Cat. No. RPN1607), 
according to manufacturer's instructions. 
2.2.17 	Hybridisation 
Membranes previously UV crosslinked were pre-hybridised in church buffer (see 
Table 2.3) with salmon sperm DNA for at least 1 hour at 65°C prior to the 
addition of radiolabelled probe. The membranes were then hybridised at 65°C 
overnight. Membranes were washed (40 mM NaPi/ 1% SDS) at 65°C until the 
desired signal remained. Generally this was 1 x 5 minutes, 1 x 20 minutes and I 
x 10 minutes. The membranes were exposed to photographic film at -80°C for 
the appropriate length of time depending on the strength of the signal. In some 
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cases the signal was visualised using the phosphoimager (Storm 860, Molecular 
Dynamics). 
	
2.2.18 	RNA preparation 
RNA was prepared from tissue culture cells using TRizo! (Total RNA Isolation 
Reagent) obtained from Invitrogen and carried out according to the 
manufacturer's instructions. If 1.5 x 106  DT40 cells were used, the pellet was re-
suspended in 20 il DEPC- treated water (0.1%) and heated to 50°C for 10 
minutes to re-suspend. 
2.2.19 	Bacteriophage lambda techniques 
In all, three bacteriophage lambda (X) libraries were screened, DT40 genomic 
library (Earnshaw laboratory), DU249 cDNA library (Earnshaw laboratory) and 
Xenopus cDNA library (Rabagliati et al., 1985). The techniques used for 
screening these libraries were identical, with the only difference being the 
bacterial cells used as shown in Table 2.9. 
Table 2.9. Cells used for library screens 
Library Cells 
Genomic DT40 (chicken cells) MRA-P2 
cDNA DU249 (chicken cells) XL 1-Blue MRF 
SOLR (for in vivo excision) 
cDNA Xenopus oocyte C600 
To plate the library, 4 LB agar texas (22 cm x 22 cm) plates were prepared with 
5 x 105 pfu of phage on each. These were then incubated at 37°C until separated 
plaques had formed - generally this took around 8 hours. 
Plating cells were grown with the addition of MgSO 4 (10 mM) and maltose 
(0.2%) to an OD600 = 0.5 prior to being spun down and re-suspended in 10 mM 
MgSO4 to an OD of 0.5. Plating cells (200 p1) were mixed with the phage and 
incubated at 37°C for 15 minutes. Normally, various dilutions of the phage stock 
were required and these were diluted in SM buffer (see Table 2.3) prior to 
incubation with the cells. To this, 3 ml of top agarose, previously melted and 
kept at 50°C until required, was added and the mixture poured quickly onto an 
LB agar plate, which had been previously dried and warmed at 37°C. 
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To titre phage, 6 x 10 fold serial dilutions of phage were prepared in SM buffer, 
using 1 p1 of undiluted, and then serial 10 fold dilutions, and plated out as 
described above. 
Plaque lifts were performed using nylon membranes. In the case of library 
screens, two membranes were lifted from each plate. This was to ensure the 
validity of any plaques picked by choosing only those that appeared on both 
membranes, 'double positives'. The membranes were placed on the plates for 2 
minutes, during which time marks were made with ink in order to orientate the 
membranes with the plates after hybridisation. The membranes were then 
transferred through denaturation (1.5 M NaCl, 0.5 M NaOH), neutralisation (1.5 
M NaC1, 0.5 M Tris-HC1 pH 8.0) and rinse solution (0.2 M Tris, 2 x SSC). The 
DNA on the membrane must first be denatured in order that the probe can 
hybridise and then subsequently it is neutralised. The membranes were then 
bloted dry on Whatmann paper before UV crosslinking (see section 2.15). 
Hybridisation was carried out as described in section 2.2.16 and 2.2.17. 
Positive plaques were picked from plates using a cut pipette tip. The plaques 
were put into 500 tl SM buffer plus 30 j.tl chloroform and vortexed. These were 
stored at 4°C for at least three hours to let the phage diffuse out of the plugs 
before plating. 
High titre stocks were prepared by scraping the top agar from a plate that had a 
high concentration of plaques and mixing this with an equal volume, (3 ml) of 
SM buffer, and 200 jtl of chloroform. After being incubated at 4°C for 3 hours, 
this was centrifuged at 3300 g for 15 minutes and the clarified solution was 
divided and stored both at 4°C and in 7% DMSO at -80°C. 
2.2.20 	Tissue culture techniques 
Various cultured cells were grown, Table 2.10 indicates these cell types and how 
they were cultured. All cells were grown in Iwaki plasticware. Cells were frozen 
down for both -80°C and liquid nitrogen storage in FBS + 10% DMSO. 
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Table 2.10. Tissue culture media 
Media 	- Supplier 
RPMI-1640 Gibco BRL 
L15 Sigma 
Trypsin Gibco BRL 
Glutamine Gibco BRL 
PBS-EDTA Prepared in lab, Duibeco's 
PBS plus 5 mM EDTA 
Fetal Bovine Serum (FBS) Sigma 
Chicken Serum Gibco BRL 
Optimem Gibco BRL 
Table 2.11. Cell types and growth conditions 
Cell type Description Medium Culture 
conditions 
HeLa Human, cervical cancer RPM! + 10% FBS 37°C, 5% CO2 
DU249 Chicken, embryonic RPMI + 10% FBS 37°C, 5% CO2 
hepatoma cell line  
MSB-1 Chicken, lymphoblastoid RPMI + 10% FBS 37°C, 5% CO, 
cell line  
DT40 Chicken, B - cell RPM! + 10% FBS + 1% 39°C, 5% CO2 
lymphoma chicken serum  
A6 Xenopus, normal kidney L 1 medium 25°C, 	sealed 
supplemented with 10% flask 
FBS and glutainine  
Table 2.12. Drugs used for DT40 selection 
Drug Final concentration for DT40 
selection 
G418 (Invitrogen) 2 mg/ml 
Histidinol (Sigma) I mg/ml 
Hygrornycin B (Calbiochem, info) 2.5 mg/ml 
Puromycin (Calbiochem) 0.5 p.g/rnl 
Blasticidin (Calbiochem) 25 jig/ml 
Zeocin (Invitrogen) 400 p.g/mI 
2.2.21 	Transient transfections 
Transient transfections were carried out using FuGENE 6 reagent (Boeringer 
Mannheim) according to the manufacturer's instructions. In summary, cells were 
plated out in 6 well plates and 97 p.1 of serum free medium was mixed with 3 p.1 
FuGENE 6 per well of cells to be transfected, and this was incubated for 5 
minutes at room temperature. This diluted FuGENE was then added dropwise to 
a separate tube containing 1-1.5 p.g of DNA and incubated at room temperature 
for 15 minutes. The DNA-FuGENE mix was then added dropwise to the cells. 
The cells were fixed after 24 hours to assess the phenotype by microscopy. 
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2.2.22 	Stable transfections 
DT40 stably transfected cell lines were generated by electroporation. 10 mls of 
approximately 1 x 106  cells per ml were centrifuged at 300 g for 5 minutes and 
then washed in either PBS or Optimem depending on the protocol to be 
followed. The protocol using Optimem resulted in a larger number of colonies 
being generated in the transfection. The cells were then centrifuged again at 300 
g for 5 minutes, re-suspended in 0.5 ml of either PBS or Optimem, and 
transferred to an electroporation cuvette (Bio-Rad, 0.4 cm). 20-25 p.g of 
linearised DNA was added to the cells and incubated on ice for 10 minutes, 
before being electroporated using the Gene Pulsar apparatus from Bio-Rad. If 
PBS was used, the electroporation conditions were, 550 V and 25 .tF on the 
bacterial plug. If Optimem was used, the electroporation conditions were 300 V 
and 950 pFD on the mammalian plug. The electroporated cells were then placed 
on ice for 10 minutes before diluting them in 10 ml of medium, plating them in a 
dish and incubating at 39°C for 24 hours. 
After 24 hours, the transfected cells were plated out in selective media at the 
concentrations shown in Table 2.9. 200 p.1 of cells were put into each well of 4 x 
96 well plates and then incubated at 39°C until the colonies were visible through 
the bottom of the plate. The colonies were then picked into 3 ml of medium 
without the addition of selective drugs and incubated at 39°C until confluent. 
2.2.23 	Immunofluorescence 
Many different cell types were fixed and stained for immunofluorescence using a 
range of different antibodies. Below is a summary of the protocols used. 
2.2.23.1 	Paraformaldehyde fixation 
Generally, cells to be stained for microtubules were fixed with 4% 
paraformaldehyde in cytoskeleton buffer (see Table 2.3 (Wheatley & Wang, 
1998)) in order to maintain the best morphology of the microtubules. The 
cytoskeleton buffer was preheated to 37°C before fixing cells for 10 minutes at 
room temperature. The cells were then washed 3 times in PBS and 
permeabilised in 0.15% Triton X-100 (Bio-Rad) in cytoskeleton buffer for 2 
minutes at room temperature. Again the cells were washed 3 times in PBS and 
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then blocked in 1% BSA (Sigma) in PBS for 1 hour at room temperature or 
overnight at 4°C. This fixation could also be carried out using PBS instead of 
CB. Both primary and secondary antibodies were diluted to the appropriate 
concentration (see Table 2.2) in 1% BSA in PBS and incubated at 37°C for 1 
hour. The DNA was then stained with DAPI (1 tg/m1 final) by incubation at 
room temperature for 10 minutes. The cells were mounted using Vectashield 
mounting medium (Vector). The cells were visualised using the NA 1.4 100 x, 
oil immersion lens on the Ziess Axioplan2 microscope and images captured 
using the Princeton camera and the IP Lab software. The images were then 
formatted using Adobe Photoshop. Where stated, the Deltavision deconvolution 
microscope was used. 
2.2.23.2 	Staining Xenopus cells 
Two Xenopus-specific protocols were attempted in order to stain A6 cells with 
anti-Zw 10. 
Fixation with methanol 
This protocol was used to successfully stain Xenopus cells with anti-Mad2 
antibodies. Initially the coverslips were rinsed in MMR (see Table 2.3), and then 
the cells fixed in a solution of 50% acetone/50% methanol at room temperature 
for 2 minutes. These were then rinsed in PBS four times before blocking and 
antibody incubation as described above. 
Fixation with paraformaldehyde 
This protocol was used to successfully stain Xenopus cells with anti-Bub3 
antibodies. As above, initially the coverslips were rinsed in MMR, then the cells 
were swollen in Hanks' Balanced salts (GibcoBRL cat. #24020-091) at room 
temperature for 10 minutes. The cells were then fixed in a 3% paraformaldehyde 
solution diluted in MMR for 10 minutes at room temperature. The cells were 
then rinsed twice in PBS before permeabilisation in 0.5% Triton X-lOO in PBS 
for 2 minutes at room temperature. The cells were then washed 4 times in PBS 
before blocking and antibody incubation as described above. 
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2.2.23.3 	Permeabilisation before fixation using TEEN buffer. 
This staining procedure was used in order to permeabilise the cells before 
fixation. In some cases this allowed the partial unmasking of antigens so they 
could be recognised by the antibody. The cells were initially treated with a 
permeabilisation solution of 0.5% triton in TEEN buffer (see Table 2.3) for 5 
minutes at room temperature. After washing 3 times in TEEN buffer the cells 
were then fixed in 4% PFA diluted in TEEN for 10 minutes at room temperature. 
The cells were then washed in PBS then blocked and incubated with primary and 
secondary antibodies as described in section 2.2.23.1. 
	
2.2.23.4 	Methanol fixation 
Cells were washed in PBS (prewarmed to 37°C) and then plunged into 95% 
methanol with 5 mN4 EGTA (pre-chilled to -20°C) and incubated for 10 minutes. 
Thereafter the cells were washed 3 times in PBS and then blocked and processed 
with antibodies as described in section 2.2.23.1. 
2.2.23.5 	Metaphase Spreads 
To block the cells in metaphase, cultures were treated with colcemid (Sigma, 0.1 
ig/m1 final) for 2-3 hours. During this time a 3:1 methanol:acetic acid fixative 
mix was chilled to -20°C and 75 mM KC1 was warmed to 37°C. 10 ml of cells 
were spun down at 300 g for 10 minutes, the medium removed carefully and the 
cells re-suspended in an equal volume (10 ml) of 75 mM KCI. The cells were 
then incubated at room temperature to swell for 8-10 minutes. It should be noted 
that changing this time can be crucial to the amount of swelling. The cells were 
then spun down again at 300 g for 5 'minutes and the supernatant removed. A 
few drops of the fixative mix were added and the tube vortexed in order to re-
suspend the cells with no clumps. The volume was then made up to the starting 
volume (10 ml) with fixative mix and incubated at room temperature for 15 
minutes. The cells were then centrifuged again at 300 g for 5 minutes, after 
which time most of the fix was removed, leaving only 0.5 ml in the bottom of the 
tube in which to re-suspend the cells. Cells were spread onto ethanol washed 
slides by dropping from a height of 10-20 cm. The spreads were checked under 
the microscope before staining. The cells could be kept stored in fixative at 
-20°C. 
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After dropping the cells onto the slides, they were left to dry briefly before being 
washed in PBS -for 5 minutes. The cells were then treated with 1 x TEEN (see 
Table 2.3) supplemented with 0.1% Triton X-100 and 1% BSA 3 times for I 
minute each. The primary antibodies were diluted in this buffer at the appropriate 
concentration (as shown in Table 2.2) and incubated at 37°C for 30 minutes. 
The slides were then washed with KB (see Table 2.3) for 2, 5 and 3 minutes, 
prior to incubation with the secondary antibody which was diluted in KB and 
incubated at 37°C for 30 minutes. The wash was repeated as above and the cells 
stained with DAPI and mounted as described in section 2.2.23.1. 
2.2.23.6 	Cytospin and KCM staining 
The cells were collected by mitotic shake off and centrifuged at 300 g for 8 
minutes. The medium was removed and the cells re-suspended in 10 ml of KC1 
(pre-warmed to 37 °C) and incubated at room temperature for 10 minutes. The 
cells were then centrifuged again at 300 g for 8 minutes and re-suspended in 4 ml 
KC1. 500 l.tl  of cells were used per slide for cytospining (Shandon, Cytospin 3) at 
800 rpm for 5 minutes. The cells on the slide were circled with a pen before 
incubating in KCM solution (see table 2.3) for 10 minutes. The primary 
antibody was diluted (see Table 2.2) in KCM with 10% Normal Goat Serum 
(NGS) and incubated at 37°C for 30 minutes. The cells were then washed 3 
times 5 minutes with KCM. The secondary antibody was also diluted in KCM 
with 10% NGS and incubated at 37°C for 30 minutes. After washing, 3 times for 
5 minutes each in KCM, the cells were fixed in 4% PFA in KCM for 10 minutes 
at room temperature. They were then washed, 3 times for 5 minutes in KCM, 
DAPI stained and mounted in Vectashield as described in section 2.2.23. 1. 
2.2.24 	WS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
Equipment - large gels 14 x 14 cm (Hoeffer SE 400 Sturdier Vertical Units). 
small gels 8 x 10 cm (Biorad Mini-PROTEAN II cell). 
The recipe for 20 ml of lower gel acrylarnide mix is shown in Table 2.13. 30% 
acrylamide/ bis acrylamide stock was purchased from Severn Biotech Ltd. The 
recipe for 10 ml of stacking gel, containing urea is shown in Table 2.14. 
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Table 2.13. Lower gel mix for SDS-PAGE 
- 7.5% 10% 12.5% 13% 13.5% 15% 16% 
1.5MTnspH8.8 5 m 5 5 5 5 5 5 
30% 	acrylamide/bis 5.4 6.7 
stock  
8.3 8.65 9 10 10.3 
20% SDS 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
H20 9.4 8.1 6.5 1 	6.15 5.8 4.8 4.5 
100 mM EDTA 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
10% APS 0.2 0.2 0.2 0.2 012 0.2 1  0.2 
TEMED 0.02 0.02 0.02 0.02 0.02 0.02 1 0.02 
All volumes are in ml. 
Table 2.14. Stacking gel mix for SDS-PAGE 
1 OmI 
Urea 4.8 g 
0.5 M Tris pH 6.8 2.5 
30% acrylarnide/bis stock 1.34 
20% SDS 0.05 
H20 6 
100mM EDTA 0.1 
10%APS 0.1 
TEMED 0.01 
All volumes are in ml. 
Cell extracts were prepared by centrifuging at 240 g for 5 minutes, washed in 
PBS and centrifuging again. The cell pellet was then re-suspended in sample 
buffer with -mercaptoethanol (see Table 2.3) and the sample sonicated 3 times 
for 10 seconds each using the micro-tip on setting 3 (Ultrasonic Processor, 
Misonix Incorporated). If to be stored, the samples were heated to 95°C for 5 
minutes and then stored at -20°C. All samples were heated to 95°C for 5 
minutes before loading on the gel and clarified by centrifugation if necessary. 
Protein markers, (Broad Range, 2-212 kDa) and prestained protein markers, 
(Broad range, 6-175 kDa), obtained from New England Biolabs, were loaded on 
all gels. 
Mini gels were generally run at 200 V for around 45 minutes in running buffer 
(see Table 2.3). Large gels were generally run for a total of 90 mA hours, but 
this varied depending upon the percentage of the gel and the size of the protein to 
be analysed. 
2.2.25 	Coomassie Brilliant Blue R Staining 
In order to visualise proteins in the gel they were stained with Coomassie Blue 
R. A 5 x stock solution of 0.5% Coomassie Blue in methanol was diluted to 1 x 
in diluent (see Table 2.3) before use. The 1 x solution was added to the gel 
directly after running for 30 minutes or more on a rocking platform. The gel was 
then de-stained (see Table 2.3) for as long as necessary. For best results, the de-
stain was changed a number of times and a piece of exposed autoradiography 
film was used to soak up the Coomassie. In order to prevent the gel from 
cracking, during drying, it was immersed in a 10% glycerol solution for 15 
minutes. Gels were air-dried using the BioRad GelAir Dryer system. 
2.2.26 	Western Blotting 
SDS-polyacrylamide gels were transferred to nitrocellulose membrane 
(Amersham ECL). This was carried out using both wet and semi-dry transfer 
depending upon the experiment. Wet transfer was performed using the Biorad 
Trans-Blot Cell in transfer buffer (see Table 2.3) for 3.5 hours at 400 mA at 4°C. 
Semi-dry transfer was carried out using the same buffer in the Hoefer Semiphor 
Semi-dry transfer unit according to manufacturer's instructions. After blotting, in 
order to visualise the protein, the membrane was rinsed three times in dH 20 
before adding Ponceau S (0.1% Ponceau S, 5% acetic acid) for approximately 5-
10 minutes, after which time the membrane was rinsed in dH 2O. The addition of 
Ponceau was repeated as necessary in order to clearly see the protein markers. 
Finally, the Ponceau was rinsed off and the membrane either stored dry or 
prepared for antibody incubation. 
2.2.26.1 	Antibody detection by Enhanced Chem iluminescence (ECL) 
In order to decrease background, the membranes were first blocked with a 10% 
milk solution (dried skimmed milk purchased from Safeway) in PBS-Tween 20 
(0.05%). (PBS-T), for 30 minutes - 1 hour on a rocking platform at room 
temperature. Antibodies were diluted at the concentrations as shown in Table 
2.2. Different percentages of milk were used depending on the antibody ranging 
from 0.5% - 5%. This is due to the fact that some of the polyclonal antibodies 
used recognise non-specific bands and the addition of more milk during the 
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antibody incubation can help to decrease this background. In general, 
membranes were incubated with antibodies for 1 hour at room temperature and 
any differences to this are indicated in the text. The membranes were then 
washed with PBS-T, 3 times for 5 minutes each at room temperature, before the 
addition of secondary antibody. All secondary antibodies used for ECL detection 
were horseradish peroxidase (HRP) conjugated, diluted in PBS-T (see Table 2.2) 
and incubated with the membrane for 45 minutes at room temperature. The 
membranes were then washed again, as above, before visualizing with ECL 
(Amersham), according to the manufacturer's instructions and exposure to 
autoradiograph film. 
2.2.26.2 	Antibody detection by protein A -I 
Some of the antibodies used required detection using protein A J25I  rather than 
ECL. The membranes were initially blocked in PTX-BSA, (2.5% BSA solution 
in PBS + 0.2% Triton X-100), for 20 minutes at room temperature. The primary 
antibody, diluted in PTX-BSA, was added as described in section 2.26.1. The 
membrane was then washed 5 times for 3 minutes with Gerace buffer (see Table 
2.3). After this, the membrane was rinsed briefly in PTX, then a minimal 
amount of PTX-BSA was added and incubated at room temperature for 5 
minutes. The protein A 125I  was diluted 1:1000 into this solution and incubated 
with the membrane at room temperature for 30 minutes. The membrane was 
then washed 5 times for 3 minutes each with Gerace buffer, dried thoroughly on 
Whatmann paper and exposed to autoradiograph film at —80°C for the desired 
length of time. 
2.2.27 	Expression of recombinant proteins in Eschericia coil 
This protocol was used for the expression of tagged fusion proteins in E. coli 
following induction with IPTG. 
Following successful cloning into an expression vector, the plasmid was then 
transformed into competent BL21 cells following the protocol described in 
section 2.8. A single colony was then grown overnight at 37°C. The following 
day this culture was diluted 1:100 in superbroth medium and grown at 37°C to 
an OD 0 of 0.5. At this time, a imi sample was collected for analysis of the 
expression pattern before the induction by IPTG. Expression was then induced 
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by the addition of IPTO to the culture followed by growth of the culture for a 
further 3-4 hours at 30°C. In order to optimise the expression of the recombinant 
protein, the concentration of IPTO used (range 0.05 - 1 mM), the temperature 
(18 - 37C), and the time of induction can be varied. After induction, a further 1 
ml sample was collected and the remainder of the cells centrifuged at 3,300 g for 
15 minutes, the supernatant removed and stored frozen at -80°C if required. 
2.2.28 	Purification of GST fusion protein 
In order to purify recombinant GST fusion proteins from bacterial cells 
glutathione agarose beads were used. 
The bacterial cell pellet from a 50 ml culture was re-suspended in 600 tl of TEN 
(100 mM NaCl, 2 mM Na-EDTA, 20 mM Tris pH8.0), which was supplemented 
with the protease inhibitors, CLAP, PMSF and aprotinin in order to reduce 
proteolysis, and vortexed until easily pipettable. 200 t1 of lysozyme (5 mg/ml 
diluted in TEN) solution was then added and incubated on ice for 30 minutes. 
The cells were then sonicated 3 times for 10 seconds at setting 3 on the micro-
tip. Triton X-100 was then added to 1% final concentration and the cells 
centrifuged at 10,000 g for 5 minutes to remove the cell debris from the cytosolic 
extract. The supernatant was transferred to a fresh tube and glutathione agarose 
beads (glutathione agarose 4B, Amersham) were added. 50 .il of a 50% slurry 
(according the to manufacturer's instructions) was mixed with 200 il 
supernatant and this was incubated on a rotating wheel for 1 hour at 4°C. After 
this time, the beads were washed 3 times with TEN + 0.5% Triton-X 100. The 
fusion protein could then be eluted from the beads by boiling in sample buffer or 
eluted with 10 mM glutatione in TEN with the pH adjusted to 8.0, the same bead 
volume was added and 4 elutions were collected. 
The eluted protein was then quantitated using the BioRad Protein Assay (Dye 
Concentrate cat# 500-0006) at 0D 595 and, if necessary, concentrated by spin 
column (Ultrafree concentrator devices purchased from Millipore cat# UFV5 
BGC25). 
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2.2.29 	Preparation of recombinant protein as antigen for 
immunisatior 
Recombinant protein was purified as described in section 2.2.28 and run on an 
SDS-polyacrylamide gel. A comb with only one wide tooth was used so the 
largest possible amount of protein could be run. Initially the gel was washed in 
dH2 O, 3 times for 10 minutes each. The gel was then stained with aqueous 
Coomassie blue (0.1 % Coomassie in 1 x running buffer without SDS (section 
2.2.24). After visualisation of the band, the gel was dc-stained with running 
buffer without the addition of SDS. The protein band was then cut out using a 
scalpel and ground up in liquid nitrogen using a pestle and mortar. The gel band 
was ground to a powder fine enough that it could pass through a syringe so that it 
could be injected into the rabbit. The ground powder was then placed in a tube 
and an equal volume of PBS was added. This was stored at -80°C until required. 
2.2.30 	Affinity purification of antibody from serum 
2.2.30.1 	Purification against specific peptide 
This was carried out in order to increase antibody specificity. The fusion protein 
used to generate the antibody was run on an SDS -poly acrylamide gel as 
described in section 2.2.30. This was then transferred to nitrocellulose 
membrane and stained with Ponceau S as described in section 2.2.27. The band 
was then cut from the membrane and blocked in 5% milk PBS-T as described in 
section 2.2.27. After washing the membrane with PBS the nitrocellulose was cut 
into small pieces and transferred to a 2 ml eppendorf tube. The membrane was 
then incubated with undiluted serum from the immunised rabbit for 2 hours at 
room temperature, the serum was then removed and kept to test the level of 
depletion from the serum. The membranes were then washed with PBS to 
remove the serum. The washes were later assayed for the decrease in protein 
concentration indicative of the serum being removed. Once washed, the protein 
was eluted twice in 100 mM glycine, pH 3.0 for 20 minutes at room temperature. 
This was then neutralised with Tris pH 8.8, and the protein concentration 
assayed by Bio-Rad assay as described in section 2.2.29. If necessary, this was 
concentrated using a spin column as described in section 2.2.29. The antibody 
was then stored at 4 °C or diluted 1 x in glycerol and stored at —80°C. 
2.2.30.2 	Purification of antibody using Protein A 
In some cases it was found that purification of serum from an immunised rabbit 
over a protein A column decreased the background signal of the antibody. 1 ml 
of Affi-Prep Protein A matrix (Bio-Rad #156-0005) was added to a column. This 
was then washed with 5 x column volumes of 100 mM Tris, pH8.0. 1/10 volume 
of 1M Tris, pH 8.0 was added to the rabbit serum (1 ml) and this was then passed 
over the column 5 times. The column was then washed with 5 x column 
volumes of 100 mM Tris, pH 8.0 and 5 x column volumes of 10 mM Tris, pH 
8.0. The antibody was then eluted with 100 mM glycine, pH 3.0 in small 
aliquots (200 ml) into eppendorf tubes containing 1/10 volume 1M Tris, pH 8.0 
in order to neutralise the antibody. The protein concentration was then 
determined by Bio-Rad assay and concentrated using a centrifugal concentrator 
if necessary. The antibody was stored at 4°C or diluted 1 x in glycerol and stored 
at —80°C. 
2.2.31 	Making Xenopus Iaevis egg extracts 
Xenopus iaevis extracts were made according to protocols (Murray, 1991). The 
solutions required and a brief description of the procedure are described below. 
PMSG - Pregnant Mare Serum Gonadotropin 
HCG - Human Chorionic Gonadotropin 
Cytochalasin B - 10mg/mi in DMSO stored at -80°C. 
The frogs were primed for ovulation by injection of PMSG, 50 units on day 1 
and 25 units on day 3. They were then induced to ovulate between day 5 to day 
12 with 150 units HCG. At this time, the frogs were placed in containers with lx 
MMR and kept at 16°C. Generally, the frogs took around 14 hours to lay. Both 
laid and squeezed eggs were used, however, freely laid eggs were checked in 
case lysis had begun to occur and discarded if necessary. The eggs were then 
washed several times in MMR to remove any skin or other contaminants. 
Initially, the eggs were incubated in dejellying solution, which was changed 
several times until all eggs were dejellied and packed tightly together. The eggs 
were then washed 4 times in XB, then 2 times in CSF-X13 with the addition of 
protease inhibitors, PMSF and CLAP mix (see Table 2.3). The eggs were next 
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transferred to a centrifuge tube using a cut pipette tip in order to prevent 
disrupting the eggs. CSF-XB with CLAP and cytochalasin B at 100 .tg/m1 were 
added, in order to depolymerise the actin cytoskeleton. A packing spin at 1000 
rpm for 1 minute and 2000 rpm for 30 seconds was performed in the Heraeus 
benchtop megafuge 1 OR. The CSF-XB was removed from on top of the eggs, 
which were then centrifuged at 10,000 rpm in the SW55 rotor of the Beckman 
ultracentrifuge for 10 minutes in order to crush them. This resulted in 3 layers, 
bottom-yolk, middle-cytoplasm and top-lipid. The cytoplasmic layer was then 
collected by inserting a needle and syringe at the bottom of the straw-coloured 
cytoplasmic layer. CLAP (1000x), cytochalasin B (10 tg/ml final) and 1/20 
volume CSF energy mix were then added to the extract and it was kept on ice or 
stored at -80°C. This was the starting material for both SDS -poly acrylamide 
gels and immunoprecipitation. For sucrose gradients it was necessary to 
centrifuge at 70,000 rpm for 30 minutes at 4°C to generate a purified high speed 
supernatant. 
2.2.32 	Immunoprecipitation from Xenopus egg extracts 
Immunoprecipitation (IP) from Xenopus egg extracts was performed using 
protein A agarose beads (Biorad). These were initially washed in PBS and then 
in CSF-X13 (with protease inhibitors, CLAP, PMSF and aprotinin, see Table 
2.3). The antibody or control pre-immune serum was bound to the beads by 
incubation with rotation for 1 hour at 4°C. Generally, 20 jil beads was mixed 
with 5 p1 of serum. The beads were washed 3 x with CSF-XB to remove the 
unbound antibody. 40 t1 of extract was added to the beads, and the total volume 
made up to 100 tl with CSF-XB (plus protease inhibitors). The beads and 
extract were then incubated together on a rotating wheel for 1 hour at 4°C, after 
which the beads were washed, 3 x with XB, 1 x with XB + 0.2% Triton X- 100, 1 
x XB + 0.5 M NaCl. Sample buffer was then added to the beads, boiled and 
loaded on an SDS-polyacrylamide gel. In order to assess the effectiveness of the 
immunoprecipitation, the starting extract, supernatant after binding to the beads 
and the washes were also loaded on the gel. 
In addition to the protocol set out above, some changes were made to the buffers 
used. In some experiments the extract was incubated with the beads in RIPA 
buffer (PBS with 1% NP40, 0.5% sodium deoxychiorate and 0.1% SDS), and 
72 
then washed in either XB as described above, or a Tris Buffer (50 mM Tris pH 
7.4 and 500 mM NaC1). In other experiments, the extract was incubated with the 
beads in XB buffer and then washed in either XB or Tris buffer. 
In an additional modification of the protocol the antibody was first incubated 
with the extract in the presence of protease inhibitors for 30 minutes at 4°C on 
the rotating wheel. The protein A beads were then added and incubated for 1 
hour at 4°C. The protein A beads were then washed with XB as described 
above. 
2.2.33 	Sucrose Gradients 
To examine whether proteins were present in a complex, Xenopus egg extracts 
were separated on sucrose gradients and then blotted to discover if proteins were 
present in the same fractions. 
A stock solution of 66% sucrose in water was prepared, the appropriate weight 
of this was then diluted in 1 x CSF-XB with CLAP. Table 2.15 shows the 
weight of 66% sucrose need to make 10 ml of each solution. 
Table 2.15. Weight of 66% sucrose need for 10 inl of solution. 
Final % w/w 
sucrose solution 















5-20% sucrose gradients were prepared in two different ways, the first used 5, 
10, 15 and 20% solutions which were layered underneath, i.e, 5% first, then 10% 
underneath, etc. 2 ml gradients were formed, by allowing them to diffuse for I 
hour, 50 minutes at room temperature and the last 10 minutes at 4°C. 
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The second method involved using the sucrose solutions shown in Table 2.16, to 
make either 5 --20 or 10 - 40% gradients. The volumes used are shown to make 
a 2 ml gradient. As above the solutions were layered underneath. These gradients 
were left to form for 16 hours at 4°C. 100 .t1 of clarified high speed supernatant 
from Xenopus extract (see section 2.3 1) was loaded on each gradient and then 
spun in the Beckman Ultrtacentrifuge, rotor TLS 55 at 53,000 rpm for 4 to 5.5 
hours at 4°C depending on the gradient and experiment being carried out. 
Protein standards, BSA (4S) and catalase (I IS ), were also run on a parallel 
gradient. 
Table 2.16. Volume of sucrose solution needed for indicated gradient 
5-20% Volume 10-40% Volume 
2% 0.4 ml 8% 0.4 ml 
12.5% 0.6 ml 25% 0.6m1 
17% 0.6 ml 35% 0.6 ml 
22% 0.4 ml 42% 0.4m1 
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Chapter 3 
Cloning and Characterisation of Chicken BubRi 
3.1 	Introduction 
BubRi is a mitotic checkpoint kinase that has been identified in a number of 
species including human, Drosophila and Xenopus. The aim of this work was to 
identify and clone the cDNA of this kinase in chicken (Gallus gallus), in order 
that antibodies could be generated and used for biochemical experiments in 
chicken cells. More specifically the aim was to generate a stable MSB 1 (chicken) 
cell line that expressed BubRi with a C-terminal HA-His fusion and then use 
this to investigate the kinetochore structure in vertebrates. BubRl is localised to 
the outer plate of the kinetochore (Jablonski et at., 1998) and therefore would be 
an ideal tool for purification of kinetochore-associated proteins by affinity 
chromatography or immunoprecipitation. A number of approaches could be 
used, such as immunoprecipitation with anti-BubRI or with anti-HA antibodies 
or nickel chelate chromatography using the His tag to pull down complexes after 
crosslinking BubR 1 to other kinetochore components. 
Chicken BubRi cDNA was cloned and sequenced and a rabbit polyclonal 
antibody was raised for immunolocalisation and biochemical studies. Sequencing 
of this cDNA revealed that chicken BubRi has a high degree of sequence 
similarity to other vertebrate BubRl proteins. In addition the antibody raised 
revealed that BubRi localises in a manner typical of other checkpoint proteins in 
chicken cells. 
3.2 Results 
3.2.1 Cloning chicken BubRl from a cDNA library 
Initially an EST was obtained from the Buerstedde DT40 (chicken cell) database 
designated dkfz426-4hz with the annotation mad3l/bubla (in the database' 
2 In this Thesis the term database refers to the NCBI sequence database unless otherwise stated. 
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human BubRi is also called Mad3L (Mad3 Like) and Bub la. The EST received 
in the Laboratory' was cloned into the pSPORT vector with an insert size of 
1.8kb. This EST was sequenced, as outlined section 2.2.9, and a small restriction 
map determined by digestion with Not I, Sal I, Hind III and Pst 1 (not shown). 
Sequencing revealed that this plasmid contained the 3' end of chicken BubRi 
and restriction mapping revealed that a 0.6 kb Hind IIIIEcoR I fragment was the 
most 5' sequence available. This fragment was therefore used as a probe to 
screen a cDNA library. The eDNA library used was made from DU249 cells, and 
cloned into XZAPII bacteriophage, and the screen was carried out as described in 
section 2.2.19. In total, 2 million phage were screened. From the primary screen, 
44 phage were identified as positive on duplicate membranes; 10 of these were 
subsequently taken through to a secondary, and 9 to the tertiary screen before in 
vivo excision was carried out. This resulted in the cDNAs being recovered as 
pBluescript phagemid vector inserts. These cDNAs were initially investigated 
by restriction digest as shown in Figure 3.1. Digestion with the enzymes EcoR I 
and Xho I present in the polylinker of pBluescript released the cloned inserts. By 
adding up the sizes of the bands generated after digestion, it was possible to 
determine that four were potentially full length, CI-15, C3-5, C3-9 and C4-16. 
Since the human and mouse full length cDNAs in the database are in the region 
of 3.5 kb it seemed reasonable to estimate that the cDNA clone would be 
approximately 3.5 kb in length. 
Initially the 5 and 3' ends of these four clones were sequenced using the T3 and 
T7 primers. Although all clones contained the 3 end of the gene, as expected, 
not all were the same in their 5' region. Sequencing of clones C 1-15, C3-5, C3-9 
and C4-16 revealed that they were all either full length or nearly full length. In 
order to establish if the most 5' end of the gene had indeed been cloned, 5' RACE 
(rapid amplification of cDNA ends) was carried out, (see Figure 3.2A for 
explanation). Initially this was carried out on DT40 (chicken cell line) RNA and 
a band of approximately 300 bp was generated (Figure 3.2131). This was the 
expected size according to the region where the primers had been designed and 
based on the fact that the clones identified from the library screen were indeed 
full length. This PCR product was cloned and sequenced and found to be 
identical to the longest clones from the library, when compared to the human 
In this Thesis the term Laboratory refers to the Laboratory of Professor William Earnshaw 
Wellcome Centre for Cell Biology, ICMB, University of Edinburgh., 
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BubRi sequence at the 5 end it can be noted that this sequence is shorter by 14 
amino acids (Figure 3.2C). In order to further verify whether this was the ATO, 
the 5 RACE experiment was repeated on DT40 cells and in addition on two 
other chicken cell lines, MSB 1 and DU249. As shown in Figure 3.213ii, a similar 
size product was generated from all three cell lines and upon sequencing these 
were all found to be identical. A comparison of the 5 UTR sequences from 
human, mouse, Xenopus and chicken is shown in Figure 3.2C, and although 
these differ in length, the clustal alignment shows that certainly the chicken and 
Xenopus sequences are very similar in this region. In addition the Kozak 
sequence was investigated. This is the sequence immediately upstream of the 
initiation codon which acts as a signal for the initiation of translation. The work 
of Kozak (1987), identified a consensus sequence of GCCA/GCCATGG, with 
the most conserved nucleotide being at position —3, which is nearly always a 
purine and most commonly alanine (Kozak, 1987). From the data shown in 
Figure 3.2C it can be seen that although the sequences do not conform closely to 
the consensus they all have A at position —3. In conclusion the ATG of chicken 
BubRi was identified as shown. 
The full length cDNA sequence of chicken BubR 1 was determined and found to 
be 3711 bp in length with the ATG-STOP being 3264 bp, the ATG at position 48 
in the sequence (start of transcription is zero) and the polyadenylation signal at 
position 3660 as indicated. This sequence is shown in Appendix 1. The sequence 
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Figure 3.1 cDNA library screen for chicken BubRi. Nine clones isolated from cDNA screen were 
digested with EcoR I and Xho I and run on a 1% agarose gel in order to determine the insert size of 
the clones. These clones were subsequently sequenced in order to determine which clones were full 





































—3OObp _____________ 	 cDNA clone 
m R NA 
Homo- 
polymeric 	. 	. 	 GSP1 - AT 
tail AAP 
4 4 GSP2-PCR1 
UAP 	4 .................................................... 4.. 	GSP3 - PCR2 
Figure 3.2. 5 'RACE and identification of the ATG of chicken BubRi. A, Schematic 
representation of 5 RACE reaction. Firstly eDNA is synthesised from RNA using reverse 
transcriptase from a gene specific primer (GSP1). This cDNA is then tailed and this tailed 
product can be amplified by PCR using GSP2 and a primer to the homopolymeric tail. A 
second round of amplification was then carried out using GSP3 in order to generate a visible 
product. B, 5 RACE was carried out on DT40 cells, resulting in a PCR product of around 300 
bp (I), subsequently this was repeated on DT40 cells and two other chicken cell lines, CHEPS 
and MSB-I. All cell lines gave a similar sized product (ii), and when sequenced were found to 
be identical. 
79 
Figure 3.2 Continued 
Chicken BubRi 
TTC GCG CGG TCG CCT GAG AGC TGG GGC TGC GGC GCT CAG AGC TTG AAG ATG TCA CGG GAC 
F 	A 	R 	S 	P 	Q 	S 	W 	G C 	G A 	Q S 	L 	K 	M 	S 	R 	D 
GGT GAC GAT GAG TGG GAG CTG AGC AAG GAG AAC GTG CAG CCG CTG CGG CAG GGC CGG GTC 
G 	D 	D 	E 	W 	E 	L 	S 	K E 	N V 	Q P 	L 	R 	Q 	G 	R 	V 
Human BubR]. 
TTG TTA GGG AGT CGT GTG CGT GCC TTG GTC GCT 'IT GTA GCT CCG AGG GCA GGT TGC 
L 	L 	G 	S 	R 	V 	R 	A 	L V 	A S 	V A 	P 	R 	A 	G 	C 
GGA AGA AAG CCC AGG CGG TCT GTG GCC CAG AGG AAA GGC CPG CAG CAG GAC GAG GAC CTG 
G 	R 	K 	P 	R 	R 	S 	V 	A Q 	R K 	G L 	Q 	Q 	D 	E 	D 	L 
AGC CAG GM TGC AGG A'-'G GCG GCG GTG AAG AAG GAA GGG GGT GCT CTG AGT GAA GCC ATG 




GAA CTT GGC GGC CCT TGC GTG ATG GGG CGT GAG GTG GCT ATT CTG AGA AGG AGT CGG ATG 
E 	L 	G G 	P C 	V M 	G 	R 	E 	V 	A 	I 	L 	R 	R 	S 	R 	M 
CGT GGT TTT GTT TAG GAG CAC GGG GTG ACG ATC TPC GCA GCT CCA GAG CCA GCT GAA GGT 
R 	G 	F V 	* E 	H G 	V 	T 	I 	F 	A 	A 	P 	E 	P 	A 	E 	G 
TGA GGG GGG CTC AGT TAG CAC TCG GAG GAT AAA GGT CTG CGG AAG GGC GAG AGC AAG TAT 
* 	G 	G L 	5 * 	H S 	E 	D 	K 	G 	L 	R 	K 	G 	E 	S 	K 	Y 
TGG GAA TGC AGG ATG GCG GAG GCG AGT GAA GCC ATG TGC CTG GAG GGA GCA GAG TGG GAG 
W 	E 	C R 	M A 	E A 	S 	E 	A 	M 	C 	L 	E 	G 	A 	E 	W 	E 
Zenopus BubRi 
GGAG TTT GAA TGT GCC GAA AGC GGG CGA GAC GGA GGA CAG TGG CGA AGT GTT AGA GTA CCT 
E 	F 	E C 	A E 	S G 	R 	D 	G 	G 	Q 	W 	R 	S 	V 	R 	V 	P 
GAC CGG AGT TTG AAT GTG CCG AAA GCG GGC GAG ACG GAG GAC AGT GGC GAA GTG TTA GAG 
D 	R 	S L 	N V 	P K 	A 	G 	E 	T 	E 	D 	S 	G 	E 	V 	L 	E 
TAC CTG ACC AT• 	GCA CAA GCT GGA GAT GAA TGG GAG CTA AGC AAA GAA AAT GTG CAA CCC 
Y 	L 	T M 	A Q 	A G 	D 	E 	W 	E 	L 	S 	K 	E 	N 	V 	Q 	P 
D 	 * ********.*++*-**.*#** + 
Chicken --------------- 
Xenopus -------------- Qi&—DEWEL SKENVQPLRQ&RVtISTLQEVL 
human 	 &G-AL SEAtISL E&—DEWEL SKENVQFLI&Rfl1STLQC4JA 
mouse ------- WEhSEt1' LEG—kEWEL SKENIQPLRH&RVL1STLQ&1LA 
Figure 3.2 Contiwied. C, Sequence comparison between the 5' UTR sequence of chicken, human, 
mouse and Xenopus is shown, with the Kozak sequence underlined and ATG indicated in red D, A 
clustal alignment of the amino acids at the N-terminus of BubRi are shown, indicating that chicken is 
most similar to the Xenopus protein in this region. Key to Clustal symbols, * - amino acid fully 
conserved, strong group fully conserved, STA, NEQK, NHQK, NDEQ, QHRK, MILV, MIL, HY, 
FYW, . Weaker group fully conserved CSA, ATV, SAG, STNK, STAP, SGND, SN1)EQK, 
NDEQI-[K, NEQHRK, FVLIM, HFY. Colouring of Clustal alignment Blue: AFILMVW, Purple: ED, 
Green: NQST, Yellow: P, Orange: G, Red:KR, Turquoise: YH, Salmon: C. 
C 
EIIJ 
3.2.2 Chicken BubRi shows sequence similarity to other vertebrate 
BubRi's. 
Cloning and sequencing revealed that the chicken BubRi cDNA encodes a 
protein of 1085 amino acids. Sequence analysis reveals that the protein is highly 
homologous to other vertebrate BubRis over its entire length. The clustal 
sequence alignment between human and chicken BubR 1 shows that the proteins 
are 52% identical and 79% similar (Figure 3.3A). It was possible to identify 
various domains within the chicken sequence as indicated in Figure 3.313. These 
were the putative destruction box, the putative nuclear localisation signal and the 
kinase domain, with the active site. In addition a putative KEN box has been 
identified at amino acid position 13. This motif has a function similar to the 
destruction box, which signals proteins for destruction by the APC (Pfleger & 
Kirschner, 2000), the difference being that the cdc20 activating subunit 
recognises the destruction box, whereas cdhl recognises the KEN box, as 
discussed in Section 1.8.10. It is known that BubRl contains a putative 
destruction box as shown in Figure 3.3, which is not present in Bubl. A 
comparison between these two Bubi proteins in mouse and how they may be 
targeted for destruction is discussed by Davenport et al.,. The authors conclude 
that Bubib (BubRi) in mouse may be targeted for destruction by the APC/C 
after it is released from the chromosomes, but since Bubl does not contain a 
destruction box it must be degraded by other means (Davenport et al., 1999). 
Since it is known, that in organisms ranging from Drosophila to humans two 
closely related proteins, Bubi and BubRi, are present, it was also important to 
demonstrate that the cDNA cloned did indeed encode for chicken BubRi rather 
than Bubl. Sequence comparison revealed that the overall sequence similarity 
between the proteins was 21% for the gene cloned versus human Bubl and 52% 
versus human BubRl. This evidence, along with a detailed comparison between 
the known homology domains of BubRi as shown in Figure 3.4, led to the 
conclusion that the cloned cDNA does indeed encode for chicken BubRl rather 
than Bub I. 
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Figure 3.3 Comparison of human and chicken BubRi sequence. A, Clustal alignment of human (hs) and chicken (gg) BubRi sequence, overall 
00 	similarity is 79% and identity is 52%. The putative KEN box is shown at position 13, putative destruction box at position 214, and putative nuclear 
localisation signal at position 403, all these domains are conserved as compared to the human sequence. The kinase domain with the active site, 
lysine 830, is indicated (red asterix).B, Diagram showing the domains as in A, including the region used to generate the polyclonal antibody is also 
(aa653-778). Key to Clustal symbols, * - amino acid fully conserved,: strong group fully conserved, STA, NEQK, NHQK, NDEQ, QHRK, MILV, 
MIL, HY, FYW, . Weaker group fully conserved CSA, ATV, SAG, STNK, STAP, SGND, SNDEQK, NDEQHK, NEQHRK, FVLIM, HFY. 
Colouring of Clustal alignment Blue: AFILMVW, Purple: ED, Green: NQST, Yellow: P. Orange: G, Red:KR, Turquoise: YH, Salmon: C. 
As mentioned previously BubRi is also referred to as Mad3L, due to the fact that 
it shares regions of homology with the S. cerevisae protein Mad3. Figure 3.4 
shows a comparison of chicken BubR 1 in the homology regions 1 and 2 as 
described by Hardwick et al., 2000, and it can be seen that chicken BubRl is 
more similar to Mad3 than it is to human Bub I. 
3.2.3 Generation of an antibody to chicken BubRi 
To further characterise chicken BubR 1, polyclonal rabbit antibodies were raised 
to the protein. Since Bubi and BubRi have a high degree of sequence homology 
within some domains, (Figure 3.4 and the kinase domain), it was important to 
raise the antibody against a region of the protein that was not within these 
domains, in order to avoid cross reactivity (Figure 3.3). A fragment encoding 
amino acids 653-778 was therefore cloned into the vector pGEX-4T-1, which 
creates an N-terminal GST fusion protein. This cloning was carried out using 
primers HD1 and HD2 as outlined in Tables 2.7 and 2.8. After inducing the 
expression of this protein using IPTG in B121 cells the fusion protein was 
purified over glutathione agarose beads as described in Section 2.2.27 and 
2.2.28. The fusion protein expresses well as a protein of approximately 45 kDa 
(20 kDa for BubRl peptide plus 25 kDa for GST), as shown in Figure 3.5A. 
This protein was then prepared as described in Section 2.2.29 for injection into 
two rabbits. The bleeds were tested initially on immunoblots of whole cell 
lysates from chicken cells using ECL, as described in Section 2.2.26. A clear 
band of approximately 140 kDa can be seen by immunoblot on chicken MSB 1 
cells (Figure 3.5B) and DT40 cells (Figure 3.6B), which is not seen with the pre-
immune serum. The predicted molecular weight of chicken BubRl is 122 kDa, 
however, human BubRl migrates at 120 kDa and Xenopus migrates at 145 kDa. 
Subsequently, the antisera were also tested by immun fluorescence on various 
chicken cell lines including, MSB1 (Figure 3.7C), DU249 and DT40 (Figure 
3.5C), as described in section 2.2.23. The antibody worked well for 
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4. 	 +4- 	±4- 	+ 
PLIVQW±UI0LITQEV --- VLuICKDKVTh3-VEEFSFEEIRAEVY 	--- AEEEI 415 
?LQRVQ 	 433 
pVyQIIT1IlQEK[DCFKLIYCEDEE SGF'LEF SLEEVLLL SF1YVR---T111i- 401 
PVY1I1TP&FXFEBIVFNF1LIYPENDE ------ EFITEEILa&LYIQR --- GI{- 356 
SEY SVHS sLSKvrvEQv---v1YcIa.IRJ-E SEFSFEELRAQKYWRRKREQWTNEDRfl- 274 
Figure 3.4 Sequence alignment of chicken BubRi. A, Clustal sequence alignment showing homology regions 1 
and 2 (Hardwick et al., 20(X)) compared to chicken BubRi sequence. See Figure 3.2 for Clustal alignment 
symbol and colour explanation. 
BubRi localises at the kinetochores of cells in prometaphase and remains at this 
location until the kinetochores become attached to microtubules, at which time 
the signal can no longer be seen at any particular cellular location, but remains 
diffuse throughout the cell. 
To characterise this antibody further I was interested to address the question as to 
what happened to BubRi after treatment of cells with the microtubule 
depolymerising drug colcemid and the microtubule stabilising drug taxol 
(paclitaxel). To this end DT40 cells were treated with these drugs and the cells 
fixed and stained for BubR 1, in addition the cell extracts were immunoblotted. 
As shown in Figure 3.6A, cells treated with colcemid arrest at metaphase with 
unattached kinetochores that stain brightly for BubRi. This result is as expected 
based on the known localisation and role of BubRi in human cells (Chan et al., 
1998; Jablonski et al., 1998; Taylor et al., 1998). In the case of taxol treatment, 
the cells look very similar, with cells blocked in metaphase and kinetochores 
stained brightly for BubRi. Current models propose that Mad2 senses spindle 
attachment whereas BubRl senses tension at the kinetochore (Skoufias et al., 
2001). In the case of taxol treatment, the result is as expected, because although 
the microtubules are stabilised rather then depolymerised they are unable to 
generate tension at the kinetochore. Cells treated with the drugs were also 
subjected to immuoblotting using the anti-BubRi antibody (Figure 3.613). A 
protein of increased molecular weight can be detected in DT40 cells after the 
addition of these drugs and presumably activation of the spindle assembly 
checkpoint. This higher molecular weight protein could be a phosphorylated 
form of BubR 1, which has been previously reported in other systems once the 
spindle assembly checkpoint is activated (Taylor etal., 2001; Chen, 2002; Fang, 
2002). This is therefore further evidence that the antibody generated does indeed 
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Figure 3.5. Generation of an antibody to chicken BubRi. A, Expression and 
purification of amino acids 653-778 of chicken BubRI fused to GST. This purified 
protein is shown here run on a 12.5% SDS-polyacrylamide gel and stained with 
Coomassie blue, (i) initial purification, (ii) subsequent improved purification 
procedure. B, MSB-I cell extracts were subjected to 10% SDS-PAGE, transferred to 
nitrocellulose and blotted with anti-BubRi, the signal was detected using ECL. The 
antibody recognised a protein of approximately 140 kDa. 
(iv) 
Figure 3.5 Continued 
C 
DNA 	(1tUbUlifl 	BubRi 	 Merge 
DNA it-tubulin 
Figure 3.5 Continued. C, DT40 cells were fixed with paraformaldehyde and stained with 
anti-BubRi (red) and anti-alpha tubulin (green ). The DNA was stained with DAPI 
(blue). Scale bar is lOpim. Anti-BubRi stains these cells in a manner typical of other 
spindle assembly components with little or no staining in interphase (i), kinetochore 
localisation in prometaphase (ii) and (iii) and then diffusely throughout the cell during 
anaphase (iv). 
Figure 3.6 
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Figure 3.6 Chicken DT40 cells treated with cokemid or taxoL DT40 cells were either 
untreated or treated with 10 p.tM taxol or colcemid (0.1 p.tg/mI) for 3 hours. A, The cells were 
then fixed and stained for BubRi (red) and the DNA stained with DAPI (blue). Scale bar is 10 
Rm. B, Cell lysates were subjected to 10% SDS-PAGE, transferred to nitrocellulose and blotted 
with anti-BubRi. The signal was detected using ECL. 
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This antibody to chicken BubRi proved to be useful in a recent study. A novel 
constitutive ceniromere protein CENP-I was identified in chicken and disrupted 
in DT40 cells by gene targeting (Nishihashi et at., 2002). The work showed that 
this protein is essential for centrornere function and its absence caused cells to 
arrest at prometaphase with misaligned chromosomes. After a substantial delay 
the cells were able to exit mitosis without cytokinesis having occurred. Using 
the antibody I generated it was possible to show that BubRl was no longer 
associated with the metaphase chromosomes 60 - 72 hours after the addition of 
tetracycline (to shut off the expression of the rescue). This may explain why the 
cells were able to exit mitosis; either because the spindle assembly checkpoint 
was turned off, or because the compromised structure of the centromere was no 
longer able to bind checkpoint proteins. In addition, by using the BubRi 
antibody it was possible to show more specifically the localisation of CENP-I 
within the kinetochore. BubR 1 has been localised to the outer kinetochore plate 
by immunoelectron microscopy (Jablonski et al., 1998), so it was possible to 
state that CENP-I is localised in or near the inner plate since the signal for 
CENP-I was inside that of BubR 1. 
3.2.4 Expression of tagged recombinant BubRi in chicken MSB1 
cells. 
As mentioned in the introduction, the main aim of the identification of the 
chicken orthologue of BubRi was to use it as a tool to investigate the structure of 
the kinetochore in chicken cells. The cell line of choice was MSB 1, a chicken 
lymphoblastoid line, which grows easily and rapidly in culture since the cells 
grow in suspension rather than by adhering. It is possible to obtain a highly 
synchronous population of cells in mitosis by treating them with microtubule 
depolymerising drugs such as colcemid. Chromosomes can then be prepared 
from these cells and used as a starting material to purify kinetochore-associated 
proteins. Another additional advantage to studying the kinetochore in chicken 
cells is that the chicken karyotype consists of around 80 chromosomes meaning 
that there are more kinetochores per cell than in other cell lines. The aim of this 
project was to tag chicken BubRI with the HA-His epitopes, generate stable cell 
lines in which the expressed recombinant protein localised appropriately to the 
kinetochore, and then use biochemical means to purify the recombinant protein 
and other co-purifying components. The reason for using BubRl as the 'handle 
for this study was that it has been shown previously that BubR 1 is localised to 
the outer plate of the kinetochore by immunoEM (Jablonski et al., 1998). The 
initial plan was to chemically cross-link the tagged BubR 1 to proteins in physical 
proximity to it at the kinetochore. The chromosomes would then be run over a 
nickel column, under denaturing conditions, which would bind the His tag. After 
the reversal of cross-linking the proteins eluted from the column would be 
identified by mass spectroscopy. 
Full length BubRi (with the stop codon removed) was cloned into the vector 
pZeo SV2HA-His (constructed by S. Kandels-Lewis), which resulted in a C-
terminal tagged protein. This cloning was carried out using primers HD1O and 
HD  1 as described in Table 2.7 and 2.8. This plasmid was transfected into 
MSB 1 cells and initially resistant clones were screened by immunoblot using an 
antibody to the HA tag (monoclonal anti-HA 12CA5). Figure 3.7A shows the 
comparison of two cell lines, H4 and H22 which were expressing the HA tagged 
transgene to the control cell line M6 and wild type MSB I cells. The M6 cell line 
was generated by Ciaran Morrison and expresses the constitutive centromere 
protein CENP-C with a C-terminal HA-His tag. The expected size for tagged 
CENP-C is around 100 kDa as shown in Figure 3.7A. In total, 24 cell lines were 
screened and 11 found to be positive by immunoblot (not shown). Subsequently, 
the cells positive by immunoblot were screened by immunofluorescence to 
determine if the tagged BubRl was indeed localised correctly and had integrated 
into the kinetochore structure. Both chromosome spreads and colcemid treated 
cells were stained. As shown in Figure 3.713, the cell lines 1-14 and H22 did not 
show clear kinetochore localisation of the HA tag as in the control line M6. It 
was also determined that the HA antibody cross-reacts with the centrosome of 
wild-type MSB 1 cells, as shown in Figure 3.7C(i). A further example of clone 
H4 is shown in Figure 3.7D. However, although the endogenous BubR 1 could be 
detected at centromeres (Figure 17C(ii)), no specific kinetochore staining was 
seen with the HA-antibody. Unfortunately, I was unable to find any MSB1 cell 
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Figure 3.7 Generation of an MSB-i cell line expressing chicken BubRi with a C-terminal 
HA-His tag. A, Western blot showing the expression of the BubRi fusion protein as judged 
by anti-HA antibody, M6 is a control cell line expressing chicken CENP-C with an HA-His 
tag. B, Immunolluorescence on metaphase spreads prepared from these two cell lines using 








Figure 3.7 Continued 




Figure 3.7 continued. C, Immunoflourescence on wild type MSB-1 cells showing that the 
anti-HA antibody cross reacst with the centrosomes ( i), and anti-BubRi stains the 
kinetochores (ii). D, The HA tagged fusion protein cannot be detected at the kinetochores of 
colcemid treated H4 cells (green), although endogenous BubRi can (red). Scale bar is 10 Rm. 
Figure 3.7 Continued 
DNA 	 HA 	Merge 
DNA 	 crjp 
L.dlM 
Figure 3.7 continued. E, DT4U cell line translcctcd with chicken BubRi -HA -His construct. (I) 
Immunofluorescence with anti-HA showing kinetochore localisation. (ii) Double staining with the 
kinetochore marker CENP-C shows that the transgene does indeed localise specifically to the 




To further explore why no BubRi-HA-His MSBI cell line with the tagged 
BubRi correct localisation was generated, I used this construct in a different cell 
line. Subsequently, I have shown that this tagged BubRi construct is able to 
localise to the kinetochore in chicken DT40 cells, so it seems that the problem 
did not arise from the construct per Se. A DT40 cell line stably transfected with 
the same BubR 1-HA-His construct shows localisation at the kinetochore region 
as determined by the anti-HA staining (Figure 3.7E(i)) and co-localisation with 
CENP-C (Figure 3.7E(ii)), confirming that tagged BubRI can localise to the 
kinetochore. 
3.3 Discussion 
3.3.1 Cloning chicken BubRi 
Cloning the BubRl cDNA from the DU249 cDNA library was successful, and it 
appeared that of the nine clones taken to the tertiary screen four of these were 
full length. Sequencing of these clones revealed that the human cDNA is longer 
by 42 bp (14 amino acids) and initially this prompted the investigation of the 5' 
end of the gene further by 5' RACE. Analysis of three chicken cell lines, 
DU249, MSB 1 and DT40 revealed that the cDNA length and the position of the 
ATG was as initially predicted, and it appears that the human sequence is indeed 
longer at the 5' end (Figure 3.213). It is also encouraging to note the similarity 
between the chicken and Xenopus sequence which has recently been published 
(Chen, 2002). The genomic sequence upstream of the ATG was also analysed in 
order to identify a possible Kozak sequence (Figure 3.2C). These observations, 
in conjunction with that of the 5' RACE, lead to the conclusion that the ATG of 
chicken BubR 1 was correctly determined. Two other possible ways to determine 
the ATG would be primer extension or RNase protection. The RNase protection 
would only address however, if this was a potential ATG, rather than whether it 
was the actual ATG used. The most striking piece of evidence that this is the full 
length sequence is that the expressed protein was able to localise to the 
kinetochore of chicken cells (Figure 3.7E). As described in Section 3.2.4, the 
cDNA was tagged with HA-His at the C-terminus and this was transfected into 
cells. Although the MSB1 cell lines generated appeared to mislocalise tagged 
BubRl, when this experiment was subsequently repeated with DT40 cells, the 
recombinant protein appeared to localise correctly to the centromere. The 
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expression in DT40 cells was carried out as part of a separate study as outlined in 
Chapter 4. 
3.3.3 Sequence alignments of chicken BubRi protein 
Sequencing of the chicken cDNA allowed the comparison of this sequence to 
other related proteins in the database. As mentioned in the introduction, BubR 1 
(Bubi related) is also referred to as Mad3-like, as it was noticed that it shares 
homology domains with yeast Mad3 in addition to yeast Bubi (see Figure 1.5). 
BubRi is more similar to Mad3 in some domains, with the main difference 
between these two proteins being that Mad3 has no kinase domain. Comparison 
of the sequence similarity between the sequence that I cloned and the database 
sequences for human Bubi and human BubRi reveals that we can conclude this 
to be chicken BubRi since it not only has a higher degree of homology, but also 
shares several distinguishing features, including the putative destruction box, 
putative nuclear localisation signal and putative KEN box (Figure 3.3). In 
addition, comparison of the Drosophila Bub sequences that are now present in 
the database, reveals that the Drosophila sequence initially referred to in (Basu et 
al., 1999) is actually a BubRi orthologue rather than Bubi, as named (not 
shown). 
3.3.4 Generation of an antibody to chicken BubRi 
An N-terminal GST fusion on amino acids 653-778 was expressed and purified 
in order to raise polyclonal antibodies to chicken BubRl. Since BubRi has a 
closely related homologue in vertebrates, BubI, it was important to raise a 
specific antibody by avoiding conserved domains. The resulting antibody 
recognises a protein of approximately 140 kDa by immunoblot of chicken cells. 
In addition, an upper band, which is likely to be the phosphorylated form of the 
protein appears after activation of the spindle assembly checkpoint by treatment 
of cells with microtubule poisons. The antibody stains the centromere region of 
chicken cells at prometaphase, when they have unaligned or unattached 
kinetochores. As these kinetochores become attached and the cell proceeds from 
metaphase into anaphase, the specific kinetochore staining is lost. This 
localisation is typical for spindle assembly checkpoint components. DT40 cells 
were treated with colcemid and taxol in order to determine how the antibody 
would respond under conditions of checkpoint activation. As discussed, the 
phosphorylated form of the protein could be detected by immunoblot (Figure 
3.613), as previously shown in human (Taylor et al., 2001; Fang, 2002) and 
Xenopu.s (Chen, 2002) studies. After treatment with both of these drugs, the 
antibody brightly stained the kinetochore regions (Figure 3.6A), indicating that 
BubRi responds to spindle damage generated by both colcemid and taxol, and 
then contributes to the block in cell cycle progression. Current models suggest 
that BubRi and Mad2 recognise distinct signals at the kinetochore, with Mad2 
sensing attachment and BubRi sensing tension at the kinetochore (Skoufias et 
al., 2001). Since colcemid depolymerises microtubules and taxol stabilises them, 
both these drugs lead to a situation where the kinetochores are not under tension. 
Therefore both would be expected to recruit BubRito kinetochores, as is the case 
here. If an antibody were available to chicken Mad2, it would be possible to test 
the hypothesis that these proteins recognise distinct signals. However, an 
antibody to chicken Mad2 has not been raised, and the published human 
antibodies remain to be tested on chicken cells. These results demonstrate that 
my antibody recognises BubRl and that the localisation and behaviour of this 
protein is similar to that published previously for human BubR 1 and other 
spindle assembly checkpoint proteins. 
3.3.5 Expression of BubRi-HA-His construct 
The initial aim of cloning chicken BubRi was so that it could be used in 
biochemical studies of the vertebrate kinetochore structure. Unfortunately, it was 
not possible to generate an MSB 1 cell line with the appropriate localisation of 
the tagged BubRI and therefore this project was not undertaken. One possible 
reason that this construct did not localise correctly was that the cDNA was not 
full length. However, subsequent experiments with this construct in DT40 cells 
show that the protein it encodes can localise properly. Therefore, an alternative 
explanation is required to explain why it was not possible to generate the line in 
MSB 1 cells. It may simply be that not enough colonies were screened to detect 
this localisation. In addition, other work on the overexpression of recombinant 
BubRl in chicken cells has shown that it can be toxic or in some way detrimental 
to the cell (as discussed in Chapter 4). It may be that the stable cell lines were 
downregulating the BubR 1-HA-His expression so as to not have this effect. This 
biochemical approach was undertaken with a very similar strategy by a co-
worker Ciaran Morrison, using the constitutive centromere protein CENP-C as 
the handle'. A stable cell line was generated called M6 and the experiments as 
outlined above -  carried out. Unfortunately, those experiments did not yield 
promising results due to the fact that CENP-C was difficult to solubilise (Ciaran 
Morrison, personal communication). The crosslinking reagent used was sodium 
tetrathionate and this could potentially be further optimised. In addition the 
starting material of Percoll purified chromosomes rather than clusters may be a 
better approach. In order to solubilise the proteins from the chromosomes so they 
can be analysed by chromatography either treatment of the chromosomes with 
dextran sulphate and heparin or sodium chloride could be used. 
Since this cell line could not be generated it was decided to adopt alternative 
approaches in order to investigate the kinetochore structure and spindle assembly 
checkpoint in vertebrate cells. Two approaches were under taken, firstly to 
answer questions regarding the vertebrate spindle assembly checkpoint and in 
particular the role of BubRi, attempts were made to generate a conditionally null 
chicken DT40 cell line as described in Chapter 4. Secondly, the kinetochore 
structure was investigated by turning to the Xenopus egg extract system as 
described in Chapter 5. 
Chapter 4 
Generation of BubRi -i-I- DT40 cells 
4.1 	Introduction 
In order to further define the role of BubRi in mitosis the aim was to generate a 
chicken DT40 cell line that has a targeted disruption of the BubRi gene. 
One of the most powerful methods for analysing the function of a gene is to 
disrupt it or knock it out. In higher eukaryotic cells this technology is hampered 
by the fact that the homologous recombination frequency is usually low, 
although the length of homology greatly affects the efficiency of targeting (Hasty 
et at., 1991; Deng & Capecchi, 1992). For a number of years the analysis of gene 
function in mammals has been made possible by knocking out genes in mouse. 
In this model system one copy of the mouse gene is targeted by homologous 
recombination in ES (embryonic stem) cells and then germ line chimeras are 
generated by injection of targeted stem cells into blastocysts. The chimeric mice 
are then bred to homozygosity. However, if a gene function is essential, then 
this results in embryonic lethality, and analysis of any phenotype can be limited 
and difficult. In this case Cre-loxP technology can be used in order to 
conditionally knockout a gene in one particular tissue of the mouse (reviewed by 
(Porter, 1998)). The targeting construct is flanked by /oxP sites, and once the 
homozygous mice are generated they are crossed with a mouse containing the 
recombinase, Crc, under the control of a tissue specific promoter (for review see 
(Kuhn & Torres, 2002)). The resulting mouse then has the essential gene 
knocked out in one particular tissue and the phenotype can be analysed. 
A different approach to analyse the role of genes with essential, ubiquitous cell 
cycle functions is targeted disruption in cultured cells. For example, genes have 
been disrupted in several human cells lines, including the fibrosarcoma cell line, 
HT1080, (Itzhaki et al., 1997) and the colorectal adenocarcinoma line, HCT1 16, 
(Chan et at., 1999). Although human cell lines are perhaps the best system with 
which to study the roles of genes involved in human disease, few laboratories 
have successfully generated these cell lines, presumably partly due to the fact 
that homologous recombination frequencies are so low. 
4.1.1 DT40 cells 
The favoured model system in this laboratory for generating genetic knockouts is 
the chicken DT40 cell line. DT40 cells are chicken cells derived from an avian 
leukosis virus (AVL)-induced bursal lymphoma. The tumour was twice 
transplanted in vivo before culturing (Baba & Humphries, 1984; Baba et at., 
1985). DT40 cells continue to undergo gene conversion of the light chain 
variable region and for this reason the cells have the unique feature of very high 
levels of homologous recombination (Buerstedde & Takeda, 1991; Arakawa et 
al., 2002), with the targeted to random DNA integration ratio of more than 1:2. 
The result is vertebrate cells that can be used for gene targeting experiments, 
and, in addition essential genes can be targeted by using the tetracycline 
regulated promoter, recently reviewed by (Hudson et al., 2002). 
The technology of knocking out genes in DT40 cells has been particularly useful 
in the investigation of two fields of cell biology, namely DNA repair (for review 
see (Morrison & Takeda, 2000)) and apoptosis (for review see (Lahti, 1999)). 
The system is now being used to investigate genes important for centromeres, 
chromosomes and cell cycle progression. Genes essential for cell viability, 
studied to date include, CENP-C (Fukagawa & Brown, 1997), Rad2l (Sonoda et 
al., 2001), CENP-H (Fukagawa et at., 2001), CENP-I (Nishihashi et at., 2002), 
Cyclin Dl (Lahti et at., 1997) and SMC2 (D. Hudson, personal communication). 
DT40 cells have on average 80 chromosomes, 11 autosomes, the ZW sex 
chromosomes (female) and 67 microchromosomes (Sonoda et at., 1998). This is 
two more than in chicken (Gallus gatlus), due to trisorny of chromosome two 
and one additional microchromosome (Smith & Burt, 1998; Sonoda et at., 1998). 
In some cases this means that three (Lyn, (Takata et at., 1994) CENP-H, 
(Fukagawa et al., 2001)) or even four copies of the gene (CbI, (Yasuda et at., 
2000)) must be targeted. 
Homologous recombination of targeting vectors in mouse ES cells can range 
from 10.2  to 10 whereas DT40 cells are capable of undergoing homologous 
recombination at several orders of magnitude higher, with the typical frequency 
of homologous recombination with a disruption vector being between 10% and 
80% (Hudson et al., 2002) 
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Initially gene disruptions in this cell line focussed on non-essential genes, for 
example Rag-2, required for V(D)J recombination, (Takeda et at., 1992) and 
HMG-17 required for splicing of pre-mRNAs (Li & Dodgson, 1995). The 
technology was then developed to create conditionally null cell lines using the 
tetracycline operator system (Gossen & Bujard, 1992). This technology allows 
the cDNA of the essential gene being disrupted, to be expressed under the 
control of the tetracycline operator. The cells are transfected with both the cDNA 
under the control of the tet operator and the tetR fused to the VP16 minimal 
domain. The result is a cell line where the expression of the transgene can be 
repressed by the addition of tetracycline, or the more potent analogue 
doxycycline, to the cell. Initial conditional knockouts were rescued with the 
human cDNA, as in the case of ASF/SF2 (Wang et al., 1996) and Rad5l 
(Sonoda et al., 1998) and subsequent studies have rescued using the chicken 
cDNA. These include CENP-C, (Fukagawa & Brown, 1997), Rad2l (Sonoda et 
at., 2001), CENP-H (Fukagawa et al., 2001) and CENP-I (Nishihashi ci al., 
2002). Additional technology using the counter-selectable marker HRPT and 
Cre/!oxP techniques is being developed in DT40 cells (Fukagawa et al., 1999). 
Presently there are seven selectable markers, which can be used in these cells 
allowing for multiple knockouts to be performed in the same cell. However, ioxP 
flanked markers are also available so that this will not be the limiting step in the 
construction of multiple knockout lines. Other advantages to DT40 cells are that 
they grow in suspension with a doubling time of 8-10 hours at 39°C. They have 
no need for fibroblast feeder layers or LIF (Leukemia inhibitory factor) as ES 
cells do, and therefore are easier to culture, transfect and subclone. In addition, 
the cells can be grown between the temperatures of 34°C to 43°C, so can be used 
in the generation of TS (temperature sensitive) mutants (Fukagawa et al., 2001). 
There is a rapidly expanding database of chicken sequences now available, 
which makes the identification of chicken homologous of genes easier 
(http://genetics.hpi .uni-hamburg.de/dt4O.html).  
4.1.2 Tetracycline Operator System 
The tetracycline operator system can be used in order to assess the phenotypes 
generated by the removal of essential genes from DT40 cells. The tetracycline 
system is based on the regulatory elements of the E.coli tetracycline resistance 
operon (Tn 10) in which the transcription of the resistance-mediating genes is 
negatively regulated by the tetracycline repressor (tetR). In the presence of 
tetracycline, tetR does not bind to its operators located within the promoter of the 
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operon, and therefore allows trranscription. A hybrid transactivator (tTa) was 
generated which fuses retR (amino acids 1-207) with the negatively charged C-
terminal activation domain (130 amino acids) of VPI6 from HSV, which is 
known to be essential for the transcription of immediate early viral genes 
(Gossen & Bujard, 1992). The tetR moiety targets the tTa to the tet operator 
sequence, and then the VP16 domain recruits polymerase. The tTa stimulates 
minimal promoters fused to tet operator sequences and is virtually silent in the 
presence of low concentrations of tetracycline or doxycycline because the tTa is 
prevented from binding to the terO sequences. The system is represented 
schematically in Figure 4.1A, which shows that in a cell containing the tTa and 
the transgene under the control of the tel operator, this will be expressed until 
doxycycline is added. 
The system has been further modified to allow different levels of transcriptional 
activity by modification of the VP16 domain of the tTA vector. The tTa 2/3/4 
plasmids express tetracycline-controlled transactivators containing minimal 
VP16 activation domains (Baron et al., 1997). The minimal domains are 
shortened VP16 moieties composed of different combinations of 13 amino acid 
repeats which differ at one amino acid in the repeat. The repeat is 
PADALDDXDLDML with the variant amino acid X. tTa 2 has three copies of 
the repeat with F at this position. tTa 3 has two copies with F at this position, and 
tTa4 has three copies each with a different amino acid at position X; G, F and Y. 
These mutated VP16 domains do not bind as efficiently to the target thus 
reducing the relative transient activation to 98%, 39% and 14% for tTa 2, 3 and 4 
respectively. This is represented schematically in Figure 4.1B. In addition the 
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Figure 4.1 Tetracycline system A, Diagram of Tet Off system, see text for further details, 
(adapted from http: Ilgwebl .ucsf.edu/labs/conklin/TechnicallTetinmice. html). B Wild type 
tTA is a fusion of amino acids 1-207 of TetR and the negatively charged C-terminal 
activation domain (130 aa) of the VP16 protein of the herpes simplex virus. The shortened 
VP16 moieties in the VPI6 minimal domain vectors are composed of different 
combinations of 13-amino acid repeals that differ at one amino acid in the repeat. tTA is 
expressed from the strong immediate early promoter of cytomegalovirus (pCMV IE). The 
transient protein level and relative activation are shown, (adapted from Clonetech 
information on plasmids tTa2/3/4). 
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DT40 cells seemed to be an ideal system in order to study the role of a 
checkpoint protein such as BubRI, which is predicted to be essential based on 
the data from other checkpoint proteins, namely Bub3 and Mad2, which are 
essential in mouse. The analysis of the phenotype of disrupting these proteins in 
mouse was severely hampered by the early embryonic lethality, and, it was 
therefore hoped that the DT40 system would permit a clear analysis of the effect 
of disruption of BubR 1 on the progression of the cell cycle, the function of the 
checkpoint, the structure of the kinetochore and the effect on other checkpoint 
components including ZwlO and Rod. In addition, the system allows for the 
analysis of the domains of a protein by use of the tet system. For example, once 
the gene is removed then a kinase dead or otherwise mutant construct could be 
introduced into the cells and the phenotype analysed, following repression of the 
transgene. 
Initially, this project required the isolation of the chicken BubR 1 genomic locus 
in the form of a genomic phage, so that targeting vectors for this gene could be 
generated. Since I predicted the gene to be essential, the aim was to generate a 
conditionally null cell line. With the cDNA expressed under the control of the 
tetracycline promoter this could be switched off once both alleles of the gene 
have been disrupted, thus allowing a window of opportunity in which to 
investigate the phenotype of cells null for this central player in the spindle 
assembly checkpoint. 
42 Results 
4.2.1 Isolation of chicken BubRi genomic phage 
A total of two million phage were screened from the X Fix II DT40 genomic 
library using the probe described in section 3.2.1 and diagrammed in Figure 
4.213. Eleven phage were identified in the primary screen as double positives 
and these were taken through a secondary and a tertiary screen. After the 
successful cloning of the full-length chicken BubRi cDNA as described in 
section 3.2.1, these phage were then screened with a 5' probe, as shown in Figure 
4.2. This led to the identification of phage 3133, which was found to contain a 5' 
portion of the BubRl gene. Subsequently the library was screened again using 
the very 5' portion of this phage as a probe, which is just upstream of the ATG, 
and again the two positive clones identified were the same as 3133, suggesting 
that phage containing the region upstream of the BubR 1 genomic locus may not 
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exist in this library. Fig 4.213 shows a partial restriction map of phage 3133 and 
the probes used -for library screens. 
Partial mapping and sequencing of the ends of this phage revealed an 
approximately 18 kb insert that contains the ATG near its 5' end. It terminates in 
an exon encoding amino acid 703 (the full length cDNA is 1085 amino acids). 
In all, 8 exons were identified, five at the 5' end of the phage and three at the 3' 
end (exon I -48 to -8, exon II -9 to 144, exon III 145 to 202, exon IV 203 to 348, 
exon V 349 to 375, exon X 1586 to 1672, exon Y 1673 to 1775, exon Z 1776 to 
2062). Human BubRi contains 23 exons and spans a genomic distance of 
59.5kb. Comparison of the some of the human intronlexon boundaries with those 
identified here in chicken reveals that there is a high level of synteny between 
these genes, with the only difference being the size of the introns. As shown in 
Table 4.1 the introns are smaller in chicken, which has led me to suggest that the 
chicken BubR 1 genomic locus is likely to be in the order of 30-40kb. 
Table 4.1 	Analysis of synteny between human and chicken BubRi 




Chicken exon Exon length 
 (base pairs) 
Intron length 
(base pairs) 
1 34 I 40 
3798 93 
2 143 II 153 
4866 undetermined 
3 59 III 57 
416 268 
4 144 IV 145 
5796 865 
5 196 V 26* not full length 
13 60 X 86 
124 undetermined 
14 105 Y 82 
3490 308 






-- =r- - 
zz 
00 0 
i... 0 00 4... 
00 
0 EZc.n C.) c tjj cflc(I) 









	 1 kb 
- 
- 	
AE S B 	 BH 	E A S BAH N 
- 
5' probe 	 3' probe 
cDNA 	 - 
1 	 2 
ATG 	 STOP 
Figure 4.2 Mapping of genomic phage 3B3. A, Southern blots using 5' and 3' probes as 
indicated in B. Digestion with Not I releases the cloned insert from the phage arms. B, The 
restriction map was generated from the Southern blots in A. The probes 1 and 2, used for 
library screen are shown. The 5' probe used for the final screen is indicated on the 3B3 map. 
Key; A- Asp 718,B-DglII,BH-BwnHI,E-EcoRI,S-SpeI,N- Not l. 
105 
A basic restriction digest map was generated from phage 3B3 by Southern 
blotting, as detailed in sections 2.2.15-2.2.17, using double digests with Not I, 
and probes to both the 3' and 5' ends (Fig 4.2A). In parallel, the DT40 BubRi 
genomic locus was also mapped, using Southern blotting (Fig. 4.3A). There are 
some slight differences in the sizes of the fragments between the phage 3133 and 
the genomic locus, however, these are small and seem to be within the range of 
inaccuracy in the sizes as determined from the Southern blots. 
In conclusion, the phage 3133 and the BubRi genomic locus in DT40 cells have 
been mapped using the same 5' and 3' probes and it can be concluded that that 
they are isogenic. Therefore phage 3133, was used as the basis of the targeting 
vector for the disruption of the BubRi genomic locus in DT40 cells. 
4.2.2 Construction of targeting vectors 
The sequence contained within phage 3133 was used to generate both a 5' and 3' 
targeting arm and both 5' and 3' external probes for mapping the targeted locus. 
Initially a 5 kb Not IJEcoR I fragment from the 3' end of the phage was cloned 
into pBluescript. This was then used to generate both the 3' targeting arm and 
the 3' external probe. A convenient BarnH I site cut this into 3 kb and 2 kb, with 
the 3 kb being cloned into pBluescript as the 3' targeting arm and the 2 kb 
fragment to be used as the 3' probe. 
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Figure 4.3 BubRi genolnic Iocus.A, Southern blots of DT4() genomic DNA digested as indicated 
and probed with 5' and 3' probes as indicated in B. B, A map of the genomic locus was 
constructed and compared to that of 3B3. Key;A -Asp 718, B - Bg/II, BH -BwnH I, E - EcoRI, 
S - Spe 1, N -No!!. 
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To generate the 5' external probe and the 5' targeting arm, a PCR approach was 
adopted. A 383 bp PCR product corresponding to the most 5' region was 
generated, using primers HD21 and HD22 (Table2.8). This sequence terminated 
at the ATG and was used as the 5' external probe. This probe was then cloned 
into the pGEM-T vector. PCR primers were then designed to several sequences 
within the cDNA in order to generate a large enough fragment for the 5' 
targeting arm. A limitation to this method was that since this DNA region was 
not sequenced, the PCR products generated would be of unknown size. This 
PCR was carried out using TAKaRa taq, as described in the section 2.2.10, 
which is a mixture of Taq and the proof reading polymerase Pfu. In this case it 
was necessary to minimise the introduction of mistakes, since these may 
decrease the targeting efficiency of the construct. A product of 1.6 kb was 
successfully generated using primers HD7 and HD8 (Table 2.8), and cloned into 
the pBluescript vector already containing the 3' targeting arm. It was then 
necessary to clone the resistance cassette between these arms into the BarnH 1 
site. Both Puromycin (Puro) resistant and Histidinol (HisD) resistant vectors 
were generated. This vector was named KOV I (knockout vector 1), as shown in 
Figure 4.4. 
Since phage 3B3 does not cover the entire gene and only contains a small portion 
upstream of the ATG the vector will not remove the entire open reading frame of 
BubRl. This construct will delete a region from amino acid 67 to 529, removing 
in the order of 10.5 kb of genomic DNA. Figure 4.4 shows this targeting vector, 
the genomic locus and the screening strategy using the 5' external probe 
The targeting vectors containing the puromycin resistance cassette and histidinol 
cassette were transfected into wild type DT40 cells (C118), and the resistant 
colonies screened using a Bgl II digest and the 5' external probe. Table 4.2 
shows the results of this initial screen. 
Table 4.2 Initial screen with KOVJ 
KOV1 Number of clones screened Apparent number of +1.. clones 
HisD 80 3 
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Figure 4.4 Knockout vector 1. Schematic representation of phage 3133 including the exons identified, l-IV 
at 5' end and X, Y,Z at 3 end. This phage was the basis for knockout vector I (KOV1)as shown. Two 
knockout vectors were constructed one with the Puromycin and one with the Histidinol resistance 
cassette. The screening strategy from these vectors is shown using a Bgl II digest and 5 external probe.c 
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It can be seen from Table 4.2 that, in all, eight cell lines were generated which 
appeared to be targeted at the BubRi locus. An example of one of these clones, 
215, targeted with the puromycin vector is shown in Figure 4.5A. In order to 
further verify that these clones were heterozygote for the locus, the cells were 
thawed from -80°C, DNA prepared from them and then re-genotyped using the 
same strategy. The results of the Southern blots however, indicated that there 
was a problem or error since the cells no longer appeared heterozygote as shown 
in Figure 4.513. One potential source of this problem was that the probe might 
spuriously hybridise to another DNA species and give a false result (Figure 
4.5A). In order to check this, the targeting vectors were transferred to membrane 
and hybridised with the probe. Indeed the probe hybridised very strongly to 
these vectors (Figure 4.5C). One potential reason for this could be that the full 
length probe recognises some vector sequence. To make the probe more 
specific, it was cut in two by digestion with Psi' I, generating a 5' 212 bp 
fragment and a 3' 171 bp fragment. These smaller probes were then labelled and 
tested to see if they hybridised to the vector (Figure 4.513). 
These both hybridised, but to a lesser degree than the full length probe. It seemed 
possible, therefore, that the problem was due to some cross reactivity between 
probe and vector sequence. Since the probe was cloned into pGEM-T it was 
being prepared for labelling by digestion and then extraction from an agarose 
gel. Although the contamination of uncut DNA containing polylinker sequences 
should have been removed by this protocol, this may be one explanation for this 
cross hybridisation. In order to avoid this problem, the probe was generated 
again by PCR, then gel extracted and labelled. A comparison was made between 
these two probe preparations as shown in Figure 4.5E. This led to the conclusion 
that the probe cut from the pGEM-T vector hybridises to the integrated targeting 
vectors in the clones which were apparently identified as heterozygotes in the 
initial screen. In the case of the smaller probes, the cleaner result may arise from 
the fact that a further digestion and gel purification has been carried out. When 
the membrane shown in Figure 4.5A was stripped and re-hybridised with the 
probe generated by PCR rather than digestion it was seen that the upper, 
'targeted' band disappeared as shown in Figure 4.5F. It is theoretically possible 
that multiple arrays of the targeting vector could be integrated randomly in the 
genome and when cut by Bgl II result in a band of approximately 9.5 kb as 
illustrated in Figure 4.5G. This may also explain why the band is unstable and 
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Figure 4.5 Investigation of cell line 251 A, Southern blot showing wild type and targeted allele (251) 
using 5 probe and BgI II digest as indicated in Figure 4.4. B, Southern blot showing that clone 251 
appears to have a different pattern of bands on another blot using the same probe. C, Southern blot of 
linearised targeting vectors (10 ng), HisD and Puro, probed with 5' probe. D, Southern blot of wild type 
DT40 DNA and Puro targeting vector digested with Bgl II and probed with the two portions of original 5' 
probe, 5' most (left) and 3' most (right), generated by PCR and then digested with Psi I to make 212 and 
171 bp fragments E, Southern blot of wild type DT40 DNA and Puro targeting vector, probed with the 5' 
probe generated by either PCR or digestion from pGEM-T plasmid. F, Southern blot as in A which has 
been stripped and re-probed with the 5 probe generated by PCR rather than digestion. G, Model 
indicating possible tandem integration of Puro targeting vector and the resulting 9.5 kb band after BgI II 
digestion. 
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4.2.2.1 	Generation of a Rescue construct 
Since it now appeared that it had not been possible to target the BubRi locus 
with KOV 1 several possible reasons were investigated. One possible reason 
could be that there is only one copy of BubRi in DT40 cells because it is located 
on the Z chromosome, (chicken sex chromosomes are designated Z and W and 
DT40 cells are female = ZW) and that the gene is essential. To potentially 
overcome the problem of disrupting an essential single copy gene, a rescue 
construct can be expressed in wild type cells before targeting. The rescue 
construct to be used in this case was the full length, untagged chicken BubR 1 
cDNA. In order to regulate the expression of this cDNA, it was cloned into the 
pUHG-l0.3 plasmid under the control of the tetracycline operator (Figure 4.1). 
Since the encoded protein was untagged it was necessary to design a strategy to 
differentiate between the exogenous and endogenous expression. To achieve this, 
the 3' UTR of chicken BubRi was mutated such that the STOP codon was fused 
to the polyadenylation signal. This construct was generated by PCR using one 
primer to a region 500 bp upstream of the STOP codon and another primer, 
which was a fusion between the sequence around the stop codon and the 
sequence at the polyadenylation signal (see Figure 4.6A). The difference 
between the endogenous and exogenous transcript was detected using an RT-
PCR strategy with primer I and primer 2, designed to the polyadenylation signal 
which would therefore amplify a product of 839 bp for the endogenous transcript 
and 507 bp for the rescue transcript (see Figure 4.613). 
Wild type DT40 cells were transfected with the rescue construct described above 
and the transactivator tTa 2 as described in the introduction to this chapter. In 
order to determine if the expressing clones were able to switch off BubRi 
expression, they were treated with 2 ig/ml doxycycline, the more stable 
analogue of tetracycline, for 48 hours. Figure 4.613 shows RT-PCR analysis of 
two such clones, which expressed BubRl and were repressed by the addition of 
doxycycline. It is curious to note that in cell lines 4 and 10, before the addition of 
doxycycline a PCR band corresponding to the rescue construct is preferentially 
amplified. In this case, the wild type band is not detected until after the 
expression of the rescue construct is repressed. In other experiments, both the 
endogenous and rescue bands could be detected by RT-PCR (Figure 4.1OA). Cell 
lines 4 and 10 were also analysed by immunoblot using the chicken BubRl 
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antibody described in Chapter 3. Indeed, the overexpression and repression could 
also be clearly seen using the antibody (Figure 4.6C). Notably, these clones were 
expressing quite a high level of BubRl as compared to the wild type cells. 
Based on these results, clones 4 and 10 were then used in targeting experiments. 
KOV 1 was transfected into these two lines and the results of these experiments 
are shown in Table 4.3. 
Table 4.3 Numbers of colonies screened with KOVI in a rescued background. 
Cell line Resistance 
marker 




4 HisD 47 0 
4 Puro 41 0 
10 HisD 67 0 
10 Puro 67 0 
Since no targeting was observed even in the presence of a rescue construct, the 
final possibility was that the targeting vector contained too small a region of 
homology to efficiently target this size of genomic region. In order to overcome 
this problem a new vector was constructed with a longer 5' targeting arm. Again, 
this longer 5' homology arm was generated by PCR using phage 3133 as the 
template and primers designed to the cDNA sequence. A fragment of 3 kb was 
successfully generated by PCR using primers HD7 and HD9 (Table 2.8), and 
cloned into the targeting vector in place of the shorter 5' arm. This vector now 
had a total homology length of 6 kb, and would remove amino acids 125 to 529 
of the protein. This vector was generated with four different resistant cassettes, 
Blasticidin (Bsr), Hygromycin (Hyg), Histidinol (HisD and Puromycin (Puro). 
The new vector was designated KOV2 and the screening strategy using both a 5' 
and 3' external probe is shown in Figure 4.7. 
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Figure 4.6 
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Figure 4.6 Rescue Strategy. A, Cloning strategy of rescue construct. Primers I and 2 were used to 
generate a PCR product, which was cloned into the cDNA from which the original 3' end had been 
removed. B, RT-PCR strategy to determine if the rescue construct is expressed and repressed. +dox 
indicates treatment with 2 Vg/ml doxycycline for 48 hours. Two repressing cell lines, 4 and 10, are 
shown alongside wild type cells. C, Western blot showing expression and repression of the rescue 
construct in clones 4 and 10 after treatment with 2 tg/ml doxycycline for 48 hours. Anti-tubulin was 
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Figure 4.7 Knockout vector 2. A longer 5 arm was cloned in order to generate knockout vector 2 (KOV2) 
with a longer region of homology than KOV1. The screening strategy using a BgIIJ digest and 5 external 
probe is shown. In addition the 3 strategy using an EcoR I digest and 3' external probe is shown. 
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4.2.3 Generation of +1- DT40 cells 
KOV2 was transfected into wild-type DT40 cells, and also into clone 4 and clone 
10, which express the rescue construct as discussed in section 4.2.2. The resistant 
colonies were screened using a Bgl II digest and the 5' external probe. Targeting 
with KOV2 was successful and four different heterozygote cell lines were 
generated (Table 4.4). Three of these cells were in the wild type background, 
and one was in the clone 4 background, which was previously transfected with 
the rescue construct. 
As shown in Figure 4.8A, the 5' external probe strategy clearly shows that clones 
433, 511, 812 and 821 have been targeted, resulting in two bands after digestion 
with Bgl II. In order to confirm that the locus was targeted at both the 5' and 3' 
ends the clones were also screened using the 3' external probe and an EcoR I 
digest. The Puro-targeted clones 812 and 821 have an additional EcoR 1 band as 
shown in Figure 4.813. The EcoR 1 strategy and the 3' probe is unsuitable for the 
HisD and Hyg targeted clones since these resistance cassettes all have an EcoR I 
site at the 3' ends which is very close to the location of the genomic EcoR I that 
was removed by the cloning of the 3' arm (Figure 4.7). In this case an alternative 
strategy is needed to check the targeting at the 3' end of the locus. This may be 
possible by using a different digest or by using a PCR strategy. A number of 
digests and double digests were attempted in order to further map the 3' end, 
however it was not possible to design another strategy with the information 
available. The PCR strategy was not attempted for these clones. 
Table 4.4 Screen with KOV2 




Wild type (C1 l8) Bsr 26 0 
HisD 63 2 	(#812,#821) 
Hyg 70 0 
Puro 20 1 	(#511) 
Clone 4 Bsr 73 0 
Hyg 85 1 	(#433) 
Puro 12 0 
Clone 10 Bsr 74 0 
Puro 55 0 
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Since one heterozygote clone, namely 433 was targeted with the Hyg resistance 
cassette in the rescue clone 4 background, this seemed to be a suitable cell line in 
which to attempt targeting of the second allele. From the initial Southern blotting 
analysis, which identified 433 as a targeted clone, (Figure 4.8A), it can be seen 
that the intensity of the wild type and targeted bands were unequal, which was 
not the case for clones, 511, 812 and 821. This is potentially due to a mixed 
population of cells. There is always a possibility when picking the resistant 
clones from 96 well plates after selection that two colonies will be present. Every 
effort is made to minimise this chance by carefully picking single colonies at the 
correct stage, however, one could be much larger than the other and obscure the 
small colony. The cells were subcloned by limiting dilution and re-genotyped by 
Southern blot. As can be seen in Figure 4.8C all the subcloned cells again had an 
unequal intensity of wild type and targeted bands indicating that this was not a 
result of a mixed population of cells. In the meantime the original clone 433 
cells were targeted with KOV2 Puro and the result was that the puro vector was 
able to both replace the hygromycin marker (not shown) and target a further 
allele, giving rise to three bands of equal intensity on the Southern blot (Figure 
4.81)). This result was most unexpected and may suggest that BubRl is present 
in three copies in DT40 cells. Although the karyotype of DT40 cells is near 
diploid it is known that they have one extra copy of the macrochromosome 2 and 
one extra rnicrochromosome. However, this difference in band intensity seen for 
clone 433 was not seen with the other +1- cell lines 511, 812 and 821, leading to 
the speculation that some rearrangement or change in the karyotype had occurred 
in this particular cell line. From the known role of BubRI in the spindle 
assembly checkpoint and maintenance of the stability of the genome, it can be 
hypothesised that disruption of one allele caused the cell to rearrange its 
genotype and retain an extra copy of the chromosome containing BubR I. In the 
future, the number of copies of the BubRi locus could be determined by FISH. 
In addition to the problems with the number of copies of BubRi in clone 433 
there also appeared to be problems with the expression of the rescue construct in 
these cells. The overexpression could no longer be detected by RT-PCR or 
immunoblot, and it appeared that with time the expression of the exogenous 
cDNA had been lost. This was the first observation that expression of BubRi in 
DT40 cells may in some way be toxic or detrimental and that there may be a 
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Figure 4.8 Generation of Bu.bRl +1- DT40 cells. A, Southern blot showing targeting at the 
5' end of the BubRI locus as judged by Bgl II digest and 5' external probe. B, Southern blot 
showing targeting of the 3 end of the BubR 1 locus as judged by EcoR I digest and 3' 
external probe. It is impossible to determine if cell lines 433 and 511 are targeting using this 
strategy since there is an EcoR I site present at the end of the resistance cassettes very close 
to the location of the genomic EcoR I site. C, Southern blot showing subcloning of cell line 
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Figure 4.8 Continued. D,Southcrn blot showing that heterozygote cell line 433 was targeted with 
KOV2 Puro and a further allele was apparently generated as shown. 
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Since it now appeared that clone 433 was not the ideal cell line to work with, in 
order to target the second allele, the aim was to generate other heterozygote lines 
expressing the rescue construct. 
The targeting frequency of these vectors varies quite considerably, from 1/20 for 
Puro to 2/63 for HisD and 1/85 for Hyg, but it is difficult to state conclusively 
how efficient these vectors are. In the case of the Puro vector, 1/20 clones 
screened were positive, however, since only 20 colonies were screened and only 
1 detected this is not statistically significant. Therefore, the Puro vector was used 
subsequently in the attempts to target clone 433. In this case, out of 45 colonies 
screened, one Hyg targeted allele was replaced by Puro, and in two cases a 
second allele appears to have been targeted. It therefore seems that the most 
efficient vector, with the frequency of targeting being around 1/15 (6%), is Puro. 
It could therefore be estimated that the frequency of targeting for the second 
allele using this vector would be around 1/30 (3%). 
In order to test the prediction that BubRi is an essential gene I attempted second 
allele targeting in two of the heterozygote cell lines in the absence of a rescue 
construct. Transfections were carried out in the cell lines 5 11, which was 
targeted with the HisD marker and 812, which was targeted with the Puro 
marker. No targeted clones were identified, thereby supporting the conclusion 
that BubRI is essential in these cells. 
4.2.4 Analysis of heterozygous (+1-) cells 
Initial phenotypic analysis of the heterozygous cells 511, 812 and 821 showed 
that they grew normally in culture and appeared normal in morphology. In order 
to investigate the cells more carefully, their growth rate was calculated and 
compared to that of wild type DT40 cells (Figure 4.9A). This experiment was 
carried out in triplicate, however, all three experiments gave similar results and 
the results of just one are plotted here. The results show that the cell line 511 
grows more slowly than the other heterozygote lines 812, 821 or wild type cells. 
Clone 18 (wild-type DT40) had a doubling time of 6.9 hours, clone 511 had a 
doubling time of 9.5 hours, clone 812 had a doubling time of 7.25 hours and 
clone 821 had a doubling time of 7.2 hours. 
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Immunofluorescence microscopy re-affirmed initial observations that the cells 
appeared normal in morphology and divided normally. In addition it was shown 
that BubRi staining is normal in these +1- cells (Figure 4.913). Since it has been 
reported that the spindle assembly checkpoint component Mad2 is 
haploinsufficient in mouse (Michel etal., 2001) it was interesting to determine if 
this was also the case for BubR 1 in DT40 cells. To test if the spindle assembly 
checkpoint was intact, +1- cells were treated with the microtubule drugs colcemid 
and taxol (paclitaxel). Colcemid is a microtubule depolymerising agent, whereas 
taxol suppresses microtubule dynamics. According to current hypotheses, BubR 1 
senses tension at the kinetochore (Skoufias etal., 2001) and so should respond to 
treatment with both colcemid and taxol. In order to determine if the checkpoint 
was intact in the +1- cells, the mitotic index was counted after treatment with 
these drugs and compared to wild type cells. In addition, the cells were stained 
with the antibody to BubRi to determine if the protein was at the kinetochore. 
As shown in Figure 4.9C the cells did respond to spindle damage induced by 
both colcemid and taxol, resulting in a mitotic block with BubR 1 present on 
unattached kinetochores. In order to quantify this response the number of cells 
in mitosis was counted before and after treatment with the microtubule drugs and 
compared to wild type cells. The results of this analysis are shown graphically in 
Figure 4.913. It can be seen from this analysis that the spindle assembly 
checkpoint appears to be active in these +1- cells, as they block in mitosis. In 
order to further confirm this result the samples were also prepared for 
immunoblotting. After treatment with the microtubule drugs the cells were 
subjected to SDS-PAGE, transferred to membrane and then blotted for BubR 1. 
The results of this experiment (Figure 4.9E), reveal that the +1- cells do indeed 
respond to the checkpoint, as judged by the presence of the upper putative 
phosphorylated band of BubRl after treatment with these drugs (as discussed in 
chapter 3). This experiment also allowed me to determine the level of BubRl in 
the +1- cells. 
Although the protein loading was not absolutely equal for the untreated samples, 
as judged by the a-tubulin loading control, it appears that the level of BubRl 
protein is reduced in the heterozygote cells as compared to wild type DT40 cells. 
In conclusion, the heterozygotes appear to grow normally with no obvious 
kinetochore or mitotic defects and to have an active spindle assembly checkpoint 
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Figure 4.9 Analysis of BubRi +1- DT40 cells. A, Growth curve of heterozygotes as compared to wild 
type (Cl 18) DT40 cells. The cells were seeded at a density of 1 x 10 per ml and counted every 24 hours 
for 5 days. When the cells reached a density of 1 x 106  per ml they were split 1:10 into fresh medium. 
This experiment was carried out in triplicate. The results of all three experiments were very similar and 
one is plotted here. B, Immunofluorescence of heterozygote cells stained for BubRi (red), alpha tubulin 
(green) and DNA with DAPI (blue), scale bar is 10 [tm. 
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Figure 4.9 Continued. C, BubRi responds to spindle damage in +1- cells. BubRi +1- DT40 
cells and wild type cells (Cl18) were treated with either colcemid (0.1 tg/ml) or taxol (10 
1iM) for 3 hours and then stained for BubRi. Scale bar is 10 Rm. D, +1- cells block in 
mitosis in response to spindle damage. The mitotic index was determined after treatment 
with either colcemid or taxol as described above. 
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Figure 4.9 Continued 
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Figure 4.9 Continued . E, BubRi protein levels are reduced in +1- cells but BubRi is 
phosphorylatcd in response to spindle damage. BubRi +1- DT40 cells were treated with 
colcemid or Ltxol as described in C, and the cell lysates were then subjected to 10% SDS-
PAGE, transferred to membrane and immunoblotted for BubRi. The signal was detected using 
ECL. Inset shows longer exposure time. Alpha tubulin was used as a loading control. ClIS are 
wild type DT40 cells. 
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Since the evidence led to the conclusion that BubRl is essential in these cells, 
attention was focussed on the generation of heterozygote cell lones expressing 
stable levels of the BubRi cDNA, which could be repressed by the addition of 
doxycycline. 
4.2.5 Generation of +I. cells expressing rescue construct 
As discussed in the Introduction, different levels of rescue expression could be 
produced by co-transfection with different transactivator vectors, tTa2, tTa3 and 
tTa4. Lines were generated with all three transactivators in the I-IisD resistant 
cell lines 812 and 821, so that the more efficient KOV2 Puro vector could be 
used for targeting the second allele. Initially the strategy was to check that these 
lines could express and repress the transgene by either immunoblot or RT-PCR. 
The cells expressing the rescue construct were also analysed by 
immunofluorescence (IF). The results of this analysis were quite surprising, 
because although by RT-PCR and western blot it seemed that these cell lines 
were expressing fairly high levels of the transgene, the IF indicated that this 
expression was very heterogeneous within the population (see Figure 4. lOB). It 
was observed that only a low percentage of the cells appeared to be actually 
expressing the rescue construct, as judged by BubRi antibody staining. This was 
quantified for some cell lines, and was never higher than 10%. Since the rescue 
construct was untagged, then it was very difficult to determine on a cell by cell 
basis if the transgene was expressed, unless this was at a high enough level to 
detect it with an antibody. The best way to determine this would be by using a 
rescue construct with a tag, however previous experience led me to worry that 
this might disrupt the function of the protein. A series of targeting experiments 
were carried out, the results of which are detailed in Table 4.5. In brief the 
targeting experiments were unsuccessful. The most likely reason for this was that 
the transgene was not being expressed at all, or expressed at the correct levels in 
a large enough population of cells, thus making the chances of targeting fadingly 
slim. An example of the RT-PCR results for two of the cell lines is shown in 
Figure 4.lOA, indicating that they did express the transgene and that it could be 
repressed by doxycycline. Some examples of the IF images of +1- cells 
transfected with the rescue construct are shown in Figure 4.10B. It was very 
difficult to determine if these cells were actually progressing through mitosis or 
if the expression of the rescue construct was having a toxic effect leading to the 
cell shutting off expression. In the top panels (i) several normal looking cells 
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expressing various levels of the transgene are shown in various stages of normal 
progression through mitosis. In the middle panels (ii), overexpressing cells, 
which appear apoptotic, are shown. In the bottom panels (iii), some cells with 
abnormal multipolar spindles are shown. Thus, although some expressing 
different levels of the transgene appeared normal and progressed through 
mitosis, many cells highly overexpressing BubRI appeared to be 
apoptotic(Figure 4. IOB(ii). This led to the hypothesis that overexpression of 
BubRi may lead to apoptosis. 
Table 4.5 Attempts at targeting in cell lines expressing the rescue construct. 
+1- Background (Ta Cell line Number screened -I- 
812 2 2/16 40 0 
812 3 3/1 55 0 
821 3 All  50 0 
812 4 4/34 61 0 
812 4 4/36 60 0 
812 4 4/41 35 0 
812 4 Al2 69 0 
821 4 B13 77 0 
In order to overcome the problem of heterogenous expression levels of the 
rescue construct, a number of possible approaches were considered. Firstly, in 
order to try and generate a more stable population of cells, transfections with the 
rescue construct were carried out in the presence of doxycycline (10 ng/ml). 
Cells were cultured in doxycycline for 2-3 days before the transfection and then 
plated out into selective medium with doxycycline present. When the colonies 
were visible, they were split evenly between medium with and without 
doxycycline. The hope was that this would prevent the potentially toxic 
expression of the protein and allow for the generation of a more stable 
population. Unfortunately, this protocol also resulted in cell lines with very 
heterogeneous levels of expression. Two of these cell lines, which repressed in 
the presence of doxycycline, namely A 12 and 1313  were transfected with the 
KOV2 Puro. However, as shown in Table 4.5 this targeting was unsuccessful. 
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Figure 4.10 BubRi heterozygote DT40 cells expressing rescue construct. A, Example of 
expression of rescue lines A 12 and B13 as shown in A as judged b RT-PCR. The expression of 
the transgcne is repressed after treatment with doxycycline (10 ng/ml) for 48 hours. All lines in 
Table 4.5 were tested for expression or repression by either immunoblot or RT-PCR. 
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Figure 4.10 Continued 
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paraformaldehyde and stained for BubRi (red), alpha tubulin (green), DNA with DAPI (blue), scale 
bar islORm. 	 128 
One further experiment was attempted, in which both the rescue construct and 
the second allele targeting vector were transfected at the same time, in the hope 
that targeting and introduction of the rescue construct would occur 
simultaneously, thereby placing the rescue construct under positive selection 
pressure. In this case, however, it would be impossible to assess whether the 
rescue could be repressed until after a targeted cell line had been generated. This 
experiment was carried out in two independent +1- cell lines. However, no 
colonies were obtained. 
4.2.6 BubRi is cleaved in DT40 cells when apoptosis is induced 
Upon further investigation of the apoptotic cells apparently expressing high 
levels of BubRi it was noticed that wild type DT40 cells in some stages of 
apoptosis also appear to stain brightly with this antibody, as shown in Figure 
4.1 IA. There are several possible explanations for this. For example, the 
secondary antibody used might stain apoptotic cells. However, use of the 
secondary antibody anti-rabbit Texas Red in the absence of primary antibody did 
not give this result. Another potential explanation is that the rabbit polyclonal 
serum might recognise a protein that is overexpressed in apoptotic cells. 
Alternatively, BubRi might be upregulated in apoptotic cells. This could cast 
doubt on the hypothesis that overexpression of BubR 1 causes apoptosis, since 
the apoptotic cells in a wild type culture also appeared to overexpress BubRi. In 
order to investigate this further, apoptosis was induced in DT40 cells using 10 
.tM etoposide for 1, 2, 3 or 4 hours. Cell extracts were then subjected to SDS-
PAGE and immunoblotted with anti-BubRi. The results of this experiment, as 
shown in Figure 4.1113, reveal that BubRl is apparently cleaved as DT40 cells 
undergo apoptosis. The cleavage product detected is approximately 80-90 kDa. It 
is worth noting that this cleavage occurs fairly early in the apoptotic progression, 
being complete by 3 hours after induction of apoptosis. It is unclear what 
happens to the protein at around 2 hours since neither the full-length protein nor 
the cleavage product was visible by immunoblot. It is possible that there are two 
cleavages: one, which is earlier and unstable; and another, which produces a 
stable product of around 80-90 kDa. It also appears that the levels of the protein 
increase as judged relative to the loading control. The loading control used in 
this experiment was alpha tubulin, however it can be seen from the blot in Figure 
4.11 B that the amount of this protein was not constant. This experiment was set 
up by splitting a population of cells into different wells of a six well plate and 
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then adding the etoposide at the appropriate time, and collecting all samples and 
preparing them - for SDS-PAGE at the same time. Since the starting culture was 
spilt between different wells, it is unlikely that this much variation would occur. 
However, it must also be taken into account that the control population was 
growing over the course of the experiment whilst in other cells apoptosis was 
being induced. Also, when apoptosis is induced, a large number of cellular 
proteins are cleaved and degraded (Earnshaw et al., 1999). It is possible to see 
from the immunofluorescence of apoptotic cells, that alpha tubulin is degraded 
or destabilised, Figure 4.10. This protein therefore may not be the ideal loading 
control for an experiment such as this. However, it was evident from this 
experiment that there is more BubRi cleavage product present at the end of the 
experiment than there was intact BubRl at the beginning. 
A further question was whether BubRi is cleaved in this manner once the 
checkpoint has been satisfied and cells progress into anaphase. In order to 
investigate this, DT40 cells were blocked using nocodazole (0.5 tg/ml) for 3 
hours. Nocodazole is a microtubule depolymerising drug and was used rather 
than colcemid because it is more readily reversible by washing it out of the cells. 
The drug was then removed from the cells by washing twice in warm medium, 
and cells were allowed to release into anaphase. Time points were collected as 
indicated in Figure 4.12 and samples prepared for SDS-PAGE. In addition, at the 
1 and 2 hour time points, cells were fixed and stained with DAPI to check for 
mitotic progression after release. At the 1 hour time point, 16% of cells were in 
mitosis, and 22% of these were in anaphase. At the 2 hour time point only 1% of 
cells were mitotic, but 100% of these were in anaphase. This indicates that the 
cells were released from the block and progressed through anaphase. The results 
of this experiment showed that BubRl was not cleaved as DT40 cells were 
released from a nocodazole block. In a manner similar to treatment with 
colcemid and taxol, an upper phosphorylated form of BubRI was detected when 
cells were treated with this drug, presumably because the spindle assembly 
checkpoint was activated. The membrane was then blotted with alpha-tubulin as 
a loading control and it can be seen that at later time point, when less BubRi was 
present, the level of tubulin remained constant. This indicates that the amount of 
BubRi was decreasing in the cells as they released from nocodazole arrest and 
exited mitosis. 
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Figure 4.11 BubRi is cleaved in DT40 cells after treatment with etoposide. A, 
Immunofluorescence of wild type DT40 cells stained with anti-BubRi (red), alpha-tubulin (green) 
and DNA with DAPI (blue), scale bar is 10 [tm. It can be clearly seen that apoptotic cells stain 
brightly for BubR 1. B, DT40 cells were treated with 10 sM etoposide for the number of hours 
shown and then extracts from the number of cells indicated were subjected to 10% SDS-PAGE and 
transferred to nitrocellulose membrane. The membrane was blotted for BubRi (above) and alpha-
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Figure 4.12 BubRI is not cleaved after nocodazole block and release into anaphase. DT40 
cells were treated with nocodazole for 3 hours (0.5 pig/ml), this was then washed out and cells 
released for the time shown. Cell extrracts were subjected to 10% SDS-PAGE and 
immunoblotted with anti-BubRI(above), and the loading control alpha tubulin (below). Signal 
was detected using ECL. 
132 
4.3 Discussion 
4.3.1 Screening genomic library for BubRi phage. 
Screening of the X Fix II DT40 genomic library resulted in the identification of 
phage 3B3, which contains a 5' portion of the BubRi locus. Unfortunately this 
did not contain the entire genomic region and only contained a small portion 
upstream of the ATG. This limited the possibility of knocking out the entire 
ORF, or of deleting the ATG. The final targeting vector constructed, KOV2 will 
leave 375 bp of cDNA, which could potentially produce a small fragment of 125 
amino acids of the very N-terminus of the protein. However, it is suspected that 
this product will not be made, since a small, unpolyadenylated rnRNA will be 
generated and it is likely that this will be unstable and degraded. There is also the 
possibility that this fragment could be generated and have a dominant effect. In 
order to assess this, an antibody could be generated to this portion of the protein. 
Attempts were made to do this and although the fragment was cloned with a N-
terminal 6xHis tag the fragment did not express well and I was unable to purify it 
over nickel agarose beads. 
Another way to avoid this problem would be to find a phage with more sequence 
in the 5' region of the gene and generate targeting vectors that would remove the 
ATG. For this reason, the library was screened a second time, this time using a 
probe derived from the most 5' 400 bp of phage 3133. In this case, two positive 
phage were identified, however restriction analysis showed that these were 
identical to phage 3133. It was therefore concluded that no other phage exist in 
the library with a more 5' region of BubR 1. To solve this problem a new library 
would have to be generated and due to time limitations this was not possible. 
4.3.2 Construction of Targeting Vectors 
The main problem encountered in the construction of targeting vectors was that 
the majority of the phage sequence was unknown. The 3' arm was fairly 
straightforward to clone since a convenient 5 kb portion of the 3' end of the 
phage was subcloned into pBluescript. In order to orientate this fragment, partial 
sequencing of the ends was carried out. Fortunately this identified exons, 
allowing the 5' and 3' ends of this fragment to be defined. This subcloned 
fragment was then used as the basis of the 3' targeting arm and 3' external probe. 
Cloning a suitable 5' arm was more problematic, and in this case a PCR 
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approach was undertaken. However, the problem was that the genomic sequence, 
and in particular the size of the introns was unknown. Several primers were 
designed to positions likely to be the start of exons based on the known rule that 
introns begin with GU and end in AG, and PCR fragments were generated. In the 
first instance, a fragment of 1.6 kb was cloned and used to construct a 5' 
targeting arm. However, it was subsequently found that this was too short a 
length of homology to target a genomic region of around 10 kb. A longer 3 kb 5' 
arm was generated by PCR and this was the basis of the KOV2 vector, which 
was able to target the locus. A potential way to overcome these cloning 
problems would be to have the phage entirely sequenced. In fact this strategy has 
been adopted within the Laboratory, for a number of genes, which have been 
successfully disrupted ((Samejima et al., 2001) N. Korfali, personal 
communication). The approach allows the 5' and 3' arms to either be cloned by 
restriction digest directly from the phage, or PCR fragments to be generated with 
restriction sites on the end for even more convenient cloning. This approach can 
save time in the construction of the vectors. In addition, because the screening 
strategy must be determined by mapping the locus, this is much easier if the 
sequence of the phage is available. 
4.3.3 Generation of BubRi +1- DT40 cells 
The main problem encountered in the generation of +1- cells was the total length 
of homology used. When this was increased from 4.6 kb to 6 kb, targeting events 
occurred. As mentioned above, cloning of longer arms can be made easier if the 
sequence of the entire phage is available. The efficiency of targeting may be 
increased even further if this length is increased. For example, it is known that 
the ovalbumin locus can be targeted at an efficiency of 80% using a vector with a 
total of 8 kb, although this is a disruption rather than a replacement (Buerstedde 
& Takeda, 1991). The targeting efficiencies with the vectors were zero for Bsr, 
3% for HisD, 1% for Hyg and 6% for Puro. These are relatively low compared to 
what is usually expected for DT40 cells, which may be explained by the size of 
the region being removed. In order to increase the targeting efficiency the size 
of the region to be deleted could be decreased. Simply by the generation of a 
construct which disrupts a gene with a resistance marker, targeting efficiencies 
can be increased (P. Vagnarelli, personal communication). If the targeting of this 
locus was to be started again it would certainly be worth considering an approach 
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which either disrupted the open reading frame or removed only a small portion 
of the Send. 
Three heterozygous cell lines were analysed, 511, 812 and 821. These were 
investigated by immunofluorescence and found to divide normally and have 
normal BubRi kinetochore localisation. In addition the growth rate of these cells 
was calculated and although this varied from 6.9 hours in wild type cells to 9.5 
hours for +1- 511 cells this was within the normal range for DT40 cells. To 
address the question as to whether BubRI is haploinsufficient in the +1- cells, the 
checkpoint activity was assessed following exposure of the cells to the drugs 
taxol or colcemid. In both cases, the cells'arrested in mitosis with BubRl at the 
kinetochores. In addition, an upper, presumably phosphorylated, band was 
detected by immunoblot after treatment with these drugs. In conclusion, the 
spindle assembly checkpoint appears to be active in the +1- cells although the 
BubR 1 protein levels are reduced. 
4.3.4 Generation of +1- cells expressing rescue construct 
One of the biggest problems faced in this project was the expression of BubRi in 
DT40 cells. It is possible that the overexpression of BubRi was toxic to the 
cells, which in turn selected against cells expressing it. Problems with 
heterogeneous levels of expression, low numbers of cells actually expressing, 
and changes in expression levels with time in culture were all experienced. It 
was difficult to determine whether a cell overexpressing BubRi was actually 
able to progress through the cell cycle, or whether the overexpression meant that 
the cell was unable to turn off the spindle checkpoint in order to allow the APC 
to become inactivated and anaphase to progress. I was also unable to determine 
if the overexpressed protein was actually localising to the kinetochore. It was 
obvious from the immunoflourescence that the protein was being mis-expressed 
throughout the entire cell but this could have been due to the fact that the 
kinetochores were saturated and no more could bind. Other experiments with 
overexpression of full length BubRi in chicken cells were also carried out. These 
include BubRl with an HA-His tag at the C-terminus transfected into MSB 1 
cells and DT40 cells and EGFP-BubRl transfected into DT40 cells. In the case 
of the MSBI cells, as discussed in Chapter 3, this construct did not localise 
appropriately to the kinetochores as judged by immunostaining using the anti-
HA antibody 12CA5. However, when this same construct was transfected into 
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DT40 cells it was possible to detect the recombinant protein at the kinetochores 
of prometaphasë cells, although heterogeneous levels of expression and low 
percentages of cells expressing were again observed. In the case of the 
expression of EGFP-BubRl this was not seen to localise to the kinetochores and 
similar problems with heterogeneous expression were encountered. One reason 
for this may be due to the tag, and in order to overcome this problem it may be 
necessary to tag the protein at the C-terminus. The advantage to using a tagged 
rescue construct is that expression levels can be determined on a cell by cell 
basis. However, the main and outstanding disadvantage is that the tag may 
interfere in some way with the function of the protein, which must be able to act 
normally to rescue the cells. In this study, it was decided that an untagged 
version of the protein was best and since the rescue construct was based on the 
same cDNA as the HA-His tagged version there is no reason to suspect that the 
rescue construct cannot localise properly. 
There are several reports of human BubRl being expressed in cells either as GFP 
(Chan etal., 1998) or GST (Sudakin et al., 2001; Taylor et al., 2001) fusions, 
however these were transient transfections. Since it does not appear that any 
stable cell lines expressing human BubRi have been reported, this may indicate 
that problems of expression have been encountered in this system also. 
In order to try and overcome some of these problems with expression two 
experiments were carried out. The first of which was to keep the cells in the 
presence of doxycycline until a stable line had been generated, which had the 
potential to express and repress the rescue construct. Several such cell lines were 
generated, two of which were tested for targeting of the second allele, namely 
Al2 and B13. As shown in Table 4.5, no targeted clones were generated, and the 
results of immunofluorescence showed that the population still expressed BubR 1 
at heterogeneous levels. In addition, the rescue construct, tTa and targeting 
vector was transfected into heterozygote cells at the same time in order to try and 
overcome the problems of expression. Unfortunately, no colonies were obtained 
from these transfections, which were carried out on two independent cell lines. 
One reason for this might be that random and homologous recombination may 
not be able to occur at the same time in the same cell. Another possibility is that 
the ratio of DNAs used was incorrect. 
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An ideal way to overcome difficulties encountered would be to express the 
protein from its-  endogenous promoter. This would mean that it is expressed at 
the correct levels and regulated correctly during the cell cycle. In order to 
achieve this the Tet operator would have to be knocked into the locus after the 
first allele had been targeted and a stable cell line generated. A cell line could 
then be generated which expressed BubRi at appropriate levels throughout the 
cell cycle and could be repressed by the addition of doxycycline. This cell line 
would then be the basis of the attempts to target the second allele. The 
generation of such a cell line would require some knowledge of the promoter 
sequence and also the question would arise as to which transactivator should be 
used. Yet again, this approach relies on sequence of the 5 region, which is not 
currently available. Unfortunately time constraints prevented this approach being 
adopted with this project. 
In addition to the Tet system, an IRES approach could be adopted to improve the 
expression levels of chicken BubRi in DT40 cells. The IRES or internal 
ribosome entry site allows the expression of a dicistronic transcript: the 
translation of two open reading frames from one mRNA. In this case the BubRi 
cDNA and the hygromycin B resistance marker would hopefully force the cell to 
express the BubRl cDNA in order for the cell to survive in medium containing 
the drug hygromycin B. The IRES is a 500 bp element derived from the 
picinovirus family, which allows the virus to express dicistronic transcripts in 
mammalian cells (Mountford et al., 1994). Unfortunately, the cloning of the 
BubRl cDNA and the IRES-Hyg construct into the pUHG 10.3 plasmid so that it 
would be under the control of the tet operator proved not to he possible in the 
time allowed. As with the previous rescue strategy, the 3 UTR of chicken 
BubR 1 was modified in order that a difference in size could be detected by RT-
PCR. In this case the polyadenylation signal was removed. Once this construct is 
cloned it could be used to generate a heterozygote cell line which can maintain a 
stable level of BubRl expression. 
A further method of generating a conditionally null cell line would be to utilise 
the Cre recombination system (Kuhn & Torres, 2002). This is a bacterial 
recombinase which very specifically recombines sequences at target sites called 
loxP sites. These are 32 bp long and can be inserted artificially into a desired 
sequence. In a cell line expressing loxP a particular DNA sequence can be 
removed by recombination. The way to use this system for DT40 would be to 
137 
first target loxP sites into an intron at the 5' end of the gene, screen by Southern 
blotting to confirm this, then add Cre recombinase which would result in one 
ioxP site remaining. Then, an intron further downstream would be targeted in a 
similar manner, recombination would be induced by Cre, and the resulting locus 
would have IoxP sites in two introns. In this way, the locus could be disrupted by 
the addition of Cre to this cell line without the need for expression of a rescue 
construct. The second allele could be removed or disrupted in a more 
conventional manner. The disadvantages of this system are that Cre is not 100% 
efficient, and perhaps only 90% at best (Zheng et al., 2000). The outcome would 
therefore be that in some cells the locus might not be removed, allowing for 
some expression of the gene. This may be acceptable if the phenotype is 
analysed on a cell by cell basis by immunofluorescence, however would cause 
problems for biochemical experiments where a whole population of cells is used. 
4.3.5 BubRi is cleaved in DT40 cells after the induction of 
apoptosis 
Although targeted disruption of BubRi has not been possible thus far, work on 
the expression of the protein has led to some interesting observations. The most 
striking of these being that BubRi appears to be upregulated or stabilised in 
DT40 cells undergoing apoptosis as judged by immunofluorescence with the 
BubR I antibody. In order to determine that this was not just an artefact of 
staining, the secondary antibody was used alone and no staining of apoptotic 
cells was observed. In order to further investigate this observation, apoptosis 
was induced in DT40 cells using etoposide. The cell extracts were then 
immunoblotted with BubR 1, which revealed that the protein is cleaved to an 80-
90 kDa species after 3 hours of etoposide treatment. It also appears that this 
product is stabilised, as there is more present at the end of the experiment than at 
the beginning. It could be speculated that this stabilisation is due to the fact that 
the cleaved product is lacking one or both of the putative degradation signals, the 
destruction box or KEN box. 
One major family of proteins involved in the progression of apoptosis and 
protein cleavage is the caspases, which are cysteine/aspartase proteases. There 
are 14 known mammalian caspases, 7 of which have been implicated to have a 
role in apoptosis, and the consensus cleavage sites for these is known. The 
sequence of BubRi has therefore been investigated to see if there are any 
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obvious caspase cleavage sites within it. This was carried out using the 
computer programme, (http://ca.expasy.org/tools/peptidecutter  enzymes.html) 
ExPASy Peptide-Cutter tool and by eye. Two sequences, which were close to the 
consensus, were identified. These are KEED at amino acid 357, and FEKD at 
position 785. The molecular weights of the fragments generated by cleavage at 
these sites has been calculated and found to be 41 kDa and 81 kDa for KEED 
and 88 kDa and 34 kDa for FEKD. Since the observed cleavage product is 
around 80 - 90 kDa, either of these sites may be theoretically possible. Also it 
must be noted that the antibody is generated to amino acids 653 - 778 so would 
recognise the larger fragment if it were to be generated by cleavage at either of 
these sites. However, it has been noted that neither of these sites is completely 
conserved in human BubRi, which may make them unlikely candidates. 
Once a strong candidate site is identified this could be mutated by site directed 
mutagenesis in order to determine if this is a real cleavage site. In addition 
specific caspases could be tested in an in vitro assay. This would require the 
transcription and translation of BubRi in order that it could be labelled with S 35 
methionine, then the addition of purified caspases in order to determine if they 
have the ability to cleave BubRi in vitro. In addition, an immunoprecipitation 
experiment could be carried out using anti-BubRi antibodies after the induction 
of apoptosis. Sequencing of the cleavage fragment would reveal whether the N 
and C-terminus of the protein is stabilised and may lead to the identification of 
the cleavage site. 
It is known that caspases cleave a wide variety of substrates during apoptotic 
execution. These substrates include structural proteins, DNA repair proteins and 
kinases (for review see (Earnshaw et al., 1999)). It is therefore interesting to 
speculate if the cleavage of BubRl in apoptosis is important for apoptotic 
progression and whether or not the cleavage product may have any additional 
roles. 
It is not clearly understood how the spindle assembly checkpoint is turned off 
after all microtubules are aligned in order to allow the cell to proceeds into 
anaphase. Proteins such as BubRl may be regulated by phosphorylation or 
dephosphorylation or may be degraded. As discussed previously, BubRi has 
both a putative destruction box and a putative KEN box. However, to date it has 
not been shown whether BubRi is targeted for destruction by the APC. 
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I therefore investigated if BubRi is cleaved in this manner after the spindle 
assembly checkpoint is inactivated and cells are released into anaphase. DT40 
cells were blocked with nocodazole, which stimulated the checkpoint as judged 
by the presence of phosphorylated BubRi, and then released into anaphase. In 
this experiment the 80-90 kDa cleavage product was not observed, although the 
levels of the protein were quite dramatically reduced towards the end of the 
experiment as compared to the loading control. In order to further investigate 
this, cells could be blocked at different stages of the cell cycle. For example a 
double thymidine block can be used to arrest cell in S phase, mimosine to block 
in G  or serum starvation to block at G0/bl. This would therefore address the 
question as to if this cleavage occurs at other points during the cell cycle. It will 
also be interesting to determine the levels of expression at these different stages. 
In addition it will be interesting to try and determine how BubRl is inactivated 
after the checkpoint is satisfied, if it is targeted for degradation by the APC/C or 
some other means. This could perhaps be done by mutation of the putative KEN 
and destruction box identified in chicken BubRi. In addition it will be 
interesting to determine if overexpression of BubRi causes cells to go into 
apoptosis, and if this is related to a potential role of the BubRl cleavage product 
in progression of the apoptotic cascade. 
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Chapter 5 
A Screen to Identify Kinetochore Associated Proteins in 
Xenopus Iaevis 
5.1 	Introduction 
The aim of the work described in this chapter was to identify and clone kinetochore 
components from the organism Xenopus laevis. The reason for choosing this 
organism is that an extract made from the unfertilised eggs is an ideal tool for the 
biochemist. These eggs are very large, 1 mm in diameter, and contain stockpiles of 
proteins required by the egg, once fertilised, in order that it can undergo rapid, 
synchronous cell divisions as the embryo starts to develop. Manipulation of this 
system has led to the identification of a number of complexes required for mitotic 
progression. These include, identification of the 8S (XCAP-C and XCAP-E) (Hirano 
& Mitchison, 1994) and 13S (XCAP-C and XCAP-E and XCAP-H (Barren)) 
condensin complexes (Hirano et al., 1997). In addition, the cohesin complex was 
also identified in Xenopus, as a 9S complex composed of XSMC1 and XSMC3 and 
a 14S complex (Losada et al., 1998). In this Laboratory the passenger complex of 
INCENP and Aurora-B was identified in Xenopus egg extracts (Adams et al., 2000). 
It was therefore decided that Xenopus might be an ideal system in which to attempt 
to identify both known and novel kinetochore components. The hypothesis that a 
pre-kinetochore complex may exist in the eggs, enabling identification of the 
components of the kinetochore was drawn up. In addition to the identification of 
novel complexes, the Xenopus system also lends itself to functional studies by both 
depletion and 'add back' experiments. For example, proteins can be specifically 
immunodepleted, and the effect on progression of the cell cycle assayed in this in 
vitro system. In addition, components can then be added back to ensure that the 
effect is specific and also other proteins can be added in excess to determine the 
order of components in a pathway. 
Initial experiments focussed on the constitutive centromere protein CENP-C with 
efforts being made to clone the Xenopus orthologue. CENP-C is a DNA binding 
protein, which is localised to the centromere throughout the cell cycle. It is 
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specifically localised to the inner kinetochore plate and is generally believed to have 
a structural role within the kinetochore. Cloning of this gene was attempted in a 
number of ways including screening Xenopus extract using antibodies raised to 
CENP-C from different organisms, using degenerate PCR primers to try to amplify a 
fragment of the gene from a Xenopus cDNA library and screening the library using 
CENP-C probes from different organisms. 
Attempts were also made to clone two other kinetochore associated proteins namely, 
CENP-H and Zwint. The Xenopus cDNA library was screened for these genes using 
human probes. 
The focus of attention then changed to the identification of the spindle assembly 
checkpoint components ZwlO and Rod, which are localised to the kinetochore in 
Drosophila and vertebrate cells (Basto et al., 2000) (Chan et al., 2000). As 
discussed in Chapter 1, these proteins form a complex in Drosophila which is 
involved in the spindle checkpoint. These proteins have not been identified in yeast 
and their interactions, if any, with the Mad and Bub components of the checkpoint 
are presently unknown. For this reason it was interesting to investigate if these 
proteins are present in a complex in Xenopus and if so which other proteins they are 
associated with. No known functional domains have been identified in either ZwlO 
or Rod, so any information regarding these proteins in another organism will be 
potentially interesting. 
5.2 Results 
This work was carried out in collaboration with Ciaran Morrison, in particular the 
degenerate PCR for CENP-C and the library screen for CENP-C, CENP-H and 
hZwint. The cloning, expression and analysis of ZwlO and Rod was entirely my 
own work. 
5.2.1 Screening Xenopus egg extracts with antibodies to centromere 
proteins 
Since a large number of antibodies to centromere proteins from various organisms 
were available in the Laboratory, these were used in order to try to identify 
orthologues in Xenopus. The aim was to screen Xenopus egg extracts for these 
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proteins by immunoblotting. If any antibodies were found to cross-react, the plan 
was to immunoprecipitate the antigen from extract and analyse the proteins 'pulled 
down', and any other potentially interesting interactors, by mass spectrometry. Once 
a specific sequence was obtained this would allow for the generation of primers in 
order to amplify the sequence by PCR or RT-PCR and allow screening of a library. 
The cloned genes could then be expressed and purified to enable the generation of 
Xenopus-specific antibodies. 
The antibodies used were, anti-human CENP-C, human broad spectrum Anti-
Centromere Antibodies (ACA), anti-chicken CENP-C, anti-chicken BubR 1 and anti-
human Rod (Table 5.1). All antibodies 'were used at 1:500 dilution for the 
immunoblot, which was carried out as described in section 2.2.26. The results of this 
screen (Table 5. 1), show that the majority of antibodies do not cross-react with 
Xenopus extract proteins to give bands of the appropriate size based on the predicted 
or apparent molecular weight, as shown in Table 5.2. However, a band was observed 
with the anti-chicken BubRi antibody of around 100 kDa in Xenopus extract. Since 
this antibody recognises a protein of 140 kDa in chicken cells (as discussed in 
Chapter 3), it was decided that this might be a spurious band and no further 
investigation was carried out. It should be noted that the predicted molecular weight 
of Xenopus BubRi is 117 kDa. Furthermore, one antibody to human CENP-C, 
designated 558, did show a band at approximately 90 kDa in Xenopus egg extracts 
(Figure 5.1). It should be noted that the predicted molecular weight of CENP-C is 
100 kDa, but human, mouse and chicken CENP-C migrate at 140 kDa. Further 
experiments using this antibody included immunoprecipitation from extracts, 
immunoblotting of sucrose gradients and attempts at staining Xenopus tissue culture 
cells. 
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Table 5.1 Results of antibody screen 
Antibody Results 
Human CENP-C- 350 No cross reactivity 
Human CENP-C- 418 No cross reactivity 
Human CENP-C- 420 No cross reactivity 
Human CENP-C- 422 No cross reactivity 
Human CENP-C- 554 No cross reactivity 
Human CENP-C- 556 No cross reactivity 
Human CENP-C- 558 Band of approximately 90 kDa 
Chicken BubRi Potential band of approximately 100 kDa 
Chicken CENP-C No cross reactivity 
ACA - 1 No cross reactivity 
ACA - 2 No cross reactivity 
ACA - 3 No cross reactivity 
Human Rod I No cross reactivity 
Human Rod antibody was kindly given to me by F. Scaerou. 
Table 5.2 Predicted and apparent molecular weight of proteins used in this study 




BubRi human 119,469 120 
chicken 122,226 140 
Xenopus 117,337 145 
CENP-A human 15,980 17 
CENP-B human 65,131 85 
CENP-C human 106,860 140 
chicken 97,177 140 
CENP-H human 28,462 34 
chicken 26,783 34 
Rod human 250,588 205 
Drosophila 240,581 200 
ZwIO human 88,772 85 
chicken 85,598 Not published 
Drosophila 82,210 85 






















Figure 5.1 Anti-human cENP-C 558 recognises a protein of approximately 90 Wa in Xenopus egg 
extracts. Immunoblot of HeLa lysate and Xenopus egg extracts using anti-human CENP-C 558 and 
detected using protein-A I. 
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Immunoprecipitation experiments showed that a protein of around 90 kDa could be 
'pulled down', from Xenopus extracts, by the human CENP-C antibody 558, as 
detected by immunoblot (Figure 5.2A). Silver staining of the immunoprecipitated 
proteins revealed a species at around 90 kDa. However, in addition to this there were 
many contaminating proteins of lower molecular weight also in this lane. A sucrose 
gradient of Xenopus egg extracts was immunoblotted with this antibody in order to 
investigate if the protein being recognised was indeed part of a complex, and if so of 
what size. Unfortunately the results of this experiment were somewhat ambiguous 
since the antibody recognised two proteins; one of around 80 kDa, and one of 
around 140 kDa (Figure 5.213). The sucrose gradient showed that the 140 kDa 
protein was present in fractions 7-9, whereas the smaller 80 kDa protein was present 
in fractions 5-9. In order to give a rough estimation of the size of this complex, the 
gradient was also immunoblotted with anti-INCENP. INCENP is known to be 
present in an 11 S complex with aurora-B in Xenopus egg extracts (Adams et al., 
2000). Both proteins recognised by anti-human 558 were present in a complex 
smaller than 1 IS. The protein of around 80 kDa was likely to be the species initially 
identified in Xenopus egg extracts as shown in Figure 5.1 and the potential 
immunoprecipitated protein as shown in Figure 5.2A. However, this protein was of 
lower molecular weight than the apparent molecular weight of human and chicken 
CENP-C. The sucrose gradient showed that anti-human 558 recognises two proteins 
that are partly present in the same size complex. The larger of these proteins, which 
is around 140 kDa, was similar in size to the apparent molecular weight of chicken 
and human CENP-C. It could therefore be hypothesised that this is indeed Xenopus 
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Figure 5.2, Immunoprecipitation from Xenopus egg extracts using anti-CENP-C 558. A, anti-
CENP-C 558 was used in immunoprecipitation from Xenopus egg extracts, i) silver stained gel and 
ii) western blot, detected by ECL. B, 5-20% sucrose gradient of Xenopus high speed supernatant 
(HSS) run at 53,000 rpm for 5h30. The gradient was fractionated into 17 samples, run on a 7.5% 
SDS-Polyacrylamide gel and blotted with anti-CENP-C 558 (above) and anti-INCENP (below). 
Anti-CENP-C 558 recognises two proteins as indicated by the arrows, one of approximately 80-90 
kDa and the other 130-140 Wa. 	 147 
Since immunoblot experiments had resulted in confusion over the size of the 
potential CENP-C - protein it was decided that immunofluorescence might be the best 
technique to use to address the question as to whether anti-CENP-C 558 did indeed 
cross react with Xenopus CENP-C. Several attempts were made to stain Xenopus A6 
tissue culture cells using various different staining conditions, described in section 
2.24. land 2.24.2. The antibody 558 recognised the kinetochores of HeLa cells as 
shown in Figure 53A. However, although the A6 cells had an excellent morphology 
for immunofluorescerice, as shown (Figure 5.313), no specific staining was observed 
(not shown). Since I was unable to determine conclusively by immunofluorescence, 
immunoblot or immunoprecipitation whether 558 actually recognised Xenopus 
CENP-C, it was decided to adopt a different approach towards the identification of 
Xenopus CENP-C. 
5.2.2 Using degenerate PCR to clone Xenopus CENP-C 
It is known that vertebrate CENP-C shares at least two regions of homology with the 
S. cerevisiae protein Mif-2 (Brown, 1995). These homology blocks are in the C-
terminal region of the protein. CENP-C has been identified in diverse species 
including, human, sheep, mouse, chicken, maize, Arabidopsis, tomato, C. elegans, S. 
cerevisiae, S. pombe and Neurospora crassa. However, surprisingly CENP-C has 
not been identified in Drosophila. 
As shown in Table 5.3 a number of different primers were designed to the C-
terminal homology regions (Figure 5.4, Xenopus sequence added since it has been 
recently identified and placed in the database). Initially, primers 1-6 were designed 
to the sequences 1, 2 and 3 as indicated. Unfortunately, no PCR products were 
generated. Some of these primers were then replaced with primers containing the 
base inosine rather than the degenerate base N (7, 8 and 9). This modified nucleotide 
can bind to all four bases with varying affinities. In addition, primers 10 and 11, the 
published primers used by Fukagawa in cloning chicken CENP-C (Fukagawa & 




Figure 5.3 Iminunofluorescence using anti -CENP-C 558 A, HeLa JW cells stained with anti-CENP-C 
558 (red), alpha-tubulin (green) and DNA with DAPI (blue). B, Xenopus A6 cells stained for alpha tubulin 
(green) and DNA with DAPI (blue), scale bar is 10 tm. 	 149 


























The template used for this PCR screen was DNA prepared from the Xenopus oocyte 
cDNA library (Rebagliati et al., 1985). Also RT-PCR was attempted using RNA 
prepared from Xenopus A6 cells. Various combinations of degenerate primers were 
used, as indicated in Figure 5.4, and many different conditions were attempted, 
including various temperatures ranging from 44°C - 54°C for the annealing 
reaction. In addition, the primer concentration was varied from 0.2 to 0.5 PM and 
the polymerases Roche Taq and TaKaRa Taq were both used. Additional controls to 
assess the PCR were used. For the library PCR, Zw 10 specific primers were used as 
described in section 5.2.4. For the RT-PCR, both Xenopus specific primers were 
used to assess the PCR, and chicken RNA was prepared and used with chicken 
specific primers in order to asses the reverse transcription reaction. Unfortunately no 
specific bands were generated using any of these primers. 
5.2.3 Screening a Xenopus cDNA library for CENP-C 
As described in sections 5.2.1 and 5.2.2, attempts to identify Xenopus CENP-C 
using human antibodies and degenerate PCR both failed. It was therefore decided to 
adopt another approach to this problem, namely screening a Xenopus cDNA library. 
As discussed in the previous section, a number of sequences are available for CENP-
C proteins and regions of homology have been identified between the S. cerevisae 
protein Mif2 and vertebrate CENP-C. As with the degenerate PCR, the screen was 
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chicken RGQtItIfl('1'SyyLTS&flYpyp&NGy1qIpiff.LNEE SVLW'I'Qt-- 
human 	 LVFYVIff&D LLCTLKETPYIL ST&D SFY VP S&NYYNULP1EE SVLLFTQI- - 
xextopus IVFYI1T13SVQLTL1HLTTY1LKT&DFFYIPP&*1yIITNLLNEDALLIFTQIK& 
rnif 2 	 ITFHVIQ&IVEVTVCKNKFL SVI:&S!FQIP&RE!?LIANPJ3NDEAE11YFVQV-- 
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Figure 5.4 CENP-C and Mij2 homology domains. Clustal alignment of homology domains, block 2 and 
3, identified between S. cerevisae mnzj2 and vertebrate CENP-C (Brown, 1995). Sequences used to design 
primers for degenerate PCR are indicated. See Figure 3.2 for Clustal alignment symbol and colour 
explanation. 
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Since all the probes used were from species other than Xenopus, the library 
membranes were tiybridised at the low stringency temperature of 42°C. The cDNA 
library used was generated from X. laevis oocytes and cloned into XgtlO. It contains 
around 2 x 106  independent clones with an average insert size of 2.5 kb (Rebagliati 
et al., 1985). Three different CENP-C probes were used to screen the library as 
detailed in Table 5.4. 
Tahia id CFJPC nrnhp.c ,icpé 
Probe 	 - Details Tertiary Screen Clone identification 
human CENP-C nt 778-943 contains 2 clones syndecan-2 
block 3 identified  
chicken CENP-C nt 667-872 contains 3 clones metavinculin 
part of block 2 and identified 
block 3  
mif-2 full length 6 clones Ran-GAP I 
identified  
Human and chicken CENP-C clones used were obtained from Ciaran Morrison, Mif-2 cDNA was a 
kind gift from Kevin Hardwick. 
Plaques were purified through a tertiary screen and then inserts were amplified by 
PCR and cloned so they could be sequenced, thereby avoiding time-consuming 
DNA preparations from each phage. The method used to generate the template 
DNA is described in section 2.10.5. The XgtlO forward and reverse primers were 
used and the insert amplified and cloned into pGEM-T so that it could be sequenced. 
Again this approach failed to identify the Xenopus cDNA for CENP- C (Table 5.4). 
It is unknown why the genes shown in Table 5.4 were identified in the screen since 
no sequence homology could be found between these genes and CENP-C from any 
organism. 
Since this screen also failed to identify Xenopus CENP-C, it was decided to focus 
attention on cloning other centromere-associated proteins, as described in the 
following sections. However, during the period of writing this Thesis, an EST from 
Xenopus (Sirulana) tropicalis, became available in the database. The sequence was 
deposited on 16/09/02, with the accession number AL894189, as shown in 
Appendix 2. Presently, there is an initiative to clone Xenopus tropicalis genes and 
sequence the genome, since this organism is being developed in order to make 
transgenic animals. X. tropicalis has advantages over X. !aevis in that it is diploid 
and has a shorter generation time of S months as compared to 1-2 years. It has 
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slightly smaller eggs than X. laevis but these are still amenable to manipulation. 
Figure 5.4 showgthe alignment between the C-termini of CENP-C from various 
species, including the X. tropicalis sequence, indicating the block 2 and block 3 
homology regions. It should be noted that the published sequence appeared to be 
wrong in the most 3' region. This was noticed because the level of homology 
deceased in this region. It seems that the published sequence is missing one base 
pair, and the sequence shown here has been adjusted accordingly, with the reading 
frame simply changing from +2 to +3 for the last 28 amino acids. Analysis of the X. 
tropicalis protein reveals that it is very highly conserved in block 2 and 3 relative to 
the vertebrate sequences and Mif2. This EST has been obtained by the Laboratory 
and in the future could be used to generate a Xenopus-specific antibody such that 
some of the questions and ideas postulated in the introduction to this chapter may be 
addressed. 
5.2.4 Screening a Xenopus cDNA library for the centromere 
associated proteins CENP-H and Zwint 
The Xenopus cDNA library was screened for the constitutive centromere protein 
CENP-H. CENP-H is known to be required for cell cycle progression. It is localised 
to the inner kinetochore plate, and is required for the targeting of CENP-C, but not 
CENP-A, to the kinetochore (Fukagawa et al., 2001). To date this protein has only 
been identified in human, mouse and chicken. At the time of this work, the chicken 
sequence was not published, so the full length human cDNA was used as a probe. 
The probe was generated from the full length EST and again this was radiolabelled 
and hybridised with the membranes at the low stringency temperature of 42°C. The 
results of this screen identified 6 putative clones to the tertiary screen. The 
sequences contained within these phage were then amplified by PCR using the 
XgtlO primers. These PCR products were then cloned into pGEM-T and sequenced. 
Unfortunately, the sequences identified had no homology to vertebrate CENP-H. 
As with CENP-C, the Xenopus database was recently searched for CENP-H. Again a 
clone had been newly deposited, with the accession number BF047824, as shown in 
Appendix 2. In this case, the sequence was from Xenopus laevis. CENP-H is highly 
conserved between human, chicken and Xenopus, with 42% similarity to human. As 
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with CENP-C, this EST has been obtained by the Laboratory to enable the 
generation of an antibody to Xenopus CENP-H. 
The human centromere-associated protein hZwint was identified in a yeast two 
hybrid screen based on an interaction with ZwlO (Starr etal., 2000). As discussed in 
Section 1.9, ZwlO is a checkpoint protein, which along with its binding partner, 
Rod, participates in the spindle assembly checkpoint in metazoans. In an approach 
similar to that used for CENP-C, the cDNA library was screened using the human 
full length sequence. This sequence was generated by RT-PCR, using primers HD19 
and HD20, as shown in Table 2.5. The eDNA was radiolabelled and hybridised to 
the library at the low stringency temperature of 42°C. Unfortunately, although 
clones were obtained through to the level of the tertiary screen, upon sequencing, 
these were found not to be homologous to hZwint. As in the case of CENP-C and 
CENP-H, the Xenopus database was recently searched for potential Zwint 
sequences, and as with the other two genes, a putative X. iaevis EST sequence was 
identified. This was deposited on 10/12/01 with the accession number BJ06 1344, as 
shown in Appendix 2. 
5.2.5 Cloning and characterisation of Xenopus ZwlO 
Since attempts to clone Xenopus genes by degenerate PCR and low stringency 
library screening had failed, an alternative, more direct approach of using Xenopus 
specific sequences in order to clone kinetochore associated genes and raise 
antibodies was adopted. Short EST sequences were identified in the Xen opus 
database for the kinetochore associated proteins ZwlO and Rod. These proteins 
have been shown to be components of the spindle assembly checkpoint in both 
Drosophila (Basto et al., 2000) and human cells, (Chan et al., 2000). 
An EST was identified in the database with homology to ZwlO with the accession 
number BE680749, (see Appendix 2). This was 460 bp in length and corresponded 
to the 3 end of the cDNA. Primers were designed to this sequence and a PCR 
product was generated using the DNA prepared from the cDNA library. The PCR 
successfully generated a fragment of 177 bp when using one specific primer (HD 12, 
Table 2.8) and one Xgtl0 primer. This fragment was cloned into pGEM-T and then 
excised in order to generate a probe for library screening. In this case, the 
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temperature used for hybridisation to the library was 65°C. Five positive phage were 
identified at the tertiary screen and these sequences were amplified using the ?gtlO 
primers as described previously. Sequences were obtained from these phage with the 
longest clone being 1.3 kb, encoding 325 amino acids of Xenopus ZwlO. The 
sequencing of these clones revealed that the database sequence was wrong, as it had 
an extra base A, which resulted in a frameshift of the last 23 amino acids. In order to 
clone the full length ZwlO cDNA, 5' RACE was attempted. The full length human 
and Drosophila sequences are known and are 2337 bp and 2163 bp respectively, it 
was therefore predicted that the Xenopus sequence was missing around 1 kb of 
sequence. Unfortunately, attempts at cloning the remainder of the gene failed. This 
may be because the distance was too far for the 5' RACE reaction to work. Another 
possibility would be to screen the library again with the most 5' sequence now 
available. Since the project was focussed on generating antibodies rather than using 
the full length construct, it was decided not to proceed with this. The sequence of 
the longest clone, as compared to human and chicken sequence, is shown in Figure 
5.5. It has been calculated that the Xenopus sequence is 77% identical to that of the 
human over this C-terminal portion of the protein. Figure 5.6 shows the comparison 
between the partial sequence of Xenopus ZwlO and the other known ZwlO proteins, 
human, chicken and Drosophila. 
The initial ZwlO sequence generated by PCR was cloned into pGEM-T. This was 
then used as a template for PCR in order to create a GST fusion for antibody 
production. This PCR product was cloned into pGEX-4T- I. This construct encoded 
the final 50 amino acids of Xenopus ZwlO (as indicated in Figure 5.5), with an N-
terminal GST tag. The construct was cloned and expressed, as described in section 
2.2.27, resulting in a polypeptide of approximately 30 kDa (5 kDa for ZwIO peptide 
plus 25 kDa for GST), as shown in Figure 5.7A. This polypeptide was used as an 
antigen and injected into rabbits in order to generate polyclonal antibodies. The 
bleeds were tested on Xenopus extract to see if they recognised a protein of the size 
expected for ZwlO. The human and Drosophila proteins migrate at 85 kDa. The 
second bleed from rabbit 1107 recognises a band of approximately 80 kDa in 
Xenopus extracts as shown in Figure 5.713, which is not seen with the pre-immune 
serum. From now on, this serum will be referred to as anti-ZwlO. 
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Figure 5.5 
human 	 ____ 	 150 
xenopug------------------------------------------------------------------------------------------------------------------------------------------------------ 
ruler 1 ....... 10 ........ 20 ........ 30 ........ 40 ........ 50 ........ 60 ........ 70 ........ 80 ........ 90 ....... 100 ....... 110 ....... 120 ....... 130 ....... 140 ....... 150 
human DL 	 LQWLXVWEPP ___ _E IPW?P .LU5VL agUtLIi4ThRPCPI V 	 1Jv,8LLVL 300 
xenopuB --------------------------------------------------------------------------------------------------------------------------------------------------- - -- 
ruler ....... 160 ....... 170 ....... 180 ....... 190 ....... 200 ....... 210 ....... 220 ....... 230 ....... 240 ....... 250 ....... 260 ....... 270 ....... 280 ....... 290 ....... 300 
human ___________________________________________ 	 450 
	
xenopua--------------------------------------------------------------------------------------------------------------- -- - --- - - - --------------------------- IU 	3 
ruler ....... 310 ....... 320 ....... 330 ....... 340 ....... 350 ....... 360 ....... 370 ....... 380 ....... 390 ....... 400 ....... 410 ....... 420 ....... 430 ....... 440 ....... 450 
human 	 600 
xenopus EKQL$QRAPGLENVKI.NQHT#ALPTCRISESVQKLMEI.AYQTLSEATASSKPCSIQLmVRNI FHLFYDVVPTYHK84I.QELPQL8AIHIflWCMYIAB1iLLTLGHQFRYHLPBQI.8DGAATFVPMVPG8RRLQTE8PLAQ14RPQGDL 153 
ruler 	 4y 	 4A 	.......4c0 ................. 	 .. 	 ....I) 	...... 
human LERI.alARrBNMtgYsAASXAVRQVLRQL1(RLGIVWQt)VLPVNITCKAMGTLLNTAI SEVIGXITALEDI$ED(DR - LY8LCKTV?4DECPQVPAFL8RE8XKKYQKEVPVVPnI8WFSL4LQASLQEIQDRWADGXGPZa 749 
xenopus LERLSNARL 	 I XFQEPVQ1ndK,.ZQX IzQASLQEIVDRW).DGxQPX. 	303 
ruler 	.......60 .......620 .......430 .......640 .......650 .......660 .......670 .......680 .......690 .......700 ..........0 .......720 .......730 .......740 .......750 
human 	 P2MXMW 779 
x.nopua TopIMMMILZIRMALL . . --- 325 
ruler ....... 760 .......770 ....... 780 
Figure 5.5 Human ZwIO versus Xenopus partial sequence. Clustal alignment of full length human Zw 10 compared to the partial cloned sequence of 
Xenopus ZwlO. This sequence is 90% similar and 73% identical over its length. The red bar indicates the region used as an antigen. Key to Clustal symbols, 
* - amino acid fully conserved,: strong group fully conserved, STA, NEQK, NHQK, NDEQ, QHRK, MILV, MIL, HY, FYW, . Weaker group fully 
conserved CSA, ATV, SAG, SINK, STAP, SOND, SNDEQK, NDEQHK, NEQHRK, FVLIM, HFY. Colouring of Clustal alignment Blue: AFILMVW, 
Purple: ED, Green: NQST, Yellow: P, Orange: G, Red: KR, Turquoise: YH, Salmon: C. 
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chicken 	 _______ 	 118 
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human ------ MA$YV*vLA1q- - RDWVVLSE.LXQLSWS 
 	
CXWVTRLS 	142 
drosophila PR,VaqGNO 	1iITRVNRF1RVK$IEDNEFNNT 
	
EXATVLDL  150 
ruler 1. ....... 10 ........ 20 ........ 30 ........ 40 ........ 50 ........ 60 ........ 70 ........ 80 ........ 90 ....... 100 ....... 110 ....... 120 ....... 130 ....... 140 ....... 150 
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xenopua------------------------------------------------------------------------------------------------------------------------------------------------ 
human 	 IRFE - - - IIMTNLflP8P 	289 
droaophila -------------------------------------------------------------- AFIYGDDSVDr.DAQVATPLIVRRIFKALECYETIKVKYHVQAYNLQQSLQERFARLVQLQCKSFPTNRCVTLQVSRDQMQDIVQALF 239 
ruler ....... 160 ....... 170 ....... 180 ....... 190 ....... 200 ....... 210 ------- 220 ....... 230 ....... 240 ------- 250 ------- 260 ....... 270 ....... 280 --------90 .......300 
chicken VIVFDKII- -- 	 343 
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human SVPTXIR-- - LVL!VLQXQLLDLPLDTDLKNXT STVPLA1IUGD38IwEDLlECLIKXCLVY$IPTxLW5EEI XQBTEPZNA1. ........ KENRYLKGDWLLKYAMIMMAXKKC§DVIVAARXLMMIUIWMIPD 428 
drosophila (2PNPARLClVLLDNCIEPVXNRP1LADYSEEADGQTYVRLSLsYKEP- SSABVRPNTKQVLENLRLLLRTLAQINCBVS 9J2QHVFGIIGDXVXDn6LKLLVDECLXPAVPESVE!QTST LCEAQLEQLLVL)ØFIXIiPEQDRAL 397 
ruler 	.......310 .......320 .......330 .......340 .......350 .......360 .......370 .......380 .......390 .......400 .......410 .......420 .......430 .......440 .......450 
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human pXNVPELPTPDEDNXLEVQXVSNTQYEEVNNLEPENTLDQHS ------- FSLPTCRISESVKKLMELAYQTLLRATTS8 . DQCAVQLFYSVRNIFXLFXDVVPTYHENLQKLPQLAAIRNcr.rjIABHLLTLGaQFRLRL,ApILCDG 570 
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chicken 	 LY8LC 1, 1 MVEEGPQVFI PEEL' KNKKYQEEVPVYVQK 	633 
xanopn 273 
human 	 - LYSLCKTV34IEGPQVPAPLOBBOKNKKYQEEVPVYVPI( 	719 
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chicken WMMPKLNI ILQANLQEIVDQWADQXGPIJ.AEF9PkEVSLIRALFQNTERRAAALXxz 693 
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ruler 	......76 1 .......'70 ....... 780.... 793 - - - -- -- 830 .......510 
— Figure 5.6 ZwIO sequences compared to Xenopus partial sequence. Clustal alignment of full length human, chicken and Drosophila Zw 10 compared 
to the partial cloned sequence of Xenopus ZwlO. Key to Clustal symbols, * - amino acid fully conserved, : strong group fully conserved, STA, NEQK, 
NHQK, NDEQ, QHRK, MILV, MIL, HY, FYW, . Weaker group fully conserved CSA, ATV, SAG, STNK, STAP, SGND, SNDEQK, NDEQHK, 
NEQHRK, FVLIM, HFY. Colouring of Clustal alignment Blue: AFILMVW, Purple: ED, Green: NQST, Yellow: P, Orange: 0, Red:KR, Turquoise: 
YH, Salmon: C. 
To further verify that this antibody was specific and recognised Zw 10, it was used to 
stain the kinetocl-iores of Xenopus A6 tissue culture cells. Cells were fixed using a 
number of different conditions. These included paraformaldehyde fixation and 
methanol fixation on whole cells treated with and without colcemid synchronisation 
(see Section 2.2.23.1 and 2.2.23.4). In addition, methods recommended to me 
(R.Adams and L. Campbell, Personal Communication) for fixation of Xenopus cells 
were attempted as described in Section 2.2.23.2. Unfortunately, no signal was seen 
with either the serum or affinity purified antibody under any of these conditions. 
Two control antibodies were used, 1186 which although raised against chicken 
INCENP recognises the Xenopus protein and Xenopus Bub3. Since staining whole 
cells was proving difficult attempts were also made at staining metaphase spreads. 
Two protocols were used, as described in section 2.2.23.3 and 2.2.23.6, with the 
later protocol giving better results. This method involves staining the cells before 
fixation. In this case the antibody clearly stained the kinetochores of the metaphase 
chromosomes, as shown in Figure 5.7C, and it was concluded that the serum did 
specifically recognise Xenopus ZwlO. Unfortunately, it was not possible to 






































Figure 5.7. Anti-Xenopus ZwIO recognises a protein of approximately 80 kDa in egg extracts and 
stains the kinetochores of A6 cells. A, 12.5% SDS-Polyacrylamide gel showing induction of ZwlO 
peptide with 0.5 mM IVFG for 4 hours at 30°C and purification from glutathione agarose beads. This 
peptide was used as an antigen for antibody production. B, Western blot of Xenopus egg extracts 
showing that anti-Xenopus ZwlO recognises a band of approximately 80 kDa in egg extracts as 
indicated. C, Xenopus A6 chromosomes stained with anti -Xenopus ZwlO antibody (red) and DNA with 
DAPI (blue), scale bar is 10 ttm.This image was captured using the DeltaVision deconvolution 















In order to address the initial aims of this project, immunoprecipitation experiments 
were carried out -using anti-ZwlO antibodies (see Section 2.32). In an attempt to 
precipitate entire complexes from the extract, conditions were kept non-denaturing 
to preserve the complexes in the native state. The results of two such 
immunoprecipitation experiments are shown in Figure 5.8. The antibody recognised 
ZwlO in the starting extract and this protein appeared to be immunoprecipitated as 
shown in lanes 4, 5, 6 and 7 of Figure 5.8A. The precipitated protein, however, may 
be slightly larger than that in the starting lane. This experiment was repeated using 
various bleeds from the two rabbits injected with antigen (1107 and 1109), in 
addition to the pre-immune serum. The results of this experiment (Figure 5.813) 
again showed that the antibody recognised a protein, presumably ZwlO in the 
starting extract. However, in the lanes containing the immunoprecipitate a large 
band of around 80-90 kDa was recognised by the antibody in addition to the heavy 
chain IgG band at 55 kDa. Since this protein was also pulled down by the pre-
immune sera (lanes 2 and 6) it is most likely that this was a non-specific 
contaminant, rather than a protein specifically bound by the anti-ZwlO antibody. It 
was therefore concluded that these experiments were unsuccessful, with the one 
possible explanation for the result shown in Figure 5.8 being due to the heavy chain 
IgG potentially generating a dimer. The protocol used did not involve the 
crosslinking of the antibody to the beads, so when they were boiled in sample buffer 
the antibody could fall off. In addition, the sample buffer, although containing - 
mercaptethanol did not contain DTT, and therefore a possibility of antibody dimer 
formation remains. In conclusion, I was unable to immunoprecipitate ZwlO or any 
interacting proteins from Xenopus egg extracts using the antibodies generated, either 
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2 - pre-immune control (RIPA/XB) 
3 - pre-immune control (RIPA/TRIS) 
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1 - extract 
2 - 1107 pre-immune serum 
3 - 1107 bleed 2 
4 - 1107 bleed 3 
5-1107 affinity purified 
6 - 1109 pre-immune serum 
7-1109 bleed 2 
—66.4 
—55.5 
Figure 5.8. Immunoprecipitation from Xenopus egg extracts using and-ZwIO. A, The antibody (1107) 
was bound to beads then washed in RIPA buffer, the beads were then incubated with extract and then 
washed in either XB or TRIS buffer, as shown in table. The samples were subjected to SDS-PAGE, 
transferred to membrane, blotted with anti-ZwlO and the signal detection using Protein-A-1 1 . 
B, Subsequent immunoprecipitation from Xenopus egg extracts using anti-Zw 10 serum from two rabbits 
(1107 and 1109) in addition to the pre-immune serum. The conditions used were as in lane 4 above. 
Detection using ECL. 
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5.2.6 Cloning and characterisation of Xenopus Rod 
In a manner very similar to that described above for ZwlO, a short database 
sequence was available for the kinetochore-associated protein, Rod. This sequence 
allowed generation of antibodies to the protein for further analysis in Xenopus. 
Two short EST sequences were present in the database with homology to the C-
terminal region of human and Drosophila Rod, with the accession numbers 
BG233529 (I) and BG159891 (2) as shown in Appendix 2. Primers for PCR were 
designed to these regions and products generated (Figure 5.9A) using the DNA from 
the cDNA library as a template. These two products were cloned into pGEM-T. 
Unfortunately, one PCR product stretching from the most 5' of EST 1 to the most 3' 
of EST 2 could not be generated. However, since the two products were generated 
using the forward and reverse version of the same primer, the sequence could be 
pieced together. In an attempt to clone the full length cDNA the most 5' available 
sequence, which was cloned into pGEM-T-XlRod5', was isolated by restriction 
digest, radiolabelled and used as a probe to screen the cDNA library. Nine positive 
phage were identified to the tertiary screen, the DNA was then amplified by PCR 
and cloned into pGEM-T as described previously. These plasmids were sequenced 
revealing that 2.5 kb of Xenopus Rod cDNA had been cloned. This encoded the C-
terminal 759 amino acids of the protein. 
The full length cDNA of Drosophila and human Rod is 6627 bp and 6294 bp 
respectively. Since the longest clone identified was 2607 bp, this was still around 4 
kb from full length, out with the range for 5' RACE reactions. One possible way to 
clone this would be to screen the library again with the now most 5' available 
sequence. However, since the aim of the project was to raise antibodies, it was 
decided not to screen again. The sequence alignment of the C-terminal third of the 
protein is compared with human Rod in Figure 5.913. Over this region of the 
protein, Xenopus Rod is 54% identical to the human sequence. 
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Figure 5.9 Rod sequences compared to Xenopus partial sequence. A, Diagram representing the Xenopus Rod EST sequences in the database and the primers 
used to amplify these sequences. B, Clustal alignment of partial sequence of human Rod compared to the partial cloned sequence of Xenopus Rod. The human 
sequence begins at amino acid 1451. The red bar indicates the region used as an antigen. Key to Clustal symbols, * - amino acid fully conserved, : strong group 
fully conserved, STA, NEQK, NHQK, NDEQ, QHRK, MILV, MIL, FlY, FYW, . Weaker group fully conserved CSA, ATV, SAG, SFNK, STAP, SGND, 
SNDEQK, NDEQHK, NEQHRK, FVLIM, HFY. Colouring of Clustal alignment Blue: AFILMVW, Purple: ED, Green: NQST, Yellow: P, Orange: G, 
Red:KR, Turquoise: YH, Salmon: C. 
To generate antibodies to Xenopus Rod, PCR primers were designed to enable 
cloning of the last 126 amino acids of the protein with an N-terminal GST fusion. 
The PCR product was generated using pGEM-T XlRod3' (see Table 2.7) as a 
template and cloned into pGEX-4T-1, using primers HD 17 and HD 18 as detailed in 
Table 2.8. This construct was expressed, and a polypeptide of approximately 40 
kDa purified using glutathione agarose (as shown in Figure 5.10B). This 
corresponded to 14.3 kDa for the Rod peptide and 25 kDa for GST. This 
polypeptide was purified and used as an antigen to generate rabbit polyclonal 
antibodies. Rabbit serum was obtained and tested for activity on Xenopus egg 
extracts. After affinity purification the serum from rabbit UED6 recognised a protein 
of approximately 200 kDa (as shown in Figure 5.10C), which is not seen with the 
pre-immune serum. The size of human and Drosophila Rod is around 200-205 kDa. 
As in the case of ZwlO, it was necessary to determine whether this serum was 
specific for Xenopus Rod. Immunofluorescence on Xenopus A6 cells was attempted 
using a number of different fixation and staining conditions as described for ZwlO 
in section 5.2.5, however these attempts failed to show any specific staining. The 
bleeds and affinity-purified antibodies were also tested, but none gave a positive 
signal. Finally in a manner similar to the experiments described for ZwlO, 
immunoprecipitation was attempted using serum and affinity purified antibodies. 




































Figure 5.10 Generation of an antibody to Xenopus Rod. A, Rod peptide expression was induced with 0.1 mM 1Ff G 
for 3hrs 30mins at 30°C and purified over glutathione agarose, before being subjected to 12.5% SDS-PAGE. This 
purified peptide, as indicated, was used as an antigen for antibody production. B, Xenopus egg extracts blotted with 
anti-Rod antibody, detected using ECL. 
165 
5.2.7 Preliminary Investigation of the ZwlO/Rod complex in Xenopus 
egg extracts 
Since ZwlO and Rod have been reported in a complex in both Drosophila and 
human cells, it was of interest to determine whether this complex could be identified 
in Xenopus egg extracts. In Drosophila, this complex is approximately 19S, as 
judged by Superose 6 gel exclusion column (Scaerou et al., 2001). To address this 
question in Xenopus, sucrose gradients were used to separate high speed supernatant 
(HSS) from egg extracts. As described in section 2.2.23, HSS was run on either 5-
20% or 10-40% sucrose gradients. The fractions from each gradient were then run 
on a gel, transferred to membrane, and blotted with the antibody of interest. Initial 
experiments with the 5-20% gradient showed Zw 10 at the bottom of the gradient, in 
a large complex (Figure 5.1 IA). Zw 10 in this experiment is present in both the crude 
extract and HSS, which is the starting material of the experiment. The ZwlO 
antibody recognises a protein present in fractions 15, 16 and 17. This gradient was 
also blotted with an anti-INCENP antibody. As discussed earlier, INCENP is present 
in a complex of approximately 1 IS in Xenopus egg extracts (Adams et al., 2000), so 
this was used as a control for the size of the complex. INCENP is present in 
fractions 12, 13 and 14, indicating that the ZwlO complex is larger than this. To 
determine more accurately the size of this complex, a 10-40% gradient was run for 4 
hours. ZwlO is present in fractions 6, 7, 8, 9 and 10 (Figure 5.1113). This gradient 
was then probed with anti-Rod, which recognised a protein in fractions 7, 8, 9 and 
10. As in 5.1 1A, this gradient was also blotted with a component of the INCENP 
complex, Aurora-B, which was found to be present in a number of fractions but with 
the greatest intensity at 6 and 7. The membrane was also blotted with anti-INCENP 
and it was possible to determine that the complex was in fractions 6 and 7 (not 
shown). In order to determine the size of this complex, standards were run on a 
parallel gradient as shown. These standards confirmed the size of the 
INCENP/aurora B complex as I 1S and showed that the ZwlO/Rod complex is larger 
than this. In conclusion, ZwlO and Rod are present in a complex of larger than 1 IS 
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Figure 5.11 ZwIO and Rod are present in a complex of larger than ]IS in Xenopus egg extracts. A, 5-
20% sucrose gradient of Xenopus high speed supernatant (HSS) run at 53,000 rpm for 5h 30mins. The 
gradient was fractionated into 17 samples, run on a 7.5% SDS-PAGE and blotted with anti-ZwlO 
(below) and anti-INCENP (above). B, 1040% sucrose gradient of Xenopus high speed supernatant 
(HSS) run at 53,0(X) rpm for 4 hours. The gradient was fractionated into 17 samples, run on a 7.5% 
SDS-Polyacrylamide and blotted with anti-Rod (top), anti-ZwlO (middle) and anti-Aurora-B (bottom). 
BSA and catalase standards were run on a parallel gradient and the fractions were stained with 
Coomassie blue. 167 
5.3 Discussion 
5.3.1 Attempts at cloning the Xenopus orthologue of CENP-C 
A number of different approaches were attempted in order to clone Xenopus CENP-
C, including antibody screening, degenerate PCR and low stringency library 
screening using cross species probes. Unfortunately, none of these attempts were 
successful. The screening of antibodies identified one human CENP-C antibody, 
which potentially cross-reacted with Xenopus. However, immunoprecipitation 
experiments were difficult to interpret and sucrose gradients revealed two different 
sized proteins being recognised by the antibody. These proteins were of 
approximately 80 kDa and 140 kDa. Although the predicted molecular weight of 
human CENP-C is just over 100 kDa it runs at 140 kDa on protein gels. It may, 
therefore be possible that the antibody did indeed recognise Xenopus CENP-C, 
which is around 140 kDa, as shown in the sucrose gradient, (Figure 5.213). However, 
another protein or degradation product of around 90-100 kDa was also recognised 
by this antibody. Another possible experiment would be to immunoprecipitate from 
the fractions of the sucrose gradient. In order to determine conclusively if anti-
human 558 did indeed recognise Xenopus CENP-C, this would have had to be 
shown either by immunofluorescence on Xenopus cells or immunoprecipitation, and 
sequencing by mass spectrometry. Unfortunately, neither immunoprecipitation 
experiments nor immunofluorescence were successful. 
Since the CENP-C sequence was available from a number of diverse species, 
degenerate PCR primers were designed. The primers were based mainly on the 
amino acids conserved between the S. cerevisae protein Mif2, and the human and 
chicken sequences. The degenerate primers were designed to the blocks of 
homology as identified by Brown, (1995) and were based on the degenerate primers 
used by Fukagawa et al., 1997 to clone chicken CENP-C. Unfortunately attempts to 
generate PCR products using either the cDNA library as a template, or RT-PCR 
using Xenopus A6 cell RNA as a template, failed. In the case of both the RT-PCR 
and PCR from the library, primers to Xenopus ZwlO were used as a positive control. 
An additional control for the RT-PCR used RNA from chicken cells as a positive 
control and chicken specific primers. The final approach adopted was to screen the 
Xenopus cDNA library with cross species probes by low stringency Southern 
hybridisation at 42°C. The probes used were human and chicken sequences 
containing the homology domains or, alternatively, the full length Mif2 sequence. 
Although some positive clones were identified to the stage of a tertiary screen, upon 
sequencing, these were found not to be CENP-C. Why in particular these genes were 
cloned is unknown, since no sequence homology was identified. One explanation is 
that the temperature used was too low, and therefore allowed the probes to hybridise 
to non-specific library sequences. If these experiments were to be repeated, the 
temperature could be increased slightly. In addition, the washing conditions could be 
varied in order to prevent false positives. The conditions used for washing were 40 
mM NaPi and 1% SDS at 42°C. The stringency of this wash could be increased, by 
decreasing the salt and SDS concentrations. 
Since a partial sequence for the CENP-C gene in a related Xenopus species, Xenopus 
(Sirulana) tropicalis, has recently been made available, it is now possible to assess 
the similarity between the sequences and speculate why the adopted approaches 
failed. The regions of homology designated block 2 and block 3 are highly 
conserved (Figure 5.4), although it should be noted that the database sequence is 
most likely wrong for the translation of the last 28 amino acids, presumably due to 
one missing nucleotide and a frame change from +2 to +3. This new sequence is 
highly conserved as compared to the vertebrate CENP-C sequences and Mif2. By 
looking at the partial sequence now available, the reasons why the library screen was 
unsuccessful are not at all clear. 
Reasons for the failure of the degenerate PCR may be because of several key 
differences between the Xen opus sequence and that of yeast Mif2 and the other 
vertebrate species. The degenerate primers were based on the regions indicated in 
Figure 5.4. In some cases it seemed clear that an amino acid would be conserved. In 
others any amino acid was expected, and in the third scenario, a guess was made 
based on the Mif2, chicken or human sequence. The result is that all three primers 
designed had two errors compared to the actual sequence. In the light of this 
knowledge, it is unsurprising that the experiment failed. What is surprising, 
however, is that the sequence of the Xenopus protein varies in these conserved 
regions as compared to the other sequences. In the case of primer 1, the mistake at 
amino acid 3 was due to the fact that the human and chicken have a glutamic acid at 
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this position and Mif2 a glutamine. It was therefore reasoned that one of these would 
be conserved in Xenopus. In actual fact the amino acid is alanine in Xenopus. The 
second mistake in primer 1 is at amino acid position 6. In Mif2, human and chicken 
this is an arginine. However, in Xenopus it is lysine. Primer 2 also has two 
mistakes, the first at position 3. This residue is valine in Mif2, human and chicken. 
However, in Xenopus it is isoleucine. The second mistake in primer 2 is at position 
5. This is a different amino acid in all three organisms, therefore a primer with high 
degeneracy was designed. This could have encoded for asparagine, lysine, serine, 
arginine, histidine, or glutamine. Unluckily the Xenopus amino acid is threonine. In 
primer 3, again there are two mistakes, the first at position 2, which is alanine in 
Mif2, human and chicken, but proline in Xenopus. The second mistake is at position 
7 which is asparagine in both chicken and human. However the amino acid in 
Xenopus is lysine. Therefore since all three primers had two mistakes, it is unlikely 
that they could have annealed specifically in order to generate a product. 
5.32 Screening a Xenopus cDNA library for CENP-H and MINT 
Library screening, using cross species probes for the centromere associated proteins, 
CENP-H and Zwint, also failed, presumably due to the fact that the temperature 
used was incorrect or the washing conditions were incorrect as discussed previously. 
In the case of CENP-H a partial Xenopus !aevis EST is now available in the database 
and when compared to the human sequence is 43% identical over this region. 
As with CENP-C and CENP-H, a partial Xenopus laevis EST is now also available 
for Zwint and when compared to the human sequence is 26% identical. To date, the 
only information concerning Zwint is that it interacts with human ZwlO. 
Identification of the Xenopus protein in the database revealed that it is conserved 
and hopefully further investigation will determine if it is in a complex with ZwlO 
and Rod in Xenopus egg extracts. 
5.3.3 Cloning and Characterisation of Xenopus ZW10 
After identification of a short EST sequence for Xenopus ZwlO in the database, 
amplification by PCR from the library DNA was relatively simple. This sequence 
was then used as a probe to screen the cDNA library. The longest clone obtained 
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contained 1.3 kb of the C-terminal portion of Zw 10 cDNA. Sequencing of this clone 
revealed that the C-terminal half of Xenopus Zw 10 is 77% identical to the human 
sequence. Unfortunately, attempts to clone the full length cDNA by 5' RACE 
failed. The reason for this could be that the distance between the specific primers 
and the 5' end was beyond the range of this reaction. To clone this sequence, the 
best solution may be to screen the library again with the most 5' sequence now 
available to see of there is a longer clone which was missed on the initial screen. 
The library is generated from polyA primed sequences so many clones will not be 
full length in the 5' region. 
To generate an antibody to ZwlO, the most C-terminal 50 amino acids were cloned 
into a pGEX vector, resulting in an N-terminal GST fusion. This fusion protein was 
expressed, purified and injected into rabbits. The serum from two rabbits was tested 
and rabbit 1107 recognised a band of approximately 80 kDa, potentially ZwlO. To 
verify that this was indeed an antibody specific for ZwlO, immunofluorescence 
experiments on Xenopus tissue culture cells were carried out. On metaphase 
chromosome spreads it was possible to show that the antibody recognised the 
kinetochores of Xenopus cells. Unfortunately, attempts to determine the localisation 
of this protein throughout mitosis were unsuccessful. The reason why this 
immunofluorescence failed may be that the antigen is somehow masked at the 
kinetochore, making it difficult for the antibody to interact. Kinetochores did stain in 
chromosome spreads. However, it was noted that the chromosomes with the worst 
morphology, which had been harshly treated with the hypotonic solution, had the 
strongest staining with the antibody, an indication that the antigen may be masked 
somehow. The antibody either as serum or affinity purified was used in 
immunoprecipitation experiments in order to 'pull down' a potential complex from 
Xenopus egg extracts. Unfortunately, the immunoprecipitation experiments failed to 
'pull down' ZwlO or any interacting proteins. Initial confusion over whether the 
experiment had been successful arose because an unknown band, recognised by the 
ZwlO antibody was present in the IP lane. Upon further investigation, this band was 
also identified in the control lanes and is most likely due to the antibody. One way to 
resolve this problem would be to crosslink the antibody to the protein A beads, using 
20 mM dimethyl pimeliminidate in 0.2 M sodium borate pH 9.0, preventing it 
coming off when the beads are boiled in sample buffer. The identity of this species 
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is still unknown since the heavy and light chain IgG molecules are easily identifiable 
on the gels. The sample buffer, although containing -mercaptoethanol, which is a 
reducing agent that breaks disulphide bonds between protein molecules, does not 
contain DTT. The presence of DTT may be advantageous in preventing any 
complexes from remaining in the gel. However, since the gel is denaturing, this may 
be an unlikely explanation. The conditions used to do these immunoprecipitation 
experiments were non-denaturing so that whole complexes could be pulled down. 
However, in order to determine if this antibody works, it may be necessary to 
change the conditions to denaturing ones and see if Zw 10 alone can be pulled down. 
If ZwlO is present in a very large complex this may have prevented the interaction 
between antibody and antigen. A scenario could be imagined where the epitope 
recognised by this antibody is buried in a complex and not accessible. Since only a 
small fragment was used to generate the antibody, this may be a possibility. In 
addition, it may have been a limiting factor that relatively small volumes of extract 
were used for the immunoprecipitation experiments compared to the large scale 
experiments, using up to 100 times more extract, which lead to the identification of 
the INCENP/Aurora B complex in egg extracts (Adams et al., 2000). 
5.3.4 Cloning and characterisation of Xenopus ROD 
In a manner very similar to that described for ZwlO, database identification of ESTs 
allowed a portion of the C-terminus of Xenopus Rod to be cloned. cDNA encoding 
the last 759 amino acids of Xenopus Rod was cloned. Sequencing revealed that the 
identity to human is 54% over the C-terminal third of this protein. A rabbit 
polyclonal antibody was raised to the C-terminal 126 amino acids. This antibody 
recognised a band of approximately 200 kDa on immunoblot of Xenopus egg 
extracts. 
As with Zw 10, immunoprecipitation experiments were attempted, but failed to pull 
down Rod or any interacting proteins. As discussed above for ZwlO, if these 
experiments were to be repeated, it might be best to use denaturing conditions in 
case a complex was preventing the association between epitope and antibody. In 
addition, the attempts at immunofluorescence using anti-Rod on Xenopus cells did 
not yield positive results, even though a number of protocols were used. 
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Recently, the cloning and generation of antibodies to Xenopus ZwlO and Rod has 
been reported by another group and used in the study of the Ndc80 kinetochore 
complex in Xenopus (McCleland et al., 2003). The authors state that the antibodies 
raised to Xenopus ZwlO and Rod recognises bands of 80 and around 250 kDa 
respectively on western blot, which is consistent with the results described here. 
By sucrose gradient fractionation of Xenopus HSS it was possible to show that 
Zw 10 and Rod are present in a complex. The complex size was determined to be 
larger than 1 IS by using protein standards and blotting with the antibodies to 
INCENP and Aurora-B. These passenger proteins have been identified in an 1 IS 
complex in egg extracts (Adams et al., 2000). The results of this blot (Figure 
5.1 lA), showed that the passenger complex is distinct from that containing ZwlO 
and Rod in a 5-20% gradient. However, in a 10-40% gradient, as shown in 5.1 lB, 
the complexes were closer together. This may be due to the fact that this gradient 
was run for a shorter time. In order to further separate these complexes it might be 
necessary to run a 10-40% gradient for 5-6 hours. In addition, a larger protein 
standard could be run in order to determine more accurately the size of this complex. 
An additional approach to the identification of the components of this complex 
might be to immunoprecipitate from the sucrose gradient fractions. In this case there 
would be less contaminating proteins, and this might favour a positive result. In 
addition, the presence of any other proteins in the complex could be investigated. 
Zw 10 and Rod have been reported to interact with the dynein/dynactin complex and 
if antibodies were available to these, the gradient fractions could be probed by 
immunoblotting. The size of this complex is somewhat different from that identified 
in Drosophila (Scaerou et al., 2001), where it was found to be 700-900 kDa by a 
Superose-6 sizing column and was said to sediment at 19S. It may be that the 
complex identified in Drosophila has additional components not present in the 
Xenopus complex. 
Both ZwlO and Rod have no known domains or motifs in common with other 
proteins. Their role in cell cycle progression and in particular the spindle assembly 
checkpoint is unclear, and any further information regarding these proteins may be 
of potential interest. Although this study was unable to draw any significant 
conclusions regarding this complex or the kinetochore in general in Xenopus, other 
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than confirmation that a complex does exist, it is hoped that the reagents generated 
will be useful in addressing the initial aims. If the antibodies generated to Xenopus 
ZwIO and Rod are not useful for immunoprecipitation experiments, then others 
could be generated based on the sequences now cloned. In addition, identification of 
Xenopus CENP-C, CENP-H and Zwint in the database will allow them to be cloned 
and antibodies raised in order that they can be further studied in the Laboratory. 
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Chapter 6 
Discussion and Future Work 
6.1 	Discussion 
Chicken BubRi cDNA was cloned from a library and sequencing revealed that it is 
52% identical to human BubRi. Clustal alignments revealed that it is highly 
conserved as compared to BubRl from other species and to S. cerevisae Mad3 in the 
conserved domains (Figure 3.3 and 3.4). An antibody was raised against this protein 
by the expression of a fragment (653-778) as a GST fusion. In order that an antibody 
specific for BubR 1, and not Bub 1 would be generated this portion of the protein was 
out with the kinase domain or any other identified motifs. Immunofluorescence 
with this antibody revealed that BubR 1 is localised in chicken cells in a manner 
similar to that reported for BubRi and other spindle assembly checkpoint 
components in various species. BubRi becomes localised to the kinetochores during 
prometaphase and then the signal is decreased as kinetochores become attached to 
microtubules and are under tension. The signal is most intense as the cell proceeds 
from metaphase to anaphase, and no specific staining is seen during later stages of 
the cell cycle. In addition, the antibody brightly stains the kinetochores of cells 
treated with the microtubule depolymerising drug colcemid and the microtubule 
stabilising drug taxol, both of which activate the spindle assembly checkpoint. The 
antibody was also used for immunoblots of chicken cell extracts. This revealed that 
BubRi migrates at approximately 140 kDa although the predicted molecular weight 
is 122 kDa. After treating cells with colcemid and taxol, to activate the checkpoint, 
cell lysates were immunoblotted with the antibody. This revealed that a higher 
molecular weight form, presumably phosphorylated BubRi is detectable after 
activation of the checkpoint. This form of the protein is present in untreated cells, 
but appears to be more abundant after treatment with these drugs. As discussed in 
Chapter 3, this antibody has been useful in a number of studies in DT40 cells in 
order to assess the checkpoint and also the kinetochore. Hopefully, it will be of 
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further use in the future in the study of DT40 knockouts, or other studies in chicken 
cells. 
Attempts at generation of a stable MSB 1 cell line with which to investigate the 
structure of the kinetochore were unsuccessful. The aim was to generate a cell line 
with a tagged version of BubR 1 expressed at the kinetochore. Since it is known that 
BubR 1 is localised to the outer kinetochore plate, this was intended to be used as a 
handle with which to identify novel kinetochore components and BubRi interactors. 
Unfortunately, although some MSBI cell lines were generated none showed 
kinetochore localisation of BubR 1. Subsequently, investigation of the expression of 
exogenous BubRi in a different chicken cell line, DT40, revealed that stable 
expression is very difficult to maintain. This led to the hypothesis that exogenous 
BubRI may be toxic. Whilst investigating BubRi expression in DT40 cells with the 
aim of generating a rescued cell line, the tagged construct was expressed. In this 
case a cell line was observed with tagged BubRl at the kinetochores. This may, 
therefore, be a useful tool with which to investigate the kinetochore in chicken cells. 
Alternatively, it may be better to use a constitutive centromere protein such as 
CENP-C or CENP-H as the 'handle'. In addition, it may be easier to do these 
experiments in human cells. Although there is a chicken database and an ever-
increasing number of chicken sequences are deposited, this is far from the 
comprehensive human genome data now available. For this reason, the identification 
of proteins by mass spectrometry would be much easier if they were human. 
In order to investigate the roles of BubRi in mitosis, the aim was to generate a 
conditionally null DT40 cell line. Initially, this required cloning of the BubRi 
genomic locus for use as the basis of targeting vectors. A phage, 3B3, was identified 
which contained the ATG and around half of the predicted exons of chicken BubR 1. 
Unfortunately, this phage had little sequence upstream of the ATG, and re-screening 
the library proved unsuccessful in the identification of subsequent phage with more 
sequence in the 5' region of the gene. Targeting vectors were generated with a 
number of resistance cassettes, and it was determined that the total length of 
homology of 4.6 kb was insufficient to target the genomic region of approximately 
10 kb. When the total homology was increased to 6 kb targeting occurred, however, 
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at a low frequency for DT40 cells (Table 4.4). The resulting cell lines, heterozygous 
for BubRi, were investigated in a number of ways. Since it is known that Mad2 is 
haploinsufficient in mouse (Michel et al., 2001), it was interesting to determine if 
this was the case for BubRi in chicken cells. Initially, the +1- cells were visualised 
by immunofluorescence microscopy and it could be seen that they progressed 
through mitosis apparently normally with BubRi localised to the kinetochores 
during prometaphase. The cells grew normally in culture and their growth rate was 
compared to wild type cells. As shown in Figure 4.9, the heterozygote cell 812 and 
821 grow at a very similar rate to wild type DT40, Cl 18. However, the heterozygote 
cell line 511 appears to grow a little more slowly, although within the normal range 
for DT40 cells. Although it has been shown that BubRi is present at the 
kinetochores of heterozygote cells, it was interesting to ask if the checkpoint was 
still active. In order to do this, the cells were treated with colcemid and taxol, both 
of which activate the checkpoint. The mitotic index was calculated, and the cells 
were prepared for immunofluorescence and immuoblotting. The results of this 
experiment show that the heterozygote cells respond normally to spindle damage, as 
judged by an increase in the mitotic index, the presence of BubRi at the 
kinetochores of arrested cells, and the increase in the phosphorylated form of BubRi 
as judged by immunoblot. Finally, the amount of BubRl protein was quantified in 
these cells by immunoblot, and it can be seen that it is reduced as compared to wild 
type cells. These results therefore demonstrated that BubRI does not appear to be 
haploinsufficient in DT40 cells and that the heterozygote cells have an active spindle 
assembly checkpoint, although the levels of BubRl are reduced. 
Unfortunately, generation of null cells was unsuccessful. Targeting experiments in 
the absence of a rescue cDNA showed that the gene was essential. A strategy with 
the rescue construct (cDNA) under the control of the Tet operator was therefore 
adopted. However, it proved difficult to'express the cDNA even though different tTa 
plasmids were used. Although the expression was detected by RT-PCR and 
immunoblot it was very difficult to determine the expression levels on a cell by cell 
basis. One way to overcome this problem may be to express a tagged rescue 
construct. Both a GFP-BubRl construct and a BubR 1-HA-His construct were made 
and tested in DT40 cells. The GFP construct did not localise appropriately. As 
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discussed previously a cell line was generated with the BubR 1-HA-His localised to 
the kinetochore, however this construct was not cloned under the control of the Tet 
promoter, so therefore could not be used as a rescue. In the future, however, this is a 
possibility. An additional possibility would be to use the cDNA from a different 
species in order to rescue the knockout. In this case an antibody specific for the 
exogenous BubRl would be used in order to determine the expression levels in a 
particular cell or cell line. Several attempts were made at controlling the expression 
levels by using different tTa plasmids. However, even with the weakest tTa 4 which 
should give an expression level of 10%, as compared to the original plasmid, some 
cells were seen with very high levels of the protein as judged by 
immunofluorescence. To try and avoid some of the detrimental effects of exogenous 
BubRi expression, transfections were carried out in the presence of doxycycline. In 
this case, the transgene would not be expressed until the drug was removed. 
However, in targeting experiments carried out in these cell lines, no homozygous 
clones were identified. In conclusion, expression of the transgene proved very 
difficult. Cell lines generated showed extremely heterogenous expression levels as 
judged by immunofluorescence with the BubRl antibody. It is predicted that this 
would make targeting experiments very difficult as there might be few or no cells, 
expressing BubRi at the correct levels, which could be targeted. Obviously, if the 
targeting was more efficient, this might be overcome by screening more colonies. 
However, with the reagents currently available, this may be an impossible task. 
A few other possibilities exist in order to overcome this problem. As discussed in 
Chapter 4, an IRES construct may be a potential approach. In this case, the 
expression of the transgene would have to be maintained by the cell in order that it 
was drug resistant. Unfortunately, plans to attempt this approach were not completed 
since the construct proved extremely problematic to clone. This still remains a 
possibility for the future. In addition, approaches using Cre technology may be the 
answer, as this would allow the rescue to be expressed from the endogenous 
promoter, hopefully bypassing any toxicity issues. 
If a BubRl null cell line were generated in the future there are many questions 
which could be addressed. Firstly, an assessment of the checkpoint function would 
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be very interesting. It is known that the checkpoint has a number of components, and 
recent experiments have drawn the conclusion that BubRi and Mad2 sense distinct 
tension and attachment checkpoints. This would be an ideal system with which to 
address this hypothesis, since the function of only one of the proteins would be 
removed. In addition, the function of various domains of the protein could be 
dissected. It would be possible to put back structural mutants into the cell line and 
ask if they can rescue the function. In particular the function of the kinase domain 
could be addressed in this manner. Site directed mutagenesis was carried out on 
chicken BubRi to generate the kinase dead form (K830R). This construct could be 
used firstly to address whether the kinase domain is required for the checkpoint to 
function, and if not, an alternative role could be investigated. Also, it would be 
interesting to address the affect on other checkpoint components such as ZwlO and 
Rod if BubRi were missing and the checkpoint therefore potentially inactive. The 
structure of the kinetochore could also be studied by electron microscopy. 
Surprisingly, BubRl appears to be overexpressed or stabilised in apoptotic cells. 
Initially, this was seen by immunofluorescence on apoptotic cells using the BubRi 
antibody. Subsequent investigation has shown that BubRl is apparently cleaved 
after DT40 cells are induced to go into apoptosis by treatment with etoposide. This 
data is preliminary, but intriguing, especially since it is known that caspases cleave 
other kinases during apoptosis. These kinases often then have a role to play in the 
apoptotic process (reviewed by (Earnshaw etal., 1999; Utz & Anderson, 2000)). To 
investigate this further BubRi, could be in vitro translated and tested for cleavage 
with a number of purified caspases. In addition the fragment could be 
immunoprecipitated and then sequenced. This would identify the end of the protein 
which is stabilised. 
The method of BubR 1 destruction or inactivation after the checkpoint is satisfied is 
unclear. It has a putative destruction box and also a putative KEN box, which could 
both indicate that it is targeted for destruction by the APC. To address the question 
as to if this cleavage seen during apoptosis also occurs once the checkpoint is 
satisfied in a normal cell cycle, cells were treated with nocodazole and then released 
into anaphase. This cleavage is not observed after the cells are released from a 
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nocodazole block (fig 4.12), which may indicate another mechanism is active, since 
the protein levels do decrease. 
An alternative approach to study the kinetochore and spindle checkpoint in 
vertebrates was attempted in the Xenopus egg extract system. Initially, attempts 
were made at cloning the constitutive centrornere proteins CENP-C and CENP-H. A 
number of approaches were employed in order to clone Xenopus CENP-C, including 
screening extract with antibodies, degenerate PCR and screening a cDNA library. 
Unfortunately these attempts were unsuccessful. As discussed in Chapter 5, the 
Xenopus homologue has recently been deposited in the database. This information 
shows that the C-terminal of Xenopus CENP-C is conserved and that it contains the 
domains conserved in the S. cerevevisae protein Mif2. Perhaps the temperature used 
for the library screen was inappropriate, resulting in the identification of false 
positives. The reasons for failure of the degenerate PCR appear to be due to bad luck 
with the choice of primers. Now that the sequence is available, the EST has been 
obtained by the Laboratory and antibodies may be generated to this protein. 
Hopefully, these will be useful in immunoprecipitation experiments leading to the 
investigation of the kinetochore in Xenopus. The cloning of Xenopus CENP-H also 
proved to be unsuccessful. However, as with CENP-C a Xenopus homologue of 
CENP-H is now available in the database and this could also be used to generate 
antibodies and investigate the kinetochore. 
Since library screening with cross species probes proved unsuccessful, a more direct 
approach was adopted. Short EST sequences were identified for the checkpoint 
proteins Zw 10 and Rod. These sequences were used to generate GST fusions for 
antibody production and as probes for cDNA library screens. Around one half of the 
Xenopus ZwIO cDNA was cloned and this is highly conserved compared to human 
ZwlO. In addition, antibodies were raised that recognise a protein of approximately 
80 kDa by immunoblot and stain the kinetochores of Xenopus A6 cell. In a similar 
manner, around one third of the Xenopus Rod cDNA was cloned. Sequencing 
revealed that it is homologous to the human Rod. An antibody was generated which 
recognises a protein of approximately 200 kDa by immunoblot. Unfortunately this 
antibody was not useful in immunofluorescence studies. Although 
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immunoprecipitation experiments failed, it was possible to determine that ZwlO and 
Rod were present in a complex in Xenopus egg extracts. The size of this complex 
was estimated to be larger than 1 IS. The size of this complex could, perhaps, be 
determined more accurately by running gradients for different lengths of time. In 
addition more protein standards could be used. This complex differs in size from 
that identified in Drosophila which is estimated to be 19S (Scaerou et al., 2001). 
One possible explanation for this could be that this complex identified in Xenopus 
contains less components, or that there are multiple complexes which contain ZwlO 
and Rod. Hopefully, the generation of these Xenopus reagents will be useful in 
future studies into the spindle checkpoint and ZwlO and Rod interactors. 
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Summary 
We identified a novel essential centromere protein, 
CENP-1, which shows sequence similarity with fission 
yeast Mis6 protein, and we showed that CENP-1 is a 
constitutive component of the centromere that cob-
calizes with CENP-A, -C, and -H throughout the cell 
cycle in vertebrate cells. To determine the precise 
function of CENP-I, we examined its role in centromere 
function by generating a conditional loss-of-function 
mutant in the chicken DT40 cell line. In the absence 
of CENP-I, cells arrested at prometaphase with misa-
ligned chromosomes for long periods of time. Eventu-
ally, cells exited mitosis without undergoing cytokine-
sis. Immunocytochemical analysis of CENP-l-deficient 
cells demonstrated that both CENP-1 and CENP-H are 
necessary for localization of CENP-C but not CENP-A 
to the centromere. 
Introduction 
The centromere is an essential component of the chro- 
mosome that is required for accurate segregation of 
chromosomes during mitosis and meiosis in eukaryotes. 
'Correspondence: tfukagaw@lab.nig.ac.jp  
Its functions include sister chromatid cohesion and sep-
aration, microtubule attachment, chromosome move-
ment, and mitotic checkpoint control (Choo, 1997). Al-
though problems in chromosome segregation can lead 
to aneuploidy, cancer, and cell death, the mechanism 
by which centromeres interact with microtubules of the 
spindle apparatus during cell division is not fully under-
stood in any organism. 
The centromere of the budding yeast Saccharomyces 
cerevisiae has been characterized extensively. A combi-
nation of biochemical and genetic studies has led to 
identification of a 125 bp cis-acting CEN DNA and many 
associated proteins (Lechner and Carbon, 1991; Doheny 
et al., 1993). In comparison to centromere DNAs of 
S. cerevisiae, centromere DNAs of the fission yeast 
Schizosaccharomyces pombe are significantly larger. 
These DNAs range in size from 35 to 110 kb and contain 
repetitive DNAs flanking a central region (Pidoux and 
Allshire, 2000). Screening of fission yeast mutants that 
lose a minichromosome at the nonpermissive tempera-
ture has led to identification of proteins such as Mis6 
and Misl 2 that bind specifically to the central regions 
of S. pombe centromere DNA5 (Takahashi et al., 1994; 
Saitoh et al., 1997; Goshima et al., 1999). Evolutionar -
ily conserved centromere-specific proteins such as 
CENP-A and CENP-C are also present in fission yeast 
centromeres (Pidoux and Allshire, 2000). 
Centromere proteins in vertebrate cells have been 
identified primarily by immunological methods. Antibod-
ies against centromere proteins have been isolated from 
patients with autoimmune diseases and from immu-
nized animals, and this has led to the identification of 
several centromere-associated proteins known as 
CENPs (Moroi et al., 1980; Earnshaw and Rothfield, 
1985; Pluta et al., 1995; Craig et al., 1999; Dobie et 
al., 1999; Choo, 2000; Tyler-Smith and Floridia, 2000; 
Sullivan, 2001; Sullivan et al., 2001). CENP-A, a variant 
of histone H3, is present in both yeasts (Stoler et al., 
1995; Meluh et al., 1998; Takahashi et al., 2000), C. ele-
gans (Buchwitz et al., 1999), D. melanogaster (Henikoff 
et al., 2000; Blower and Karpen, 2001), and vertebrate 
cells (Palmer and Margolis, 1987). Immunobocalization 
of CENP-A suggests a distinct nucleosome structure 
at the inner kinetochore plate of active centromeres 
(Warburton et al., 1997; C.A. Cooke and W.C.E., unpub-
lished data). Nucleosomes can be assembled in vitro 
from purified CENP-A and from histones 1 ­12A, H2B, and 
H4 (Yoda et al., 2000). Data from analyses of CENP-A 
knockout mice suggest that CENP-A plays a role in early 
organization of the centromeric chromatin during in-
terphase (Howman et al., 2000). Therefore, it seems 
likely that a centromeric nucleosome containing a spe-
cific variant of H3 is a fundamental feature of eukaryotic 
kinetochore organization (Palmer and Margolis, 1987). 
To establish kinetochore assembly and function, other 
centromere components including CENP-C (Saitoh et 
al., 1992), which is an evolutionarily conserved protein, 
interact with the CEN P-A-containing nucleosome struc-
ture (Howman et al., 2000; Moore and Roth, 2001; 
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Oegema et al., 2001). CENP-C is also an important com-
ponent in kinetochore function, because inactivation of 
CENP-C results in cell death due to kinetochore disrup-
tion, chromosome missegregation, and metaphase ar-
rest (Tomkiel et al., 1994; Fukagawa and Brown, 1997: 
Kalitsis et al., 1998; Fukagawa et al., 1999a). We recently 
found that CENP-H, a newly identified centromere com-
ponent, is required for centromere targeting of CENP-C 
in vertebrate cells (Fukagawa et at., 2001). 
CENP-A, -C, and -H are known to play important roles 
in the establishment of centromere identity in cells of 
higher vertebrates, and we hypothesized that there are 
other components involved in the centromere function. 
Therefore, one of the current goals of our research is to 
identify and characterize potential centromere compo-
nents so as to develop an assembly pathway for the 
vertebrate kinetochore. In this paper, we report identifi-
cation of a novel component of vertebrate centromeres, 
CENP-l. CENP-1 shows sequence similarity with Mis6, 
which is necessary for recruitment of CENP-A to form 
proper centromeres in fission yeast (Takahashi et at., 
2000). We show that CENP-1, like CENP-A, -C, and -H, is 
associated with centromeres throughout the cell cycle. 
Furthermore, we report the generation of a conditional 
mutant of CENP-1 in the hyperrecombinogenic chicken 
B lymphocyte cell tine DT40 to evaluate the in vivo func-
tion of CENP-1 in higher vertebrate cells. Phenotypic 
analysis of these mutants revealed that CENP-I plays an 
essential role in the formation of functional centromeres 
and in mitosis. Immunofluorescence analysis of in-
terphase .CENP-1 cells revealed that CENP-1 is neces-
sary for recruitment of CENP-C and CENP-H to form 
functional centromeres in higher vertebrate cells. 
Results 
Isolation of a Chicken Gene Homologous 
to Fission Yeast Mis6 Gene 
Mis6 was previously identified as a centromere-associ-
ated protein in fission yeast (Saitoh et at., 1997). After 
searching DNA databases, Saitoh et at. (1997) reported 
a potential vertebrate homolog of Mis6, LRPR1, which 
is regulated by follicle-stimulating hormone. However, 
the function of this early response protein and its relation 
to the centromere are unknown. Therefore, we at-
tempted to isolate a chicken homolog of Mis6 to charac-
terize the gene product in chicken DT40 cells. We cloned 
and sequenced several cDNAs that contained the entire 
coding sequence. The full-length sequence encodes a 
753 amino acid polypeptide with a predicted molecular 
mass of 86.9 kDa. The deduced chicken Mis6 protein has 
56% amino acid sequence identity with human LRPR1, 
52% amino acid identity with rat LRPR1, and 25% amino 
acid identity with S. pombe Mis6 (data not shown). Like 
fission yeast Mis6, the chicken Mis6 is basic (p1, 7.90) 
and relatively rich (45%) in hydrophobic amino acids. 
Chicken Mis6 Homolog Associates with Chicken 
Inner Centromeres and Is Designated CENP-1 
To determine the subcellular localization of the chicken 
Mis6 homotog, green fluorescent protein (GFP) was 
tagged to the C terminus, and the fused gene was ex-
pressed in DT40 cells. The fusion protein was functional 
and able to fully suppress the phenotype of chicken 
Mis6 knockout cells (described below). Subcellutar lo-
calization of chicken Mis6-GFP was observed by fluo-
rescence microscopy in combination with immunostain-
ing with anti-CENP-C antibody. CENP-C was used as a 
centromeric marker because it localizes to centromeres 
throughout the cell cycle. Chicken Mis6-GFP signals 
and anti-CENP-C signals throughout the cell cycle are 
shown in Figure 1A. During interphase, M1s6-GFP was 
colocalized with CENP-C as discrete signals in the nu-
cleus (Figure 1A, panel 1). Colocalization of Mis6-GFP 
with CENP-C was also observed during prophase (Fig-
ure 1A, panel 2), metaphase (Figure 1A, panel 3), and 
anaphase (Figure 1 A, panel 4) of mitosis. We also gener-
ated a potyclonal antibody against the central region 
of chicken Mis6 and examined the distribution of this 
protein in a cell line in which the CENP-H gene had been 
replaced with a gene encoding CENP-H-GFP (Fukagawa 
et at., 2001). CENP-H-GFP signals colocalized with anti-
Mis6 signals throughout the cell cycle (Figure 1 B). Our 
results indicate that chicken Mis6 is localized to the 
centromere throughout the cell cycle in vertebrate cells. 
Therefore, we have designated the chicken homolog of 
Mis6 as centromere protein I (CENP-l). 
CENP-l-GFP signals on metaphase chromosomes of 
DT40 cells showed a typical paired-dot pattern at every 
centromere. To determine the precise localization of 
CENP-1 on metaphase chromosomes, we stained CENP-
l-GFP-marked chromosomes with anti-BubRi and anti-
ZW1 0 antibodies. BubRi was shown by immunoelec-
tron microscopy to be localized in the outer kinetochore 
plate (Jablonski et at., 1998), and ZW1 0 is thought to be 
localized in the fibrous corona (Starr et at., 1998). Our 
results indicate that CENP-1 is located internal to BubRi 
and ZW1 0 (Figures 1 C and 10). These data, together 
with the finding that CENP-C and CENP-l-GFP colocal-
ize (Figure 1E), suggest that CENP-1 is localized in or 
near the inner kinetochore plate. 
Generation of Conditional Mutants of CENP-1 
in DT40 Cells 
To investigate the role of CENP-1 in higher vertebrate 
cells, we generated conditional mutants of CENP-1 in 
which cells with disruptions of the CENP-I gene were 
sustained by expression of the CENP-i cDNA under con-
trol of a tetracycline (tet)-repressible promoter. A CENP-1 
deletion construct was generated such that the 2.5 kb 
genomic fragment encoding amino acids 221-402 was 
replaced with one of several selection cassettes (Figure 
2A). Three CENP-1 alleles were found to be present in 
the chicken DT40 genome by fluorescence in situ hybrid-
ization (FISH; data not shown). We sequentially trans-
fected CENP-I disruption constructs containing either 
the histidinol or puromycin resistance cassettes into 
DT40 cells (Figure 2A) and isolated CENP-I clones 
(Figure 213). One CENP-I' ' clone was cotransfected 
with a chicken CENP-I transgene under the control of 
a tet-repressible promoter and a tet-repressible trans-
activator containing a zeocin (zeo) resistance cassette. 
We selected zeo-resistant colonies and identified sev -
eral clones carrying those constructs integrated at ran-
dom sites in the genome (CENPI Ptmns9e,1 Four 
clones with CENP-I" / ICE trs/e genotype were trans-
fected with the neomycin CENP-I disruption construct 
to disrupt the remaining CENP-1 allele (Figure 2B). We 
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Figure 1. Chicken CENP-1 Localizes to Centromeres throughout the Cell Cycle and Is Located in or near the Inner Kinetochore 
Localization of CENP-l-GFP at progressive stages of the cell cycle in DT40 cells. Cells were stained with anti-CENP-C antibody (red), and 
green signals are specific for CENP-I-GFP. Nuclei and chromosomes were visualized by counterstaining with DAR (blue). The scale bars 
correspond to 10 m. 
Cells with expression of CENP-H-GFP (green) were fixed and stained with anti-CENP-1 antibody (red). As shown in the merged images, 
CENP-H-GFP signals are colocalized with CENP-1 signals throughout the cell cycle. 
CENP-1 localizes in or near the inner kinetochore. CENP-l-GFP signals (green) are internal to signals of anti-BubRi (red) on the metaphase 
chromosome (blue). 
ZW1 0 signals (red) are external to CENP-l-GFP-signals (green). 
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Figure 2. Generation of a CENP-I 	Clone Carrying a Chicken CENP-I Transgene under the Control of a Tet-Repressible Promoter 
Restriction maps of the CENP-I locus, the gene disruption constructs, and the targeted loci. Black boxes indicate the positions of exons, 
and the targeted constructs are expected to disrupt four exons. EcoRl and Sacl restriction sites are shown. The position of the probe used 
for Southern hybridization is indicated. Novel 14.5-17 kb Sad fragments hybridize to the probe if targeted integrations of the constructs 
occur. 
Restriction analysis of the targeted integration of the CENP-1 disruption constructs. Genomic DNAs from wild-type DT40 cells (Wt), a clone 
after first round targeting (~ 1+1-. 11,  a clone after second round targeting (+/-/-, 2), a clone after second round targeting and random 
integration of the CENP-! transgene (+1-I- CENP-l+, V ~ cDNA), and a clone after third round targeting (-I--f- CENP-l--, V -4- cDNA) 
were analyzed by Southern hybridization with the probe indicated in (A). 
Western blot analysis of M90 whole-cell extracts with anti-CENP-1 antibody at the indicated times following addition of tet. Protein contents 
of extracts were measured with the DC protein assay (Bio-Rad). Equal amounts of extracts were separated by SDS-PAGE and analyzed by 
Western blot with anti-tubulin antibody. 
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Figure 3. CENP-1 Is Essential for Normal Progression of the Cell Cycle 
Representative growth curves for the indicated cell cultures. Tet was added at time 0 to the M90 CENP-l-deficient cell --tet culture, and 
the number of cells not stained with trypan blue was counted. Each experiment was performed twice, and each time point was examined in 
duplicate. 
Total cell number plotted in (A). 
Cell cycle distribution of M90 cells following inhibition of CENP-I transgene expression due to addition of tet at time 0. Cells were stained 
with FITC-anti-BrdU (y axis, log scale) to detect BrdU incorporation (DNA replication) and with propidium iodide to detect total DNA (x axis, 
linear scale). The lower left box represents Gi phase cells, the upper box represents S phase cells, and the lower right box represents G2JM 
phase cells. The numbers given in the boxes indicate the percentage of gated events. Arrows at 48 and 60 hr indicate further BrdU uptake 
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obtained two clones with the CENP-! 	'-' '' ge- 
notype, and one clone, M90, was chosen for further 
analysis. CENP-1 protein in M90 cells was not detected 
by Western blot analysis at 48 hr after addition of let 
(Figure 2C), indicating that CENP-I is actively turned 
over. 
Deletion of CENP-1 Results in Accumulation 
of Cells in Prometaphase and Subsequent 
Cell Death 
The growth curve of M90 cells (CENP-1, -tet) was 
indistinguishable from that of wild-type DT40 cells (Fig-
ures 3A and 313). M90 cells (-tet) and wild-type DT40 
cells divided approximately nine times during the 96 hr 
culture, which indicates that the doubling time of these 
cells is approximately 10.6 hr (Figures 3A and 3B). We 
then examined cell proliferation and viability following 
the addition of tet to the medium. M90 cells (CENP-1 -, 
+tet) stopped proliferating approximately 2.5 cell cycles 
after the addition of tet (Figures 3A and 3B), and most 
cells had died by 96 hr, indicating that depletion of 
CENP-1 results in growth arrest and subsequent cell 
death. 
For cell cycle analysis following CENP-1 depletion in 
M90 cells, we measured both cellular DNA content and 
DNA synthesis by fluorescence-activated cell sorting 
(FACS) after pulse labeling with BrdU (Figure 3C). 
CENP-1 - M90 cells (+tet) started to accumulate in G2/M 
phase 24 hr after addition of let, reaching a maximum 
by 36 hr (Figure 3C). After a prolonged delay in G2/M, 
further uptake of BrdU occurred between 48 and 60 hr 
(Figure 3C) as cells progressed to the next cycle without 
undergoing cytokinesis (see below). Degradation of 
chromosomal DNA due to massive cell death was ob-
served between 72 and 96 hr (Figures 3C and 4B). 
To determine the exact nature of the mitotic delay, we 
used DNA staining and immunocytochemical staining 
of microtubules to examine the time course of events 
following the depletion of CENP-1 (Figures 4A and 4B). 
The mitotic index began to increase at 24 hr and reached 
36% at 48 hr after the addition of tet. We did not observe 
any anaphase cells at 48 hr (Figure 4B). By considering 
FAGS data with data from cytological analysis, we esti-
mated that 16% (52% - 36%) of cells are in G2 phase 
at 48 hr (Figures 3C and 4B). In control cultures (0 hr), 
3%-4% of cells are in mitosis (Figure 4B) and 18% of 
cells are in G2/M as determined by FAGS (Figure 3C), 
and 14%-15% of cells are in G2 phase. These data 
indicate that CENP-l-deficient cells accumulate in M 
phase rather than G2 phase and that they arrest prior 
to anaphase. 
Deletion of CENP-1 Causes Chromosome 
Aberrations and Leads to Chromosome 
Missegregation 
In the course of cytological analysis of CEN P-I-deficient 
cells, we observed many abnormal mitotic cells with 
hypercondensed chromosomes that failed to congress 
normally to a metaphase plate (Figure 4A; 24, 48, and 
72 hr). Eventually, the cells underwent apoptotic death 
(Figure 4A; 72 hr). In controls, chromosomes appeared 
ordered and aligned on the metaphase plate (Figure 4A; 
0 hr, metaphase). 
Control cells cultured in the absence of let showed 
well-ordered bipolar spindles during both metaphase 
and anaphase (Figure 4A; 0 hr). At 48 hr, most cells 
cultured in the presence of tet appeared to have normal 
bipolar spindles, but some contained multi- or monopo-
lar spindles (Figures 4A and 4C). This might in part ac-
count for the abnormal chromosome alignments de-
scribed above; however, even in the 70% (48 hr after 
addition of tet) and 30% (72 hr after addition of tet) of 
mutant cells that had proper bipolar spindle poles, some 
chromosomes failed to achieve a proper alignment (Fig-
ures 4A and 4C). In other cells, chromosome alignment 
was completely disordered. Double staining of M90 cells 
with anti-tubulin and anti-GENP-A antibodies at 48 hr 
after addition of let revealed that congressed chromo-
somes appeared to attach to microtubules, whereas 
misaligned chromosomes appeared not to be attached 
(Figure 4D). These results indicate that CENP-1, like 
CENP-H (Fukagawa et al., 2001), is required either di-
rectly or indirectly for congression and/or maintenance 
Figure 4. CENP-I-Deficient Cells Show Prometaphase Delay Associated with Aberrant chromosomes and Spindles that Lead to Chromosome 
Missegregation 
Chromosome morphology and (-tubulIn staining (green) in the absence or presence of tet. DNA was counterstained with DAPI (blue). In 
the absence of tet, cells show the normal staining pattern for -tubulin (upper three panels). In the presence of tet, cells in which chromosomes 
were not aligned at the metaphase plate were observed. Arrows indicate misaligned chromosomes at the metaphase plate or lagging 
chromosomes in anaphase at 24 or 48 hr after addition of tet. Apoptotic cells were observed at 72 hr after addition of tet. An apoptotic cell 
was detected by TUNEL assay (green). We also detected cells with monopolar and multipolar spindles. The scale bars correspond to 10 im. 
Quantitation of aberrant M90 cells following inhibition of CENP-1 transgene expression after addition of tet at time 0. We scored the number 
of interphase cells, normal metaphase cells, aberrant metaphase cells described in (A), anaphase cells, and apoptotic cells. Apoptotic cells 
were detected by TUNEL assay. 
Quantitation of cells with misaligned chromosomes after addition of tet at time 0. Misaligned chromosomes were classified as bipolar 
spindle with misaligned chromosomes, monopolar spindle, or multispindle. 
Double staining of M90 cells at 0 hr (-tet) or 48 hr (+tet) after addition of tet with anti--tubulin (green) and anti-CENP-A (red) antibodies. 
Arrows indicate misaligned chromosomes that do not appear to attach to microtubules, although many other chromosomes appear to have 
formed microtubule attachments. 
To examine chromosome loss, we used FISH analysis with chromosome-specific painting probes. We used painting probes for chicken 
chromosomes 1 and 2. Because 0140 cells have three copies of chromosome 2, we detected five painted chromosomes in normal cells 
(upper left panel). M90 cells with loss of chromosomes (upper right panel) and increase in chromosomes (lower panels) were detected after 
addition of tet. 
Distribution of the number of painted chromosomes per cell. M90 cells were cultured after addition of tet. At the indicated time, cells were 
treated with colceniid for 3 hr. 
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Figure 5, Dynamics of Chromosomes and Microtubules in CENP-l-Deficient Cells by Time-Lapse Observation 
Selected images of chromosomes (upper) and microtubules (middle) from prophase to telophase in M90 tells (-tet). In the superimposed 
images (lower), chromosomes and microtubules are displayed in red and green, respectively. The r..,noers at the top of each image represent 
the time from telophase in minutes. The scale bar corresponds to 10 m. 
From 40 hr after addition of tet, one prophase cell was followed for time-lapse observations. Selected frames are shown. Once the cell 
entered mitosis, it was arrested at prometaphase for more than 800 mm. At 859 mm, the cell proceeded to the next cell cycle without normal 
cell division. We observed interphase-type microtubules between 859 and 906 mm. 
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Figure 6. CENP-l-Deficient Cells Proceed 
72 h through the Cell Cycle without Undergoing 
Cytokinesis 
A) lmmunofluorescence analysis of (pro)-
metaphase M90 cells at 0, 48, 60, and 72 
r after addition of tet with antibody against 
BubRi checkpoint protein (red). In the control 
experiment (- let), cells were treated with col-
cemid for 3 hr before staining of BubRi. DNA 
was counterstained with DAR (blue). The 
scale bar corresponds to 10 tm. 
(B) Quantitation of (pro)metaphase chromo-
somes with strong, weak, or no BubRi signals. 
The numbers of (pro)metaphase chromo-
somes with strong BubRl signals decreased 
following addition of tet to M90 cells. 
of stable chromosome alignment and, ultimately, for 
progression from metaphase to anaphase. 
We next examined whether mitotic defects caused by 
CENP-1 depletion were associated with the induction of 
aneuploidy. We performed FISH analysis of metaphase 
spreads with chromosome painting probes specific for 
chicken chromosomes 1 and 2. Because DT40 cells 
contain three copies of chromosome 2, five fluorescent 
chromosomes can be observed for each wild-type cell 
(Figure 4E, upper left panel). As shown in Figure 4E, we 
observed abnormal numbers of painted chromosomes 
in CENP-l-deficient M90 cells in the presence of tet. The 
proportion of these aneuploid cells gradually increased 
after 24 hr (Figure 4F), suggesting that CEN P-I deficiency 
induces chromosome missegregation. 
Dynamic Behavior of Chromosomes and 
Microtubules in CEN P-I-Deficient Cells 
To determine the consequences of CENP-1 deficiency 
in greater detail, we observed the dynamic behavior 
of individual living cells after suppression of CENP-1 
expression (Figure 5; see Supplemental Movies Si and 
S2 [corresponding to Figures 5A and SB, respectively] 
at http://www.developmentalcell.com/cgi/content/full/  
2/41463/DC1). To visualize niicrotubules in living cells, 
human (-tubuIin gene fused with GFP was integrated 
into the genome of M90 cells. We then stained the chro-
mosomes of living M90 cells expressing GFP-tubulin 
with Hoechst 33342 and observed the cells microscopi-
cally at 37C. An example of the time-lapse data for M90 
cells in the absence of tet (control) is shown in Figure 
5A. We were able to observe a well-ordered metaphase 
plate and bipolar spindle in control cells (6-18 mm). 
Chromosomes began segregating as the central spindle 
elongated (22 mm). Cells then underwent cytokinesis, 
the mitotic spindle disassembled (24 mm), and the chro-
mosomes decondensed (34 mi. Phototoxicity induced 
by UV light irradiation is known to cause mitotic arrest. 
To avoid this, we used an ND filter and did not observe 
cells arrested at mitosis in control experiments. Control 
cells (n = 10) required approximately 34 min to progress 
from prophase to telophase. After addition of tet to M90 
cells, we observed abnormal mitotic behavior (Figure 
5B). Time point 0 in Figure 56 corresponds to 40 hr after 
addition of tet to cultures of M90 cells. The cell shown 
in Figure SB entered mitosis (2 mm) as condensed indi-
vidual chromosomes appeared and the mitotic spindle 
formed. However, chromosome congression to the 
metaphase plate and subsequent anaphase were not 
observed. Instead, the cell remained arrested in pro-
metaphase for 800 min with hypercondensed chromo-
somes. During this prolonged mitotic delay, the spindle 
structure underwent a series of abnormal changes. Early 
after mitotic entry (Figure SB, 2-22 mm) a normal-looking 
bipolar mitotic spindle formed. We subsequently ob-
served fragmentation of the spindle poles (Figure 513, 
42 mm) and formation of a multipolar spindle (Figure 
5B, 25 and 257 mm). After prolonged mitotic arrest, the 
chromosomes decondensed, and the mitotic spindle 
disassembled without chromosome segregation (859-
906 mm). Ultimately, this cell underwent apoptosis (Fig-
ure SB, 978 mm). 
CENP-l-Deficient Cells Exit Mitosis without 
Normal Cytokinesis 
FAGS and cytological analysis showed that after a 
lengthy prometaphase delay, M90 cells exited mitosis 
without cytokinesis and underwent a further round of 
DNA replication between 48 and 72 hr after the addition 
of tet (Figures 3C and 413). These findings suggest that 
the mitotic checkpoint is inactivated by 72 hr after the 
addition of tet. Accordingly, we stained the prometa-
phase-arrested cells with antibody against the BubRi 
checkpoint protein (Jablonski et al., 1998; Chan et al., 
1999). In controls, we stained the metaphase chromo-
somes of M90 cells (-tet, CENP-1-4-) arrested with col-
cemid and observed strong centromere staining of 
BubRi (Figure 6A, - tet). We then stained chromosomes 
of M90 cells with anti-BubRi after addition of tet. We 
detected BubRl signals on some metaphase cells at 48 
hr after addition of tet (Figures 6A and 613). However, 
the signal intensity became weak at 60 hr, and weak or 
+t 
11 
LNP-A signal GENE-C signal GENE-H signal 
Anti-CENP-A Anti-CENP-C 
j I! 







10O - 	 m0  
0481, 
50 
Discrete 	Diffuse or weak  
-  . 100 	 lob 
E.L so 
. [_ I. 
a 	i _ 
Discrete 	Diffuse or weak  
1, 
i00 	
10 i. 1- 
a I — 
Lx 50 - 
I — 
C I — 
I - 
0 1 — 
Discrete 	Weak or diffuse 
C 	











CENP-1 signal in CENP-H-deficient cells 
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Figure 7. Localization of Other Centromere Proteins in CENP-l-Deficient Cells 
(A) Immunofluorescence analysis of M90 cells at 0 hr (-tet) or 48 hr ( tet) after addition of tet. Interphase cells were stained with anti-CENP-1, 
anti-CENP-A, anti-CENP-C, and anti-CENP-H antibodies. Antibody signals were detected with Cy3-conjugated secondary antibodies (red). 
DNA was counterstained with DAR (blue). The scale bars correspond to 10 p.m. 
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no signals were detected at 72 hr after addition of tet 
(Figures 6A and 613), suggesting that the association of 
the checkpoint signaling proteins with the kinetochore 
structure is lost by 72 hr. In control experiments, if wild-
type cells were arrested with nocodazole for 60 hr, the 
majority of cells died, although 5%-6% of cells pro-
gressed to the next cell cycle. 
Localization of Other Centromere Proteins 
in CENP-l-Deficient Cells 
CENP-A, -C, and -H are thought to form a "prekineto-
chore structure" that exists throughout the cell cycle 
and marks the location of the centromere on the chro-
mosome in vertebrate cells. To understand the role of 
CENP-1 in formation of the prekinetochore structure, we 
asked whether CENP-1 was required to target CENP-A, 
-C, and -H to the kinetochore. Interphase nuclei of M90 
cells were analyzed with antibodies against chicken 
CENP-A, -C, -H, and -1 in the presence or absence of tet. 
Typical results are shown in Figure 7A. In the absence of 
tet, all four antibodies gave strong, discrete signals on 
interphase nuclei of M90 cells (Figure 7A, upper panel). 
At 48 hr after the addition of tet, we could not detect 
CENP-1 signals in interphase nuclei of M90 cells, consis-
tent with the complete depletion of CENP-1 (Figure 7A, 
lower left panel). CENP-A antibody gave positive signals 
on interphase nuclei of CENP-l-deficient cells (Figure 
7A, lower panel, lane 2); however, the normal prominent, 
discrete CENP-C (Figure 7A, upper panel, lane 3) and 
CENP-H (Figure 7A, upper panel, lane 4) signals were 
absent. Instead, diffuse or weak signals for CENP-C and 
CENP-H were observed (Figure 7A, lower right panel). 
We counted interphase cells that showed diffuse or 
weak signals (Figure 78) and found that approximately 
83% and 98% of interphase cells displayed diffuse 
CENP-C and CENP-H signals, respectively, after addi-
tion of tet (Figure 713). 
Immunocytochemical analysis of CENP-l-deficient 
cells showed that CENP-1 is necessary for localization 
of CENP-H to the centromere. It was, therefore, of inter-
est to determine whether CENP-H was necessary for 
CENP-1 localization to the centromere. To address this 
question, we performed immunofluorescence analysis 
of the #5-5 cell line, which is a conditional loss-of-func-
tion mutant of CENP-H (Fukagawa et al., 2001). We pre-
viously showed that CENP-H signals were lost and that 
CENP-C signals were diffuse in #5-5 cells 48 hr after 
addition of tet (Fukagawa et al., 2001). We then analyzed 
localization of CENP-1 and found that CENP-1 signals 
were also lost (Figures 7C and 70) in CENP-H-deficient 
cells. These results suggest that CENP-1 and CENP-H  
are mutually interdependent for targeting to the preki-
netochore structure and that both are necessary for 
CENP-C localization to centromeres. 
Although our data showed that CENP-A localization 
did not change in CENP-l-deficient cells (Figure 7A), it 
is possible that we observed only CENP-A that was 
previously targeted to the centromere and that newly 
synthesized CENP-A is not targeted to centromeres. To 
address this question, we expressed CENP-A-3HA in 
M90 cells and detected it with anti-HA after addition of 
tot (Figure 7E). We found that newly synthesized 
CENP-A-3HA was targeted to the centromere in CENP-l-
deficient cells. 
We showed that CENP-C staining was diffuse in 
CENP-l-deficient cells by immunocytochemistry (Figure 
7A). To confirm the mislocalization of CENP-C biochemi-
cally, we extracted the CENP-C-enriched nuclear frac-
tion with 1 M NaCl. The majority of CENP-C in M90 cells 
was detected in this fraction when cells were cultured 
without tet. However, little CENP-C was detected in this 
fraction after addition of tet (Figure 7F). 
Discussion 
CENP-1 Is Required for Centromere Function 
during Mitosis 
This study describes CENP-1, a novel essential compo-
nent of vertebrate centromeres, which has sequence 
similarity with the S. pombe MisG protein. CENP-1 local-
izes to the centromere throughout the cell cycle in 
chicken DT40 cells. Simultaneous colocalization experi-
ments with CENP-l-GFP and antibodies against several 
centromere proteins suggest that CENP-I, like CENP-A, 
-C, and -H (Saitoh et al., 1992; Warburton et al., 1997; 
Fukagawa et al., 2001), localizes in or near the inner 
kinetochore plate. Phenotypic analysis of a conditional 
loss-of-function mutant of CENP-1 in the hyperrecombi-
nogenic chicken DT40 cell line reveals that CENP-1 is 
required for mitosis in vertebrate cells. 
CENP-I-deficient cells underwent a lengthy delay in 
prometaphase, characterized by the presence of hyper-
condensed chromosomes and abnormal spindle struc-
tures. The cells eventually exited mitosis following loss 
of spindle checkpoint components from kinetochores, 
rereplicated their DNA, and ultimately underwent apo-
ptosis. Lengthy delays in prometaphase had previously 
been observed with targeted disruptions of the kineto-
chore proteins CENP-C and CENP-H (Fukagawa and 
Brown, 1997; Fukagawa et al., 2001), suggesting that 
this phenotype is characteristic of the loss of inner kinet-
ochore plate function in vertebrate cells. 
Quantitation of M90 interphase cells with diffuse CENP-A, CENP-C, and CENP-H signals. The graphs provide a quantitative representation 
of the data. We scored approximately 2000 iriterphase cells. 
lmrnunofluorescence analysis of #5-5 (.CENP-H, CENP-H transgene) cells grown in the absence (-tet) or presence (+tet, restrictive 
conditions) of tet for 48 hr. Rabbit antibodies to CENP-H or CENP-1 were applied to iriterphase cells and detected with Cy3-conjugated second 
antibodies (red). DNA was counterstained with DAPI (blue). 
Quantitation of #5-5 interphase cells with diffuse or weak CENP-1 signals. We scored approximately 2000 interphase cells. 
Immunofluorescence analysis of M90 cells transiently expressing CENP-A-3HA. M90 cells were cultured for 24 hr with tet and transfected 
with a CENP.A-3HA construct. At 48 hr after addition of tet, cells were stained with anti-HA (red). 
Western blot analysis of the nuclear fraction of M90 cells extracted with I M NaCl with anti-CENP-C. C, cytoplasm fraction; N, 1 M NaCl 
fraction. The CENP-C band is weak in the 1 M NaCl fraction after addition of tet. 
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Role of CENP-1 in Assembly of the Inner 
Kinetochore 
Recent data suggest that centromere-specific nucleo-
some structures including CENP-A may determine cen-
tromere identity (Karpen and Allshire, 1997; Ahmad and 
Henikoff, 2001; Choo, 2001; Lo et al., 2001). However, 
the mechanism of CENP-A loading into centromeric 
nucleosomes and which proteins are involved with the 
CENP-A-containing structure in vertebrate cells are not 
understood. Mitotic defects caused by CENP-I defi-
ciency occur after passage through Gi phase (Figure 
3), suggesting that a functional "centromere chromatin" 
structure is formed during interphase. This was also the 
conclusion of prior experiments in which the cell cycle 
effects of microinjection of anti-centromere antibodies 
were examined (Bernat et al., 1990, 1991). 
In fission yeast, CENP-A localization is altered in Mis6 
mutants, suggesting that Mis6 may be involved in 
CENP-A localization to the centromere (Takahashi et al., 
2000). The situation in vertebrate cells appears to be 
different. We found that depletion of CENP-1 does not 
alter the discrete, typical centromeric signals of CENP-A, 
whereas discrete centromeric CENP-C and CENP-H sig-
nals are lost in CENP-l-deficient cells (Figure 7). Further-
more, the normally discrete CENP-1 signals are diffuse 
in CENP-H-deficient cells, indicating that CENP-H and 
CENP-1 are mutually interdependent fortargeting to cen-
tromeres. A preliminary E. co/i two-hybrid analysis using 
CENP-H and CENP-1 revealed that the N-terminal region 
of CENP-H interacts with the N terminus of CENP-1 (see 
Supplemental Figure Si; details will be published else-
where). Our present data, together with our previous 
results showing that CENP-H is necessary for recruit-
ment of CENP-C to form a functional centromere (Fuka-
gawa et al., 2001), suggest that formation of CENP-A-
containing nucleosomes, which is mediated by unknown 
factors, occurs first, and that CENP-H and CENP-1 are 
then targeted to these structures, possibly as a macro-
molecular complex. CENP-C then interacts with 
CENP-A/CENP-H/CENP-1 chromatin to form the kineto-
chore plate structure. 
Vertebrate CENP-I, unlike S. pombe Mis6, is not re-
quired for centromere targeting of CENP-A in our model. 
A similar conclusion has recently been reached using 
microinjection with anti-Mis6 antibody (T. Yen, personal 
communication). Also, Measday et al. (2002) reported 
that Ctf3p, the Mis6 budding yeast homolog, is not re-
quired for loading of CENP-A homolog Cse4p onto CEN 
DNA. As will be seen below, our results suggest that 
vertebrate kinetochores may not be assembled in a sim-
ple linear pathway. 
CENP-1 Is Required for Normal Mitotic 
Progression 
Individual CENP-l-deficient cells observed in real time 
by live-cell analysis after addition of tet were delayed 
in prometaphase for more than 10 hr and underwent 
an aberrant mitosis. This phenotype resembled that of 
CENP-H-deficient cells (Fukagawa et al., 2001) or cells 
injected with anti-CENP-C antibody (Tomkiel et al., 
1994). Inactivation of CENP-C has previously been 
shown to alter or disrupt kinetochore structure in af-
fected cells (Tomkiel et al., 1994). In that and other stud-
ies, we showed that cells with disrupted kinetochores 
(confirmed by electron microscopy) could bind to micro-
tubules, and in some cases congress normally to a meta-
phase plate (Tomkiel et al., 1994; Bernat et al., 1991). 
The affected cells eventually executed a highly aberrant 
exit from mitosis following an extensive delay in pro-
metaphase. We concluded from those studies that as-
sembly of an ordered trilaminar kinetochore structure 
is not required for microtubule binding, but may be re-
quired for the mitotic checkpoint to be inactivated fol-
lowing chromosome attachment to the spindle (Bernat 
et al., 1991). 
Our cytological and live-cell analyses of CENP-l-defi-
cient cells showed that many chromosomes attached 
to microtubules and congressed normally, although in 
each cell several chromosomes failed to align at the 
metaphase plate. The similarity of this phenotype to our 
previous antibody injection experiments and studies of 
CENP-H-disrupted cells suggests that kinetochores as-
sembled in the absence of CENP-1 can bind microtu-
bules but not inactivate the mitotic checkpoint. In sup-
port of this hypothesis, we observed that many of the 
bioriented chromosomes in M90 cells arrested in pro-
metaphase 48 hr after the addition of tet showed positive 
labeling with the BubRi checkpoint protein (Figure 4D). 
This suggests that the prolonged mitotic delay observed 
in CENP-l-deficient cells is due to synergistic effects 
arising from defects in the kinetochore structure and 
activation of the checkpoint. 
The lengthy delay in mitosis observed in CENP-l-defi-
cient cells eventually ends, and the cells exit mitosis 
without undergoing cytokinesis. This appears to reflect 
the eventual adaptation of the checkpoint pathway, 
leading to loss of checkpoint proteins such as BubRi 
from the kinetochore (Figure 6). This may indicate that 
as previously seen with antibody-injected HeLa cells, 
the mitotic checkpoint is only able to delay the exit from 
mitosis for a limited time if a mitotic spindle is present. 
Whatever the explanation, the cells eventually exit from 
mitosis, reform a nuclear membrane around the near-
tetraploid genome, and ultimately undergo apoptosis. 
The fact that microtubule binding and mitotic check-
point signaling can proceed even though a number of 
essential components of the inner kinetochore plate are 
absent reveals that kinetochore assembly does not fol-
low a simple linear ordered assembly pathway in verte-
brates. Partial outer kinetochore function can be ob-
served even when assembly of the inner kinetochore 
structure is disrupted. Furthermore, these results sug-
gest that one function of the inner kinetochore plate may 
be to create a foundation that enables the checkpoint 
proteins in the outer kinetochore to detect when the 
chromosome is properly attached to the spindle. 
Experimental Procedures 
Molecular Biology 
The chicken Mis61LRPR110ENp-I gene was isolated by degenerate 
RT-PCR of mRNA extracted from DT40 cells. The sequences of the 
degenerate primers were 5-TC(ACG) A(AG)(AG) CA(AG) TG(AGT) 
AT(AG) TT-3' and 5-TA(CT) AA(AG) 11(CT) U(CT) GC(ACT) CC-3. 
We screened a chicken testis cDNA library (Stratagene) with the 
RT-PCR product as a probe. We used the chicken CENP-J cONA 
as a probe to isolate genomic clones specific for CENP-I from a 
DT40 genomic DNA library. 
Full-length CENP-1 cDNA was cloned into the EcoRl site of 
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pUHD1 0-3 (Fukagawa et al., 2001) to yield a tetracycline-sensitive 
expression plasmid, pUHD-CENP-l. The left (4.5 kb) and right (4.5 
kb) arms of the CENP-I disruption constructs were cloned sequen-
tially into pBluescript. For the disruption constructs, the histidinol 
(hisD), puromycin (puro), or neomycin (nec) resistance cassette un-
der control of the 3-actin promoter was inserted between the two 
arms. 
To generate the expression construct for the CENP-l-GFP fusion 
gene, a full-length chicken CENP-i cDNA was inserted into pEGFP-
Ni plasmid (Clontech). An expression construct for GFP-tubulin 
(pEGFP-Tub) was purchased from Clontech. 
Cell Culture and Cell Cycle Analysis 
DT40 cells were cultured and transfected as described previously 
(Fukagawa and Brown, 1997). G418 (Sigma) was used at a final 
concentration of 2 mg/ml, puromycin (Clontech) at a final concentra-
tion of 0.5 .&g/ml, hygromycin (Wako) at a final concentration of 2.5 
mg/ml, histidinol (Sigma) at a final concentration of 1 mg/mI, and 
zeocin (Invitrogen) at a final concentration of 1 mg/ml to select for 
stable transfectants. To suppress expression of the tetracycline-
responsive CENP-1 transgene, tetracycline (Sigma) was added to 
the culture medium to a final concentration of 2 g/ml. 
Cell cycle analysis was carried out as described previously (Fuka-
gawa et al., 2001). Flow cytometry was performed with an Epics 
Altra cytometer (Beckman-Coulter). 
Antibody Production 
A chicken CENP-1 expression construct (amino acids 307-525) was 
created in vector pET28a (Novagen). The histidine-tagged recombi-
nant protein was expressed in E. coil BL21 (DE3) cells after 4 hr 
induction with 0.5 mM IPTG and purified by nickel column chroma-
tography. Purified recombinant CENP-1 was used to immunize a 
rabbit. Serum was affinity purified against recombinant CENP-1 pro-
tein on a CNBr-activated Sepharose 4B column. 
lmmunocytochemistry and FISH Analysis 
Immunofluorescent staining of whole cells was performed as de-
scribed previously (Fukagawa et al., 1999a). Anti--tubulin mono-
clonal antibody (1:50; Sigma), rabbit anti-chicken CENP-A antibody 
(1:50; Fukagawa et al., 2001) ' rabbit anti-chicken CENP-C antibody 
(111000; Fukagawa et al., 1999a), rabbit anti-chicken CENP-H anti-
body (1:2000; Fukagawa et al., 2001), or rabbit anti-chicken CENP-1 
antibody (1:2000) were used. Binding of primary antibodies was then 
detected with either FITC-conjugated rabbit anti-mouse lgG diluted 
1:200 (Jackson lmmunoResearch Laboratories) or Cy3-conjugated 
goat anti-rabbit lgG diluted 1:1000 (Amersham) in PBS/0.5% BSA. 
Aberrant metaphase cells or mitotic spindles were observed and 
scored at the indicated time points. Approximately 3000 cells were 
scored for each time point. TUNEL assay was performed with an 
apoptosis detection system (Promega). 
Metaphase chromosome spreads for immunofluorescence stain-
ing were prepared by a method modified from Eamshaw et al. (1989). 
Chromosome spreads were stained with rabbit anti-chicken ZW1 0 
antibody (1:200; Fukagawa et at., 1999a) or rabbit anti-chicken 
BubRi (1:500). 
FISH was performed as described previously (Fukagawa et al., 
1999b). For chromosome stability assay, the number of chromo-
somes 1 and 2 (five in normal cells) were scored in approximately 
1000 metaphase cells at the indicated time points. 
All immunofluorescence and FISH images were collected with a 
cooled CCD camera (Photometrics Image Point) mounted on a Zeiss 
Axioscope microscope with a 63x objective (Zeiss) together with a 
filter wheel. Images were manipulated with Iplab software (Signal 
Analytics). 
Fluorescence Microscopy in Living Cells 
Cells were stained with Hoechst 33342 for 10-15 min at a final 
concentration of 100 ng/ml and washed three times with culture 
medium. For microscopic observation, HEPES buffer (pH 7.4) was 
added to a final concentration of 20 mM to avoid the need for 
CO2 gas. Fluorescently stained living cells were observed with an 
Olympus inverted microscope lX70 with an oil immersion objective 
lens (PlanApo 60/, NA = 1.40). The DeltaVision microscope system 
used in this study was purchased from Applied Precision. For tem-
perature control during microscopic observations, the system was 
assembled in a custom-made, temperature-controlled room (Ham-
guchi et at., 1997, 1999). Time-lapse images were recorded at 2 mm 
intervals with an exposure time of 0.2-0.3 a. 
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ABSTRACT 	 INTRODUCTION 
The essential Aurora B klnase is a chromosomal 
passenger protein that is required for mitotic 
chromosome alignment and segregation. Aurora B 
function is dependent on the chromosome pas-
senger, INCENP. INCENP, in turn, requires sister 
chromatid cohesion for its appropriate behaviour. 
Relatively few substrates have been identified for 
Aurora B, so that the precise role it plays in con-
trolling mitosis remains to be elucidated. To identify 
potential novel mitotic substrates of Aurora B, 
extracted chromosomes were prepared from mito-
ticatly-arrested HeLa S3 cells and incubated with 
recombinant human Aurora B in the presence of 
radioactive ATP. Immunoblot analysis confirmed 
the HeLa scaffold fraction to be enriched for known 
chromosomal proteins Including CENP-A, CENP-B, 
CENP-C, ScIl and INCENP. Mass spectrometry of 
bands excised from one-dimensional polyacryl-
amide gels further defined the protein composition 
of the extracted chromosome fraction. Cloning, 
fluorescent tagging and expression in HeLa cells of 
the putative GTP-binding protein NGB/CRFG 
demonstrated it to be a novel mitotic chromosome 
protein, with a perichroniosomal localisation. Identi-
fication of the protein bands corresponding to those 
phosphorylated by Aurora B revealed topo-
isomerase II alpha (topo ila) as a potential Aurora B 
substrate. Purified recombinant human topo lla was 
phosphorylated by Aurora B in vitro, confirming this 
proteomic approach as a valid method for the initial 
definition of candidate substrates of key mitotic 
kinases. 
Progression through mitosis is regulated by a number of 
protein kinases (1). One of these is Aurora B. an essential 
kinase that is required for chromosome alignment at the 
metaphase plate and for completion of cytokinesis in 
metazoan cells (2-7; reviewed in 8). Aurora B may also be 
involved in mitotic chromosome condensation, but the extent 
of this involvement is unclear (3.6,9.10). Aurora B is a 
chromosomal passenger protein. Chromosomal passengers are 
a class of proteins that show a complex and defined 
localisation during mitosis; associating along the chromosome 
during prophase, concentrating at the centromere at metaphase 
and moving from the centromere to the central region of the 
mitotic spindle at anaphase (II). Other chromosome passen-
gers include INCENP and survivin, both of which physically 
interact with Aurora B. INCENP or survivin deficiency causes 
Aurora B mislocalisation and cellular defects indistinguish-
able from those occasioned by Aurora B deficiency, while the 
loss of Aurora B prevents both INCENP and survivin from 
behaving normally (2,4,6,12-15). The appropriate localisation 
of INCENP and survivin also requires the cohesin subunit, 
Sccl [(16) and C.Morrison, P.Vagnarelli and W.C.Earnshaw, 
unpublished data], implying that the activities of the chromo-
some passengers are closely linked to the other key processes 
occurring during mitosis. 
Histone H3 is serine-phosphorylated by Aurora B 
(2,3,6,14,17), as are CENP-A (18) and myosin 11 regulatory 
tight chain (19), although the effects of these modifications are 
not yet clear. The in vitro activity of the caenorhabditis 
elegans Aurora B kinase, AIR-2, is enhanced by the presence 
of ICP-1, the Celegans INCENP, which is a target for serine 
phosphorylation by the kinase (20). The budding yeast 
homologue of Aurora B, Ipi-1p, which is necessary for 
symmetric chromosome segregation, phosphorylates the 
kinetochore component NdclQp (21,22), and a recent model 
for lpl-1 p  function has suggested that an unknown kinetochore 
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Ipi-Ip target may be the mediator of Ipi-ip control of the 
attachments between the spindle pole bodies and the kineto-
chores that result in bipolar kinetochore attachment (23). 
Clearly, the identification of further substrates of Aurora B 
kinase is an important issue in defining the mechanism by 
which the passengers control mitotic events. 
Recent advances in the ability to identify peptides present in 
mixed protein samples using mass spectrometry have provided 
an invaluable tool for the analysis of cellular subfractions 
(24-26). One such fraction is the metaphase chromosome, 
which can be prepared from mitotically-blocked tissue culture 
cells (27). The chromosome scaffold fraction comprises the 
residual insoluble, non-histone proteins that remain after 
extraction of nuclease-digested, isolated metaphase chromo-
somes by high salt, low ionic strength or chaotropic buffers 
(27). Proteins that have been identified in this fraction include 
CENP-E, DNA topoisomerase II and the condensin subunit, 
ScIl (28-31) and kinetochores are also components of the 
scaffold (32). Candidate Aurora B substrates might be 
anticipated in metaphase chromosomes, or in the chromosome 
scaffold fraction. Here we describe experiments in which we 
characterise the components of partially-extracted metaphase 
chromosomes using mass spectrometry in order to identify 
potential Aurora B substrates. 
MATERIALS AND METHODS 
Cloning, protein overexpression and purification and 
antibody preparation 
An EST containing a cDNA for human Aurora B was obtained 
from the UK HGMP Resource Centre (Babrahain, UK) and 
subcloned into pGEX4T (Amersham Biosciences UK, Little 
Chalfont, UK). For site-directed niutagenesis of the pGEX4T-
Aurora B construct, the QuikChange kit (Stratagene, La Jolla, 
CA) was used, following the manufacturer's instructions, with 
the primer 5'-CAT TTC ATC GTG GCG CTC CGA GTC CTC 
TI'C AAG TCC-3'. Bacterial overexpression and chromato-
graphy over glutathione-sepharose was performed as pre-
viously described (2). For polyclonal antibody generation, 
rabbits were immunised with gel-purified GST-Aurora B: this 
yielded anti-Aurora B antiserum R902. Human topoisomerase 
II alpha (topo ha) was expressed and purified from 
Saccharo,nyces cerevisiae as described previously (33,34). 
Total RNA was extracted from HeLa S3 cells using Trizol 
(Invitrogen, Carlsbad, CA) and reverse transcription using 
oligo(dT) primers performed using the Superscript system 
(Invitrogen). Amplification of the CRFG sequence was 
performed with LA-Taq (Takara Bio, Shiga. Japan) and the 
product cloned into pEGFP-N I and pEGFP-Cl (BD Clontech 
UK, Cowley, UK) using the Xliv! and Hindul sites contained 
in the primers 5'-AT CGA GAA ATG GCA CAT TAC AAC 
1TC AAG-3' and 5'-AAA GT TFC TCC TOT CCF iTT 
TAC CAG C-3', respectively. 
Cell culture, transfection and microscopy 
HeLa JW cells were grown in RPM! 1640 medium 
(Invitrogen) supplemented with 10% foetal bovine serum 
(FBS) and antibiotics, while HeLa S3 cells were grown in the 
same medium supplemented with only 5% FBS and anti-
biotics. HeLa S3 cells were treated with colcemid (0.1 .tg/m1) 
for 2 h before harvest and were then hyptotonically swollen in 
75 mM KCI for 10 rain before being dropped on to polylysine 
coated slides. Transfection of HeLa JW cells was performed 
using Fugene 6 reagent (Roche, Basel, Switzerland). For 
microscopy, cells were fixed with 4% paraformaldehyde and 
permeabilised with 0.15% Triton in cytoskeleton buffer 
(137 mM NaCl, 5 mM KCI, 1.1 mM Na,HPO4, 0.4 mM 
KH 2PO4 . 2 MM  MgCl 2. 2 mM EGTA, 5 mM PIPES, 5.5 mM 
glucose). Monoclonal anti-a-tubulin B512 was from Sigma 
(St Louis, MO) and was used in immunofluorescence appli-
cations at 1:2000 dilution. The monoclonal AIM-I, which 
recognises Aurora B, was used at 1:200 dilution and was 
obtained from BD Transduction Laboratories (Lexington, 
KY). Rabbit polyclonal anti-topoisornerase 11 (29) was used at 
1:50. Fluorescently labelled secondary antibodies were from 
Jackson lmmunoresearch Laboratories (West Grove, PA) and 
were used at 1:200 dilution. Micrographs consist of single 
plane projections of deconvolved, three-dimensional data sets 
taken with a DeltaVision microscope (Applied Precision, 
Issaquah, WA) or of images captured with a CCD camera 
(Princeton Instruments, Trenton, NJ) from an Axioplan 2 
microscope (Zeiss, Jena, Germany). 
Chromosome preparation and immunoblotting 
Chromosomes were prepared by sequential sucrose and 
Percoll gradients from colcemid-treated HeLa S3 cells 
according to Lewis and Laemmli (27). Unless otherwise 
stated, chromosomes were resuspended in 5 mM Tris—CI 
pH 7,4, 2 mM KCI, 375 tM spermidine (Sigma, St Louis 
MO), 0.01% Animonyx Lo, 1 MM  CaCl 2 plus protease 
inhibitors (aprotinin, PMSF and chymostatin, leupeptin, 
antipain and pepstatin) and digested for 1 h at 4°C with 
30 .tg/mI micrococcal nuclease (Sigma). For partial extraction 
(27,35,36), chromosome suspensions were diluted 1:1 with 
2X dextran sulphate/heparin lysis buffer [20 mM Tris—CI 
pH 8.8, 20 mM Na-EDTA, 0.2% Ammonyx Lo, 0.4 mg/ml 
dextran sulphate (Amersham), 0.04 mg/ml heparin (Sigma)], 
incubated for 5 min on ice and spun for 10 min at 10 000 g. 
More extensive extractions were performed as previously 
described (27,36). Pellets were resuspended in SDS-
polyacrylamide gel electrophoresis (SDS—PAGE) sample 
loading buffer and chromosome protein samples were 
resolved on SDS—PAGE gels and transferred to nitrocellulose 
membranes by standard means. Membrane strips were incu-
bated with antibodies to Sc!! (37) at 1:2500, human anti-
centromere antiserum OS (38) at 1:2500, anti-CENP-C (39) at 
1:2500, anti-INCENP ra2 (40) at 1:1000 and anti-Aurora B 
(R902), prepared as described above, at 1:500. Antibody 
binding was visualised by incubation with 125 1-Protein A 
(Amersham). Immunblotting with the monoclonal MPM-2 
(Upstate Biotechnology, Lake Placid, NY) was performed at 
1:1000 dilution and signal was visualised by enhanced 
chemiluniinesence (Amersham). 
Kinase assays 
Chromosomes were resuspended in kinase buffer 1 (10 mM 
1-LEPES pH 7.5, 100 mM KCI), kinase buffer 2 (10 mM 
HEPES pH 7.5, 20 mM KC1), kinase buffer 3 (50 raM Tris—Ci 
pH 7.5, 100 mM KCI) or kinase buffer 4 (50 mM Tris—CI 
pH 7.5, 20 mM KC1), containing 10 MM  MgCl2 and 1 mM 
CaCl2 , plus a protease inhibitor cocktail. Following 
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inicrococcal nuclease digestion as described above, heat 
treatment, if indicated, consisted of 10 min incubation at 
65°C followed by at least 5 min incubation on ice. Topo Ha 
was heat-treated prior to its being incubated with or without 
Aurora B kinase in kinase buffer. Kinase assays were carried 
out in the presence of I mM ATP, 1 mM dithiothreitol, 20 mM 
EGTA and 2.5-5 iCi [y- 32P]ATP per 100 pil, along with fresh 
protease inhibitors, at 37°C for 20 mm, at which point 
reactions were extracted as described above and prepared for 
SDS—PAGE. 
Matrix-assisted laser desorption/ionization time-of-flight 
mass spectrometry (MALDI-TOF MS) 
Protein identification was accomplished by peptide mass 
fingerprinting and sequence database searching (41). Proteins 
were separated by SDS—PAGE and relevant protein bands 
were cut from the gel by using a scalpel. In-gel digestion of 
protein by trypsin was performed as previously described (42), 
followed by sample preparation using miniaturised sample 
concentration/desalting techniques (43). Two separate mass 
spectrometry research laboratories were involved in these 
experiments. However, several proteins were identified in both 
sets of experiments, thereby confirming both protocols. For 
one preparation of proteins, the mass spectrometry system was 
Reflex IV (Bruker-Daltonics, Bremen, Germany), for another 
we used a PerSeptive Biosystems Voyager DEIMSTR 
MALDI-TOF mass spectrometer (Applied Biosystems, 
Foster City, CA). Peptide ion signals were assigned with a 
mass error <50 p.p.m. Lists of tryptic peptide masses were 
used to search protein sequence databases using the ProFound 
internet-based protein identification tool (44) available at 
http://prowl.rockefeller.edu/cgi-bin/ProFound  or the MS-Fit 
tool (http://prospector.ucsf.edu/ucsfhtml4.0/msfit.htm) . For 
positive identification, a MOWSE (45) score of 10 and at 
least 20% coverage of the protein by the peptide fragments 
was required for small' proteins (<100 kDa), but 5-10% 
coverage was allowed for high molecular weight proteins 
(>100 kDa). Where indicated, we used an 'Exp value', 
which is a probability based expectation value which in all 
cases provided a significant score for a positive protein 
identification. 
RESULTS 
A metaphase chromosome fraction can be prepared from 
colcem id- treated tissue culture cells by Dounce homogenisa-
tion and sequential density gradients (27). The metaphase 
chromosome scaffold generated by stringent extraction of 
histones from this fraction includes the kinetochore and 
contains several prominent protein bands upon SDS—PAGE 
resolution, notably topoisomerase H and Sc!! (27,29,32, 
35,36). A less stringent procedure was followed here, to 
retain more chromosome-associated material in the search for 
candidate Aurora B substrates. To confirm that the resultant 
fraction, shown in Figure IA and B. indeed contained the 
chromosome scaffold proteins, we performed immunoblot 
analysis with antibodies specific for various proteins expected 
to be in the scaffold. As shown in Figure IC, this partially-
extracted scaffold contained CENP-A, CENP-B, CENP-C, 
INCENP, Aurora B and Sell. The monoclonal antibody 
MPM-2, which recognises a mitotic phosphoepitope, also 
detected a number of bands. To confirm the reproducibility of 
this extraction protocol. 11 separate chromosome preparations 
were run on the same one-dimensional gel. Visual inspection 
of the band patterns of these different preparations revealed 
them to have essentially the same composition (data not 
shown). To examine how this extraction procedure compared 
with the more stringent protocols previously published, we 
performed gel electrophoresis on equivalent amounts of 
chromosomal protein extracted by differing methods. As 
shown in Figure ID, there exist clear differences between the 
protein scaffold fractions prepared by the different extraction 
methods, but further analysis will be necessary to determine to 
what extent the content of minor, possibly unknown, 
components of the scaffolds is increased under the different 
conditions. 
To define the components of this chromosome subfraction. 
we subjected the preparations to one-dimensional SDS-
PAGE (Fig. IA and B) and excised individual bands from 
Coomassie-stained gels. MALDI-TOF analysis of the peptide 
composition of these bands was performed and proteins in the 
fraction identified by database comparison. Table I lists the 
proteins identified in this initial analysis of the extracted 
chromosome fraction and Figure 2 summarises these results 
graphically. Of the 62 proteins identified in the fraction, 29% 
are nuclear or chromosome-associated. Some 34% are 
primarily associated with membranes or the cytoskeleton, 
18% are mitochondrial, 3% centrosomal and the remainder are 
from the cytoplasm, act as chaperones or have unknown 
properties. Since the extent to which the cytoskeletal proteins 
interact with the chromosomes in forming a scaffold is not 
clear, some of the cytoskeletal proteins may actually represent 
chromosome-associated material, rather than artefactual or 
contaminant protein. We hypothesise that the mitochondria 
may be co-fractionating with the chromosomes in the Percoll 
density gradients, which would explain the relatively high 
proportion of niitochondrial proteins identified. 
To test whether the identification of proteins by this method 
can define new chromosomal proteins, we examined the 
localisation of the putative GTP-binding protein NGB/CRFG 
during mitosis. Green fluorescent protein (GFP)-tagging in 
pEGFP-Cl and transfection of the gene encoding this protein 
into HeLa JW cells revealed that it forms subnuclear 
assemblies in interphase, as has been noted previously (46), 
but that it is associated with chromosomes throughout mitosis 
(Fig. 3). Transfection with pEGFP-Nl-CRFG did not result in 
any detectable GFP signal and use of the vector alone gave rise 
to the typical diffuse staining of GFP throughout the cell cycle 
(data not shown). The perichromosomal localisation, seen 
clearly in metaphase (Fig. 3B), has been observed for a 
number of nucleolar proteins, but does not exclude a role for 
this protein in mitotic chromosomes, nuclear function or in 
cell cycle control (47,48). These findings confirm that the 
analysis of scaffolds in this manner is a useful means to 
discover new proteins associated with mitotic chromosomes. 
Since Aurora B itself was shown to be in the chromosome 
fraction, we tested whether there was a kinase activity 
associated with the preparation. A number of different buffer 
conditions were assayed and a reproducible pattern of 
phosphorylated bands was found to result upon incubation 
of the chromosomes with ['y- 32P]ATP (Fig. 4A), irrespective of 
the buffer used. This activity was lost upon heat treatment 
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Figure 1. Preparation of chromosome scaffold Fractions from cokemid-tieaced HeLa S3 cells. Proteins were separated by 12.5% (A) and 7.5% (B) 
SDS–PAGE and gels stained with Coomassie Blue. Apparent molecular masses are shown in kDa on the left. (C) Immunoblot characterisation of the 
partially-extracted chromosome scaffold friction. After SDS–PAGE. proteins were transferred to a nitrocellulose membrane and strips of the same membrane 
were hybridised with antibodies as follows, lane I. anti-INCENP; lane 2. anti -centromere antibodies (ACA); lane 3, anti-CENP-C; lane 4. anti-Aurora B; 
lane 5. anti-Sell; lane 6. MPM-2 monoclonal. Arrowheads indicate the CENP-C polypcptidc recognised by the ACA and the CENP-C-specific antibody. 
Apparent molecular masses are shown in kDa on the left. (D) Comparison of scaffold fractions resulting from extraction under different conditions. A 12.5% 
polyaerylamidc gel was silver stained after separation of proteins by electrophoresis. To control for protein loading, different cell equivalents were used as 
follows; lane I. total chromosomes from 10" cells; lane 2. partially-extracted chromosome scaffold prepared as described in this paper from 5 X 10" cells; 
lane 3. chromosome scaffolds extracted by dextran sulphate-heparin as described (36) from 12.5 X 10" cells; lane 4, chromosome scaffolds extracted by NaCl 
as described (36) from 12.5 X 101 cells. Arrowheads indicate the two abundant protein bands typically found in chromosome scaffolds. Set and Sell. 
Apparent molecular masses are shown in kDa on the left. 
(Fig. 413). At present, the identities of the endogenous kinases 
that carry out this phosphorylation are unknown. 
To identify new potential substrates of Aurora B, we next 
incubated the heat-inactivated, extracted chromosomes with 
recombinant human Aurora B kinase. As shown in Figure 413. 
incubation of the chromosomes with the recombinant enzyme 
resulted in the phosphorylation of a number of proteins, 
notably giving rise to a strong band at the approximate size of 
the histones. Distinct bands were observed that indicated 
substrates with apparent molecular masses of approximately 
16. 20, 22, 32, 39. 52, 56, 62, 76. 105 and 170 kDa (Fig. 413). 
That these were not the same as those found following the 
incubation of the chromosomes with radiolabel but without 
recombinant enzyme indicates that Aurora B is not the only 
kinase in the fraction and that the recombinant enzyme we 
prepared has a restricted specificity for its activity. Next, to 
identify candidate substrates for Aurora B. we performed one-
dimensional SDS-PAGE and excised bands that corresponded 
in size to those phosphorylated in parallel experiments 
(Fig. 413). MALDI-TOF analysis of these bands identified 
the proteins listed in Table 2. MALDI-TOF analysis of a 
negative control region, which contained no distinct bands, 
gave a complex mixture of peptides and no protein was 
identified. This list includes a number of potentially relevant 
Aurora B substrates, based on intracellular distribution. It 
should be noted that the most common investigator-derived, 
artefactual keratin contaminants are keratins 1. 2 and 10, so  
that the keratins 8 and 17 found here are likely real 
components of the HeLa preparation. Three nuclear 
proteins—the GTP-binding protein NOB. topo IIa and CAP-
C—were identified as candidate Aurora B substrates in this 
screen, with the DEAD/H box polypeptide 30 representing a 
possible fourth. It should be noted that the experiment 
performed to identify potential Aurora B substrates (using 
ProFound) was carried out at the beginning of our study. 
separately to the work used to generate the bulk of the data in 
Table I (using MS-Fit, generating MOWSE scores), so that 
the peptides identified in the screen in Table 2 are clearly not 
the only components of the bands we examined. 
Since it is known that topo ha is a phosphoprotein (49-54), 
we then tested whether it could serve as an in vitro substrate 
for Aurora B. Recombinant topo lla and recombinant Aurora 
B were co-incubated in the presence of [y- 32 P]ATP and we 
found that Aurora B did indeed phosphorylate the topo-
isomerase, as well as itself (Fig. 5). As a control for the 
specificity of this phosphorylation, we incubated topo ha with 
a recombinant kinase-inactive Aurora B in which a key active 
site residue was mutated from lysine to arginine (7). This 
protein failed to phosphorylate topo Net (Fig. 5). confirming 
that this is an activity derived only from functional Aurora B. 
It is noteworthy here that the Aurora B activity was very 
dependent on buffer choice, even though the kinase was active 
on chromosomes to essentially the same extent in either Tris-
or HEPES-containing buffers (data not shown). This may 
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Table I. Classification of proteins identified from partially-extracted metaphase chromosomes by intracellular localisation 
Apparent 	Protein 	 - 	 MOWSE 	 Calculated Coverage GenBank 	Classification 
mass (kDa) mass 	(%) 	accession no. 
>212 A kinase anchor protein 9 (PRKA9. AKAP450, AKAP350) 1.78E + 09 4536710 8 Q99996 C 
43 Actin 1.76E + 08 40220.4 51 BC012854 S 
>212 Actin cross-linking family protein 7 2.80E + 05 620365.6 9 Q9UPN3 S 
29 Adenine nucicodc translocator-2 1.94E + 04 32895.4 42 M57424 M 
>212 Ankyrin I.34E+04 206278.5 8 P16157 S 
So APC2 protein 5.80E + 04 80877.7 16 AJ012652 N 
>212 Apolipoprotein 0-100 154E + IS 515566.9 11 P04114 Y 
50 ATP synthase a subunit 2.35E + U. 8.3E -5' 59750.9 46, 31h 014710 M 
49 ATP synthase 13 subunit 1.54E + II, 4.2E - 3' 56560.2 44, 20k' BC()101 II M 
50 13 tubulin 5.24E + 04 49907.3 17 X79535 S 
66 BIP 9.25E . 	13. 0.039' 72333.3 50 17b Ai271729 S 
>212 Breast cancer type 2 susceptibility protein 5.51E + 06 384228.5 6 P51587 N 
>212 Bullous pcmphigoid antigen I 8.43E + 07 313090.5 12 Q0300l S 
>212 Cadherin 23 precursor (Otocadherin) 7.54E + 10 369527.8 9 Q91­1251 S 
SO Carnithinc paimiioyltransfcrasc 1 1.22E + 09 86239.6 30 BC000II(5 M 
<20 Cdc23 1.95E + 04 68285.9 17 ABOI 1472 N 
>212 CENP-E 3.77E + 07 312092.9 12 Q02224 N 
158 Chromosome-associated polypcptidc C 0.016' 147090 14" NP- (X)5487 N 
>212 Chromodomain hclicasc-DNA-binding protein 4 7.89E + 05 217992.4 8 Q14839 N 
>212 Ciliary dyncin 1. 14E + 07 511935.6 8 Q9NYC9 Y 
>212 Collagen a 3 (VI) chain precursor 1.44E + 04 343555.2 4 P12111 5 
90 Collin 3 4.16E + 08 88930.7 29 AF064087 N 
62 DEAD/U box polypeptide 30 2.1E - 3' 124173 14" XMJ084133 N 
>212 Dcsmoplakin 3.36E + 10 331778.6 15 P15924 S 
170 DNA topo II a 1.95E + 04, 0.014' 174386.6 10, 6h P11388 N 
170 DNA topo If 13 3.17E + 04 183298.7 7 Q02880 N 
>212 DNA-dependent protein kinase 9.94E + 17 469145.2 16 P78527 N 
>212 Dystrophin 2.33E + 08 426680.1 9 P11532 S 
82 Glutaminy1-1RNA synthetase 3.43E + 05 87799.2 21 X76013 V 
<2() Glycerol-3-phosphate dchydrogenasc 8.20E + 03 44734.8 23 U79250 M 
76 GTP-binding protein NGB/CRFG 0.020' 73786 12" AF120334 N 
66 Heat shock protein. 71 kDa 227E + 09 70898.4 40 Y00371 H 
62 Hypothetical protein FL110709 0.026' 66177 IS" NP_060658 U 
ISO Isolcucyl-IRNA syntheta.cc 1.58E + 07 144959.9 12 P41252 Y 
>212 Kcndrin 7.66E + 10 376355 12 095613 C 
90 Keratin I 8.93E + 09 66018.0 35 M98776 S 
52 Keratin 8 4.8E - 3' 53671 25" NP 002264 S 
50 Keratin 17 93E - 3' 48076 34" NP-MX 13 S 
46 KJAA 1692 protein ISlE + 04 97050.6 20 ABO5 1479 U 
95 Ksam/FGFR2 1. 15E + 07 92832.7 23 AB030()75 S 
66 Lamin A/C 4.08E + 08 65135.1 21 BC0005II N 
95 MADI 8.16E + 07 83067.3 40 BC(X)9964 N 
33 Mitochondrial carrier homologue 2 1.29E + 04 33331.1 37 BC000875 M 
82 Mitolilin, inner membrane protein mitochondrion 2.24E + 10 83668.3 35 D21092 M 
>212 Monocytic leukemia zinc finger protein 7.14E + 05 225057.8 10 Q92794 N 
>212 Myosin 1.02E + 08 224037.7 15 P11055 S 
>212 Myosin XV 7.92E + 10 395177.8 9 Q9UKN7 S 
66 NADH dchydrogcnasc precursor. 75kDa subunit 2.41E + 08. 9.8E - 3' 79574.1 20, 20' X61 100 M 
>212 Plectinl 6.83E+ 17 531741.0 17 Q15149 V 
29 Prohihitin 1.87E + 04 29804.2 34 S85655 M 
>212 Protein-tyrosinc phosphaxa.sc delta precursor 8.33E + 06 214761.7 13 P23468 N 
>212 Ryanodine receptor 2 9.68E + 09 564503.5 S Q92736 N 
>212 Sacsin 1.80E + 07 436980.0 6 Q9NZJ4 H 
>212 Speclrin a chain, fodrin 6.61E + 15 284284.3 20 Q13813 S 
>212 Specti-in 3  chain 1.64E + 05 288987.7 7 Q91­1254 S 
>212 Talin 4.99E + 07 269720.3 9 Q9Y490 S 
62 T0133 AAA ATPasc 3.96E + 09 66218.6 38 AK001571 M 
40 Tubutin, 13 7.23E + 05 50433.0 25 BC000748 S 
95 Un-named protein product 7.56E + 06 697516 19 AK023035 U 
>212 Utrophin 5.07E + 08 394497.6 II P46936 S 
33 VDAC (porinl) 6.52E + 06 30722.7 50 AJ250032 M 
>212 Zinc finger protein HRX 1.56E + 06 431895.2 6 t03164 N 
Each protein identified was given only a single classification. Abbreviated classifications were: C. centrosomal; H. chaperone: M. mitochondrial: N, nuclear! 
chromosomal; S. cytoskeletal/membrane component; U. unknown: Y, cytoplasmic. Apparent masses were derived from the preparative gels from which 
MALDI-TOF identification was performed. Degradation and/or protcotytic cleavage is assumed to account for sizes significantly smaller than the published 
molecular weight. MOWSE scores were derived using the MS-Fit tool and 'Eap values" using the ProFound programme. 
"Eap values' obtained with ProFound analysis. 
'Coverage in the experiments generating the Exp value. 
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reflect the likely presence of co-factors necessary for optimal 
activity of the enzyme, e.g. INCENP. in the chromosome 
preparation, which are not available to the reaction with 
recombinant protein. Attempts to localise phosphorylation 
sites using Fe(III)-IMAC and electrospray tandem mass 
spectrometry (55) revealed one endogenously phosphorylated 
residue in the recombinant topoisomerase II. No Aurora B 
phosphorylation sites in topo ha were identified, due perhaps 
to the low efficiency of the phosphorylation activity and to the 
large size and complexity of the topoisomerase molecule (i.e.. 
there are approximately 200 serines and threonines in the 
peptide sequence). Since there is, as yet. no clear consensus 
site for the Aurora B kinase, it has been difficult to further 
explore this observation. 
In order for the in vitro data to have any significance in vii i. 
topoisomerase II and Aurora B must be able to interact during 
mitosis. Both are known to he nuclear proteins during mitosis 
and to examine the relationship between them we performed 
immunofluorescence localisation experiments. As shown in 
Figure 6, topo ha is located along the axis of the chromo-
somes, while Aurora B is centromeric, as expected. These 
findings show that at least a subfraction of the topo llu 
population is available for phosphorylation by Aurora B and. 
given recent evidence for the mobility of the topoisomerase 
(56,57), suggests that Aurora B may be able to phosphorylate a 
significant amount of this substrate during mitosis. 
DISCUSSION 
Here we present the first mass spectrometry-driven proteome 
analysis of metaphase chromosomes prepared from HeLa S3 
cells. The preparative method used has been previously used 
successfully in the identification of CENP-E. DNA topo-
isomerase II and condensin (28-31). all of which are found in 
the preparation we describe here. Despite the levels of 
cytoskeletal and mitochondrial material, the useful percentage 
of chromosome-associated material found in this preparation 
makes it an attractive source for further analysis. It is 
important to note that the relative amount of any given protein 
Figure 3. Losalisation ol NGB/CRlG a' a chiu.iiial protein in mitosis. 
(A) 10 HeLa JW cells were transiently translctcd with 2 tg pEGFP-Cl- 
CRFG. Cells were fixed 24 h after transfcction as described, and were 
immunostained for a-tuhulin and stained with DAPI. Cells in interphase 
and in different stages of mitosis are shown. Black-and-white images show 
G'P-CRFG staining, which is shown in green in the merged images. 
Tubulin staining is shown in red and DNA in blue. Images arc of single 
focal planes. Scale bar is 10 tam. (B) Deconvolved image of a transfected 
cell in metaphase to show the perichromosomal localisation of the GFP- 
CRFG signal more clearly. Separate channels are shown as indicated and 
the merged image uses the same colour scheme as in (A). 
in the preparation cannot be assessed by the techniques we 
used here, as the various peptides from tryptic digests may 
behave differently during mass spectrometry—indeed. the 
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Figure 4. A> Assay for kinase activity in chromosome scaffold tiacti.)ti. 
Lanes 1-4 show autoradiographic image of an SDS-polyacrylamtdc gel 
used to separate proteins after chromosomes in kinase buffers 1-4. respect-
ively, were incubated with ly- °PIdATP and then extracted. Apparent 
molecular masses are shown in kDa on the left. (B) Assay for Aurora B 
kinase substrates in chromosome scaffold fraction. Chromosomes were 
heat-treated and then incubated in the presence of ly--PldATP  without 
(lanes 1 and 3) or with (lanes 2 and 4) recombinant Aurora B and extracted 
before being subjected to SDS-PAGE. Lanes I and 2 show an autoradio-
graphic image of a 12.5% gel and lanes 3 and 4 show the same gel stained 
with Coomassic Blue. Arrowheads indicate phosphorylated proteins and 
apparent molecular masses are shown in kDa on the left. 
relatively low scores obtained for the known scaffold 
component, topoisomerase II, emphasise this point. We 
attribute the absence of many of the proteins known to be in 
the scaffold (e.g. the CENP proteins) from the MALDI-TOF 
profile to their relatively low abundance and to the possibility 
of their being poor subjects for mass spectrometric analysis. 
Our observations suggest that the further use of mass 
spectrometry against a more stringently-extracted scaffold 
fraction might reveal novel components of the chromosome 
scaffold that have not been identified by antibodies. 
The further characterisation of the unknown and/or poorly-
characterised proteins identified in the current screen will 
require their localisation. This was done for the putative GTP -
binding protein NGB/CRFG by fluorescently tagging it and 
Figure 5.5. Conhrmaiton Ri p. 	Jo a 	II Aui I a B uhstrate in vitro. 
showing an autoradiograph of an SDS-polyaciylamidc gel on which recom-
binant, heat-treated topo ha was resolved following incubation with wild-
tpc (1ST-Aurora 13 (lanes 1-4) or GST-Aurora B KI06R (lanes 5-8) in 
kinasc buffer I (lanes I and 5), kinase buffer 2 (lanes 2 and 6), kinase 
hufti.r 3 (lanes 3 and 7) or kina.se buffer 4 (lanes 4 and 8). Apparent 
molecular masses are shown in kDa on the left. 
Os erexpressing it in tissue culture cells. The perichromosomal 
localisation, seen clearly in metaphase, does not clearly define 
the likely role of this protein (58-62). It may reflect a 
tiucleolar function for the protein (47). as might be expected 
from its apparent localisation in interphase (46). However, it 
may also indicate some role in cell cycle control—a similar 
mitotic localisation has also been observed for the BCR 
oncogene product (47,48), which interacts with and activates 
GTP-binding proteins. The chromosomal localisation of NGB/ 
CRFG we describe here may. therefore, be in some way 
related to its putative role in renal disease (46), but very little 
is known about this protein to date. 
In the search for new Aurora B substrates, the most likely 
candidates are those known to have an association with 
chromosomes or the spindle, such as CAP-C/SMC-4 and topo 
ha. Investigation of the Xenopus condensin complex showed 
no mitotic phosphorylation of CAP-C (63). Therefore, topo 
ha, which has been well described as a phosphoprotein 
(49-54), was tested as an Aurora B substrate. Recombinant 
Aurora B indeed phosphorylated recombinant topo ha in vitro. 
The functions of DNA topo hIa during mitosis have long been 
of interest and its phosphorylation, which varies throughout 
the cell cycle and is regulated by a number of kinases, appears 
to be of great importance in modulating its activities (64.65). 
While the localisation of topo ha during mitosis is somewhat 
controversial (53.56.66-68). its locations are consistent with 
its being a potential Aurora B substrate. The localisation of 
topo ha at the centromere (69) further enhances the likelihood 
of the Aurora B interaction being significant. but our inability 
to specify the target residue(s) by mass spectrometry has 
Table 2. Candidate Aurora B substrates identified by MALDI-TOF MS from partially-extracted metaphase 
chromosomes 
Apparent 	Proteins identified 
mass (kDa) 
52 	 Keratin 17 
56 ATP synthase. H transporting. mitochondnal H complex u subunit: ATP synthase, 
3 subunit; keratin 8 
62 	 DEAD/H box polypcptidc 30; hypothetical protein FU 10709 
76 GTP-binding protein NGB; NADH.ubiquinone oxidoreductase 75 kDa subunit precursor. 
BiP protein 
170 	 Topo Ha; chromosome-associated polypcptide C (CAP-C/SMC4) 
Note that additional data are provided for each of these identifications in Table I; the ProFound analysis 
refers to these proteins. 
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hampered our efforts to define this significance. To date, no 
consensus Aurora B phosphorylation signal has been descri-
bed, so we cannot speculate on the potential target residues on 
topo ha. While there remain further candidate substrates to be 
identified, the complexity of the metaphase chromosome 
fraction may necessitate the use of two-dimensional electro-
phoresis to resolve phosphorylated proteins sufficiently for 
their conclusive identification. 
In conclusion, we present the proteomic analysis of 
partially-extracted metaphase chromosomes as a means by 
which novel mitotic chromosome components may be 
described and by which chromosomal kinase substrates may 
be identified. The ability to remove kinase activity endo-
genous to the preparation by heat treatment means that any 
kinase may be tested on chromosomes and the more abundant 
of its potential substrates described. 
ACKNOWLEDGEMENTS 
We thank Rhys C. Roberts for assistance with phosphopeptide 
analysis by mass spectrometry and Sally P. Wheatley for help 
with microscopy. C.M. received an EMBO Long Term 
Postdoctoral Fellowship during this study. H.D. is the 
recipient of a Wellcome Trust Prize Studentship. Support 
was received from the Danish Natural Sciences Research 
Council to the Danish Biotechnology Instrument Center 
(O.N.J.). Work in N.O.'s laboratory was supported by NIH 
grant GM 33944. Work in W.C.E. 's laboratory is supported by 
the Wellcome Trust, of which he is a Principal Research 
Fellow. 
REFERENCES 
I. Nigg,E.A. (2(X)I) Mitotic kinases as regulators of cell division and its 
checkpoints. Nature Rev. Mo!. Cell Biol.. 2. 21-32. 
2. Adams.R.R., Majato,H., Earnshaw,W.C. and Carmena.M. (2001) 
Essential roles of Drosophila inner centromere protein UNCENP) and 
aurora B in histonc H3 phosphorylation, metaphase chromosome 
alignment, kinetochore disjunction and chromosome segregation. J. Cell 
Bled., 153. 865-880. 
Giet.R. and Glover.D.M. (2001) Drosophila aurora B kinase is required 
for histonc H3 phosphorylation and condensin recruitment during 
chromosome condensation and to organize the central spindle during 
cytokinesis. J. Cell Biol., 152, 669-682. 
Kaitna.S., Mendoza.M., Jantsch-Plunger.V. and Glotzer.M. (2000) 
lncenp and an aurora-like kinase form a complex essential for 
chromosome segregation and efficient completion of cytokinesis. Curr. 
Biol.. 10, 1172-1181. 
Kallio,MJ., McClcland.M.L.. Stukcnberg.P.T. and Gorbsky.G.J. (2002) 
Inhibition of aurora B kinase blocks chromosome segregation, overrides 
the spindle checkpoint, and perturbs microtubule dynamics in mitosis. 
Curr. Biol., 12. 900-905. 
Speliotes.E.K.. Uren.A.. Vaux,D. and Horvitz,H.R. (2000) The survivin-
like C. elegans BtR-1 protein acts with the Aurora-like kinase 
AIR-2 to affect chromosomes and the spindle midzone. Mol. Cell, 6. 
211-223. 
Terada.Y.. Tatsuka.M., Suzuki.F.. Yasuda.Y.. Fujita,S. and Otsu.M. 
(1998) AIM-I: a mammalian midbody associated protein required for 
cytokinesis. EMBO J., 17, 667-676. 
Adams,R.R.. Carmcna,M. and Earnshaw,W.C. (2001) Chromosomal 
passengers and the (aurora) ABCs of mitosis. Trends Cell. Bled., 11. 
49-54. 
MacCallum.D.E., Losada.A.. Kobayashi.R. and Hirano.T. (2002) ISWI 
remodeling complexes in Xcnopus egg extracts: identification as major 
chromosomal components that are regulated by INCENP-aurora B. Mo!. 
Biol. Cell. 13, 25-39, 
Sumara.l., Vorlaufer.E., Stukenberg,P.T.. Kclm.O.. Redemann.N.. 
Nigg.E.A. and Peters.J.-M. (2002) The dissociation of cohesin from 
chromosomes in prophase is regulated by polo-like kinase. Mo!. Cell. 9. 
515-525. 
II. Eamshaw,W.C. and Bemat,R.L. (1990) Chromosomal passengers: 
towards an integrated view of mitosis. Glironwson,a, 100. 
139-146. 
Adams.R.R.. Whcailcy.S.P.. Gouldsworthy.A.M. Kandels-Lewis,S.E.. 
Carmena.M.. Smythe.C.. Gerloff.D.L. and Earnshaw.W.C. (2000) 
INCENP hinds the Aurora-related kina.se AIRK2 and is required to target 
it to chromosomes, the central spindle and cleavage furrow. Curr. Bled., 
10,1075-1078. 
Ocgema.K.. Desai.A., Rybina.S.. Kirkham.M. and Hyman.A.A. (2001) 
Functional analysis of kinctochore assembly in Caenorhabditis elegan.s. 
J. Cell Biol., 153. 1209-1226. 
Uren.A.G.. Wong.L., Pakusch.M., Fowler.KJ., Burrows.F.J.. Vaux.D.L. 
and Choo,K.H. (20(X)) Survivin and the inner centromcre protein 
INCENP show similar cell-cycle localization and gene knockout 
phenotype. Curr. Biol., tO, 319-328. 
IS. Wheatley,S.P., Carvalho,A.. Vagnarelli.P. and Eamshaw.W.C. (2001) 
tNCENP is required for proper targeting of Survivin to the centromeres 
and the anaphase spindle during mitosis. Curr. Biol.. 11. 886-890. 
5326 Nucleic Acids Research, 2002, Vol. 30, No. 23 
Sonoda.E.. Matsusaka,T.. Momson,C., Vagnarelli.P., Hoshi 3O., 
Ushiki.T., Nojima.K.. Fukagawa.T., Waizcnegger.I.C.. PetcmJ.-M. etal. 
(200 1) See I/Rad2l/Medl is required for sister chromatid cohesion and 
kinetochorc function in vertebrate cells. Dev. Cell., 1, 759-770. 
Hsu.J.-Y.. SunZ.-W.. Li.X.. Reubcn.M.. Tatehcll.K., Bishop.D.K.. 
Grusheow.J.M.. Bramc,CJ., CaldweIl,J.A., Uunt,D.F. et al. (2000) 
Mitotic phosphorylation of historic 143 is governed by lpl/ aurora kinase 
and glc7/PP I phosphatase in budding yeast and nematodes. Cell. 102, 
272-291. 
Zeitlin,S.G.. Shelby,R.D. and Sullivan,K.F. (2001) CENP-A is 
phosphorylated by Aurora B kinase and plays an unexpected role in 
completion of cytokinesis. J. Cell Bin!., 155, 1147-1157. 
Murata-Hori,M., Fumow,K., Fukuta,Y.. lwasaki.T., Kikuchi,A, 
Tatsuka.M. and Hosoya,H. (2000) Myosin II regulatory light chain as a 
novel substrate for AIM- 1. an aurora(lpl I p-related kinas.c from rat. 
J. !3iot'hem. (Tokyo). 128, 903-907. 
Bishop.J.D. and Schumacher,J.M. (2002) Phosphorylation of the 
carboxyl terminus of inner cenomere protein (INCENP) by the Aurora 
B kinase stimulates Aurora B kinase activity. I. Rio!. Cheni., 277, 
27577-27580. 
Biggins.S.. Scverin.F.F., BhaIla,N, Sassoon.l., Hyman,AA. and 
Murray.A.W. (1999) The conserved protein kinase IpIl regulates 
microtubule binding to kinctochores in budding yeast. Genes Dcv., 13. 
532-544. 
Sassoon,1., Severin.F.F.. Andrews,P.D.. Taba,M.R., Kaplan,K.B., 
Ashford,AJ.. Stark,M..L, Sorgcr.P.K. and Hyman.A.A. (1999) 
Regulation of Saccharomyces cerevisiae kinctochores by the type I 
phosphatase Glc7p. Genes Des'., 13. 545-555. 
Tanaka.T.U., Rachidi.N, Janke,C., PcreiraG.. Galova.M., Sciebel,E.. 
Stark.M.J.R. and Nasmyth.K. (2002) Evidence that the IpIl-S1i15 
(Aurora kinasc- INCENP) complex promotes chromosome bi-orientation 
by latering kinctochore-spindic pole connections. Cell. 108. 317-329. 
Andcrscn.J.S., Lyon.C.E., Fox,A.H., Lcung.A.K., Lam.Y.W., Stccn.H.. 
Mann.M. and Laniond.A.l. (2002) Directed proteomic analysis of the 
human nucleolus. Cum. Biol., 12, I-Il. 
Mann.M.. Hendrickson.R.C. and Pandcy.A. (2001) Analysis of 
proteins and proteomes by mass spectrometry. An,w. Rev. Biochern., 70, 
437-473. 
Mintz.P.J.. Pattcraon.S.D., Ncuwald,A.F.. Spahr,C.S. and Spector.D.L. 
(1999) Purification and biochemical characterization of intcrchromatin 
granule clusters. EMBO J.. 18. 4308-4320. 
Lcwis.C.D. and LaemmlLU.K. (1982) Higher order mctaphase 
chromosome structure: evidence for metal loprotein interactions. Cell, 29, 
171-181. 
Compton.D.A.. Yen.TJ. and Cleveland,D.W. (1991) Identification of 
novel centromere/kinetochorc-associated proteins using monoclonal 
antibodies generated against human mitotic chromosome scaffolds. 
J. Cell Rio!., 112. 1083-1097. 
Earnshaw,W.C., Halligan.B., Cookc.C.A.. HeckM.M. and Liu,L.F. 
(1985) Topoisomerasc Il is a structural component of mitotic 
chromosome scaffolds. I. Cell Bin!.. 100, 1706-1715. 
Fields,A.P. and Shaper.J.H. (1988) A major 62-kD intranuclear matrix 
polypeptidc is a component of metaphasc chromosomes. J. Cell Biol., 
107.833-840. 
Ycn,TJ., Compton.D.A., Wisc,D., ZinkowskiR.P. Brinklcy.B.R.. 
Earnshaw,W.C. and Cleveland,D.W. (1991) CENP-E. a novel human 
centromere-associated protein required for progression from metaphase 
to anaphase. EMBO J., 10. 1245-1254. 
Earnshaw.W.C.. Halligan.N.. Cooke,C. and Rothfield,N. (1984) The 
kinetochore is part of the metaphase chromosome scaffold. J. Cell Biol., 
98. 352-357. 
Kingusa.P.S.. Greider,C.A. and Oshcroff.N. (1997) Spontaneous DNA 
lesions poison human topoisomcrase Ilalpha and stimulate cleavage 
proximal to leukemic I 1q23 chromosomal breakpoints. Biochemistry, 36, 
5934-5939. 
Wa.sscrrnan.R.A., Austin.C.A.. Fisher.L.M. and Wang,J.C. (1993) Use of 
yeast in the study of anticancer drugs targeting DNA topoisomerases: 
expression of a functional recombinant human DNA topoisomerase II 
alpha in yeast. Cancer Re,',.. 53, 3591-3596. 
Adolph.K.W.. Chcng.S.M. and Lacmmli,U.K. (1977) Role of nonhistone 
proteins in metaphase chromosome structure. Cell. 12. 805-816. 
Earnshaw.W.C. and Laemmli.U.K, (1983) Architecture of metaphase 
chromosomes and chromosome scaffolds. J. Cell Biol., 96, 84-93. 
Saitoh.N.. Goldberg.l.G.. WOOd.E.R. and Eamshaw,W.C. (1994) Sell: an 
abundant chromosome scaffold protein is a member of a family of 
putative AlPascs with an unusual predicted tertiary structure. I. Cell 
Bin!., 127, 303-3 18. 
Earnshaw.W.C. and Rothfield,N. (1985) Identification of a family of 
human centmmerc proteins using autoimmunc sera from patients with 
scleroderma. Chmmosomn, 91, 31.3-321. 
Tomkicl,J.E., Cooke,C.A.. Saitoh,H., Bernat,R.L. and Earnshaw,W.C. 
(1994) CENP-C is required for maintaining proper kinetoehore 
size and for a timely transition to anaphase. J. Cell Biol.. 125. 
531-545. 
Mackay,A.M.. Eckley,D.M.. Chuc.C. and Eamshaw.W.C. (1993) 
Molecular analysis of the INCENPs (inner centromerc proteins): separate 
domains are required for association with microtubules during intcrphase 
and with the central spindle during anaphase. J. Cell Bin!., 123, 
373-385. 
Jcnsen.O.N.. Larscn,M.R. and Roepstorff.P. (1998) Mass spectrometric 
identification and nsicrocharacterization of proteins from elcctmphoretic 
gels: strategies and applications. Proteins Srruci. Fuiw. Genes.. Suppl 2, 
74-89. 
Shcvchcnko.A., Wilm,M.. Vorm,O. and Mann,M. (1996) Mass 
spectrometric sequencing of proteins silver-stained polyacrylamide gels. 
Anal. ('hem., 68. 850-858. 
Gobom,J., Nordhoff.E., Mirgorodskaya.E., Ekman,R. and Roepstorff,P. 
(1999) Sample purification and preparation technique based on nano-
scale reversed-phase columns for the sensitive analysis of complex 
peptide mixtures by matrix-assisted laser desnrptionIionization mass 
spectrometry. J. Mass Speetrom., 34. 105-116. 
Zhang.W. and Chait.B.T. (2000) ProFound: an expert system for protein 
identification using mass spectrometric peptide mapping information. 
Anal. ('hen,., 72, 2482-2489. 
Pappin,Di.C.. Flojrup,P. and Blcasby,AJ. (1993) Rapid identification of 
proteins by peptidc-mass fingerprinting. Curr. Blot., 3, 327-332, 
Laping.N.i.. Olsoni3.A. and Zhu.V. (2001) Identification of a novel 
guanosine triphosphatc-binding protein differentially expressed in renal 
disease. J. Am. Soc. Nephrol., 12. 883-890. 
Hemundcz-Verdun.D, and Gauticr,T. (1994) The chromosome periphery 
during mitosis. Bioe.ssavs, 16, 179-185. 
Wetzler,M., Talpaz.M., Yce,G., Sta.ss.S.A., Van Ettcn.R.A., Andreeff,M.. 
Goodacre,A.M.. Klcine.H.D.. Mahadevia.R.K. and Kurzrock.R. (1995) 
Cell cycle-related shifts in subeellular localization of 8CR: association 
with mitotic chromosomes and with heterochromatin. Proc. Nat! Acad. 
ScL USA, 92. 3488-3492. 
Escargucil.A.E., Plisov,S.Y.. Filhol.O.. Coehet,C. and Larsen,A.K. 
(20(X)) Mitotic phosphorylation of DNA topoisomerasc 11cr by protein 
kinase CK2 creates the MPM-2 phosphoepitope on Ser- 1469. J. Rio!. 
('hem.. 275. 34710-34718. 
Hcck,M.M., Hittelman.W.N. and Earnshaw.W.C. (1989) In vivo 
phosphoryl at ion of the 170-kDa form of eukaryotic DNA topoisomerase 
II. Cell cycle analysis. J. Biol. ('hem.. 264, 15161-15164. 
SI. lshida,R., lwai.M.. Marsh,K.L., Austin,C.A.. Yano,T.. Shihata.M., 
Nozaki,N. and Hara,A. (1996) Thrconinc 1342 in human topoisomerasc 
Ilalpha is phosphorylated throughout the cell cycle. J. Dial. Chem., 271, 
31)1)77-30082. 
Kimura.K., Nozaki.N.. Enomoto.T., Tanaka.M. and Kikuchi,A. (1996) 
Analysis of M phase-specific phosphorylation of DNA Lopoisomerase U. 
J. Rio!. Chem.. 271. 21439-21445. 
Taagepera,S., Rao,P.N.. Drake.F.H. and (]orbsky.G.i. (1993) DNA 
topoisomerasc Ilca is the major chromosome protein recognized by the 
mitotic phosphoprotcin antibody MPM-2. Proc. Nat! AcacL Sci. USA, 90, 
8407-841l. 
Wells.NJ.. Fry.A.M.. Guano,E. No,-bury,C. and Hickson.I.D. (1995) 
Cell cycle phase-specific phosphorylation of human topoisomera.sc 11 
alpha. Evidence of a role for protein kinase C. J. Bin!. ('hem. 270. 
28357-28363. 
Stcnsballc.A. and Jcnsen,O.N. (2001) Simplified sample preparation 
method for protein identification by matrix-assisted laser desorption/ 
ionization mass spectrometry: in-gel digestion on the probe surface. 
Protessmk's. 1. 955-966. 
Christenscn.M.O., Larsen.M.K.. Barthclmes.H.U.. Hock.R., 
Andersen.C.L., Kjeldsen.E.. Knudscn.B.R.. Westergaard.O., Boegc.F. 
and Miclkc,C. (2002) Dynamics of human DNA topoisomcrases 11cr and 
113 in living cells. J. Cell Biol., 157. 31-44. 
Nucleic Acids Research, 2002, Vol. 30, No. 23 5327 
Tavormina.P.A.. Come.M.CL, Hudson.J.R.. Mo,Y.Y.. Beck.W.T. and 
Gorbsky.GJ. (2002) Rapid exchange of mammalian topoisomcra.se II 
alpha at kinctochores and chromosome arms in mitosis.  J. Cell Biol.. 158. 
23-29. 
Chaly.N.. Bladon,T., Settcrlield.G., LitticJ.E.. Kaplan.J.G. and 
Brown,D.L. (1984) Changes in distribution of nuclear matrix antigens 
during the mitotic cell cycle. J. Cell Biol. 99. 661-671. 
Dilworth.S.M. (1991) A pcnchromosomal region contains proteins 
phosphorylated during mitosis in Xenopus laevis cells. J. Cell Sc'i.. 98. 
309-315. 
McKcon,F.D.. Tuffandlli.Di.. Kobayashi.S. and Kirschncr.M.W.(1984) 
The redistribution of a conserved nuclear envelope protein during the 
cell cycle suggests a pathway for chromosome condensation. Cell, 36. 
83-92. 
Wataya-Kaneda.M., Kaneda.Y.. Sakurai.T.. Sugawa.H. and Uchida.T. 
(1987) A monoclonal antibody against the nucleus reveals the presence 
of a common protein in the nuclear envelope, the pcnchromosomal 
region, and cytoplasmic vesicles. J. Cell Biol., 104, 1-7. 
Yasuda,Y. and MauI.G.G. (1990) A nuelcolar auto-antigen is part 
of the major chromosomal surface component. Ch,vmosonia. 99. 
152-160. 
Kimura.K.. Hirano.M.. Kobayashi.R. and Hirano.T. (1998) 
Phosphorylation and activation of 13S condensin by Cde2 in vitro. 
Science. 282, 487-490. 
Wangj.C. (1996) DNA topoisomerases. Annu. Rev. Iiiochem.. 65. 
635-692. 
Warburton,P.E. and Earnshaw.W.C. (1997) Untangling the role of DNA 
topoisomerasc 11 in mitotic chromosome structure and function. 
Bioessay.s. 19, 97-99. 
Earnshaw.W.C. and Heck.M.M.S. (1985) Localization of topoisomase 
11 in mitotic chromosomes. iCe!! Biol.. 100. 1716-1725. 
Sumner.A.T. (1996) The distribution of topoisomerase II on mammalian 
chromosomes. Chromosome Res., 4, 5-14. 
SwedlowJ.R.. Sedat.J.W. and Agard.D.A. (1993) Multiple chromosomal 
populations of topoisomcrasc II detected in vivo by time-lapse, three 
dimensional wide-field microscopy. Cell. 73, 97-108. 
Rattnerj.B.. Hendzcl.M.J.. Furbee,C.S.. MuIIer,M.T. and 
Bazen-Joncs,D.P. (1996) Topoisomerase 11 alpha is associated with the 
mammalian centromere in a cell cycle- and species-specific manner and 
is required for proper ccmromerc/kinctochorc structure. J. Cell Biol., 
134. 1097-1107. 
